Properties and Units in the Clinical Laboratory Sciences Part X

Home , Androstanolone, Cerebroside, Homocitrulline, Hydroxylysine, Metanephrine, Pregnanediol

Pure Appl. Chem., Vol. 72, No. 5, pp. 747–972, 2000. © 2000 IUPAC INTERNATIONAL FEDERATION OF CLINICAL CHEMISTRY AND LABORATORY MEDICINE SCIENTIFIC DIVISION COMMITTEE ON NOMENCLATURE, PROPERTIES AND UNITS (C-NPU)# and INTERNATIONAL UNION OF PURE AND APPLIED CHEMISTRY CHEMISTRY AND HUMAN HEALTH DIVISION CLINICAL CHEMISTRY SECTION COMMISSION ON NOMENCLATURE, PROPERTIES AND UNITS (C-NPU)§

PROPERTIES AND UNITS IN THE CLINICAL LABORATORY SCIENCES PART X. PROPERTIES AND UNITS IN GENERAL CLINICAL CHEMISTRY

(Technical Report) (IFCC–IUPAC 1999)

Prepared for publication by HENRIK OLESEN1, INGE IBSEN1, IVAN BRUUNSHUUS1, DESMOND KENNY2, RENÉ DYBKÆR3, XAVIER FUENTES-ARDERIU4, GILBERT HILL5, PEDRO SOARES DE ARAUJO6, AND CLEM McDONALD7

1Office of Laboratory Informatics, Copenhagen University Hospital (Rigshospitalet), Copenhagen, Denmark; 2Dept. of Clinical Biochemistry, Our Lady’s Hospital for Sick Children, Dublin, Ireland; 3Dept. of Standardisation in Laboratory Medicine, Kommunehospitalet, Copenhagen, Denmark; 4Dept. of Clinical Biochemistry, Ciutat Sanitària i Universitària de Bellvitge, Barcelona, Spain; 5Dept. of Clinical Chemistry, Hospital for Sick Children, Toronto, Canada; 6Dept. of Biochemistry, IQUSP, São Paolo, Brazil; 7Regenstrief Inst. for Health Care, Indiana University School of Medicine, Indianapolis, Indiana, USA

#§The combined Memberships of the Committee and the Commission (C-NPU) during the preparation of this report (1994 to 1996) were as follows:

Chairman: H. Olesen (Denmark, 1989–1995); D. Kenny (Ireland, 1996). Members: X. Fuentes-Arderiu (Spain, 1991–1997); J. G. Hill (Canada; 1987–1997); D. Kenny (Ireland, 1994–1997); H. Olesen (Denmark, 1985–1995); P. L. Storring (UK, 1989–1995); P. Soares de Araujo (Brazil, 1994–1997); R. Dybkær (Denmark, 1996–1997); C. McDonald (USA, 1996–1997).

Please forward comments to: H. Olesen, Office of Laboratory Informatics 76-6-1, Copenhagen University Hospital (Rigshospitalet), 9 Blegdamsvej, DK-2100 Copenhagen, Denmark. E-mail: [email protected]

Republication or reproduction of this report or its storage and/or dissemination by electronic means is permitted without the need for formal IUPAC permission on condition that an acknowledgment, with full reference to the source, along with use of the copyright symbol ©, the name IUPAC, and the year of publication, are prominently visible. Publication of a translation into another language is subject to the additional condition of prior approval from the relevant IUPAC National Adhering Organization. 747 748 H. OLESEN et al.

Properties and units in the clinical laboratory sciences. Part X. Properties and units in general clinical chemistry (Technical Report)

Abstract: A coding scheme has been prepared for general clinical chemistry.

PREFACE The present document is part ten (X) of a series on properties and units in the clinical laboratory sciences initiated in 1987. The series will comprise:

I. Syntax and semantic rules [1] II. Kinds-of-property [2] III. Elements (of properties) and their code values [3] IV. Properties and their code values [4] V. Properties and units in thrombosis and haemostasis [5] VI. Properties and units in IOC-prohibited drugs [6] VII. Properties and units in inborn errors of metabolism VIII. Properties and units in clinical microbiology [7] IX. Properties and units in trace elements [8] X. Properties and units in general clinical chemistry (this report) XI. Coding systems: structure and guidelines [9] XII. Properties and units in clinical pharmacology and toxicology [10] XIII. Properties and units in reproduction and fertility [11] XVI. Properties and units in clinical allergology [12]

The size and complexity of Parts III and IV are such that their lists will be presented in electronic format. This is for ease of handling and to facilitate expression of concepts in different languages. At the end, systematic terms, elaborated according to international standards and recommendations, should be available in the different domains of clinical laboratory sciences. The core of the series is code value strings representing concepts, that in combination delineate and define each type of property regardless of linguistic expression, thus avoiding errors during translation between languages.

FOREWORD AND SCOPE Clinical laboratory sciences are characterized by the exacting nature of the work performed and the demand for an accurate presentation of the outcome. Furthermore, the domain is transnational, international or “global”. The adherent informatics system, therefore, needs to identify the findings accurately and to present them with the degree of detail required. At the same time, it has to facilitate the transfer over linguistic and cultural barriers without distortion or loss of clarity, in order to promote clear, unambiguous, mean- ingful, and fully informative communication in different terminologies. The degree to which a message (such as a laboratory report) needs to be expressed in a formal, systematic language depends on the geographical, linguistic, social, or professional distance between the communicating parties. The greater the distance, the greater the risk of misunderstanding.

Within one laboratory, local jargon terms may be used which are usually well understood between colleagues, but which would not be sufficiently widely known for communication with the out- side world. Likewise, a laboratory and its local community of users, such as hospital or community physicians, may use a “local dialect” of the language of laboratory medicine which is well understood by all concerned; but when the communication possibilities are wider, even transnational, risks of seri- ous misunderstanding arise. The purpose of this document is to apply the IFCC–IUPAC recommended syntax structures for request and report and to create a systematic terminology that can be used as the basis for encoding laboratory messages in the domain of general clinical chemistry. This is to facilitate communication of messages about such properties through computing and telecommunication between databases, messages that contain sufficient information to allow translation from and to the required “local dialect” at each end. Each entry in the list is formed following the rules given in [1] and in [9]. The systematic names recommended here are primarily for the purpose of unambiguous data exchange. Their use in routine language by clinicians or laboratory practitioners is optional but encour- aged.

ELEMENTS OF AN ENTRY The terms recommended are given in bold, e.g., the systematic term for the type of property, the unit, and the code value.

1 Name of system and parenthetic specification spelled out in full, and followed by a long dash (em dash). 2 Alphanumeric chemical prefixes to component name. 3 Recommended name of component and parenthetic specification. Shifted to the left for alphabetical sorting and searching, and followed by a semicolon. 4 Kind-of-property and parenthetic specification. 5 Unit. 6 Presently recommended calibrator. 7 Previous calibrators. 8 Other term(s). 9 Authority: Code value for the international organization recommending the name of the component or the combined elements of an entry. 10 Note(s) with any further information. 11 [NPUXXXXX] Coding scheme identifier and code value, intended for interlaboratory transmission between databases. 12 Example in abbreviated form.

The term “arbitrary”, in principle, cannot be related to a volume. In clinical chemistry, however, a less well-defined “inhouse” or regional calibrator is often referred to and is expressed in “arbitrary unit per liter” in order to enable comparison of patient data over time and regionally. In each of these instances, further information should be given in the parenthesis “procedure”. This could be information on the calibrator used, e.g., “BCR/CRM148/149R”, or it could refer to the in-laboratory document “procedure xx” that is available on request. In the examples given, a question mark, “?”, has been used to represent the value of a result for properties including quantities.

REFERENCES 1. Commission/Committee on Nomenclature, Properties and Units of the IUPAC–IFCC (International Union of Pure and Applied Chemistry–International Federation of Clinical Chemistry). Properties and units in the clinical laboratory sciences. I. Syntax and semantic rules. Prepared for publication by H. Olesen. Pure Appl. Chem. 67, 1563–74 (1995); Eur. J. Clin. Chem. Clin. Biochem. 33, 627– 36 (1995); Clin. Chim. Acta 245, S5–S21 (1996). 2. Commission/Committee on Nomenclature, Properties and Units of the IUPAC–IFCC (International Union of Pure and Applied Chemistry–International Federation of Clinical Chemistry). Properties and units in the clinical laboratory sciences. II. Kinds-of-property. Prepared for publication by D. Kenny and H. Olesen. Pure Appl. Chem. 68, 1015–42 (1997); Eur. J. Clin. Chem. Clin. Biochem. 35, 317–44 (1997). 3. Commission/Committee on Nomenclature, Properties and Units of the IUPAC–IFCC (International Union of Pure and Applied Chemistry–International Federation of Clinical Chemistry). Properties and units in the clinical laboratory sciences. III. Elements (of properties) and their code values. Technical report 1997. Prepared for publication by I. Bruunshuus, W. Frederiksen, H. Olesen, I. Ibsen. Pure Appl. Chem. 69, 2577–82 (1997). 4. Commission/Committee on Nomenclature, Properties and Units of the IUPAC–IFCC (International Union of Pure and Applied Chemistry–International Federation of Clinical Chemistry). Properties and units in the clinical laboratory sciences. IV. Properties and their code values. Technical report 1997. Prepared for publication by H. Olesen, D. Kenny, I. Bruunshuus, I. Ibsen, K. Jørgensen, R. Dybkær. Pure Appl. Chem. 69, 2583–91 (1997). 5. Scientific and Standardization Committee of the ISTH (International Society on Thrombosis and Haemostasis) and Commission/Committee on Nomenclature, Properties and Units of the IUPAC– IFCC (International Union of Pure and Applied Chemistry–International Federation of Clinical Chemistry). Properties and units in the clinical laboratory sciences. V. Properties and units in thrombosis and haemostasis. Prepared for publication by M. Blombäck, R. Dybkær, K. Jørgensen, H. Olesen, S. Thorsen. Thrombosis and Haemostasis 71-375-94 (1994); Eur. J. Clin. Chem. Clin. Biochem. 33, 637–60 (1995). Pure Appl. Chem. 69, 1043–79 (1997). 6. Commission/Committee on Nomenclature, Properties and Units of the IUPAC–IFCC (International Union of Pure and Applied Chemistry–International Federation of Clinical Chemistry). Properties and units in the clinical laboratory sciences. VI. Properties and units in IOC-prohibited drugs. Recommendations 1997. Prepared for publication by H. Olesen, D. Cowan, I. Bruunshuus, K. Klempel, G. Hill. Pure Appl. Chem. 69, 1081–1136 (1997); Eur. J. Clin. Chem. Clin. Biochem. 35, 805–31 (1997). 7. Commission/Committee on Nomenclature, Properties and Units of the IUPAC–IFCC (International Union of Pure and Applied Chemistry–International Federation of Clinical Chemistry). Properties and units in the clinical laboratory sciences. VIII. Properties and units in clinical microbiology. Technical report 1999. Prepared for publication by U. Forsum, H. Olesen, W. Frederiksen, B. Persson. Pure Appl. Chem. 72, 555–745 (2000); JIFCC, in press. 8. Commission/Committee on Nomenclature, Properties and Units of the IUPAC–IFCC (International Union of Pure and Applied Chemistry–International Federation of Clinical Chemistry). Properties and units in the clinical laboratory sciences. IX. Properties and units in trace elements. Technical report 1997. Prepared for publication by R. Cornelis, X. Fuentes-Arderiu, I, Bruunshuus, D. Templeton. Pure Appl. Chem. 69, 2593–2606 (1997); Eur. J. Clin. Chem. Clin. Biochem. 35, 833–843 (1997).

9. Commission/Committee on Nomenclature, Properties and Units of the IUPAC–IFCC (International Union of Pure and Applied Chemistry–International Federation of Clinical Chemistry). Properties and units in the clinical laboratory sciences. XI. Coding systems - structure and guidelines. Technical report 1997. Prepared for publication by R. Cornelis, H. Olesen, I. Ibsen, I. Bruunshuus, D. Kenny. Pure Appl. Chem. 69, 2607–20 (1997). 10. Commission/Committee on Nomenclature, Properties and Units of the IUPAC–IFCC (International Union of Pure and Applied Chemistry–International Federation of Clinical Chemistry). Properties and units in the clinical laboratory sciences. XII. Properties and units in clinical pharmacology and toxicology. Technical report 1999. Prepared for publication by H. Olesen, D. Cowan, R. de la Torre, I. Bruunshuus, M. Rohde, D. Kenny. Pure Appl. Chem. 72, 479–552 (2000); JIFCC, in press. 11. Commission/Committee on Nomenclature, Properties and Units of the IUPAC–IFCC (International Union of Pure and Applied Chemistry–International Federation of Clinical Chemistry). Properties and units in the clinical laboratory sciences. XIII. Properties and units in reproduction and fertility. Technical report 1997. Prepared for publication by H. Olesen, A. Giwercman, D. M. de Kretser, D. Mortimer, H. Oshima, Troen. Pure Appl. Chem. 69, 2621–28 (1997); Clin. Chem. Lab Med. 36, 57–65 (1998). 12. Commission/Committee on Nomenclature, Properties and Units of the IUPAC–IFCC (International Union of Pure and Applied Chemistry–International Federation of Clinical Chemistry). Properties and units in the clinical laboratory sciences. XVI. Properties and units in clinical allergology. Technical report 1999. Prepared for publication by I. Bruunshuus, L. K. Poulsen, H. Olesen. Pure Appl. Chem., in press. JIFCC, in press.

INDEX OF ABBREVIATIONS CAS Chemical Abstracts Service IFCC International Federation of Clinical Chemistry and Laboratory Medicine INN International Nonproprietary Names of WHO *INN Name to be approved ISO International Organization for Standardization IUPAC International Union of Pure and Applied Chemistry MSH Medical Subject Headings WHO World Health Organization

LIST OF PROPERTIES IN GENERAL CLINICAL CHEMISTRY

Blood— NPU01011 Acanthocytes; P—Acetoacetate; subst.c. = ? mmol/l arbitrary concentration(procedure) NPU17074 Secretion(Conjunctiva; specification)— B—Acanthocytes; arb.c.(proc.) = ? Acetoacetate; substance concentration Erythrocytes(Blood)— millimole/liter Acanthocytes; NPU09351 number fraction Secr(Conj; spec.)—Acetoacetate; subst.c. = ? NPU14348 mmol/l Ercs(B)—Acanthocytes; num.fr. = ? Urine— Blood— Acetoacetate; Acetaldehyde; substance concentration substance concentration millimole/liter micromole/liter NPU04166 M = 44,05 g/mol U—Acetoacetate; subst.c. = ? mmol/l NPU01005 B—Acetaldehyde; subst.c. = ? µmol/l Patient(Urine)— Acetoacetate; Urine— substance rate Acetaldehyde; micromole/day substance concentration NPU17845 micromole/liter Pt(U)—Acetoacetate; subst.rate = ? µmol/d M = 44,05 g/mol NPU01006 Patient(Urine)— U—Acetaldehyde; subst.c. = ? µmol/l N- Acetylasparaginate; Urine— substance rate Acetoacetate; micromole/day arbitrary concentration(procedure) NPU17781 NPU10504 Pt(U)—N-Acetylasparaginate; subst.rate = ? µmol/d U—Acetoacetate; arb.c.(proc.) = ? Amniotic fluid— Urine— Acetylcholinesterase; Acetoacetate; catalytic-activity concentration(20 °C; substance concentration(120 minutes after procedure) challenge; procedure) nanokatal/liter millimole/liter Other term(s): AChE; Cholinesterase; Choline NPU10316 esterase I; True cholinesterase U—Acetoacetate; subst.c.(120 min; proc.) = ? NPU14657 mmol/l Amf—Acetylcholinesterase; cat.c.(20 °C; proc.) = ? nkat/l Urine— Acetoacetate; Amniotic fluid— substance concentration(procedure) Acetylcholinesterase; millimole/liter catalytic-activity concentration(37 °C; NPU01012 procedure) U—Acetoacetate; subst.c.(proc.) = ? mmol/l microkatal/liter Other term(s): AChE; Cholinesterase; Choline Cerebrospinal fluid— esterase I; True cholinesterase Acetoacetate; NPU01034 substance concentration Amf—Acetylcholinesterase; cat.c.(37 °C; proc.) = ? millimole/liter µkat/l NPU01010 Csf—Acetoacetate; subst.c. = ? mmol/l Erythrocytes(Blood)— Acetylcholinesterase; Plasma— entitic catalytic activity(37 °C; procedure) Acetoacetate; attokatal substance concentration Other term(s): AChE; Cholinesterase; Choline millimole/liter

esterase I; True cholinesterase Urine— NPU01035 N- Ercs(B)—Acetylcholinesterase; entitic cat.act. Acetyl-L-cystine; (37 °C; proc.) = ? akat substance concentration micromole/liter Plasma— M = 282,3 g/mol Acetylcholinreceptor antibody(Immunoglobulin G); NPU01023 arbitrary substance concentration(procedure) U—N-Acetyl-L-cystine; subst.c. = ? µmol/l arbitrary unit/liter NPU01036 Urine— P—Acetylcholinreceptor antibody(IgG); N-a- arb.subst.c.(proc.) = ? arb.unit/l Acetyl-L-lysine/Creatininium; substance ratio Urine— 10-3 b- NPU14181 Acetylglucosamine/Creatininium; U—N-a-Acetyl-L-lysine/Creatininium; subst.ratio = ? substance ratio × 10-3 10-3 NPU14183 Urine— U—b-Acetylglucosamine/Creatininium; subst.ratio = N-e- ? × 10-3 Acetyl-L-lysine/Creatininium; substance ratio Urine— NPU14182 b- U—N-e-Acetyl-L-lysine/Creatininium; subst.ratio = ? Acetylglucosamine; substance concentration Urine— micromole/liter N-e- NPU01325 Acetyl-L-lysine; U—b-Acetylglucosamine; subst.c. = ? µmol/l substance concentration mole/liter Patient(Urine)— M = 188,2 g/mol b- NPU01025 Acetylglucosamine; U—N-e-Acetyl-L-lysine; subst.c.= ? prefix ? mol/l substance rate micromole/day Urine— NPU10283 N-a- Pt(U)—b-Acetylglucosamine; subst.rate = ? µmol/d Acetyl-L-lysine; substance concentration Urine— micromole/liter N- M = 188,2 g/mol Acetyl-L-cystathionine/Creatininium; NPU01024 substance ratio U—N-a-Acetyl-L-lysine; subst.c. = ? µmol/l 10-3 NPU14179 Patient(arterial Blood)— U—N-Acetyl-L-cystathionine/Creatininium; Acid base status; subst.ratio = ? × 10-3 property(list; procedure) NPU04197 Urine— Pt(aB)—Acid base status; prop.(list; proc.) N- NPU12518 P(aB)—Base excess(H+binding group); Acetyl-L-cystathionine; subst.c.(actual-norm) = ? mmol/l substance concentration NPU01348 P(aB)—Base excess(H+binding group);

micromole/liter subst.c.(pCO2 = 5,3 kPa; 37 °C; actual-norm) = ? M = 264,3 g/mol mmol/l NPU01022 NPU04034 Pt(spec.)—Blood; temp. = ? °C U—N-Acetyl-L-cystathionine; subst.c. = ? µmol/l NPU08676 Pt—Body; temp. = ? °C NPU12476 P(aB)—Carbon dioxide(free); subst.c. = Urine— ? mmol/l N- NPU01470 P(aB)—Carbon dioxide(free); tension(37 Acetyl-L-cystine/Creatininium; °C) = ? kPa substance ratio NPU12526 P(aB)—Carbon dioxide(free); 10-3 tension(body temp.) = ? kPa NPU14180 NPU01471 P(aB)—Carbon dioxide(tot.); subst.c. = ? U—N-Acetyl-L-cystine/Creatininium; subst.ratio = ? mmol/l × 10-3

NPU01473 Hb(Fe; B)—Carbon monoxide NPU12494 P(cB)—Hydrogen ion; subst.c.(37 °C) = haemoglobin(Fe); subst.fr. = ? ? nmol/l NPU08753 Hb(tot.; aB)—Deoxyhaemoglobin; NPU12497 P(cB)—Hydrogen ion; subst.c.(body subst.fr. = ? temp.) = ? nmol/l NPU02319 B—Haemoglobin(Fe); subst.c. = ? NPU02725 Hb(Fe; B)—Methaemoglobin(Fe); mmol/l subst.fr. = ?

NPU02409 P(aB)—Hydrogen carbonate; NPU12514 Gas(cB)—Oxygen(O2); part.pr. = ? kPa

subst.c.(actual) = ? mmol/l NPU10197 Hb(tot.; cB)—Oxygen(O2); sat.fr. = ?

NPU02410 P—Hydrogen carbonate; subst.c.(pCO2 NPU12500 P(cB)—Oxygen(O2); tension = ? kPa

= 5,3 kPa; 37 °C) = ? mmol/l NPU03010 Hb(B)—Oxygen(O2); tension(halfsat.) = NPU12474 P(aB)—Hydrogen ion; pH(37 °C) = ? ? kPa

NPU02412 P(aB)—Hydrogen ion; pH(body temp.) = NPU12503 P(cB)—Oxygen(O2; free); subst.c. = ? ? mmol/l

NPU12475 P(aB)—Hydrogen ion; subst.c.(37 °C) = NPU12506 B(cB)—Oxygen(O2; total); subst.c. = ? ? nmol/l mmol/l NPU02413 P(aB)—Hydrogen ion; subst.c.(body NPU12510 Hb(Fe; deoxy+oxy; cB)— temp.) = ? nmol/l Oxyhaemoglobin(Fe); subst.fr. = ? NPU02725 Hb(Fe; B)—Methaemoglobin(Fe); NPU10754 Hb(Fe; tot.; cB)—Oxyhaemoglobin(Fe); subst.fr. = ? subst.fr. = ?

NPU03009 Gas(aB)—Oxygen(O2); part.pr. = ? kPa

NPU03011 Hb(tot.; aB)—Oxygen(O2); sat.fr. = ? Patient(cord Blood)—

NPU08977 P(aB)—Oxygen(O2); tension = ? kPa Acid base status;

NPU03010 Hb(B)—Oxygen(O2); tension(halfsat.) = property(list; procedure) ? kPa NPU12516

NPU03012 P(aB)—Oxygen(O2; free); subst.c. = ? Pt(cordB)—Acid base status; prop.(list; proc.) mmol/l NPU12519 P(cordB)—Base excess(H+binding

NPU03849 B(aB)—Oxygen(O2; total); subst.c. = ? group); subst.c.(actual-norm) = ? mmol/l mmol/l NPU10219 P(cordB)—Base excess(H+binding

NPU03014 Hb(Fe; deoxy+oxy; aB)— group); subst.c.(pCO2 = 5,3 kPa; 37 °C; actual- Oxyhaemoglobin(Fe); subst.fr. = ? norm) = ? mmol/l NPU03013 Hb(Fe; tot.; aB)—Oxyhaemoglobin(Fe); NPU04034 Pt(spec.)—Blood; temp. = ? °C subst.fr. = ? NPU08676 Pt—Body; temp. = ? °C NPU12483 P(cordB)—Carbon dioxide(free); subst.c. Patient(capillary Blood)— = ? mmol/l Acid base status; NPU10030 P(cordB)—Carbon dioxide(free); property(list; procedure) tension(37 °C) = ? kPa NPU12479 NPU12527 P(cordB)—Carbon dioxide(free); Pt(cB)—Acid base status; prop.(list; proc.) tension(body temp.) = ? kPa NPU12520 P(cB)—Base excess(H+binding group); NPU12517 P(cordB)—Carbon dioxide(tot.); subst.c. subst.c.(actual-norm) = ? mmol/l = ? mmol/l NPU12480 P(cB)—Base excess(H+binding group); NPU01473 Hb(Fe; B)—Carbon monoxide

subst.c.(pCO2 = 5,3 kPa; 37 °C; actual-norm) = ? haemoglobin(Fe); subst.fr. = ? mmol/l NPU02319 B—Haemoglobin(Fe); subst.c. = ? NPU04034 Pt(spec.)—Blood; temp. = ? °C mmol/l NPU08676 Pt—Body; temp. = ? °C NPU14265 P(cordB)—Hydrogen carbonate; NPU12482 P(cB)—Carbon dioxide(free); subst.c. = subst.c.(actual) = ? mmol/l

? mmol/l NPU02410 P—Hydrogen carbonate; subst.c.(pCO2 NPU12481 P(cB)—Carbon dioxide(free); tension(37 = 5,3 kPa; 37 °C) = ? mmol/l °C) = ? kPa NPU10016 P(cordB)—Hydrogen ion; pH = ? NPU12528 P(cB)—Carbon dioxide(free); NPU12493 P(cordB)—Hydrogen ion; pH(body tension(body temp.) = ? kPa temp.) = ? NPU12485 P(cB)—Carbon dioxide(tot.); subst.c. = ? NPU12496 P(cordB)—Hydrogen ion; subst.c. mmol/l (37 °C) = ? nmol/l NPU01473 Hb(Fe; B)—Carbon monoxide NPU12499 P(cordB)—Hydrogen ion; subst.c.(body haemoglobin(Fe); subst.fr. = ? temp.) = ? nmol/l NPU02319 B—Haemoglobin(Fe); subst.c. = ? NPU02725 Hb(Fe; B)—Methaemoglobin(Fe); mmol/l subst.fr. = ?

NPU14264 P(cB)—Hydrogen carbonate; NPU12513 Gas(cordB)—Oxygen(O2); part.pr. = ? subst.c.(actual) = ? mmol/l kPa

NPU02410 P—Hydrogen carbonate; subst.c.(pCO2 NPU12508 Hb(tot.; cordB)—Oxygen(O2); sat.fr. = ?

= 5,3 kPa; 37 °C) = ? mmol/l NPU12502 P(cordB)—Oxygen(O2); tension = ? kPa

NPU12490 P(cB)—Hydrogen ion; pH(37 °C) = ? NPU03010 Hb(B)—Oxygen(O2); tension(halfsat.) = NPU12491 P(cB)—Hydrogen ion; pH(body temp.) = ? kPa ?

NPU12478 P(cordB)—Oxygen(O2; free); subst.c. = Patient(cord Blood; venous Blood)— ? mmol/l Acid base status;

NPU12505 B(cordB)—Oxygen(O2; total); subst.c. = property(list; procedure) ? mmol/l NPU17132 NPU12509 Hb(Fe; deoxy+oxy; cordB)— Pt(cordB; vB)—Acid base status; prop.(list; proc.) Oxyhaemoglobin(Fe); subst.fr. = ? NPU17134 P(cordB; vB)—Base excess(H+binding NPU12512 Hb(Fe; tot.; cordB)— group); subst.c.(actual-norm) = ? mmol/l Oxyhaemoglobin(Fe); subst.fr. = ? NPU17136 P(cordB; vB)—Base excess(H+binding

group); subst.c.(pCO2 = 5,3 kPa; 37 °C; actual- Patient(cord Blood; arterial Blood)— norm) = ? mmol/l Acid base status; NPU04034 Pt(spec.)—Blood; temp. = ? °C property(list; procedure) NPU08676 Pt—Body; temp. = ? °C NPU17131 NPU17138 P(cordB; vB)—Carbon dioxide(free); Pt(cordB; aB)—Acid base status; prop.(list; proc.) subst.c. = ? mmol/l NPU17133 P(cordB; aB)—Base excess(H+binding NPU17140 P(cordB; vB)—Carbon dioxide(free); group); subst.c.(actual-norm) = ? mmol/l tension(37 °C) = ? kPa NPU17135 P(cordB; aB)—Base excess(H+binding NPU17142 P(cordB; vB)—Carbon dioxide(free);

group); subst.c.(pCO2 = 5,3 kPa; 37 °C; actual- tension(body temp.) = ? kPa norm) = ? mmol/l NPU17144 P(cordB; vB)—Carbon dioxide(tot.); NPU04034 Pt(spec.)—Blood; temp. = ? °C subst.c. = ? mmol/l NPU08676 Pt—Body; temp. = ? °C NPU01473 Hb(Fe; B)—Carbon monoxide NPU17137 P(cordB; aB)—Carbon dioxide(free); haemoglobin(Fe); subst.fr. = ? subst.c. = ? mmol/l NPU02319 B—Haemoglobin(Fe); subst.c. = ? NPU17139 P(cordB; aB)—Carbon dioxide(free); mmol/l tension(37 °C) = ? kPa NPU17146 P(cordB; vB)—Hydrogen carbonate; NPU17141 P(cordB; aB)—Carbon dioxide(free); subst.c.(actual) = ? mmol/l

tension(body temp.) = ? kPa NPU02410 P—Hydrogen carbonate; subst.c.(pCO2 NPU17143 P(cordB; aB)—Carbon dioxide(tot.); = 5,3 kPa; 37 °C) = ? mmol/l subst.c. = ? mmol/l NPU17148 P(cordB; vB)—Hydrogen ion; pH = ? NPU01473 Hb(Fe; B)—Carbon monoxide NPU17150 P(cordB; vB)—Hydrogen ion; pH(body haemoglobin(Fe); subst.fr. = ? temp.) = ? NPU02319 B—Haemoglobin(Fe); subst.c. = ? NPU17152 P(cordB; vB)—Hydrogen ion; mmol/l subst.c.(37 °C) = ? nmol/l NPU17145 P(cordB; aB)—Hydrogen carbonate; NPU17154 P(cordB; vB)—Hydrogen ion; subst.c.(actual) = ? mmol/l subst.c.(body temp.) = ? nmol/l

NPU02410 P—Hydrogen carbonate; subst.c.(pCO2 NPU02725 Hb(Fe; B)—Methaemoglobin(Fe); = 5,3 kPa; 37 °C) = ? mmol/l subst.fr. = ?

NPU17147 P(cordB; aB)—Hydrogen ion; pH = ? NPU17171 Gas(cordB; vB)—Oxygen(O2); part.pr. = NPU17149 P(cordB; aB)—Hydrogen ion; pH(body ? kPa

temp.) = ? NPU12508 Hb(tot.; cordB)—Oxygen(O2); sat.fr. = ?

NPU17151 P(cordB; aB)—Hydrogen ion; NPU17156 P(cordB; vB)—Oxygen(O2); tension = ? subst.c.(37 °C) = ? nmol/l kPa

NPU17153 P(cordB; aB)—Hydrogen ion; NPU03010 Hb(B)—Oxygen(O2); tension(halfsat.) = subst.c.(body temp.) = ? nmol/l ? kPa

NPU02725 Hb(Fe; B)—Methaemoglobin(Fe); NPU17158 P(cordB; vB)—Oxygen(O2; free); subst.fr. = ? subst.c. = ? mmol/l

NPU17170 Gas(cordB; aB)—Oxygen(O2); part.pr. = NPU12505 B(cordB)—Oxygen(O2; total); subst.c. = ? kPa ? mmol/l

NPU12508 Hb(tot.; cordB)—Oxygen(O2); sat.fr. = ? NPU12509 Hb(Fe; deoxy+oxy; cordB)—

NPU17155 P(cordB; aB)—Oxygen(O2); tension = ? Oxyhaemoglobin(Fe); subst.fr. = ? kPa NPU12512 Hb(Fe; tot.; cordB)—

NPU03010 Hb(B)—Oxygen(O2); tension(halfsat.) = Oxyhaemoglobin(Fe); subst.fr. = ? ? kPa

NPU17157 P(cordB; aB)—Oxygen(O2; free); Patient(mixed Blood)— subst.c. = ? mmol/l Acid base status;

NPU12505 B(cordB)—Oxygen(O2; total); subst.c. = property(list; procedure) ? mmol/l NPU09208 NPU12509 Hb(Fe; deoxy+oxy; cordB)— Pt(mixB)—Acid base status; prop.(list; proc.) Oxyhaemoglobin(Fe); subst.fr. = ? NPU09200 P(mixB)—Base excess(H+binding NPU12512 Hb(Fe; tot.; cordB)— group); subst.c.(actual-norm) = ? mmol/l Oxyhaemoglobin(Fe); subst.fr. = ? NPU09201 P(mixB)—Base excess(H+binding

group); subst.c.(pCO2 = 5,3 kPa; 37 °C; actual- norm) = ? mmol/l

NPU04034 Pt(spec.)—Blood; temp. = ? °C haemoglobin(Fe); subst.fr. = ? NPU08676 Pt—Body; temp. = ? °C NPU02319 B—Haemoglobin(Fe); subst.c. = ? NPU09204 P(mixB)—Carbon dioxide(free); subst.c. mmol/l = ? mmol/l NPU14266 P(vB)—Hydrogen carbonate; NPU09202 P(mixB)—Carbon dioxide(free); subst.c.(actual) = ? mmol/l

tension(37 °C) = ? kPa NPU02410 P—Hydrogen carbonate; subst.c.(pCO2 NPU09203 P(mixB)—Carbon dioxide(free); = 5,3 kPa; 37 °C) = ? mmol/l tension(body temp.) = ? kPa NPU12489 P(vB)—Hydrogen ion; pH(37 °C) = ? NPU09206 P(mixB)—Carbon dioxide(tot.); subst.c. NPU12492 P(vB)—Hydrogen ion; pH(body temp.) = = ? mmol/l ? NPU01473 Hb(Fe; B)—Carbon monoxide NPU12495 P(vB)—Hydrogen ion; subst.c.(37 °C) = haemoglobin(Fe); subst.fr. = ? ? nmol/l NPU02319 B—Haemoglobin(Fe); subst.c. = ? NPU12498 P(vB)—Hydrogen ion; subst.c.(body mmol/l temp.) = ? nmol/l NPU09209 P(mixB)—Hydrogen carbonate; NPU02725 Hb(Fe; B)—Methaemoglobin(Fe); subst.c.(actual) = ? mmol/l subst.fr. = ?

NPU02410 P—Hydrogen carbonate; subst.c.(pCO2 NPU03847 Gas(vB)—Oxygen(O2); part.pr. = ? kPa

= 5,3 kPa; 37 °C) = ? mmol/l NPU10199 Hb(tot.; vB)—Oxygen(O2); sat.fr. = ?

NPU09210 P(mixB)—Hydrogen ion; pH(37 °C) = ? NPU12501 P(vB)—Oxygen(O2); tension = ? kPa

NPU09211 P(mixB)—Hydrogen ion; pH(body temp.) NPU03010 Hb(B)—Oxygen(O2); tension(halfsat.) = = ? ? kPa

NPU09212 P(mixB)—Hydrogen ion; subst.c.(37 °C) NPU12504 P(vB)—Oxygen(O2; free); subst.c. = ? = ? nmol/l mmol/l

NPU09213 P(mixB)—Hydrogen ion; subst.c.(body NPU12507 B(vB)—Oxygen(O2; total); subst.c. = ? temp.) = ? nmol/l mmol/l NPU02725 Hb(Fe; B)—Methaemoglobin(Fe); NPU12511 Hb(Fe; deoxy+oxy; vB)— subst.fr. = ? Oxyhaemoglobin(Fe); subst.fr. = ?

NPU09214 Gas(mixB)—Oxygen(O2); part.pr. = ? NPU10265 Hb(Fe; tot.; vB)—Oxyhaemoglobin(Fe); kPa subst.fr. = ?

NPU09218 Hb(tot.; mixB)—Oxygen(O2); sat.fr. = ?

NPU09215 P(mixB)—Oxygen(O2); tension = ? kPa Plasma—

NPU03010 Hb(B)—Oxygen(O2); tension(halfsat.) = Acid phosphatase, prostatic type; ? kPa catalytic-activity concentration(37 °C;

NPU09216 P(mixB)—Oxygen(O2; free); subst.c. = ? procedure) mmol/l microkatal/liter

NPU09217 B(mixB)—Oxygen(O2; total); subst.c. = ? NPU01065 mmol/l P—Acid phosphatase, prostatic type; cat.c.(37 °C; NPU09219 Hb(Fe; deoxy+oxy; mixB)— proc.) = ? µkat/l Oxyhaemoglobin(Fe); subst.fr. = ? NPU09220 Hb(Fe; tot.; mixB)— Synovial fluid(specification)— Oxyhaemoglobin(Fe); subst.fr. = ? Acid phosphatase, prostatic type; catalytic-activity concentration(37 °C; Patient(venous Blood)— procedure) Acid base status; microkatal/liter property(list; procedure) NPU10609 NPU10755 Synf(spec.)—Acid phosphatase, prostatic type; Pt(vB)—Acid base status; prop.(list; proc.) cat.c.(37 °C; proc.) = ? µkat/l NPU12521 P(vB)—Base excess(H+binding group); subst.c.(actual-norm) = ? mmol/l Plasma— NPU08970 P(vB)—Base excess(H+binding group); Acid phosphatase, prostatic type;

subst.c.(pCO2 = 5,3 kPa; 37 °C; actual-norm) = ? substance concentration mmol/l micromole/liter NPU04034 Pt(spec.)—Blood; temp. = ? °C NPU01066 NPU08676 Pt—Body; temp. = ? °C P—Acid phosphatase, prostatic type; subst.c. = ? NPU12484 P(vB)—Carbon dioxide(free); subst.c. = µmol/l ? mmol/l NPU10029 P(vB)—Carbon dioxide(free); tension(37 Plasma— °C) = ? kPa Acid phosphatase; NPU12529 P(vB)—Carbon dioxide(free); catalytic-activity concentration(37 °C; tension(body temp.) = ? kPa procedure) NPU01472 P(vB)—Carbon dioxide(tot.); subst.c. = ? microkatal/liter mmol/l NPU01064 NPU01473 Hb(Fe; B)—Carbon monoxide P—Acid phosphatase; cat.c.(37 °C; proc.) = ? µkat/l

Synovial fluid(specification)— (adrenalinium) = 183,20 g/mol Acid phosphatase; NPU10541 catalytic-activity concentration(37 °C; Pt—Adrenalinium secretion; subst.rate(clonidine procedure) p.o.; list; proc.) microkatal/liter NPU10536 Pt—Clonidine(administered); am.s.(p.o.) NPU10617 = ? µmol Synf(spec.)—Acid phosphatase; cat.c.(37 °C; proc.) NPU10666 P—Adrenalinium; subst.c.(-15 min)= ? = ? µkat/l µmol/l NPU10667 P—Adrenalinium; subst.c.(-5 min)= ? Urine— µmol/l Adenosyl-L-homocysteine/Creatininium; NPU10537 P—Adrenalinium; subst.c.(0 min)= ? substance ratio µmol/l 10-3 NPU10538 P—Adrenalinium; subst.c.(60 min)= ? NPU14184 µmol/l U—Adenosyl-L-homocysteine/Creatininium; NPU10539 P—Adrenalinium; subst.c.(120 min)= ? subst.ratio = ? × 10-3 µmol/l NPU10540 P—Adrenalinium; subst.c.(180 min)= ? Urine— µmol/l Adenosyl-L-homocysteine; substance concentration Urine— micromole/liter Adrenalinium; M = 384,4 g/mol amount-of-substance(procedure) NPU01084 micromole U—Adenosyl-L-homocysteine; subst.c. = ? µmol/l NPU17545 U—Adrenalinium; am.s.(proc.) = ? µmol Urine— Adenosyl-L-methionine/Creatininium; Plasma— substance ratio Adrenalinium; 10-3 substance concentration(15 minutes before NPU14185 challenge) U—Adenosyl-L-methionine/Creatininium; subst.ratio micromole/liter = ? × 10-3 M = 183,20 g/mol NPU10666 Plasma— P—Adrenalinium; subst.c.(-15 min)= ? µmol/l Adenosyl-L-methionine; substance concentration Plasma— micromole/liter Adrenalinium; M = 399,4 g/mol substance concentration(5 minutes before NPU01085 challenge) P—Adenosyl-L-methionine; subst.c. = ? µmol/l micromole/liter M = 183,20 g/mol Urine— NPU10667 Adenosyl-L-methionine; P—Adrenalinium; subst.c.(-5 min)= ? µmol/l substance concentration micromole/liter Plasma— M = 399,4 g/mol Adrenalinium; NPU01086 substance concentration(0 minutes after U—Adenosyl-L-methionine; subst.c. = ? µmol/l challenge) micromole/liter Urine— M = 183,20 g/mol Adipate; NPU10537 substance concentration P—Adrenalinium; subst.c.(0 min)= ? µmol/l micromole/liter M = 146,14 g/mol Plasma— NPU01104 Adrenalinium; U—Adipate; subst.c. = ? µmol/l substance concentration(60 minutes after challenge) Patient— micromole/liter Adrenalinium secretion; M = 183,20 g/mol substance rate(clonidine, oral administration; NPU10538 list; procedure) P—Adrenalinium; subst.c.(60 min)= ? µmol/l Other term(s): Epinephrine secretion Note: M (clonidine) = 230,10 g/mol; M

Plasma— NPU10543 P—Adrenalinium+Noradrenalinium; Adrenalinium; subst.c.(60 min)= ? µmol/l substance concentration(120 minutes after NPU10544 P—Adrenalinium+Noradrenalinium; challenge) subst.c.(120 min)= ? µmol/l micromole/liter NPU10545 P—Adrenalinium+Noradrenalinium; M = 183,20 g/mol subst.c.(180 min)= ? µmol/l NPU10539 P—Adrenalinium; subst.c.(120 min)= ? µmol/l Urine— Adrenalinium+Noradrenalinium; Plasma— amount-of-substance(procedure) Adrenalinium; micromole substance concentration(180 minutes after NPU17624 challenge) U—Adrenalinium+Noradrenalinium; am.s.(proc.) = ? micromole/liter µmol M = 183,20 g/mol NPU10540 Plasma— P—Adrenalinium; subst.c.(180 min)= ? µmol/l Adrenalinium+Noradrenalinium; substance concentration(15 minutes before Plasma— challenge) Adrenalinium; micromole/liter substance concentration NPU10620 micromole/liter P—Adrenalinium+Noradrenalinium; subst.c.(-15 M = 183,20 g/mol min)= ? µmol/l NPU14042 P—Adrenalinium; subst.c.= ? µmol/l Plasma— Adrenalinium+Noradrenalinium; Urine— substance concentration(5 minutes before Adrenalinium; challenge) substance concentration micromole/liter micromole/liter NPU10621 M = 183,20 g/mol P—Adrenalinium+Noradrenalinium; subst.c.(-5 Other term(s): Epinephrine min)= ? µmol/l Authority: IUPAC-IUB 83 NPU14041 Plasma— U—Adrenalinium; subst.c. = ? µmol/l Adrenalinium+Noradrenalinium; substance concentration(0 minutes after Patient(Urine)— challenge) Adrenalinium; micromole/liter substance rate(procedure) NPU10542 micromole/day P—Adrenalinium+Noradrenalinium; subst.c.(0 min)= NPU14043 ? µmol/l Pt(U)—Adrenalinium; subst.rate(proc.) = ? µmol/d Plasma— Patient— Adrenalinium+Noradrenalinium; Adrenalinium+noradrenalinium secretion; substance concentration(60 minutes after substance rate(clonidine, oral administration; challenge) list; procedure) micromole/liter Other term(s): Epinephrine+norepinephrine NPU10543 secretion P—Adrenalinium+Noradrenalinium; subst.c.(60 Note: M (clonidine) = 230,10 g/mol; M min)= ? µmol/l (adrenalinium) = 183,20 g/mol; M (noradrenalinium) = 169,18 g/mol Plasma— NPU10546 Adrenalinium+Noradrenalinium; Pt—Adrenalinium+noradrenalinium secretion; substance concentration(120 minutes after subst.rate(clonidine p.o.; list; proc.) challenge) NPU10536 Pt—Clonidine(administered); am.s.(p.o.) micromole/liter = ? µmol NPU10544 NPU10620 P—Adrenalinium+Noradrenalinium; P—Adrenalinium+Noradrenalinium; subst.c.(120 subst.c.(-15 min)= ? µmol/l min)= ? µmol/l NPU10621 P—Adrenalinium+Noradrenalinium; subst.c.(-5 min)= ? µmol/l Plasma— NPU10542 P—Adrenalinium+Noradrenalinium; Adrenalinium+Noradrenalinium; subst.c.(0 min)= ? µmol/l substance concentration(180 minutes after

challenge) Lung(specification)— micromole/liter Air; NPU10545 volume P—Adrenalinium+Noradrenalinium; subst.c.(180 liter min)= ? µmol/l NPU03789 Lung(spec.)—Air; vol. = ? l Plasma— Adrenalinium+Noradrenalinium; Amniotic fluid— substance concentration Alanine transaminase; micromole/liter catalytic-activity concentration(37 °C; Other term(s): Epinephrine+norepinephrine procedure) Note: M (adrenalin) = 183,20 g/mol; M microkatal/liter (noradrenalin) = 169,18 g/mol Other term(s): Glutamic-pyruvic transaminase; NPU14044 Glutamic-alanine transaminase P—Adrenalinium+Noradrenalinium; subst.c. = ? NPU03911 µmol/l Amf—Alanine transaminase; cat.c.(37 °C; proc.) = ? µkat/l Urine— Adrenalinium+Noradrenalinium; Plasma— substance concentration Alanine transaminase; micromole/liter catalytic-activity concentration(37 °C; Other term(s): Epinephrine+norepinephrine procedure) Note: M (adrenalin) = 183,20 g/mol; M microkatal/liter (noradrenalin) = 169,18 g/mol Other term(s): Glutamic-pyruvic transaminase; NPU14120 Glutamic-alanine transaminase U—Adrenalinium+Noradrenalinium; subst.c. = ? NPU01121 µmol/l P—Alanine transaminase; cat.c.(37 °C; proc.) = ? µkat/l Patient(Urine)— Adrenalinium+Noradrenalinium; Urine— substance rate(procedure) b- micromole/day Alanine/Creatininium; Other term(s): Catecholamines; Levarterenol substance ratio NPU01105 10–3 Pt(U)—Adrenalinium+Noradrenalinium; NPU14187 subst.rate(proc.) = ? µmol/d U—b-Alanine/Creatininium; subst.ratio = ? × 10–3

Plasma— Urine— Adrenocortex antibody(Immunoglobulin G); Alanine/Creatininium; arbitrary concentration(procedure) substance ratio NPU12545 10–3 P—Adrenocortex antibody(IgG); arb.c.(proc.) = ? NPU14186 U—Alanine/Creatininium; subst.ratio = ? × 10–3 Plasma— Adrenocortex antibody; Cerebrospinal fluid— arbitrary substance concentration(procedure) b- arbitrary unit/liter Alanine; NPU01106 substance concentration P—Adrenocortex antibody; arb.subst.c.(proc.) = ? micromole/liter arb.unit/l M = 89,09 g/mol Authority: IUPAC-IUB 84 Room— NPU09017 Air; Csf—b-Alanine; subst.c. = ? µmol/l pressure kilopascal Plasma— NPU04078 b- Room—Air; pr. = ? kPa Alanine; substance concentration Room— micromole/liter Air; M = 89,09 g/mol Celsius temperature Authority: IUPAC-IUB 84 degree Celsius NPU01119 NPU04082 P—b-Alanine; subst.c. = ? µmol/l Room—Air; temp. = ? °C

Urine— Urine— b- Albumin; Alanine; amount-of-substance(procedure) substance concentration micromole micromole/liter M = 66 000 g/mol M = 89,09 g/mol NPU10270 Authority: IUPAC-IUB 84 U—Albumin; am.s.(proc.) = ? µmol NPU01120 U—b-Alanine; subst.c. = ? µmol/l System(specification)— Albumin; Cerebrospinal fluid— mass concentration Alanine; gram/liter substance concentration NPU14338 micromole/liter Syst(spec.)—Albumin; mass c. = ? g/l M = 89,09 g/mol Authority: IUPAC-IUB 84 Protein(Cerebrospinal fluid)— NPU01116 Albumin; Csf—Alanine; subst.c. = ? µmol/l mass fraction NPU04949 Plasma— Prot.(Csf)—Albumin; mass fr. = ? Alanine; substance concentration Protein(Plasma)— micromole/liter Albumin; M = 89,09 g/mol mass fraction Authority: IUPAC-IUB 84 NPU04939 NPU01117 Prot.(P)—Albumin; mass fr. = ? P—Alanine; subst.c. = ? µmol/l Protein(Urine)— Urine— Albumin; Alanine; mass fraction substance concentration NPU04944 micromole/liter Prot.(U)—Albumin; mass fr. = ? M = 89,09 g/mol Authority: IUPAC-IUB 84 Cerebrospinal fluid— NPU01118 Albumin; U—Alanine; subst.c. = ? µmol/l relative substance concentration(Cerebrospinal fluid/Plasma) Kidney— M = 66 000 g/mol Albumin clearance/Creatininium clearance; NPU04980 volume rate ratio Csf—Albumin; rel.subst.c.(Csf/P) = ? 10-3 NPU04125 Urine— Kidn.—Albumin clearance/Creatininium clearance; Albumin; vol.rate ratio = ? × 10-3 substance concentration(procedure) micromole/liter Intestine, small— M = 66 000 g/mol Albumin loss; NPU01134 substance rate(procedure) U—Albumin; subst.c.(proc.) = ? µmol/l micromole/day M = 66 000 g/mol Amniotic fluid— NPU04041 Albumin; Intest., small—Albumin loss; subst.rate(proc.) = ? substance concentration µmol/d micromole/liter M = 66 000 g/mol Urine— NPU08600 Albumin/Creatininium; Amf—Albumin; subst.c. = ? µmol/l substance ratio 10-3 Ascites— Note: M (albumin) = 60 000 g/mol; M (creatininium) Albumin; = 113,12 substance concentration NPU03918 micromole/liter U—Albumin/Creatininium; subst.ratio = ? × 10-3 M = 66 000 g/mol NPU03920 Asc—Albumin; subst.c. = ? µmol/l

Cerebrospinal fluid— Synovial fluid(specification)— Albumin; Albumin; substance concentration substance concentration micromole/liter micromole/liter M = 66 000 g/mol M = 66 000 g/mol NPU01130 NPU03921 Csf—Albumin; subst.c. = ? µmol/l Synf(spec.)—Albumin; subst.c. = ? µmol/l

Dialysis solution— Urine— Albumin; Albumin; substance concentration substance concentration micromole/liter micromole/liter M = 66 000 g/mol M = 66 000 g/mol NPU10018 NPU03903 Dialysis solution—Albumin; subst.c. = ? µmol/l U—Albumin; subst.c. = ? µmol/l

Drain fluid(specification)— Patient(Urine)— Albumin; Albumin; substance concentration substance rate(procedure) micromole/liter micromole/day NPU17046 NPU01131 Drain fluid(spec.)—Albumin; subst.c. = ? µmol/l Pt(U)—Albumin; subst.rate(proc.) = ? µmol/d

Expectorate— Plasma— Albumin; Aldolase; substance concentration catalytic-activity concentration(37 °C; micromole/liter procedure) M = 66 000 g/mol microkatal/liter NPU10272 Other term(s): 1,6-Diphosphate aldolase; Aldolase Ex—Albumin; subst.c. = ? µmol/l A; Fructose-1,6-bisphosphate triosephosphate- lyase Plasma— Authority: IUB 84 Albumin; NPU02116 substance concentration P—Aldolase; cat.c.(37 °C; proc.) = ? µkat/l micromole/liter M = 66 000 g/mol Leukocytes(Blood)— NPU01132 Aldosterone receptor; P—Albumin; subst.c. = ? µmol/l arbitrary entitic number(procedure) NPU04063 Pleural fluid(specification)— Lkcs(B)—Aldosterone receptor; arb.entitic Albumin; num.(proc.) = ? substance concentration micromole/liter Leukocytes(Blood)— M = 66 000 g/mol Aldosterone receptor; NPU03919 entitic number(procedure) Plf(spec.)—Albumin; subst.c. = ? µmol/l NPU01137 Lkcs(B)—Aldosterone receptor; entitic num.(proc.) Saliva— = ? Albumin; substance concentration Adrenal cortex— micromole/liter Aldosterone secretion; M = 66 000 g/mol substance rate(furosemide, oral administration; NPU10019 list; procedure) Saliva—Albumin; subst.c. = ? µmol/l Note: M (furosemide) = 330,75 g/mol; M (aldosterone) = 360,44 g/mol Secretion(specification)— NPU10686 Albumin; Adrenal cortex—Aldosterone secretion; substance concentration subst.rate(furosemide p.o.; list; proc.) micromole/liter NPU10419 Pt—Furosemide(administered); M = 66 000 g/mol am.s.(p.o.) = ? µmol NPU10271 NPU10684 P—Aldosterone; subst.c.(0 min) = ? Secr(spec.)—Albumin; subst.c. = ? µmol/l pmol/l NPU10685 P—Aldosterone; subst.c.(300 min) = ? pmol/l

Plasma— Plasma—

Aldosterone; Aliphatic carboxylate(C10-C26); substance concentration(0 minutes after substance concentration challenge) millimole/liter picomole/liter Other term(s): Non esterified fatty acids; NEFA M = 360,44 g/mol NPU01139

Authority: IUPAC-IUB 89 P—Aliphatic carboxylate(C10-C26); subst.c. = ? NPU10684 mmol/l P—Aldosterone; subst.c.(0 min) = ? pmol/l Intestine, small—

Plasma— Aliphatic carboxylate(C14-C26) absorption; Aldosterone; substance rate(procedure) substance concentration(300 minutes after millimole/day challenge) NPU01138

picomole/liter Intest., small—Aliphatic carboxylate(C14-C26) M = 360,44 g/mol absorption; subst.rate(proc.) = ? mmol/d NPU10685 P—Aldosterone; subst.c.(300 min) = ? pmol/l Faeces—

Aliphatic carboxylate(C14-C26); Plasma— substance content Aldosterone; millimole/kilogram substance concentration NPU03926

nanomole/liter F—Aliphatic carboxylate(C14-C26); subst.cont. = ? M = 360,44 g/mol mmol/kg Authority: IUPAC-IUB 89 NPU14040 Patient(Faeces)—

P—Aldosterone; subst.c. = ? nmol/l Aliphatic carboxylate(C14-C26)+esters; substance rate(procedure) Urine— millimole/day Aldosterone; NPU01140

substance concentration Pt(F)—Aliphatic carboxylate(C14-C26)+esters; nanomole/liter subst.rate(proc.) = ? mmol/d M = 360,44 g/mol Authority: IUPAC-IUB 89 Plasma—

NPU14039 Aliphatic carboxylate(C22:0)/Aliphatic

U—Aldosterone; subst.c. = ? nmol/l carboxylate(C26:0); substance ratio Plasma— NPU01142

Aldosterone; P—Aliphatic carboxylate(C22:0)/Aliphatic

substance concentration carboxylate(C26:0); subst.ratio = ? picomole/liter M = 360,44 g/mol Plasma—

Authority: IUPAC-IUB 89 Aliphatic carboxylate(C24:0)/Aliphatic

NPU01135 carboxylate(C22:0); P—Aldosterone; subst.c. = ? pmol/l substance ratio NPU01141

Urine— P—Aliphatic carboxylate(C24:0)/Aliphatic

Aldosterone; carboxylate(C22:0); subst.ratio = ? substance concentration picomole/liter Plasma— M = 360,44 g/mol Alkaline phosphatase type; Authority: IUPAC-IUB 89 catalytic-activity concentration(list; 37 °C; NPU03853 procedure) U—Aldosterone; subst.c. = ? pmol/l NPU04589 P—Alkaline phosphatase type; cat.c.(list; 37 °C; Patient(Urine)— proc.) Aldosterone; NPU01145 P—Alkaline phosphatase, bone type; substance rate(procedure) cat.c.(37 °C; proc.) = ? µkat/l nanomole/day NPU10601 P—Alkaline phosphatase, liver Authority: IUPAC-IUB89 canaliculus type; cat.c.(37 °C; proc.) = ? µkat/l NPU01136 NPU10600 P—Alkaline phosphatase, liver Pt(U)—Aldosterone; subst.rate(proc.) = ? nmol/d endothelial type; cat.c.(37 °C; proc.) = ? µkat/l NPU01013 P—Alkaline phosphatase, liver type;

cat.c.(37 °C; proc.) = ? µkat/l Plasma— NPU01483 P—Alkaline phosphatase, placental Alkaline phosphatase, placental type; type; cat.c.(37 °C; proc.) = ? µkat/l catalytic-activity concentration(37 °C; NPU01530 P—Alkaline phosphatase, intestinal procedure) type; cat.c.(37 °C; proc.) = ? µkat/l microkatal/liter NPU10602 P—Alkaline phosphatase, ‚other‘ NPU01483 type(spec.); cat.c.(37 °C; proc.) = ? µkat/l P—Alkaline phosphatase, placental type; cat.c. (37 °C; proc.) = ? µkat/l Plasma— Alkaline phosphatase, bone type; Leukocytes(Blood)— catalytic-activity concentration(37 °C; Alkaline phosphatase; procedure) arbitrary catalytic activity(procedure) microkatal/liter NPU01143 NPU01145 Lkcs(B)—Alkaline phosphatase; arb.cat.act.(proc.) P—Alkaline phosphatase, bone type; cat.c.(37 °C; = ? proc.) = ? µkat/l Plasma— Plasma— Alkaline phosphatase; Alkaline phosphatase, intestinal type; catalytic-activity concentration(37 °C; catalytic-activity concentration(37 °C; procedure) procedure) microkatal/liter microkatal/liter NPU01144 NPU01530 P—Alkaline phosphatase; cat.c.(37 °C; proc.) = ? P—Alkaline phosphatase, intestinal type; cat.c. µkat/l (37 °C; proc.) = ? µkat/l Urine— Plasma— Alkaline phosphatase; Alkaline phosphatase, liver canaliculus type; catalytic-activity concentration(37 °C; catalytic-activity concentration(37 °C; procedure) procedure) microkatal/liter microkatal/liter NPU10020 NPU10601 U—Alkaline phosphatase; cat.c.(37 °C; proc.) = ? P—Alkaline phosphatase, liver canaliculus type; µkat/l cat.c.(37 °C; proc.) = ? µkat/l Plasma— Plasma— Alpha-1-globulin; Alkaline phosphatase, liver endothelial type; mass concentration catalytic-activity concentration(37 °C; gram/liter procedure) NPU04650 microkatal/liter P—Alpha-1-globulin; mass c. = ? g/l NPU10600 P—Alkaline phosphatase, liver endothelial type; Cerebrospinal fluid— cat.c.(37 °C; proc.) = ? µkat/l Alpha-1-globulin; mass concentration Plasma— milligram/liter Alkaline phosphatase, liver type; NPU04658 catalytic-activity concentration(37 °C; Csf—Alpha-1-globulin; mass c. = ? mg/l procedure) microkatal/liter Urine— NPU01013 Alpha-1-globulin; P—Alkaline phosphatase, liver type; cat.c.(37 °C; mass concentration proc.) = ? µkat/l milligram/liter NPU04654 Plasma— U—Alpha-1-globulin; mass c. = ? mg/l Alkaline phosphatase, ‘other’ type(specification); catalytic-activity concentration(37 °C; Protein(Cerebrospinal fluid)— procedure) Alpha-1-globulin; microkatal/liter mass fraction NPU10602 NPU04950 P—Alkaline phosphatase, ‘other’ type(spec.); Prot.(Csf)—Alpha-1-globulin; mass fr. = ? cat.c.(37 °C; proc.) = ? µkat/l

Protein(Plasma)— Urine— Alpha-1-globulin; Alpha-globulin; mass fraction mass concentration NPU04940 milligram/liter Prot.(P)—Alpha-1-globulin; mass fr. = ? NPU14037 U—Alpha-globulin; mass c. = ? mg/l Protein(Urine)— Alpha-1-globulin; Protein(Cerebrospinal fluid)— mass fraction Alpha-globulin; NPU04945 mass fraction Prot.(U)—Alpha-1-globulin; mass fr. = ? NPU14038 Prot.(Csf)—Alpha-globulin; mass fr. = ? Plasma— Alpha-2-globulin; Protein(Plasma)— mass concentration Alpha-globulin; gram/liter mass fraction NPU04651 NPU09264 P—Alpha-2-globulin; mass c. = ? g/l Prot.(P)—Alpha-globulin; mass fr. = ?

Cerebrospinal fluid— Protein(Urine)— Alpha-2-globulin; Alpha-globulin; mass concentration mass fraction milligram/liter NPU14036 NPU04659 Prot.(U)—Alpha-globulin; mass fr. = ? Csf—Alpha-2-globulin; mass c. = ? mg/l Plasma— Urine— Aluminium; Alpha-2-globulin; substance concentration mass concentration micromole/liter milligram/liter M = 26,98 g/mol NPU04655 Authority: IUPAC/VII-C-TOX U—Alpha-2-globulin; mass c. = ? mg/l NPU01157 P—Aluminium; subst.c. = ? µmol/l Protein(Cerebrospinal fluid)— Alpha-2-globulin; Urine— mass fraction Aluminium; NPU04951 substance concentration Prot.(Csf)—Alpha-2-globulin; mass fr. = ? micromole/liter M = 26,98 g/mol Protein(Plasma)— Authority: IUPAC/VII-C-TOX Alpha-2-globulin; NPU01158 mass fraction U—Aluminium; subst.c. = ? µmol/l NPU04941 Prot.(P)—Alpha-2-globulin; mass fr. = ? Cells(Blood)— Aluminium; Protein(Urine)— substance content Alpha-2-globulin; micromole/kilogram mass fraction M = 26,98 g/mol NPU04946 Authority: IUPAC/VII-C-TOX Prot.(U)—Alpha-2-globulin; mass fr. = ? NPU01155 Cells(B)—Aluminium; subst.cont. = ? µmol/kg Plasma— Alpha-globulin; Hair— mass concentration Aluminium; gram/liter substance content NPU09261 micromole/kilogram P—Alpha-globulin; mass c. = ? g/l M = 26,98 g/mol Authority: IUPAC/VII-C-TOX Cerebrospinal fluid— NPU01156 Alpha-globulin; Hair—Aluminium; subst.cont. = ? µmol/kg mass concentration milligram/liter NPU14035 Csf—Alpha-globulin; mass c. = ? mg/l

Urine— NPU14220 U—3-Hydroxy-3-carboxy-n-propylthio- Amino acid/Creatininium; cystine/Creatininium; subst.ratio = ? × 10-3 substance ratio(list; procedure) NPU14221 U—a-Hydroxy-b-chito-g-aminobutyrate/ NPU14178 Creatininium; subst.ratio = ? × 10-3 U—Amino acid/Creatininium; subst.ratio(list; proc.) NPU14222 U—3-Hydroxyasparagine/Creatininium; NPU14186 U—Alanine/Creatininium; subst.ratio = ? subst.ratio = ? × 10-3 × 10-3 NPU14223 U—3-Hydroxyisovalerate/Creatininium; NPU14187 U—b-Alanine/Creatininium; subst.ratio = subst.ratio = ? × 10-3 ? × 10-3 NPU14224 U—3-Hydroxykynurenine/Creatininium; NPU14188 U—Amino-2-piperidone/Creatininium; subst.ratio = ? × 10-3 subst.ratio = ? × 10-3 NPU14225 U—5-Hydroxylysine/Creatininium; NPU14189 U—a-Amino-n-butyrate/Creatininium; subst.ratio = ? × 10-3 subst.ratio = ? × 10-3 NPU14226 U—4-Hydroxyproline/Creatininium; NPU14190 U—a-Aminoadipate/Creatininium; subst.ratio = ? × 10-3 subst.ratio = ? × 10-3 NPU04210 U—Hydroxyproline/Creatininium; NPU14191 U—a-Aminobutyrate/Creatininium; subst.ratio= ? × 10-3 subst.ratio = ? × 10-3 NPU14228 U—3-Hydroxyproline/Creatininium; NPU14192 U—g-Aminobutyrate/Creatininium; subst.ratio = ? × 10-3 subst.ratio = ? × 10-3 NPU14229 U—Isoleucine/Creatininium; subst.ratio NPU14193 U—b-Aminoisobutyrate/Creatininium; = ? × 10-3 subst.ratio = ? × 10-3 NPU14230 U—Kynurenine/Creatininium; subst.ratio NPU14194 U—g-Aminoisobutyrate/Creatininium; = ? × 10-3 subst.ratio = ? × 10-3 NPU14231 U—Leucine/Creatininium; subst.ratio = ? NPU14200 U—g-Carboxyglutamate/Creatininium; × 10-3 subst.ratio = ? × 10-3 NPU14232 U—Levodopa/Creatininium; subst.ratio = NPU14201 U—N-e-Carboxymethyl lysine/ ? × 10-3 Creatininium; subst.ratio = ? × 10-3 NPU14233 U—Lysine/Creatininium; subst.ratio = ? NPU14202 U—Carnitine/Creatininium; subst.ratio = × 10-3 ? × 10-3 NPU14234 U—Malate/Creatininium; subst.ratio = ? NPU14203 U—Carnosine/Creatininium; subst.ratio × 10-3 = ? × 10-3 NPU14235 U—Methionine/Creatininium; subst.ratio NPU14204 U—Citrulline/Creatininium; subst.ratio = = ? × 10-3 ? × 10-3 NPU14236 U—Methionine sulfoxide/Creatininium; NPU14205 U—Cystathionine/Creatininium; subst.ratio = ? × 10-3 subst.ratio = ? × 10-3 NPU14237 U—Methylcitrate/Creatininium; NPU14206 U—Cysteine-L-homocysteine disulfide/ subst.ratio = ? × 10-3 Creatininium; subst.ratio = ? × 10-3 NPU14238 U—1-Methylhistidine/Creatininium; NPU14207 U—Cystine/Creatininium; subst.ratio = ? subst.ratio = ? × 10-3 × 10-3 NPU14239 U—3-Methylhistidine/Creatininium; NPU14208 U—Ethanolamine/Creatininium; subst.ratio = ? × 10-3 subst.ratio = ? × 10-3 NPU14240 U—Ornithine/Creatininium; subst.ratio = NPU14209 U—Glutamate/Creatininium; subst.ratio ? × 10-3 = ? × 10-3 NPU14241 U—Phenylalanine/Creatininium; NPU14210 U—Glutamine/Creatininium; subst.ratio subst.ratio = ? × 10-3 = ? × 10-3 NPU14242 U—Phosphoethanolamine/Creatininium; NPU14211 U—Glycine/Creatininium; subst.ratio = ? subst.ratio = ? × 10-3 × 10-3 NPU14243 U—Phosphoserine/Creatininium; NPU14212 U—Glycolate/Creatininium; subst.ratio = subst.ratio = ? × 10-3 ? × 10-3 NPU14244 U—Pipecolate/Creatininium; subst.ratio NPU14213 U—Histidine/Creatininium; subst.ratio = = ? × 10-3 ? × 10-3 NPU14245 U—Proline/Creatininium; subst.ratio = ? NPU14214 U—Homoarginine/Creatininium; × 10-3 subst.ratio = ? × 10-3 NPU14246 U—d-1-Pyrroline-5-carboxylate/ NPU14215 U—Homocarnosine/Creatininium; Creatininium; subst.ratio = ? × 10-3 subst.ratio = ? × 10-3 NPU14247 U—Saccharopine/Creatininium; NPU14216 U—Homocitrulline/Creatininium; subst.ratio = ? × 10-3 subst.ratio = ? × 10-3 NPU14248 U—Sarcosine/Creatininium; subst.ratio NPU14217 U—Homocystine/Creatininium; = ? × 10-3 subst.ratio = ? × 10-3 NPU14249 U—Serine/Creatininium; subst.ratio = ? NPU14218 U—Homoserine/Creatininium; × 10-3 subst.ratio = ? × 10-3 NPU14250 U—Sulfo-L-cysteine/Creatininium; NPU10164 U—Homovanillate/Creatininium; subst.ratio = ? × 10-3 subst.ratio = ? × 10-3 NPU14251 U—Taurine/Creatininium; subst.ratio = ?

× 10-3 NPU01207 P—b-Aminoisobutyrate; subst.c. = ? NPU14252 U—Threonine/Creatininium; subst.ratio µmol/l = ? × 10-3 NPU10401 P—g-Aminoisobutyrate; subst.c. = ? NPU14253 U—Tryptophan/Creatininium; subst.ratio µmol/l = ? × 10-3 NPU01267 P—Anserine; subst.c. = ? µmol/l NPU14254 U—Tyramine-O-sulphate/Creatininium; NPU01298 P—Arginine; subst.c. = ? µmol/l subst.ratio = ? × 10-3 NPU01319 P—Asparagine; subst.c. = ? µmol/l NPU14255 U—Tyramine/Creatininium; subst.ratio = NPU01322 P—Aspartate; subst.c. = ? µmol/l ? × 10-3 NPU01503 P—Carnosine; subst.c. = ? µmol/l NPU14256 U—Tyrosine/Creatininium; subst.ratio = NPU01611 P—Citrulline; subst.c. = ? µmol/l ? × 10-3 NPU01820 P—Cystathionine; subst.c. = ? µmol/l NPU14257 U—Valine/Creatininium; subst.ratio = ? NPU01826 P—Cystine; subst.c. = ? µmol/l × 10-3 NPU02229 P—Glutamate; subst.c. = ? µmol/l NPU14258 U—Xylosylserine/Creatininium; NPU02249 P—Glutamine; subst.c. = ? µmol/l subst.ratio = ? × 10-3 NPU02289 P—Glycine; subst.c. = ? µmol/l NPU02373 P—Histidine; subst.c. = ? µmol/l Cerebrospinal fluid— NPU02397 P—Homocystine; subst.c. = ? µmol/l Amino acid; NPU02433 P—5-Hydroxylysine; subst.c. = ? µmol/l substance concentration(list; procedure) NPU02463 P—3-Hydroxyproline; subst.c. = ? µmol/l NPU09013 NPU02464 P—4-Hydroxyproline; subst.c. = ? µmol/l Csf—Amino acid; subst.c.(list; proc.) NPU02510 P—Isoleucine; subst.c. = ? µmol/l NPU01116 Csf—Alanine; subst.c. = ? µmol/l NPU02589 P—Leucine; subst.c. = ? µmol/l NPU09017 Csf—b-Alanine; subst.c. = ? µmol/l NPU02639 P—Lysine; subst.c. = ? µmol/l NPU09018 Csf—a-Aminobutyrate; subst.c. = ? NPU02726 P—Methionine; subst.c. = ? µmol/l µmol/l NPU02776 P—1-Methylhistidine; subst.c. = ? µmol/l NPU09019 Csf—b-Aminoisobutyrate; subst.c. = ? NPU02778 P—3-Methylhistidine; subst.c. = ? µmol/l µmol/l NPU02936 P—Ornithine; subst.c. = ? µmol/l NPU01297 Csf—Arginine; subst.c. = ? µmol/l NPU03070 P—Phenylalanine; subst.c. = ? µmol/l NPU01318 Csf—Asparagine; subst.c. = ? µmol/l NPU03114 P—Phosphoethanolamine; subst.c. = ? NPU01321 Csf—Aspartate; subst.c. = ? µmol/l µmol/l NPU09020 Csf—Citrulline; subst.c. = ? µmol/l NPU10399 P—Phosphoserine; subst.c. = ? µmol/l NPU09021 Csf—Cystine; subst.c. = ? µmol/l NPU03256 P—Proline; subst.c. = ? µmol/l NPU02228 Csf—Glutamate; subst.c. = ? µmol/l NPU03396 P—Sarcosine; subst.c. = ? µmol/l NPU09022 Csf—Glutamine; subst.c. = ? µmol/l NPU03415 P—Serine; subst.c. = ? µmol/l NPU02288 Csf—Glycine; subst.c. = ? µmol/l NPU03541 P—Taurine; subst.c. = ? µmol/l NPU09023 Csf—Histidine; subst.c. = ? µmol/l NPU03558 P—Threonine; subst.c. = ? µmol/l NPU09025 Csf—3-Hydroxyproline; subst.c. = ? NPU03655 P—Tryptophan(free); subst.c. = ? µmol/l µmol/l NPU03659 P—Tyrosine; subst.c. = ? µmol/l NPU09026 Csf—4-Hydroxyproline; subst.c. = ? NPU03733 P—Valine; subst.c. = ? µmol/l µmol/l NPU09027 Csf—Isoleucine; subst.c. = ? µmol/l Urine— NPU09028 Csf—Leucine; subst.c. = ? µmol/l Amino acid; NPU09029 Csf—Lysine; subst.c. = ? µmol/l substance concentration(list; procedure) NPU09030 Csf—Methionine; subst.c. = ? µmol/l NPU09012 NPU09031 Csf—Ornithine; subst.c. = ? µmol/l U—Amino acid; subst.c.(list; proc.) NPU03069 Csf—Phenylalanine; subst.c. = ? µmol/l NPU01118 U—Alanine; subst.c. = ? µmol/l NPU03255 Csf—Proline; subst.c. = ? µmol/l NPU01120 U—b-Alanine; subst.c. = ? µmol/l NPU03414 Csf—Serine; subst.c. = ? µmol/l NPU09015 U—a-Aminobutyrate; subst.c. = ? µmol/l NPU03540 Csf—Taurine; subst.c. = ? µmol/l NPU01208 U—b-Aminoisobutyrate; subst.c. = ? NPU03557 Csf—Threonine; subst.c. = ? µmol/l µmol/l NPU03653 Csf—Tryptophan; subst.c. = ? µmol/l NPU01299 U—Arginine; subst.c. = ? µmol/l NPU09033 Csf—Tyrosine; subst.c. = ? µmol/l NPU01320 U—Asparagine; subst.c. = ? µmol/l NPU03732 Csf—Valine; subst.c. = ? µmol/l NPU01323 U—Aspartate; subst.c. = ? µmol/l NPU01612 U—Citrulline; subst.c. = ? µmol/l Plasma— NPU01828 U—Cystine; subst.c. = ? µmol/l Amino acid; NPU02230 U—Glutamate; subst.c. = ? µmol/l substance concentration(list; procedure) NPU02250 U—Glutamine; subst.c. = ? µmol/l NPU09011 NPU02290 U—Glycine; subst.c. = ? µmol/l P—Amino acid; subst.c.(list; proc.) NPU02374 U—Histidine; subst.c. = ? µmol/l NPU01117 P—Alanine; subst.c. = ? µmol/l NPU09024 U—3-Hydroxyproline; subst.c. = ? µmol/l NPU01119 P—b-Alanine; subst.c. = ? µmol/l NPU02465 U—4-Hydroxyproline; subst.c. = ? µmol/l NPU01203 P—a-Aminoadipate; subst.c. = ? µmol/l NPU02511 U—Isoleucine; subst.c. = ? µmol/l NPU09014 P—a-Aminobutyrate; subst.c. = ? µmol/l NPU02590 U—Leucine; subst.c. = ? µmol/l

NPU02640 U—Lysine; subst.c. = ? µmol/l Urine— NPU02727 U—Methionine; subst.c. = ? µmol/l g- NPU02937 U—Ornithine; subst.c. = ? µmol/l Aminobutyrate/Creatininium; NPU03071 U—Phenylalanine; subst.c. = ? µmol/l substance ratio NPU03257 U—Proline; subst.c. = ? µmol/l 10-3 NPU03416 U—Serine; subst.c. = ? µmol/l NPU14192 NPU03542 U—Taurine; subst.c. = ? µmol/l U—g-Aminobutyrate/Creatininium; subst.ratio = ? × NPU03559 U—Threonine; subst.c. = ? µmol/l 10-3 NPU03654 U—Tryptophan; subst.c. = ? µmol/l NPU03660 U—Tyrosine; subst.c. = ? µmol/l Cerebrospinal fluid— NPU03734 U—Valine; subst.c. = ? µmol/l a- Aminobutyrate; Urine— substance concentration Amino-2-piperidone/Creatininium; micromole/liter substance ratio NPU09018 10-3 Csf—a-Aminobutyrate; subst.c. = ? µmol/l NPU14188 U—Amino-2-piperidone/Creatininium; subst.ratio = Plasma— ? × 10-3 a- Aminobutyrate; Urine— substance concentration Amino-2-piperidone; micromole/liter substance concentration NPU09014 micromole/liter P—a-Aminobutyrate; subst.c. = ? µmol/l NPU01173 U—Amino-2-piperidone; subst.c. = ? µmol/l Urine— a- Urine— Aminobutyrate; a- substance concentration Aminoadipate/Creatininium; micromole/liter substance ratio NPU09015 10-3 U—a-Aminobutyrate; subst.c. = ? µmol/l NPU14190 U—a-Aminoadipate/Creatininium; subst.ratio = ? × Plasma— 10-3 g- Aminobutyrate; Plasma— substance concentration a- micromole/liter Aminoadipate; Other term(s): GABA substance concentration NPU01205 micromole/liter P—g-Aminobutyrate; subst.c. = ? µmol/l NPU01203 P—a-Aminoadipate; subst.c. = ? µmol/l Urine— g- Urine— Aminobutyrate; a- substance concentration Aminoadipate; micromole/liter substance concentration Other term(s): GABA micromole/liter NPU01206 NPU01204 U—g-Aminobutyrate; subst.c. = ? µmol/l U—a-Aminoadipate; subst.c. = ? µmol/l Urine— Urine— b- a- Aminoisobutyrate/Creatininium; Aminobutyrate/Creatininium; substance ratio substance ratio 10-3 10-3 NPU14193 NPU14191 U—b-Aminoisobutyrate/Creatininium; subst.ratio = ? U—a-Aminobutyrate/Creatininium; subst.ratio = ? × × 10-3 10-3

Urine— micromole/liter g- NPU04159 Aminoisobutyrate/Creatininium; U—5-Aminolevulinate; subst.c. = ? µmol/l substance ratio 10-3 Patient(Urine)— NPU14194 5- U—g-Aminoisobutyrate/Creatininium; subst.ratio = ? Aminolevulinate; × 10-3 substance rate(procedure) micromole/day Cerebrospinal fluid— NPU01209 b- Pt(U)—5-Aminolevulinate; subst.rate(proc.) = ? Aminoisobutyrate; µmol/d substance concentration micromole/liter Urine— NPU09019 a- Csf—b-Aminoisobutyrate; subst.c. = ? µmol/l Amino-n-butyrate/Creatininium; substance ratio Plasma— 10-3 b- NPU14189 Aminoisobutyrate; U—a-Amino-n-butyrate/Creatininium; subst.ratio = ? substance concentration × 10-3 micromole/liter NPU01207 Cerebrospinal fluid— P—b-Aminoisobutyrate; subst.c. = ? µmol/l a- Amino-n-butyrate; Urine— substance concentration b- micromole/liter Aminoisobutyrate; M = 103,1 g/mol substance concentration Note: D-form of acid:CAS2623-91-8; DL-form of micromole/liter acid:CAS2835-81-6; L-form of acid:CAS1492-24-6 NPU01208 NPU01184 U—b-Aminoisobutyrate; subst.c. = ? µmol/l Csf—a-Amino-n-butyrate; subst.c. = ? µmol/l

Plasma— Plasma— g- a- Aminoisobutyrate; Amino-n-butyrate; substance concentration substance concentration micromole/liter micromole/liter Authority: IUPAC-IUB84 NPU01185 NPU10401 P—a-Amino-n-butyrate; subst.c. = ? µmol/l P—g-Aminoisobutyrate; subst.c. = ? µmol/l Urine— Urine— a- 5- Amino-n-butyrate; Aminolevulinate/Creatininium; substance concentration substance ratio micromole/liter 10-3 NPU01186 NPU09006 U—a-Amino-n-butyrate; subst.c. = ? µmol/l U—5-Aminolevulinate/Creatininium; subst.ratio = ? × 10-3 Calculus(Urine)— Ammonium; Plasma— arbitrary content(procedure) 5- Note: M(ammonia) = 17,04 g/mol Aminolevulinate; NPU09232 substance concentration Calculus(U)—Ammonium; arb.cont.(proc.) = ? micromole/liter Other term(s): d-Aminolevulinate Plasma— NPU01210 Ammonium; P—5-Aminolevulinate; subst.c. = ? µmol/l substance concentration micromole/liter Urine— Authority: IFCC/C-BGE 5- Note: M (ammonia) = 17,04 g/mol Aminolevulinate; NPU03928 substance concentration P—Ammonium; subst.c. = ? µmol/l

Plasma(arterial Blood)— NPU03923 P—Amylase, saliva type; cat.c.(37 °C; Ammonium; proc.) = ? µkat/l substance concentration micromole/liter Amylase(Plasma)— Authority: IFCC/C-BGE Amylase type; Note: M (ammonia) = 17,04 g/mol catalytic-activity fraction(list; 37 °C; procedure) NPU01226 NPU04162 P(aB)—Ammonium; subst.c. = ? µmol/l Amylase(P)—Amylase type; cat.fr.(list; 37 °C; proc.) NPU04163 Amylase(P)—Amylase, pancreatic type Urine— 3; cat.fr.(37 °C; proc.) = ? Ammonium; NPU04165 Amylase(P)—Amylase, pancreatic type substance concentration 4+5; cat.fr.(37 °C; proc.) = ? micromole/liter NPU04164 Amylase(P)—Amylase, saliva type; Authority: IFCC/C-BGE cat.fr.(37 °C; proc.) = ? Note: M (ammonia) = 17,04 g/mol NPU01227 Plasma— U—Ammonium; subst.c. = ? µmol/l Amylase, pancreatic type 3; catalytic-activity concentration(37 °C; Calculus(Urine)— procedure) Ammonium; microkatal/liter substance content NPU03922 mole/kilogram P—Amylase, pancreatic type 3; cat.c.(37 °C; proc.) Note: M(ammonia) = 17,04 g/mol = ? µkat/l NPU09238 Calculus(U)—Ammonium; subst.cont. = ? mol/kg Amylase(Plasma)— Amylase, pancreatic type 3; Patient(Urine)— catalytic-activity fraction(37 °C; procedure) Ammonium; NPU04163 substance rate(procedure) Amylase(P)—Amylase, pancreatic type 3; cat.fr.(37 micromole/day °C; proc.) = ? Authority: IFCC/C-BGE Note: M (ammonia) = 17,04 g/mol Ascites— NPU01225 Amylase, pancreatic type 3+4+5; Pt(U)—Ammonium; subst.rate(proc.) = ? µmol/d catalytic-activity concentration(37 °C; procedure) Patient— microkatal/liter Amniotic fluid; NPU08589 relative volumic mass(20 °C/water, 20 °C; Asc—Amylase, pancreatic type 3+4+5; cat.c.(37 °C; procedure) proc.) = ? µkat/l NPU10184 Pt—Amniotic fluid; rel.volumic mass(20 °C/water, Drain fluid(specification)— 20 °C; proc.) = ? Amylase, pancreatic type 3+4+5; catalytic-activity concentration(37 °C; Pancreas— procedure) Amylase production; microkatal/liter catalytic-activity rate(37 °C; procedure) NPU08590 microkatal/second Drain fluid(spec.)—Amylase, pancreatic type 3+4+5; NPU01241 cat.c.(37 °C; proc.) = ? µkat/l Pancreas—Amylase production; cat.rate(37 °C; proc.) = ? µkat/s Plasma— Amylase, pancreatic type 3+4+5; Plasma— catalytic-activity concentration(37 °C; Amylase type; procedure) catalytic-activity concentration(list; 37 °C; microkatal/liter procedure) NPU08591 NPU01242 P—Amylase, pancreatic type 3+4+5; cat.c.(37 °C; P—Amylase type; cat.c.(list; 37 °C; proc.) proc.) = ? µkat/l NPU03922 P—Amylase, pancreatic type 3; cat.c.(37 °C; proc.) = ? µkat/l Urine— NPU08591 P—Amylase, pancreatic type 3+4+5; Amylase, pancreatic type 3+4+5; cat.c.(37 °C; proc.) = ? µkat/l catalytic-activity concentration(37 °C; NPU03964 P—Amylase, pancreatic type 4+5; procedure) cat.c.(37 °C; proc.) = ? µkat/l microkatal/liter NPU08969 U—Amylase, pancreatic type 3+4+5; cat.c.(37 °C; proc.) = ? µkat/l © 2000 IUPAC, Pure and Applied Chemistry 72, 747–972 770 H. OLESEN et al.

Plasma— Drain fluid(specification)— Amylase, pancreatic type 4+5; Amylase; catalytic-activity concentration(37 °C; catalytic-activity concentration(37 °C; procedure) procedure) microkatal/liter microkatal/liter NPU03964 NPU17195 P—Amylase, pancreatic type 4+5; cat.c.(37 °C; Drain fluid(spec.)—Amylase; cat.c.(37 °C; proc.) = ? proc.) = ? µkat/l µkat/l

Amylase(Plasma)— Duodenal fluid— Amylase, pancreatic type 4+5; Amylase; catalytic-activity fraction(37 °C; procedure) catalytic-activity concentration(37 °C; NPU04165 procedure) Amylase(P)—Amylase, pancreatic type 4+5; microkatal/liter cat.fr.(37 °C; proc.) = ? NPU10603 Duodf—Amylase; cat.c.(37 °C; proc.) = ? µkat/l Plasma— Amylase, saliva type; Plasma— catalytic-activity concentration(37 °C; Amylase; procedure) catalytic-activity concentration(37 °C; microkatal/liter procedure) NPU03923 microkatal/liter P—Amylase, saliva type; cat.c.(37 °C; proc.) = ? Other term(s): Glycogenase µkat/l NPU01238 P—Amylase; cat.c.(37 °C; proc.) = ? µkat/l Amylase(Plasma)— Amylase, saliva type; Pleural fluid(specification)— catalytic-activity fraction(37 °C; procedure) Amylase; NPU04164 catalytic-activity concentration(37 °C; Amylase(P)—Amylase, saliva type; cat.fr.(37 °C; procedure) proc.) = ? microkatal/liter Other term(s): Glycogenase Duodenal fluid— NPU14072 Amylase; Plf(spec.)—Amylase; cat.c.(37 °C; proc.) = ? µkat/l catalytic-activity concentration(0-20 minutes postprandial; 37 °C) Secretion(specification)— microkatal/liter Amylase; NPU09245 catalytic-activity concentration(37 °C; Duodf—Amylase; cat.c.(0-20 min; 37 °C) = ? µkat/l procedure) microkatal/liter Duodenal fluid— NPU08601 Amylase; Secr(spec.)—Amylase; cat.c.(37 °C; proc.) = ? catalytic-activity concentration(20-40 minutes µkat/l postprandial; 37 °C) microkatal/liter System(specification)— NPU09246 Amylase; Duodf—Amylase; cat.c.(20-40 min; 37 °C) = ? µkat/l catalytic-activity concentration(37 °C; procedure) Duodenal fluid— microkatal/liter Amylase; NPU10123 catalytic-activity concentration(30-150 minutes Syst(spec.)—Amylase; cat.c.(37 °C; proc.) = ? postprandial; 37 °C) µkat/l microkatal/liter NPU01240 Urine— Duodf—Amylase; cat.c.(30-150 min; 37 °C) = ? Amylase; µkat/l catalytic-activity concentration(37 °C; procedure) Ascites— microkatal/liter Amylase; Other term(s): Glycogenase catalytic-activity concentration(37 °C; NPU01239 procedure) U—Amylase; cat.c.(37 °C; proc.) = ? µkat/l microkatal/liter NPU10276 Asc—Amylase; cat.c.(37 °C; proc.) = ? µkat/l

Duodenal fluid— NPU03543 P—Testosterone(tot.); subst.c. = ? Amylase; nmol/l catalytic-activity concentration(40-60 minutes NPU03549 P—Testosterone(free); subst.c. = ? postprandial; 37 °C) nmol/l microkatal/liter NPU09247 Urine— Duodf—Amylase; cat.c.(40-60 min; 37 °C) = ? µkat/l Androstandione; substance concentration Duodenal fluid— nanomole/liter Amylase; M = 288,43 g/mol catalytic-activity concentration(60-80 minutes NPU01251 postprandial; 37 °C) U—Androstandione; subst.c. = ? nmol/l microkatal/liter NPU09248 Urine— Duodf—Amylase; cat.c.(60-80 min; 37 °C) = ? µkat/l Androstanolone; arbitrary concentration(procedure) Pancreas— M = 290,4 g/mol Amylase+triacylglycerollipase secretion; Other term(s): Stanolone catalytic-activity rate(postprandial; list; NPU04906 procedure) U—Androstanolone; arb.c.(proc.) = ? NPU09254 Pancreas—Amylase+triacylglycerollipase secretion; Plasma— cat.rate(postprandial; list; proc.) Androstanolone; NPU09245 Duodf—Amylase; cat.c.(0-20 min; 37 substance concentration °C) = ? µkat/l nanomole/liter NPU09246 Duodf—Amylase; cat.c.(20-40 min; 37 M = 290,4 g/mol °C) = ? µkat/l Other term(s): Dihydrotestosterone; Stanolone NPU09247 Duodf—Amylase; cat.c.(40-60 min; 37 Authority: INN °C) = ? µkat/l NPU01252 NPU09248 Duodf—Amylase; cat.c.(60-80 min; 37 P—Androstanolone; subst.c. = ? nmol/l °C) = ? µkat/l NPU01240 Duodf—Amylase; cat.c.(30-150 min; 37 Urine— °C) = ? µkat/l Androstanolone; NPU09249 Duodf—Triacylglycerol lipase; cat.c.(0- substance concentration 20 min; 37 °C) = ? µkat/l nanomole/liter NPU09250 Duodf—Triacylglycerol lipase; cat.c.(20- M = 290,4 g/mol 40 min; 37 °C) = ? µkat/l Other term(s): Stanolone NPU09251 Duodf—Triacylglycerol lipase; cat.c.(40- NPU04907 60 min; 37 °C) = ? µkat/l U—Androstanolone; subst.c. = ? nmol/l NPU09252 Duodf—Triacylglycerol lipase; cat.c.(60- 80 min; 37 °C) = ? µkat/l Plasma— NPU09253 Duodf—Triacylglycerol lipase; cat.c.(30- Androstenedione; 150 min; 37 °C) = ? µkat/l substance concentration nanomole/liter Urine— M = 286,42 g/mol Anabolic steroid; NPU01253 taxon(procedure) P—Androstenedione; subst.c. = ? nmol/l NPU12014 U—Anabolic steroid; taxon(proc.) = ? Plasma— Androsterone; Plasma— substance concentration Androgen; nanomole/liter substance concentration(list; procedure) M = 290,43 g/mol NPU12019 Authority: IUPAC-IUB 84 P—Androgen; subst.c.(list; proc.) NPU01255 NPU01253 P—Androstenedione; subst.c. = ? nmol/l P—Androsterone; subst.c. = ? nmol/l NPU04121 P—Dehydroepiandrosterone sulfate; subst.c. = ? µmol/l Urine— NPU14568 P—Dehydroepiandrosterone sulfate; Androsterone; subst.c. = ? nmol/l substance concentration NPU01852 P—Prasterone; subst.c. = ? nmol/l nanomole/liter NPU03419 P—Sexual-hormone-binding-globulin; M = 290,43 g/mol subst.c. = ? nmol/l Authority: IUPAC-IUB 84 NPU09097 U—Androsterone; subst.c. = ? nmol/l

Patient(Urine)— Plasma— Androsterone; Anserine; substance rate substance concentration nanomole/day micromole/liter NPU10133 M = 240,26 g/mol Pt(U)—Androsterone; subst.rate = ? nmol/d NPU01267 P—Anserine; subst.c. = ? µmol/l Plasma— Angiotensin; Urine— arbitrary substance concentration(procedure) Anserine; arbitrary unit/liter substance concentration M = 1 045 g/mol micromole/liter Other term(s): Angiotensin II M = 240,26 g/mol Authority: IUPAC-IUB 74 NPU01268 NPU01256 U—Anserine; subst.c. = ? µmol/l P—Angiotensin; arb.subst.c.(proc.) = ? arb.unit/l Plasma— Plasma— Antichymotrypsin; Angiotensin; substance concentration substance concentration micromole/liter picomole/liter M = 69 000 g/mol M = 1 045 g/mol NPU01270 Other term(s): Angiotensin II P—Antichymotrypsin; subst.c. = ? µmol/l Authority: IUPAC-IUB 74 NPU01257 Kidney— P—Angiotensin; subst.c. = ? pmol/l Antidiuretic effect; property(desmopressin, intranasal Plasma— administration; list; procedure) Angiotensinogen; Note: M(desmopressin) = 1 069,23 g/mol substance concentration NPU12874 micromole/liter Kidn.—Antidiuretic effect; prop.(desmopressin i.n.; M = 60 000 g/mol list; proc.) NPU01258 NPU09117 Pt—Desmopressin(administered); P—Angiotensinogen; subst.c. = ? µmol/l am.s.(i.n.) = ? nmol NPU09118 Pt—Desmopressin(administered); Blood— subst.cont.(i.n.; am.s./body mass) = ? nmol/kg Annulocytes; NPU03434 U—Solute; molal.(proc.) = ? mmol/kg arbitrary concentration(procedure) NPU17078 Blood— B—Annulocytes; arb.c.(proc.) = ? Antimony; substance concentration Urine— nanomole/liter Anorectic agent; M = 121,75 g/mol taxon(procedure) Authority: IUPAC/VII-C-TOX NPU14339 NPU01271 U—Anorectic agent; taxon(proc.) = ? B—Antimony; subst.c. = ? nmol/l

Urine— Plasma— Anserine/Creatininium; Antimony; substance ratio substance concentration 10-3 nanomole/liter NPU14195 M = 121,75 g/mol U—Anserine/Creatininium; subst.ratio = ? × 10-3 Authority: IUPAC/VII-C-TOX NPU01273 Cerebrospinal fluid— P—Antimony; subst.c. = ? nmol/l Anserine; substance concentration Urine— micromole/liter Antimony; M = 240,26 g/mol substance concentration NPU01266 nanomole/liter Csf—Anserine; subst.c. = ? µmol/l M = 121,75 g/mol Authority: IUPAC/VII-C-TOX NPU01274 U—Antimony; subst.c. = ? nmol/l

Hair— Plasma— Antimony; Antitrypsin; substance content substance concentration micromole/kilogram micromole/liter M = 121,75 g/mol M = 54 300 g/mol Authority: IUPAC/VII-C-TOX Other term(s): Proteinase inhibitor; alpha 1-Pi NPU01272 NPU03303 Hair—Antimony; subst.cont. = ? µmol/kg P—Antitrypsin; subst.c. = ? µmol/l

Antitrypsin(Plasma)— Plasma— Antitrypsin Pi type; Apolipoprotein A; substance fraction(list; procedure) arbitrary substance concentration(procedure) NPU10388 arbitrary unit/liter Atrp(P)—Antitrypsin Pi type; subst.fr.(list; proc.) NPU04042 NPU10383 Atrp(P)—Antitrypsin Pi–;subst.fr. = ? P—Apolipoprotein A; arb.subst.c.(proc.) = ? NPU10385 Atrp(P)—Antitrypsin PiM; subst.fr. = ? arb.unit/l NPU10386 Atrp(P)—Antitrypsin PiP; subst.fr. = ? NPU10387 Atrp(P)—Antitrypsin PiS; subst.fr. = ? Plasma(fasting Patient)— NPU10384 Atrp(P)—Antitrypsin PiZ; subst.fr. = ? Apolipoprotein A; arbitrary substance concentration(procedure) Antitrypsin(Plasma)— arbitrary unit/liter Antitrypsin Pi–; NPU14148 substance fraction P(fPt)—Apolipoprotein A; arb.subst.c.(proc.) = ? NPU10383 arb.unit/l Atrp(P)—Antitrypsin Pi–;subst.fr. = ? Plasma— Antitrypsin(Plasma)— Apolipoprotein A; Antitrypsin PiM; substance concentration substance fraction mole/liter NPU10385 NPU01278 Atrp(P)—Antitrypsin PiM; subst.fr. = ? P—Apolipoprotein A; subst.c.= ? prefix ? mol/l

Antitrypsin(Plasma)— Plasma— Antitrypsin PiP; Apolipoprotein A1; substance fraction arbitrary substance concentration(procedure) NPU10386 arbitrary unit/liter Atrp(P)—Antitrypsin PiP; subst.fr. = ? NPU04043 P—Apolipoprotein A1; arb.subst.c.(proc.) = ? Antitrypsin(Plasma)— arb.unit/l Antitrypsin PiS; substance fraction Plasma(fasting Patient)— NPU10387 Apolipoprotein A1; Atrp(P)—Antitrypsin PiS; subst.fr. = ? arbitrary substance concentration(procedure) arbitrary unit/liter Antitrypsin(Plasma)— NPU14149 Antitrypsin PiZ; P(fPt)—Apolipoprotein A1; arb.subst.c.(proc.) = ? substance fraction arb.unit/l NPU10384 Atrp(P)—Antitrypsin PiZ; subst.fr. = ? Plasma— Apolipoprotein A1; Plasma— substance concentration Antitrypsin type; mole/liter taxon(procedure) NPU01279 NPU10618 P—Apolipoprotein A1; subst.c.= ? prefix ? mol/l P—Antitrypsin type; taxon(proc.) = ? Plasma— Expectorate— Apolipoprotein A2; Antitrypsin; arbitrary substance concentration(procedure) substance concentration arbitrary unit/liter micromole/liter NPU04044 M = 54 300 g/mol P—Apolipoprotein A2; arb.subst.c.(proc.) = ? NPU10273 arb.unit/l Ex—Antitrypsin; subst.c. = ? µmol/l

Plasma(fasting Patient)— Plasma— Apolipoprotein A2; Apolipoprotein B100; arbitrary substance concentration(procedure) substance concentration arbitrary unit/liter mole/liter NPU14150 NPU01282 P(fPt)—Apolipoprotein A2; arb.subst.c.(proc.) = ? P—Apolipoprotein B100; subst.c.= ? prefix ? mol/l arb.unit/l Plasma— Plasma— Apolipoprotein B150; Apolipoprotein A2; arbitrary substance concentration(procedure) substance concentration arbitrary unit/liter mole/liter NPU04047 NPU01280 P—Apolipoprotein B150; arb.subst.c.(proc.) = ? P—Apolipoprotein A2; subst.c.= ? prefix ? mol/l arb.unit/l

Plasma— Plasma(fasting Patient)— Apolipoprotein B/Apolipoprotein A1; Apolipoprotein B150; substance ratio arbitrary substance concentration(procedure) NPU10238 arbitrary unit/liter P—Apolipoprotein B/Apolipoprotein A1; subst.ratio NPU14153 = ? P(fPt)—Apolipoprotein B150; arb.subst.c.(proc.) = ? arb.unit/l Plasma— Apolipoprotein B; Plasma— arbitrary substance concentration(procedure) Apolipoprotein B150; arbitrary unit/liter substance concentration NPU04045 mole/liter P—Apolipoprotein B; arb.subst.c.(proc.) = ? NPU01283 arb.unit/l P—Apolipoprotein B150; subst.c.= ? prefix ? mol/l

Plasma(fasting Patient)— Plasma— Apolipoprotein B; Apolipoprotein B48; arbitrary substance concentration(procedure) arbitrary substance concentration(procedure) arbitrary unit/liter arbitrary unit/liter NPU14151 NPU04048 P(fPt)—Apolipoprotein B; arb.subst.c.(proc.) = ? P—Apolipoprotein B48; arb.subst.c.(proc.) = ? arb.unit/l arb.unit/l

Plasma— Plasma(fasting Patient)— Apolipoprotein B; Apolipoprotein B48; substance concentration arbitrary substance concentration(procedure) mole/liter arbitrary unit/liter NPU01281 NPU14154 P—Apolipoprotein B; subst.c.= ? prefix ? mol/l P(fPt)—Apolipoprotein B48; arb.subst.c.(proc.) = ? arb.unit/l Plasma— Apolipoprotein B100; Plasma— arbitrary substance concentration(procedure) Apolipoprotein B48; arbitrary unit/liter substance concentration NPU04046 mole/liter P—Apolipoprotein B100; arb.subst.c.(proc.) = ? NPU01284 arb.unit/l P—Apolipoprotein B48; subst.c.= ? prefix ? mol/l

Plasma(fasting Patient)— Plasma— Apolipoprotein B100; Apolipoprotein C; arbitrary substance concentration(procedure) arbitrary substance concentration(procedure) arbitrary unit/liter arbitrary unit/liter NPU14152 NPU04049 P(fPt)—Apolipoprotein B100; arb.subst.c.(proc.) = ? P—Apolipoprotein C; arb.subst.c.(proc.) = ? arb.unit/l arb.unit/l

Plasma(fasting Patient)— Plasma— Apolipoprotein C; Apolipoprotein C3; arbitrary substance concentration(procedure) arbitrary substance concentration(procedure) arbitrary unit/liter arbitrary unit/liter NPU14155 NPU04052 P(fPt)—Apolipoprotein C; arb.subst.c.(proc.) = ? P—Apolipoprotein C3; arb.subst.c.(proc.) = ? arb.unit/l arb.unit/l

Plasma— Plasma(fasting Patient)— Apolipoprotein C; Apolipoprotein C3; substance concentration arbitrary substance concentration(procedure) mole/liter arbitrary unit/liter NPU01285 NPU14158 P—Apolipoprotein C; subst.c.= ? prefix ? mol/l P(fPt)—Apolipoprotein C3; arb.subst.c.(proc.) = ? arb.unit/l Plasma— Apolipoprotein C1; Plasma— arbitrary substance concentration(procedure) Apolipoprotein C3; arbitrary unit/liter substance concentration NPU04050 mole/liter P—Apolipoprotein C1; arb.subst.c.(proc.) = ? NPU01288 arb.unit/l P—Apolipoprotein C3; subst.c.= ? prefix ? mol/l

Plasma(fasting Patient)— Plasma— Apolipoprotein C1; Apolipoprotein D; arbitrary substance concentration(procedure) arbitrary substance concentration(procedure) arbitrary unit/liter arbitrary unit/liter NPU14156 NPU04053 P(fPt)—Apolipoprotein C1; arb.subst.c.(proc.) = ? P—Apolipoprotein D; arb.subst.c.(proc.) = ? arb.unit/l arb.unit/l

Plasma— Plasma(fasting Patient)— Apolipoprotein C1; Apolipoprotein D; substance concentration arbitrary substance concentration(procedure) mole/liter arbitrary unit/liter NPU01286 NPU14159 P—Apolipoprotein C1; subst.c.= ? prefix ? mol/l P(fPt)—Apolipoprotein D; arb.subst.c.(proc.) = ? arb.unit/l Plasma— Apolipoprotein C2; Plasma— arbitrary substance concentration(procedure) Apolipoprotein D; arbitrary unit/liter substance concentration NPU04051 mole/liter P—Apolipoprotein C2; arb.subst.c.(proc.) = ? NPU01289 arb.unit/l P—Apolipoprotein D; subst.c.= ? prefix ? mol/l

Plasma(fasting Patient)— Plasma— Apolipoprotein C2; Apolipoprotein E; arbitrary substance concentration(procedure) arbitrary substance concentration(procedure) arbitrary unit/liter arbitrary unit/liter NPU14157 NPU04054 P(fPt)—Apolipoprotein C2; arb.subst.c.(proc.) = ? P—Apolipoprotein E; arb.subst.c.(proc.) = ? arb.unit/l arb.unit/l

Plasma— Plasma(fasting Patient)— Apolipoprotein C2; Apolipoprotein E; substance concentration arbitrary substance concentration(procedure) mole/liter arbitrary unit/liter NPU01287 NPU14160 P—Apolipoprotein C2; subst.c.= ? prefix ? mol/l P(fPt)—Apolipoprotein E; arb.subst.c.(proc.) = ? arb.unit/l

Plasma— Plasma(fasting Patient)— Apolipoprotein E; Apolipoprotein Lp(a); substance concentration arbitrary substance concentration(procedure) mole/liter arbitrary unit/liter NPU01290 NPU14163 P—Apolipoprotein E; subst.c.= ? prefix ? mol/l P(fPt)—Apolipoprotein Lp(a); arb.subst.c.(proc.) = ? arb.unit/l Plasma— Apolipoprotein E2; Plasma— arbitrary substance concentration(procedure) Apolipoprotein Lp(a); arbitrary unit/liter substance concentration NPU04055 mole/liter P—Apolipoprotein E2; arb.subst.c.(proc.) = ? NPU01293 arb.unit/l P—Apolipoprotein Lp(a); subst.c.= ? prefix ? mol/l

Plasma(fasting Patient)— Plasma— Apolipoprotein E2; Apolipoprotein Lp(q); arbitrary substance concentration(procedure) arbitrary substance concentration(procedure) arbitrary unit/liter arbitrary unit/liter NPU14161 NPU04058 P(fPt)—Apolipoprotein E2; arb.subst.c.(proc.) = ? P—Apolipoprotein Lp(q); arb.subst.c.(proc.) = ? arb.unit/l arb.unit/l

Plasma— Plasma(fasting Patient)— Apolipoprotein E2; Apolipoprotein Lp(q); substance concentration arbitrary substance concentration(procedure) mole/liter arbitrary unit/liter NPU01291 NPU14164 P—Apolipoprotein E2; subst.c.= ? prefix ? mol/l P(fPt)—Apolipoprotein Lp(q); arb.subst.c.(proc.) = ? arb.unit/l Plasma— Apolipoprotein H; Plasma— arbitrary substance concentration(procedure) Apolipoprotein Lp(q); arbitrary unit/liter substance concentration Other term(s): b-2-glycoprotein 1 mole/liter NPU04056 NPU01294 P—Apolipoprotein H; arb.subst.c.(proc.) = ? P—Apolipoprotein Lp(q); subst.c.= ? prefix ? mol/l arb.unit/l Plasma(fasting Patient)— Plasma(fasting Patient)— Apolipoprotein; Apolipoprotein H; arbitrary substance concentration(list; arbitrary substance concentration(procedure) procedure) arbitrary unit/liter Authority: MSH94 NPU14162 NPU13817 P(fPt)—Apolipoprotein H; arb.subst.c.(proc.) = ? P(fPt)—Apolipoprotein; arb.subst.c.(list; proc.) arb.unit/l NPU14148 P(fPt)—Apolipoprotein A; arb.subst.c.(proc.) = ? arb.unit/l Plasma— NPU14149 P(fPt)—Apolipoprotein A1; Apolipoprotein H; arb.subst.c.(proc.) = ? arb.unit/l substance concentration NPU14150 P(fPt)—Apolipoprotein A2; mole/liter arb.subst.c.(proc.) = ? arb.unit/l Other term(s): b-2-glycoprotein 1 NPU14151 P(fPt)—Apolipoprotein B; NPU01292 arb.subst.c.(proc.) = ? arb.unit/l P—Apolipoprotein H; subst.c.= ? prefix ? mol/l NPU14152 P(fPt)—Apolipoprotein B100; arb.subst.c.(proc.) = ? arb.unit/l Plasma— NPU14153 P(fPt)—Apolipoprotein B150; Apolipoprotein Lp(a); arb.subst.c.(proc.) = ? arb.unit/l arbitrary substance concentration(procedure) NPU14154 P(fPt)—Apolipoprotein B48; arbitrary unit/liter arb.subst.c.(proc.) = ? arb.unit/l NPU04057 NPU14155 P(fPt)—Apolipoprotein C; P—Apolipoprotein Lp(a); arb.subst.c.(proc.) = ? arb.subst.c.(proc.) = ? arb.unit/l arb.unit/l NPU14156 P(fPt)—Apolipoprotein C1; arb.subst.c.(proc.) = ? arb.unit/l

NPU14157 P(fPt)—Apolipoprotein C2; Urine— arb.subst.c.(proc.) = ? arb.unit/l Argininosuccinate/Creatininium; NPU14158 P(fPt)—Apolipoprotein C3; substance ratio arb.subst.c.(proc.) = ? arb.unit/l 10-3 NPU14159 P(fPt)—Apolipoprotein D; NPU14197 arb.subst.c.(proc.) = ? arb.unit/l U—Argininosuccinate/Creatininium; subst.ratio = ? NPU14160 P(fPt)—Apolipoprotein E; × 10-3 arb.subst.c.(proc.) = ? arb.unit/l NPU14161 P(fPt)—Apolipoprotein E2; Plasma— arb.subst.c.(proc.) = ? arb.unit/l Argininosuccinate; NPU14162 P(fPt)—Apolipoprotein H; substance concentration arb.subst.c.(proc.) = ? arb.unit/l micromole/liter NPU14163 P(fPt)—Apolipoprotein Lp(a); NPU01300 arb.subst.c.(proc.) = ? arb.unit/l P—Argininosuccinate; subst.c. = ? µmol/l NPU14164 P(fPt)—Apolipoprotein Lp(q); arb.subst.c.(proc.) = ? arb.unit/l Urine— Argininosuccinate; Cobalamin(Plasma)— substance concentration Aquocobalamin; micromole/liter substance fraction NPU01301 NPU04956 U—Argininosuccinate; subst.c. = ? µmol/l Cobalamin(P)—Aquocobalamin; subst.fr. = ? Blood— Patient— Arsenic; Arginine(administered); substance concentration substance content(intravenous administration; nanomole/liter amount-of-substance/body mass) M = 74,92 g/mol mole/kilogram Authority: IUPAC/VII-C-TOX M = 174,20 g/mol NPU01306 NPU09354 B—Arsenic; subst.c. = ? nmol/l Pt—Arginine(administered); subst.cont.(i.v.; am.s./ body mass) = ? mol/kg Plasma— Arsenic; Urine— substance concentration Arginine/Creatininium; nanomole/liter substance ratio M = 74,92 g/mol 10-3 Authority: IUPAC/VII-C-TOX NPU14196 NPU04903 U—Arginine/Creatininium; subst.ratio = ? × 10-3 P—Arsenic; subst.c. = ? nmol/l

Cerebrospinal fluid— Urine— Arginine; Arsenic; substance concentration substance concentration micromole/liter nanomole/liter M = 174,20 g/mol M = 74,92 g/mol NPU01297 Authority: IUPAC/VII-C-TOX Csf—Arginine; subst.c. = ? µmol/l NPU01308 U—Arsenic; subst.c. = ? nmol/l Plasma— Arginine; Hair— substance concentration Arsenic; micromole/liter substance content M = 174,20 g/mol micromole/kilogram NPU01298 M = 74,92 g/mol P—Arginine; subst.c. = ? µmol/l Authority: IUPAC/VII-C-TOX NPU01307 Urine— Hair—Arsenic; subst.cont. = ? µmol/kg Arginine; substance concentration Cells(Blood)— micromole/liter Arsenic; M = 174,20 g/mol substance content NPU01299 nanomole/kilogram U—Arginine; subst.c. = ? µmol/l M = 74,92 g/mol Authority: IUPAC/VII-C-TOX NPU04807 Cells(B)—Arsenic; subst.cont. = ? nmol/kg © 2000 IUPAC, Pure and Applied Chemistry 72, 747–972 778 H. OLESEN et al.

Plasma— Plasma— Ascorbate; Aspartate transaminase; substance concentration catalytic-activity concentration(37 °C; micromole/liter procedure) Other term(s): Vitamin C microkatal/liter NPU01317 Other term(s): Glutamic-aspartic transaminase; P—Ascorbate; subst.c. = ? µmol/l Glutamic-oxaloacetictransaminase; Transaminase A; Plasma(fasting Patient)— NPU01324 Ascorbate; P—Aspartate transaminase; cat.c.(37 °C; proc.) = ? substance concentration µkat/l micromole/liter NPU04143 Urine— P(fPt)—Ascorbate; subst.c. = ? µmol/l Aspartate/Creatininium; substance ratio Urine— 10-3 Ascorbate; NPU14199 substance concentration U—Aspartate/Creatininium; subst.ratio = ? × 10-3 micromole/liter NPU10017 Cerebrospinal fluid— U—Ascorbate; subst.c. = ? µmol/l Aspartate; substance concentration Urine— micromole/liter Asparagine/Creatininium; NPU01321 substance ratio Csf—Aspartate; subst.c. = ? µmol/l 10-3 NPU14198 Plasma— U—Asparagine/Creatininium; subst.ratio = ? × 10-3 Aspartate; substance concentration Cerebrospinal fluid— micromole/liter Asparagine; NPU01322 substance concentration P—Aspartate; subst.c. = ? µmol/l micromole/liter M = 132,12 g/mol Urine— NPU01318 Aspartate; Csf—Asparagine; subst.c. = ? µmol/l substance concentration micromole/liter Plasma— NPU01323 Asparagine; U—Aspartate; subst.c. = ? µmol/l substance concentration micromole/liter Plasma— M = 132,12 g/mol Atrial natriuretic peptide; NPU01319 arbitrary substance concentration(IS 85/669; P—Asparagine; subst.c. = ? µmol/l procedure) international unit/liter Urine— M = 3 081 g/mol Asparagine; Recommended calibrator: Synthetic human atrial substance concentration natriuretic factor; WHO 1st IS 85/669 micromole/liter Other term(s): Atrial natriuretic factor M = 132,12 g/mol NPU01337 NPU01320 P—Atrial natriuretic peptide; arb.subst.c.(IS 85/669; U—Asparagine; subst.c. = ? µmol/l proc.) = ? int. unit/l

Amniotic fluid— Plasma— Aspartate transaminase; Atrial natriuretic peptide; catalytic-activity concentration(37 °C; substance concentration procedure) picomole/liter microkatal/liter M = 3 081 g/mol Other term(s): Glutamic-aspartic transaminase; Other term(s): Atrial natriuretic factor Glutamic-oxaloacetic transaminase; Transaminase NPU17180 A; P—Atrial natriuretic peptide; subst.c. = ? pmol/l NPU03908 Amf—Aspartate transaminase; cat.c.(37 °C; proc.) = ? µkat/l

Plasma(arterial Blood)— Plasma— Atrial natriuretic peptide; Bactericidal permeability increasing protein substance concentration antibody(Immunoglobulin G); picomole/liter arbitrary substance concentration(ANCA; M = 3 081 g/mol procedure) Recommended calibrator: Synthetic human atrial 10³ arbitrary unit/liter natriuretic factor; WHO 1st IS 85/669 NPU17705 Other term(s): Atrial natriuretic factor P—Bactericidal permeability increasing protein NPU01338 antibody(IgG); arb.subst.c.(ANCA; proc.) = ? × 10³ P(aB)—Atrial natriuretic peptide; subst.c. = ? pmol/l arb.unit/l

Urine— Vaginal fluid— Atrial natriuretic peptide; Bacterium(specification); substance concentration arbitrary concentration(procedure) picomole/liter NPU06687 M = 3 081 g/mol Vagf—Bacterium(spec.); arb.c.(proc.) = ? Recommended calibrator: Synthetic human atrial natriuretic factor; WHO 1st IS 85/669 Urine— Other term(s): Atrial natriuretic factor Bacterium, nitrite producing; NPU14005 arbitrary concentration(procedure) U—Atrial natriuretic peptide; subst.c. = ? pmol/l NPU10506 U—Bacterium, nitrite producing; arb.c.(proc.) = ? Patient(Urine)— Atrial natriuretic peptide; Urine— substance rate Bacterium, nitrite producing; picomole/day number concentration(procedure) M = 3 081 g/mol 109/liter Other term(s): Atrial natriuretic factor NPU01341 NPU14006 U—Bacterium, nitrite producing; num.c.(proc.) = ? × Pt(U)—Atrial natriuretic peptide; subst.rate = ? 109/l pmol/d Urine— Blood— Bacterium; Atypical cells; arbitrary concentration(procedure) number concentration NPU08592 109/liter U—Bacterium; arb.c.(proc.) = ? NPU10762 B—Atypical cells; num.c. = ? × 109/l Plasma— Barium; Urine— substance concentration Azithromycin; nanomole/liter arbitrary concentration(procedure) M = 137,34 g/mol M = 748,99 g/mol Authority: IUPAC/VII-C-TOX Authority: INN NPU01346 NPU08775 P—Barium; subst.c. = ? nmol/l U—Azithromycin; arb.c.(proc.) = ? Urine— Urine— Barium; Azithromycin; substance concentration substance concentration nanomole/liter mole/liter M = 137,34 g/mol M = 748,99 g/mol Authority: IUPAC/VII-C-TOX Authority: INN NPU01347 NPU08774 U—Barium; subst.c. = ? nmol/l U—Azithromycin; subst.c.= ? prefix ? mol/l Extracellular fluid— Plasma— Base excess(H+binding group); Bactericidal permeability increasing protein substance concentration(actual-norm) antibody(Immunoglobulin G); millimole/liter arbitrary concentration(procedure) Authority: IFCC/C-BGE NPU17670 NPU03815 P—Bactericidal permeability increasing protein Ecf—Base excess(H+binding group); antibody(IgG); arb.c.(proc.) = ? subst.c.(actual-norm) = ? mmol/l

Plasma(arterial Blood)— NPU01348 Base excess(H+binding group); P(aB)—Base excess(H+binding group);

substance concentration(actual-norm) subst.c.(pCO2 = 5,3 kPa; 37 °C; actual-norm) = ? millimole/liter mmol/l NPU12518 P(aB)—Base excess(H+binding group); Plasma(capillary Blood)— subst.c.(actual-norm) = ? mmol/l Base excess(H+binding group);

substance concentration(pCO2 = 5,3 kPa; 37 °C; Plasma(capillary Blood)— actual-norm) Base excess(H+binding group); millimole/liter

substance concentration(actual-norm) Note: standard: blood; pCO2 = 5,3 kPa; 37 °C millimole/liter NPU12480 NPU12520 P(cB)—Base excess(H+binding group); + P(cB)—Base excess(H binding group); subst.c.(pCO2 = 5,3 kPa; 37 °C; actual-norm) = ? subst.c.(actual-norm) = ? mmol/l mmol/l

Plasma(cord Blood)— Plasma(cord Blood)— Base excess(H+binding group); Base excess(H+binding group);

substance concentration(actual-norm) substance concentration(pCO2 = 5,3 kPa; 37 °C; millimole/liter actual-norm) NPU12519 millimole/liter P(cordB)—Base excess(H+binding group); Authority: IFCC/C-BGE

subst.c.(actual-norm) = ? mmol/l Note: standard: blood; pCO2 = 5,3 kPa; 37 °C NPU10219 Plasma(cord Blood; arterial Blood)— P(cordB)—Base excess(H+binding group); + Base excess(H binding group); subst.c.(pCO2 = 5,3 kPa; 37 °C; actual-norm) = ? substance concentration(actual-norm) mmol/l millimole/liter NPU17133 Plasma(cord Blood; arterial Blood)— P(cordB; aB)—Base excess(H+binding group); Base excess(H+binding group);

subst.c.(actual-norm) = ? mmol/l substance concentration(pCO2 = 5,3 kPa; 37 °C; actual-norm) Plasma(cord Blood; venous Blood)— millimole/liter Base excess(H+binding group); Authority: IFCC/C-BGE

substance concentration(actual-norm) Note: standard: blood; pCO2 = 5,3 kPa; 37 °C millimole/liter NPU17135 NPU17134 P(cordB; aB)—Base excess(H+binding group); + P(cordB; vB)—Base excess(H binding group); subst.c.(pCO2 = 5,3 kPa; 37 °C; actual-norm) = ? subst.c.(actual-norm) = ? mmol/l mmol/l

Plasma(mixed Blood)— Plasma(cord Blood; venous Blood)— Base excess(H+binding group); Base excess(H+binding group);

substance concentration(actual-norm) substance concentration(pCO2 = 5,3 kPa; 37 °C; millimole/liter actual-norm) NPU09200 millimole/liter P(mixB)—Base excess(H+binding group); Authority: IFCC/C-BGE

subst.c.(actual-norm) = ? mmol/l Note: standard: blood; pCO2 = 5,3 kPa; 37 °C NPU17136 Plasma(venous Blood)— P(cordB; vB)—Base excess(H+binding group); + Base excess(H binding group); subst.c.(pCO2 = 5,3 kPa; 37 °C; actual-norm) = ? substance concentration(actual-norm) mmol/l millimole/liter NPU12521 Plasma(mixed Blood)— P(vB)—Base excess(H+binding group); Base excess(H+binding group);

subst.c.(actual-norm) = ? mmol/l substance concentration(pCO2 = 5,3 kPa; 37 °C; actual-norm) Plasma(arterial Blood)— millimole/liter Base excess(H+binding group); Authority: IFCC/C-BGE

substance concentration(pCO2 = 5,3 kPa; 37 °C; Note: standard: blood; pCO2 = 5,3 kPa; 37 °C actual-norm) NPU09201 millimole/liter P(mixB)—Base excess(H+binding group);

Authority: IFCC/C-BGE subst.c.(pCO2 = 5,3 kPa; 37 °C; actual-norm) = ?

Note: standard: blood; pCO2 = 5,3 kPa; 37 °C mmol/l

Plasma(venous Blood)— Urine— Base excess(H+binding group); Beryllium;

substance concentration(pCO2 = 5,3 kPa; 37 °C; substance concentration(Toxicology) actual-norm) nanomole/liter millimole/liter M = 9,01 g/mol Authority: IFCC/C-BGE NPU13480

Note: standard: blood; pCO2 = 5,3 kPa; 37 °C U—Beryllium; subst.c.(Toxicology) = ? nmol/l NPU08970 P(vB)—Base excess(H+binding group); Plasma—

subst.c.(pCO2 = 5,3 kPa; 37 °C; actual-norm) = ? Beryllium; mmol/l substance concentration nanomole/liter Blood— M = 9,01 g/mol Basophilocytes; Authority: IUPAC/VII-C-TOX number concentration NPU01364 109/liter P—Beryllium; subst.c. = ? nmol/l NPU01349 B—Basophilocytes; num.c. = ? × 109/l Urine— Beryllium; Blood fraction(specification)— substance concentration Basophilocytes; nanomole/liter number concentration M = 9,01 g/mol 109/liter Authority: IUPAC/VII-C-TOX NPU17547 NPU01365 B fract.(spec.)—Basophilocytes; num.c. = ? × 109/l U—Beryllium; subst.c. = ? nmol/l

Bone marrow— Plasma— Basophilocytes; Beta-1-globulin; number concentration mass concentration 109/liter gram/liter NPU04664 NPU09262 Marrow—Basophilocytes; num.c. = ? × 109/l P—Beta-1-globulin; mass c. = ? g/l

Leukocytes(Blood)— Protein(Plasma)— Basophilocytes; Beta-1-globulin; number fraction mass fraction NPU03968 NPU09265 Lkcs(B)—Basophilocytes; num.fr. = ? Prot.(P)—Beta-1-globulin; mass fr. = ?

Leukocytes(Bone marrow)— Plasma— Basophilocytes; Beta-2-globulin; number fraction mass concentration NPU04666 gram/liter Lkcs(Marrow)—Basophilocytes; num.fr. = ? NPU09263 P—Beta-2-globulin; mass c. = ? g/l Urine— Bence Jones’ protein; Protein(Plasma)— arbitrary concentration(procedure) Beta-2-globulin; NPU01351 mass fraction U—Bence Jones’ protein; arb.c.(proc.) = ? NPU09266 Prot.(P)—Beta-2-globulin; mass fr. = ? Urine— Bence Jones’ protein; Plasma— taxon(procedure) Beta-globulin; NPU09106 mass concentration U—Bence Jones’ protein; taxon(proc.) = ? gram/liter NPU04652 Plasma— P—Beta-globulin; mass c. = ? g/l Benzodiazepines; arbitrary concentration(procedure) NPU17591 P—Benzodiazepines; arb.c.(proc.) = ?

Cerebrospinal fluid— Plasma(neonatal)— Beta-globulin; Bilirubin glucuronide; mass concentration substance concentration milligram/liter micromole/liter NPU04660 NPU12532 Csf—Beta-globulin; mass c. = ? mg/l P(neonatal)—Bilirubin glucuronide; subst.c. = ? µmol/l Urine— Beta-globulin; Plasma— mass concentration Bilirubin type; milligram/liter substance concentration(list; procedure) NPU04656 NPU10022 U—Beta-globulin; mass c. = ? mg/l P—Bilirubin type; subst.c.(list; proc.) NPU01370 P—Bilirubins(tot.); subst.c. = ? µmol/l Protein(Cerebrospinal fluid)— NPU01367 P—Bilirubin albumin; subst.c. = ? µmol/l Beta-globulin; NPU01368 P—Bilirubin glucuronide; subst.c. = ? mass fraction µmol/l NPU04952 NPU17194 P—Bilirubin(conjugated); subst.c. = ? Prot.(Csf)—Beta-globulin; mass fr. = ? µmol/l NPU01366 P—Bilirubin(non-complexed); subst.c. = Protein(Plasma)— ? µmol/l Beta-globulin; mass fraction Plasma(neonatal)— NPU04942 Bilirubin type; Prot.(P)—Beta-globulin; mass fr. = ? substance concentration(list; procedure) NPU10023 Protein(Urine)— P(neonatal)—Bilirubin type; subst.c.(list; proc.) Beta-globulin; NPU04145 P(neonatal)—Bilirubins(tot.); subst.c. = ? mass fraction µmol/l NPU04947 NPU12531 P(neonatal)—Bilirubin albumin; subst.c. Prot.(U)—Beta-globulin; mass fr. = ? = ? µmol/l NPU12532 P(neonatal)—Bilirubin glucuronide; Plasma(fasting Patient)— subst.c. = ? µmol/l Bile salts; NPU17196 P(neonatal)—Bilirubin(conjugated); substance concentration subst.c. = ? µmol/l micromole/liter NPU12530 P(neonatal)—Bilirubin(non-complexed); NPU10607 subst.c. = ? µmol/l P(fPt)—Bile salts; subst.c. = ? µmol/l Plasma— Plasma— Bilirubin(conjugated); Bilirubin albumin; substance concentration substance concentration micromole/liter micromole/liter NPU17194 Other term(s): d-Bilirubin P—Bilirubin(conjugated); subst.c. = ? µmol/l NPU01367 P—Bilirubin albumin; subst.c. = ? µmol/l Plasma(neonatal)— Bilirubin(conjugated); Plasma(neonatal)— substance concentration Bilirubin albumin; micromole/liter substance concentration NPU17196 micromole/liter P(neonatal)—Bilirubin(conjugated); subst.c. = ? NPU12531 µmol/l P(neonatal)—Bilirubin albumin; subst.c. = ? µmol/l Plasma— Plasma— Bilirubin(non-complexed); Bilirubin glucuronide; substance concentration substance concentration micromole/liter micromole/liter M = 584,65 g/mol Other term(s): Bilirubin, conjugated Other term(s): Unconjugated bilirubin Note: M (bilirubin) = 584,65 g/mol NPU01366 NPU01368 P—Bilirubin(non-complexed); subst.c. = ? µmol/l P—Bilirubin glucuronide; subst.c. = ? µmol/l

Plasma(neonatal)— micromole/liter Bilirubin(non-complexed); NPU17034 substance concentration Plf—Bilirubins(tot.); subst.c. = ? µmol/l micromole/liter NPU12530 Plasma(neonatal)— P(neonatal)—Bilirubin(non-complexed); subst.c. = ? Bilirubins(total); µmol/l substance concentration micromole/liter Urine— Note: M (bilirubin) = 584,65 g/mol Bilirubins(total); NPU04145 arbitrary concentration(procedure) P(neonatal)—Bilirubins(tot.); subst.c. = ? µmol/l NPU01372 U—Bilirubins(tot.); arb.c.(proc.) = ? Secretion(specification)— Bilirubins(total); Urine— substance concentration Bilirubins(total); micromole/liter substance concentration(procedure) Note: M (bilirubin) = 584,65 g/mol micromole/liter NPU01371 Note: M (bilirubin) = 584,65 g/mol Secr(spec.)—Bilirubins(tot.); subst.c. = ? µmol/l NPU17162 U—Bilirubins(tot.); subst.c.(proc.) = ? µmol/l System(specification)— Bilirubins(total); Amniotic fluid— substance concentration Bilirubins(total); micromole/liter substance concentration Note: M (bilirubin) = 584,65 g/mol micromole/liter NPU10128 Note: M (bilirubin) = 584,65 g/mol Syst(spec.)—Bilirubins(tot.); subst.c. = ? µmol/l NPU01369 Amf—Bilirubins(tot.); subst.c. = ? µmol/l Skin(specification)— Bilirubins; Ascites— arbitrary concentration(procedure) Bilirubins(total); NPU17020 substance concentration Skin(spec.)—Bilirubins; arb.c.(proc.) = ? micromole/liter Note: M (bilirubin) = 584,65 g/mol Plasma— NPU17031 Bismuth; Asc—Bilirubins(tot.); subst.c. = ? µmol/l substance concentration nanomole/liter Cerebrospinal fluid(cell free)— M = 208,98 g/mol Bilirubins(total); Authority: IUPAC/VII-C-TOX substance concentration NPU01383 micromole/liter P—Bismuth; subst.c. = ? nmol/l NPU08602 Csf(cell free)—Bilirubins(tot.); subst.c. = ? µmol/l Urine— Bismuth; Drain fluid(specification)— substance concentration Bilirubins(total); nanomole/liter substance concentration M = 208,98 g/mol micromole/liter Authority: IUPAC/VII-C-TOX NPU17043 NPU01384 Drain fluid(spec.)—Bilirubins(tot.); subst.c. = ? U—Bismuth; subst.c. = ? nmol/l µmol/l Blood— Plasma— Blast cells; Bilirubins(total); number concentration substance concentration 109/liter micromole/liter NPU03972 Note: M (bilirubin) = 584,65 g/mol B—Blast cells; num.c. = ? × 109/l NPU01370 P—Bilirubins(tot.); subst.c. = ? µmol/l Blood fraction(specification)— Blast cells; Pleural fluid— number concentration Bilirubins(total); 109/liter substance concentration NPU17616 B fract.(spec.)—Blast cells; num.c. = ? × 109/l

Bone marrow— Patient— Blast cells; Blood; number concentration volume content 109/liter milliliter/kilogram NPU04667 NPU03808 Marrow—Blast cells; num.c. = ? × 109/l Pt—Blood; vol.cont. = ? ml/kg

Leukocytes(Blood)— Lavage fluid(specification)— Blast cells; Blood; number fraction volume NPU03971 milliliter Lkcs(B)—Blast cells; num.fr. = ? NPU14045 Lavagef(spec.)—Blood; vol. = ? ml Leukocytes(Bone marrow)— Blast cells; Patient(Sampling)— number fraction Blood; NPU04668 volume Lkcs(Marrow)—Blast cells; num.fr. = ? milliliter NPU14379 Liver— Pt(Sampling)—Blood; vol. = ? ml Blood flow; volume rate(procedure) Patient— milliliter/second Body; NPU03838 height Liver—Blood flow; vol.rate(proc.) = ? ml/s meter NPU03794 Patient— Pt—Body; height = ? m Blood fraction; property(list; procedure) Patient— NPU17593 Body; Pt—Blood fraction; prop.(list; proc.) mass increment(procedure) NPU17563 B fract.(spec.)—Erythrocytes; num.c. = kilogram ? × 1012/l NPU03805 NPU17565 B fract.(spec.)—Erythrocytes; vol.fr. = ? Pt—Body; mass incr.(proc.) = ? kg NPU17569 B fract.(spec.)—Haemoglobin(Fe); subst.c. = ? µmol/l Patient— NPU17570 B fract.(spec.)—Haemoglobin(Fe); Body; subst.c. = ? mmol/l mass NPU17571 B fract.(spec.)—Potassium ion; subst.c. kilogram = ? mmol/l NPU03804 NPU17578 B fract.(spec.)—Leukocytes; num.c. = ? Pt—Body; mass = ? kg × 109/l NPU17583 B fract.(spec.)—Sodium ion; subst.c. = ? Patient— mmol/l Body; NPU17586 B fract.(spec.)—Thrombocytes; num.c. = Celsius temperature ? × 109/l degree Celsius NPU08676 Patient(specification)— Pt—Body; temp. = ? °C Blood; Celsius temperature Cerebrospinal fluid— degree Celsius Bombesin; NPU04034 substance concentration Pt(spec.)—Blood; temp. = ? °C picomole/liter M = 2 805 g/mol Patient— Other term(s): Mammalian bombesin; Gastrin Blood; releasing polypeptide volume(procedure) NPU02162 liter Csf—Bombesin; subst.c. = ? pmol/l NPU03795 Pt—Blood; vol.(proc.) = ? l Plasma— Bombesin; substance concentration picomole/liter

M = 2 805 g/mol Patient(Urine)— Other term(s): Mammalian bombesin; Gastrin Brain natriuretic peptide; releasing polypeptide substance rate NPU02163 picomole/day P—Bombesin; subst.c. = ? pmol/l NPU17175 Pt(U)—Brain natriuretic peptide; subst.rate = ? Plasma— pmol/d Boron; substance concentration Blood— micromole/liter Bromide; M = 10,81 g/mol substance concentration Authority: IUPAC/VII-C-TOX micromole/liter NPU01400 M = 79,90 g/mol P—Boron; subst.c. = ? µmol/l Authority: IUPAC/VII-C-TOX NPU04834 Urine— B—Bromide; subst.c. = ? µmol/l Boron; substance concentration Plasma— micromole/liter Bromide; M = 10,81 g/mol substance concentration Authority: IUPAC/VII-C-TOX micromole/liter NPU04809 M = 79,90 g/mol U—Boron; subst.c. = ? µmol/l Authority: IUPAC/VII-C-TOX NPU01403 Hair— P—Bromide; subst.c. = ? µmol/l Boron; substance content Urine— micromole/kilogram Bromide; M = 10,81 g/mol substance concentration Authority: IUPAC/VII-C-TOX micromole/liter NPU04808 M = 79,90 g/mol Hair—Boron; subst.cont. = ? µmol/kg Authority: IUPAC/VII-C-TOX NPU04870 Plasma— U—Bromide; subst.c. = ? µmol/l Brainnatriuretic peptide; arbitrary substance concentration(procedure) Urine— arbitrary unit/liter Bufotenine; NPU17174 amount-of-substance(procedure) P—Brain natriuretic peptide; arb.subst.c.(proc.) = ? micromole arb.unit/l M = 204,3 g/mol Other term(s): Mappine Plasma— NPU01406 Brainnatriuretic peptide; U—Bufotenine; am.s.(proc.) = ? µmol substance concentration picomole/liter Urine— NPU17181 Cadmium/Creatininium; P—Brain natriuretic peptide; subst.c. = ? pmol/l substance ratio 10-6 Plasma(arterial Blood)— Note: M (cadmium) = 112,41 g/mol; M (creatininium) Brainnatriuretic peptide; = 113,12 g/mol substance concentration NPU09005 picomole/liter U—Cadmium/Creatininium; subst.ratio = ? × 10-6 NPU17176 P(aB)—Brain natriuretic peptide; subst.c. = ? pmol/l Blood— Cadmium; Urine— substance concentration Brainnatriuretic peptide; nanomole/liter substance concentration M = 112,41 g/mol picomole/liter Authority: IUPAC/VII-C-TOX NPU17177 NPU04874 U—Brain natriuretic peptide; subst.c. = ? pmol/l B—Cadmium; subst.c. = ? nmol/l

Plasma— Urine— Cadmium; Caesium; substance concentration substance concentration nanomole/liter nanomole/liter M = 112,41 g/mol M = 132,90 g/mol Authority: IUPAC/VII-C-TOX Authority: IUPAC/VII-C-TOX NPU01425 NPU01431 P—Cadmium; subst.c. = ? nmol/l U—Caesium; subst.c. = ? nmol/l

Urine— Hair— Cadmium; Caesium; substance concentration substance content nanomole/liter micromole/kilogram M = 112,41 g/mol M = 132,90 g/mol Authority: IUPAC/VII-C-TOX Authority: IUPAC/VII-C-TOX NPU01426 NPU01429 U—Cadmium; subst.c. = ? nmol/l Hair—Caesium; subst.cont. = ? µmol/kg

Hair— Cells(Blood)— Cadmium; Caesium; substance content substance content micromole/kilogram nanomole/kilogram M = 112,41 g/mol M = 132,90 g/mol Authority: IUPAC/VII-C-TOX Authority: IUPAC/VII-C-TOX NPU01424 NPU01428 Hair—Cadmium; subst.cont. = ? µmol/kg Cells(B)—Caesium; subst.cont. = ? nmol/kg

Cells(Blood)— Plasma— Cadmium; Calcifediol; substance content substance concentration nanomole/kilogram nanomole/liter M = 112,41 g/mol M = 400,65 g/mol Authority: IUPAC/VII-C-TOX Other term(s): Calcifediol; 25-Hydroxy-Vitamin D3 NPU04881 Authority: IUPAC-IUB 81 Cells(B)—Cadmium; subst.cont. = ? nmol/kg NPU01435 P—Calcifediol; subst.c. = ? nmol/l Patient(Urine)— Cadmium; Plasma— substance rate Calcifediol+25-Hydroxyergocalciferol; nanomole/day substance concentration M = 112,41 g/mol nanomole/liter Authority: IUPAC/VII-C-TOX NPU10267 NPU10024 P—Calcifediol+25-Hydroxyergocalciferol; subst.c. = Pt(U)—Cadmium; subst.rate = ? nmol/d ? nmol/l

Blood— Plasma— Caesium; Calcifediol+Ergocalciferol; substance concentration substance concentration nanomole/liter nanomole/liter M = 132,90 g/mol M = 400,65 g/mol Authority: IUPAC/VII-C-TOX Authority: IUPAC-IUB 81 NPU01427 NPU09105 B—Caesium; subst.c. = ? nmol/l P—Calcifediol+Ergocalciferol; subst.c. = ? nmol/l

Plasma— Plasma— Caesium; Calciferol binding protein; substance concentration substance concentration nanomole/liter micromole/liter M = 132,90 g/mol M = 58 000 g/mol Authority: IUPAC/VII-C-TOX Other term(s): Gc-globulin; Vitamin D-binding NPU01430 protein P—Caesium; subst.c. = ? nmol/l NPU01436 P—Calciferol binding protein; subst.c. = ? µmol/l

Plasma— subst.cont.(i.v.; am.s./body mass) = ? nmol/kg Calciol; NPU10378 P—Calcitonin; subst.c.(-20 min) = ? substance concentration pmol/l nanomole/liter NPU10377 P—Calcitonin; subst.c.(-10 min) = ? M = 384,62 g/mol pmol/l Other term(s): Colecalciferol; Vitamin D3 NPU10478 P—Calcitonin; subst.c.(0 min) = ? pmol/l Authority: IUPAC-IUB 81 NPU10479 P—Calcitonin; subst.c.(1,5 min) = ? NPU01437 pmol/l P—Calciol; subst.c. = ? nmol/l NPU10376 P—Calcitonin; subst.c.(2 min) = ? pmol/l NPU10480 P—Calcitonin; subst.c.(5 min) = ? pmol/l Plasma— Calcitonin gene related peptide; Plasma— substance concentration Calcitonin; picomole/liter arbitrary substance concentration(IRP 70/234; NPU10605 procedure) P—Calcitonin gene related peptide; subst.c. = ? international unit/liter pmol/l M = 3 425 g/mol Recommended calibrator: WHO 2nd IS 89/620 Urine— Calibrator(s): WHO 1st IRP 70/234 Calcitonin gene related peptide; Other term(s): Thyrocalcitonin substance concentration Authority: IUPAC-IUB 74 picomole/liter NPU04002 NPU14007 P—Calcitonin; arb.subst.c.(IRP 70/234; proc.) = ? U—Calcitonin gene related peptide; subst.c. = ? int. unit/l pmol/l Plasma— Patient(Urine)— Calcitonin; Calcitonin gene related peptide; arbitrary substance concentration(IS 89/620; substance rate procedure) picomole/day international unit/liter NPU14008 M = 3 425 g/mol Pt(U)—Calcitonin gene related peptide; subst.rate = Recommended calibrator: WHO 2nd IS 89/620 ? pmol/d Calibrator(s): WHO 1st IRP 70/234 Other term(s): Thyrocalcitonin Thyroid gland— Authority: IUPAC-IUB 74 Calcitonin secretion; NPU01438 substance rate(calcium compound, intravenous P—Calcitonin; arb.subst.c.(IS 89/620; proc.) = ? int. administration; list; procedure) unit/l Note: M (calcitonin) = 3 425 g/mol NPU10476 Plasma— Thyroid gland—Calcitonin secretion; Calcitonin; subst.rate(calcium compound i.v.; list; proc.) substance concentration(20 minutes before NPU10472 Pt—Calcium compound(administered); challenge) subst.cont.(i.v.; am.s./body mass) = ? mmol/kg picomole/liter NPU10478 P—Calcitonin; subst.c.(0 min) = ? pmol/l M = 3 425 g/mol NPU10480 P—Calcitonin; subst.c.(5 min) = ? pmol/l NPU10378 NPU10473 P—Calcitonin; subst.c.(10 min) = ? P—Calcitonin; subst.c.(-20 min) = ? pmol/l pmol/l NPU10474 P—Calcitonin; subst.c.(180 min) = ? Plasma— pmol/l Calcitonin; NPU10475 P—Calcitonin; subst.c.(240 min) = ? substance concentration(10 minutes before pmol/l challenge) picomole/liter Thyroid gland— M = 3 425 g/mol Calcitonin secretion; NPU10377 substance rate(pentagastrin, intravenous P—Calcitonin; subst.c.(-10 min) = ? pmol/l administration; list; procedure) Note: M (pentagastrin) = 770 g/mol; M (calcitonin) = Plasma— 3 425 g/mol Calcitonin; NPU10481 substance concentration(0 minutes after Thyroid gland—Calcitonin secretion; challenge) subst.rate(pentagastrin i.v.; list; proc.) picomole/liter NPU10477 Pt—Pentagastrin(administered); M = 3 425 g/mol NPU10478 P—Calcitonin; subst.c.(0 min) = ? pmol/l

Plasma— Plasma— Calcitonin; 1,25- substance concentration(1,5 minutes after Calcitriol; challenge) substance concentration picomole/liter picomole/liter M = 3 425 g/mol M = 416,3 g/mol NPU10479 Other term(s): 1,25-Dihydroxy-cholecalciferol; 1,25- P—Calcitonin; subst.c.(1,5 min) = ? pmol/l Dihydroxy-vitamin D3 Authority: IUPAC-IUB 81; INN Plasma— NPU01440 Calcitonin; P—1,25-Calcitriol; subst.c. = ? pmol/l substance concentration(2 minutes after challenge) Plasma— picomole/liter 1,25- M = 3 425 g/mol Calcitriol+1,25-Dihydroxyergocalciferol; NPU10376 substance concentration P—Calcitonin; subst.c.(2 min) = ? pmol/l picomole/liter NPU10266 Plasma— P—1,25-Calcitriol+1,25-Dihydroxyergocalciferol; Calcitonin; subst.c. = ? pmol/l substance concentration(5 minutes after challenge) Calculus(Urine)— picomole/liter Calcium carbonate; M = 3 425 g/mol arbitrary content(procedure) NPU10480 M = 100,09 g/mol P—Calcitonin; subst.c.(5 min) = ? pmol/l NPU10364 Calculus(U)—Calcium carbonate; arb.cont.(proc.) = Plasma— ? Calcitonin; substance concentration(10 minutes after Calculus(Urine)— challenge) Calcium carbonate; picomole/liter substance content M = 3 425 g/mol mole/kilogram NPU10473 M = 100,09 g/mol P—Calcitonin; subst.c.(10 min) = ? pmol/l NPU01445 Calculus(U)—Calcium carbonate; subst.cont. = ? Plasma— mol/kg Calcitonin; substance concentration(180 minutes after Kidney— challenge) Calcium clearance; picomole/liter volume rate(procedure) M = 3 425 g/mol milliliter/second NPU10474 NPU08595 P—Calcitonin; subst.c.(180 min) = ? pmol/l Kidn.—Calcium clearance; vol.rate(proc.) = ? ml/s

Plasma— Patient— Calcitonin; Calcium compound(administered); substance concentration(240 minutes after substance content(intravenous administration; challenge) amount-of-substance/body mass) picomole/liter millimole/kilogram M = 3 425 g/mol NPU10472 NPU10475 Pt—Calcium compound(administered); P—Calcitonin; subst.c.(240 min) = ? pmol/l subst.cont.(i.v.; am.s./body mass) = ? mmol/kg

Plasma— Plasma— Calcitonin; Calcium ion(free); substance concentration substance concentration(pH = 7,40; procedure) picomole/liter millimole/liter M = 3 425 g/mol Authority: IFCC/C-BGE Other term(s): Thyrocalcitonin NPU04144 Authority: IUPAC-IUB 74 P—Calcium ion(free); subst.c.(pH = 7,40; proc.) = ? NPU01439 mmol/l P—Calcitonin; subst.c. = ? pmol/l

Plasma— Calculus(Urine)— Calcium ion(free); Calcium(II; total); substance concentration arbitrary content(procedure) millimole/liter M = 40,080 g/mol Other term(s): Coagulation factor IV NPU09230 Authority: IFCC/C-BGE Calculus(U)—Calcium(II; total); arb.cont.(proc.) = ? NPU01446 P—Calcium ion(free); subst.c. = ? mmol/l Plasma— Calcium(II; total); Calculus(Urine)— substance concentration(corrected; procedure) Calcium oxalate; millimole/liter arbitrary content(procedure) M = 40,08 g/mol M = 128,10 g/mol NPU04169 NPU10365 P—Calcium(II; total); subst.c.(corr.; proc.) = ? mmol/ Calculus(U)—Calcium oxalate; arb.cont.(proc.) = ? l

Calculus(Urine)— Plasma— Calcium oxalate; Calcium(II; total); substance content substance concentration(list; corrected; mole/kilogram procedure) M = 128,10 g/mol Authority: IFCC/C-BGE NPU01447 NPU17123 Calculus(U)—Calcium oxalate; subst.cont. = ? mol/ P—Calcium(II; total); subst.c.(list; corr.; proc.) kg NPU01132 P—Albumin; subst.c. = ? µmol/l NPU01443 P—Calcium(II; total); subst.c. = ? mmol/l Calculus(Urine)— NPU04169 P—Calcium(II; total); subst.c.(corr.; Calcium phosphate; proc.) = ? mmol/l arbitrary content(procedure) M = 310,20 g/mol Amniotic fluid— NPU10366 Calcium(II; total); Calculus(U)—Calcium phosphate; arb.cont.(proc.) = substance concentration ? millimole/liter NPU08605 Calculus(Urine)— Amf—Calcium(II; total); subst.c. = ? mmol/l Calcium phosphate; substance content Ascites— mole/kilogram Calcium(II; total); M = 310,20 g/mol substance concentration NPU08608 millimole/liter Calculus(U)—Calcium phosphate; subst.cont. = ? M = 40,080 g/mol mol/kg Authority: IFCC/C-BGE NPU08603 Calculus(Synovial fluid; specification)— Asc—Calcium(II; total); subst.c. = ? mmol/l Calcium pyrophosphate; arbitrary content(procedure) Dialysis solution— M = 310,20 g/mol Calcium(II; total); NPU14141 substance concentration Calculus(Synf; spec.)—Calcium pyrophosphate; millimole/liter arb.cont.(proc.) = ? M = 40,080 g/mol Authority: IFCC/C-BGE Urine— NPU17172 Calcium(II; total)/Creatininium; Dialysis solution—Calcium(II; total); subst.c. = ? substance ratio mmol/l NPU03929 U—Calcium(II; total)/Creatininium; subst.ratio = ? Plasma— Calcium(II; total); Urine— substance concentration Calcium(II; total); millimole/liter amount-of-substance(procedure) M = 40,080 g/mol millimole Authority: IFCC/C-BGE NPU17550 NPU01443 U—Calcium(II; total); am.s.(proc.) = ? mmol P—Calcium(II; total); subst.c. = ? mmol/l

System(specification)— NPU01442 Calcium(II; total); Pt(U)—Calcium(II; total); subst.rate(proc.) = ? substance concentration mmol/d millimole/liter M = 40,08 g/mol Kidney— NPU10289 Calcium/Creatininium; Syst(spec.)—Calcium(II; total); subst.c. = ? mmol/l volume rate ratio(procedure) NPU08596 Urine— Kidn.—Calcium/Creatininium; vol.rate ratio(proc.) = Calcium(II; total); ? substance concentration millimole/liter Faeces— M = 40,08 g/mol Calcium; NPU04160 amount-of-substance(procedure) U—Calcium(II; total); subst.c. = ? mmol/l millimole NPU17549 Faeces— F—Calcium; am.s.(proc.) = ? mmol Calcium(II; total); substance content Secretion(Ileum)— millimole/kilogram Calcium; M = 40,08 g/mol amount-of-substance(procedure) NPU04212 millimole F—Calcium(II; total); subst.cont. = ? mmol/kg NPU17623 Secr(Ileum)—Calcium; am.s.(proc.) = ? mmol Faeces(specification)— Calcium(II; total); Secretion(Ileum)— substance content Calcium; millimole/kilogram substance concentration NPU08606 millimole/liter F(spec.)—Calcium(II; total); subst.cont. = ? mmol/kg NPU17548 Secr(Ileum)—Calcium; subst.c. = ? mmol/l Calculus(Urine)— Calcium(II; total); Synovial fluid(specification)— substance content Calculus composition; mole/kilogram arbitrary content(list; procedure) M = 40,080 g/mol NPU14278 NPU09236 Synf(spec.)—Calculus composition; arb.cont.(list; Calculus(U)—Calcium(II; total); subst.cont. = ? proc.) mol/kg NPU14141 Calculus(Synf; spec.)—Calcium pyrophosphate; arb.cont.(proc.) = ? Patient(Faeces)— NPU14109 Calculus(Synf; spec.)—Urate; Calcium(II; total); arb.cont.(proc.) = ? substance rate(procedure) millimole/day Urine— Authority: IFCC/C-BGE Calculus composition; NPU01441 arbitrary content(list; procedure) Pt(F)—Calcium(II; total); subst.rate(proc.) = ? NPU08868 mmol/d U—Calculus composition; arb.cont.(list; proc.) NPU09232 Calculus(U)—Ammonium; Patient(Ileum)— arb.cont.(proc.) = ? Calcium(II; total); NPU10364 Calculus(U)—Calcium carbonate; substance rate(procedure) arb.cont.(proc.) = ? millimole/day NPU10365 Calculus(U)—Calcium oxalate; NPU08607 arb.cont.(proc.) = ? Pt(Ileum)—Calcium(II; total); subst.rate(proc.) = ? NPU10366 Calculus(U)—Calcium phosphate; mmol/d arb.cont.(proc.) = ? NPU09230 Calculus(U)—Calcium(II; total); Patient(Urine)— arb.cont.(proc.) = ? Calcium(II; total); NPU09229 Calculus(U)—Carbonate; substance rate(procedure) arb.cont.(proc.) = ? millimole/day NPU10367 Calculus(U)—Cystine; arb.cont.(proc.) = M = 40,080 g/mol ? Authority: IFCC/C-BGE NPU10368 Calculus(U)—Magnesium ammonium

phosphate; arb.cont.(proc.) = ? Plasma— NPU09234 Calculus(U)—Magnesium(II; total); Cancer antigen 15-3; arb.cont.(proc.) = ? arbitrary substance concentration(procedure) NPU09231 Calculus(U)—Oxalate; arb.cont.(proc.) = 10³ arbitrary unit/liter ? NPU01449 NPU09233 Calculus(U)—Phosphate(P; inorganic); P—Cancer antigen 15-3; arb.subst.c.(proc.) = ? × arb.cont.(proc.) = ? 10³ arb.unit/l NPU10369 Calculus(U)—Urate; arb.cont.(proc.) = ? Plasma— Urine— Cancer antigen 19-9; Calculus composition; arbitrary substance concentration(procedure) substance content(list; procedure) 10³ arbitrary unit/liter NPU09359 NPU01450 U—Calculus composition; subst.cont.(list; proc.) P—Cancer antigen 19-9; arb.subst.c.(proc.) = ? × NPU09238 Calculus(U)—Ammonium; subst.cont. = 10³ arb.unit/l ? mol/kg NPU01445 Calculus(U)—Calcium carbonate; Plasma— subst.cont. = ? mol/kg Cancer antigen 50; NPU09236 Calculus(U)—Calcium(II; total); arbitrary substance concentration(procedure) subst.cont. = ? mol/kg 10³ arbitrary unit/liter NPU01447 Calculus(U)—Calcium oxalate; NPU01451 subst.cont. = ? mol/kg P—Cancer antigen 50; arb.subst.c.(proc.) = ? × 10³ NPU08608 Calculus(U)—Calcium phosphate; arb.unit/l subst.cont. = ? mol/kg NPU09235 Calculus(U)—Carbonate; subst.cont. = ? Kidney— mol/kg Carbamide clearance; NPU01827 Calculus(U)—Cystine; subst.cont. = ? volume rate(procedure) mol/kg milliliter/second NPU09240 Calculus(U)—Magnesium(II; total); NPU10028 subst.cont. = ? mol/kg Kidn.—Carbamide clearance; vol.rate(proc.) = ? NPU02649 Calculus(U)—Magnesium ammonium ml/s phosphate; subst.cont. = ? mol/kg NPU09237 Calculus(U)—Oxalate; subst.cont. = ? Ascites— mol/kg Carbamide; NPU09239 Calculus(U)—Phosphate(P; inorganic); amount-of-substance(procedure) subst.cont. = ? mol/kg millimole NPU03689 Calculus(U)—Urate; subst.cont. = ? M = 60,06 g/mol mol/kg NPU08611 Asc—Carbamide; am.s.(proc.) = ? mmol Faeces— Calprotectin; Urine— substance content Carbamide; millimole/kilogram amount-of-substance(procedure) NPU09255 millimole F—Calprotectin; subst.cont. = ? mmol/kg NPU17551 U—Carbamide; am.s.(proc.) = ? mmol Cerebrospinal fluid— Cancer antigen 125; Amniotic fluid— arbitrary substance concentration(procedure) Carbamide; 10³ arbitrary unit/liter substance concentration NPU10290 millimole/liter Csf—Cancer antigen 125; arb.subst.c.(proc.) = ? × M = 60,06 g/mol 10³ arb.unit/l NPU08610 Amf—Carbamide; subst.c. = ? mmol/l Plasma— Cancer antigen 125; Ascites— arbitrary substance concentration(procedure) Carbamide; 10³ arbitrary unit/liter substance concentration NPU01448 millimole/liter P—Cancer antigen 125; arb.subst.c.(proc.) = ? × M = 60,06 g/mol 10³ arb.unit/l NPU08609 Asc—Carbamide; subst.c. = ? mmol/l

Cerebrospinal fluid— Plasma— Carbamide; Carbohydrate-deficient transferrin; substance concentration arbitrary substance concentration(procedure) millimole/liter arbitrary unit/liter M = 60,06 g/mol NPU10005 NPU09349 P—Carbohydrate-deficient transferrin; Csf—Carbamide; subst.c. = ? mmol/l arb.subst.c.(proc.) = ? arb.unit/l

Dialysis solution— Plasma— Carbamide; Carbohydrate-deficient transferrin; substance concentration substance concentration millimole/liter micromole/liter M = 60,06 g/mol NPU17006 NPU10026 P—Carbohydrate-deficient transferrin; subst.c. = ? Dialysis solution—Carbamide; subst.c. = ? mmol/l µmol/l

Drain fluid(specification)— Transferrin(Plasma)— Carbamide; Carbohydrate-deficient transferrin; substance concentration substance fraction millimole/liter NPU10000 NPU17047 Transferrin(P)—Carbohydrate-deficient transferrin; Drain fluid(spec.)—Carbamide; subst.c. = ? mmol/l subst.fr. = ?

Plasma— Plasma(arterial Blood)— Carbamide; Carbon dioxide(free); substance concentration substance concentration millimole/liter millimole/liter M = 60,06 g/mol NPU12476 NPU01459 P(aB)—Carbon dioxide(free); subst.c. = ? mmol/l P—Carbamide; subst.c. = ? mmol/l Plasma(capillary Blood)— Secretion(Conjunctiva; specification)— Carbon dioxide(free); Carbamide; substance concentration substance concentration millimole/liter millimole/liter NPU12482 M = 60,06 g/mol P(cB)—Carbon dioxide(free); subst.c. = ? mmol/l NPU09353 Secr(Conj; spec.)—Carbamide; subst.c. = ? mmol/l Plasma(cord Blood)— Carbon dioxide(free); System(specification)— substance concentration Carbamide; millimole/liter substance concentration NPU12483 millimole/liter P(cordB)—Carbon dioxide(free); subst.c. = ? mmol/l M = 60,06 g/mol NPU10027 Plasma(cord Blood; arterial Blood)— Syst(spec.)—Carbamide; subst.c. = ? mmol/l Carbon dioxide(free); substance concentration Urine— millimole/liter Carbamide; NPU17137 substance concentration P(cordB; aB)—Carbon dioxide(free); subst.c. = ? millimole/liter mmol/l M = 60,06 g/mol NPU03930 Plasma(cord Blood; venous Blood)— U—Carbamide; subst.c. = ? mmol/l Carbon dioxide(free); substance concentration Patient(Urine)— millimole/liter Carbamide; NPU17138 substance rate(procedure) P(cordB; vB)—Carbon dioxide(free); subst.c. = ? millimole/day mmol/l NPU01458 Pt(U)—Carbamide; subst.rate(proc.) = ? mmol/d Plasma(mixed Blood)— Carbon dioxide(free); substance concentration

millimole/liter M = 44,01 g/mol NPU09204 Authority: IFCC/C-BGE P(mixB)—Carbon dioxide(free); subst.c. = ? mmol/l NPU09202 P(mixB)—Carbon dioxide(free); tension(37 °C) = ? Plasma(venous Blood)— kPa Carbon dioxide(free); substance concentration Plasma(venous Blood)— millimole/liter Carbon dioxide(free); NPU12484 gas tension(37 °C) P(vB)—Carbon dioxide(free); subst.c. = ? mmol/l kilopascal M = 44,01 g/mol Plasma(arterial Blood)— Authority: IFCC/C-BGE Carbon dioxide(free); NPU10029 gas tension(37 °C) P(vB)—Carbon dioxide(free); tension(37 °C) = ? kilopascal kPa M = 44,01 g/mol Authority: IFCC/C-BGE Plasma(arterial Blood)— NPU01470 Carbon dioxide(free); P(aB)—Carbon dioxide(free); tension(37 °C) = ? gas tension(patient body temperature) kPa kilopascal NPU12526 Plasma(capillary Blood)— P(aB)—Carbon dioxide(free); tension(body temp.) = Carbon dioxide(free); ? kPa gas tension(37 °C) kilopascal Plasma(capillary Blood)— NPU12481 Carbon dioxide(free); P(cB)—Carbon dioxide(free); tension(37 °C) = ? gas tension(patient body temperature) kPa kilopascal NPU12528 Plasma(cord Blood)— P(cB)—Carbon dioxide(free); tension(body temp.) = Carbon dioxide(free); ? kPa gas tension(37 °C) kilopascal Plasma(cord Blood)— M = 44,01 g/mol Carbon dioxide(free); Authority: IFCC/C-BGE gas tension(patient body temperature) NPU10030 kilopascal P(cordB)—Carbon dioxide(free); tension(37 °C) = ? NPU12527 kPa P(cordB)—Carbon dioxide(free); tension(body temp.) = ? kPa Plasma(cord Blood; arterial Blood)— Carbon dioxide(free); Plasma(cord Blood; arterial Blood)— gas tension(37 °C) Carbon dioxide(free); kilopascal gas tension(patient body temperature) M = 44,01 g/mol kilopascal Authority: IFCC/C-BGE NPU17141 NPU17139 P(cordB; aB)—Carbon dioxide(free); tension(body P(cordB; aB)—Carbon dioxide(free); tension(37 °C) temp.) = ? kPa = ? kPa Plasma(cord Blood; venous Blood)— Plasma(cord Blood; venous Blood)— Carbon dioxide(free); Carbon dioxide(free); gas tension(patient body temperature) gas tension(37 °C) kilopascal kilopascal NPU17142 M = 44,01 g/mol P(cordB; vB)—Carbon dioxide(free); tension(body Authority: IFCC/C-BGE temp.) = ? kPa NPU17140 P(cordB; vB)—Carbon dioxide(free); tension(37 °C) Plasma(mixed Blood)— = ? kPa Carbon dioxide(free); gas tension(patient body temperature) Plasma(mixed Blood)— kilopascal Carbon dioxide(free); NPU09203 gas tension(37 °C) P(mixB)—Carbon dioxide(free); tension(body temp.) kilopascal = ? kPa

Plasma(venous Blood)— Plasma(cord Blood; arterial Blood)— Carbon dioxide(free); Carbon dioxide(total); gas tension(patient body temperature) substance concentration kilopascal millimole/liter NPU12529 M = 44,01 g/mol P(vB)—Carbon dioxide(free); tension(body temp.) = Authority: IFCC/C-BGE ? kPa NPU17143 P(cordB; aB)—Carbon dioxide(tot.); subst.c. = ? Blood(arterial Blood)— mmol/l Carbon dioxide(total); substance concentration Plasma(cord Blood; venous Blood)— millimole/liter Carbon dioxide(total); NPU12522 substance concentration B(aB)—Carbon dioxide(tot.); subst.c. = ? mmol/l millimole/liter M = 44,01 g/mol Blood(capillary Blood)— Authority: IFCC/C-BGE Carbon dioxide(total); NPU17144 substance concentration P(cordB; vB)—Carbon dioxide(tot.); subst.c. = ? millimole/liter mmol/l NPU12524 B(cB)—Carbon dioxide(tot.); subst.c. = ? mmol/l Plasma(mixed Blood)— Carbon dioxide(total); Blood(cord Blood)— substance concentration Carbon dioxide(total); millimole/liter substance concentration M = 44,01 g/mol millimole/liter Authority: IFCC/C-BGE NPU12523 NPU09206 B(cordB)—Carbon dioxide(tot.); subst.c. = ? mmol/l P(mixB)—Carbon dioxide(tot.); subst.c. = ? mmol/l

Blood(mixed Blood)— Plasma(venous Blood)— Carbon dioxide(total); Carbon dioxide(total); substance concentration substance concentration millimole/liter millimole/liter NPU09205 M = 44,01 g/mol B(mixB)—Carbon dioxide(tot.); subst.c. = ? mmol/l Authority: IFCC/C-BGE NPU01472 Blood(venous Blood)— P(vB)—Carbon dioxide(tot.); subst.c. = ? mmol/l Carbon dioxide(total); substance concentration Alveolar gas— millimole/liter Carbon dioxide; NPU12525 partial pressure B(vB)—Carbon dioxide(tot.); subst.c. = ? mmol/l kilopascal NPU04079 Plasma(arterial Blood)— Alveolar gas—Carbon dioxide; part.pr. = ? kPa Carbon dioxide(total); substance concentration Haemoglobin(Fe; Blood)— millimole/liter Carbon monoxide haemoglobin(Fe); M = 44,01 g/mol substance fraction Authority: IFCC/C-BGE Authority: IFCC/C-BGE NPU01471 NPU01473 P(aB)—Carbon dioxide(tot.); subst.c. = ? mmol/l Hb(Fe; B)—Carbon monoxide haemoglobin(Fe); subst.fr. = ? Plasma(capillary Blood)— Carbon dioxide(total); Erythrocytes(Blood)— substance concentration Carbonate dehydratase; millimole/liter entitic amount-of-substance(procedure) NPU12485 attomole P(cB)—Carbon dioxide(tot.); subst.c. = ? mmol/l M = 30 000 g/mol Other term(s): Carbonic anhydrase; Carbonate Plasma(cord Blood)— dehydratase type I Carbon dioxide(total); NPU01474 substance concentration Ercs(B)—Carbonate dehydratase; entitic millimole/liter am.s.(proc.) = ? amol NPU12517 P(cordB)—Carbon dioxide(tot.); subst.c. = ? mmol/l

Erythrocytes(Blood)— NPU01478 Carbonate dehydratase; P—Carcinoembryonic antigen; arb.subst.c.(IRP 73/ entitic catalytic activity(37 °C; procedure) 601; proc.) = ? int. unit/l attokatal Other term(s): Carbonic anhydrase; Carbonate Plasma— dehydratase Carcinoembryonic antigen; NPU01475 substance concentration Ercs(B)—Carbonate dehydratase; entitic cat.act. mole/liter (37 °C; proc.) = ? akat Other term(s): CEA NPU03931 Calculus(Urine)— P—Carcinoembryonic antigen; subst.c.= ? prefix ? Carbonate; mol/l arbitrary content(procedure) NPU09229 Urine— Calculus(U)—Carbonate; arb.cont.(proc.) = ? Carnitine/Creatine; substance ratio Calculus(Urine)— NPU01502 Carbonate; U—Carnitine/Creatine; subst.ratio = ? substance content mole/kilogram Urine— NPU09235 Carnitine/Creatininium; Calculus(U)—Carbonate; subst.cont. = ? mol/kg substance ratio 10-3 Urine— NPU14202 g- U—Carnitine/Creatininium; subst.ratio = ? × 10-3 Carboxyglutamate/Creatininium; substance ratio Plasma— 10-3 Carnitine; NPU14200 substance concentration U—g-Carboxyglutamate/Creatininium; subst.ratio = micromole/liter ? × 10-3 M = 161,20 g/mol NPU01482 Urine— P—Carnitine; subst.c. = ? µmol/l g- Carboxyglutamate; Urine— substance concentration Carnitine; micromole/liter substance concentration M = 191,14 g/mol micromole/liter NPU01476 M = 161,20 g/mol U—g-Carboxyglutamate; subst.c. = ? µmol/l NPU01485 U—Carnitine; subst.c. = ? µmol/l Urine— N-e- Patient(Urine)— Carboxymethyl lysine/Creatininium; Carnitine; substance ratio substance rate 10-3 micromole/day NPU14201 M = 161,20 g/mol U—N-e-Carboxymethyl lysine/Creatininium; NPU10031 subst.ratio = ? × 10-3 Pt(U)—Carnitine; subst.rate = ? µmol/d

Urine— Urine— N-e- Carnosine/Creatininium; Carboxymethyl lysine; substance ratio substance concentration 10-3 micromole/liter NPU14203 NPU01477 U—Carnosine/Creatininium; subst.ratio = ? × 10-3 U—N-e-Carboxymethyl lysine; subst.c. = ? µmol/l Plasma— Plasma— Carnosine; Carcinoembryonic antigen; substance concentration arbitrary substance concentration(IRP 73/601; micromole/liter procedure) M = 226,23 g/mol international unit/liter NPU01503 Recommended calibrator: WHO 1st IRP 73/601 P—Carnosine; subst.c. = ? µmol/l Other term(s): CEA

Urine— NPU02402 U—Homovanillate; subst.c. = ? µmol/l Carnosine; substance concentration Plasma— micromole/liter Cefotaxime; M = 226,23 g/mol substance concentration NPU01504 mole/liter U—Carnosine; subst.c. = ? µmol/l NPU17025 P—Cefotaxime; subst.c.= ? prefix ? mol/l Plasma— Carotene; System(specification)— substance concentration Cells; micromole/liter arbitrary concentration(procedure) M = 536,85 g/mol NPU10292 NPU01505 Syst(spec.)—Cells; arb.c.(proc.) = ? P—Carotene; subst.c. = ? µmol/l Ascites— Faeces— Cells; Catalase; number concentration arbitrary content(procedure) 106/liter NPU04215 NPU08683 F—Catalase; arb.cont.(proc.)= ? Asc—Cells; num.c. = ? × 106/l

Urine— Cerebrospinal fluid— Catecholamine; Cells; amount-of-substance(list) number concentration NPU17625 106/liter U—Catecholamine; am.s.(list) NPU04775 NPU17545 U—Adrenalinium; am.s.(proc.) = ? µmol Csf—Cells; num.c.= ? × 106/l NPU17624 U—Adrenalinium+Noradrenalinium; am.s.(proc.) = ? µmol Pleural fluid(specification)— NPU08619 U—Dopamine; am.s.(proc.) = ? µmol Cells; NPU17626 U—3-Methoxyadrenalinium+3- number concentration Methoxynoradrenalinium; am.s.(proc.) = ? µmol 106/liter NPU17585 U—Noradrenalinium; am.s.(proc.) = ? NPU08682 µmol Plf(spec.)—Cells; num.c. = ? × 106/l

Urine— Synovial fluid(specification)— Catecholamine; Cells; substance concentration(list; procedure) number concentration NPU17594 106/liter U—Catecholamine; subst.c.(list; proc.) NPU04229 NPU14041 U—Adrenalinium; subst.c. = ? µmol/l Synf(spec.)—Cells; num.c. = ? × 106/l NPU14120 U—Adrenalinium+Noradrenalinium; subst.c. = ? µmol/l System(specification)— NPU01915 U—Dopamine; subst.c. = ? µmol/l Cells; NPU02740 U—3-Methoxyadrenalinium+3- number concentration Methoxynoradrenalinium; subst.c. = ? µmol/l 106/liter NPU17116 U—Noradrenalinium; subst.c. = ? µmol/l NPU10291 Syst(spec.)—Cells; num.c. = ? × 106/l Urine— Catecholmetabolite; Cerebrospinal fluid— amount-of-substance(list; procedure) Cells; NPU17628 number concentration U—Catecholmetabolite; am.s.(list; proc.) 109/liter NPU17568 U—Homovanillate; am.s. = ? µmol NPU08681 NPU17627 U—Vanillylmandelate; am.s.(proc.) = ? Csf—Cells; num.c. = ? × 109/l µmol Synovial fluid(specification)— Urine— Cells; Catecholmetabolite; number concentration substance concentration(list; procedure) 109/liter NPU17595 NPU08684 U—Catecholmetabolite; subst.c.(list; proc.) Synf(spec.)—Cells; num.c. = ? × 109/l NPU08685 U—Vanillylmandelate; subst.c. = ? µmol/l

Plasma— NPU17539 Centromer antibody(Immunoglobulin G); U—Chloride; am.s.(proc.) = ? mmol arbitrary concentration(procedure) NPU01518 Sweat(specification)— P—Centromer antibody(IgG); arb.c.(proc.) = ? Chloride; substance concentration(stimulated; procedure) Plasma— millimole/liter Centromer antibody(Immunoglobulin G); M = 35,45 g/mol arbitrary substance concentration(procedure) NPU04126 arbitrary unit/liter Sweat(spec.)—Chloride; subst.c.(stim.; proc.) = ? NPU12015 mmol/l P—Centromer antibody(IgG); arb.subst.c.(proc.) = ? arb.unit/l Amniotic fluid— Chloride; Leukocytes(Blood)— substance concentration Cerebroside-sulfatase; millimole/liter entitic catalytic activity(37 °C; procedure) M = 35,45 g/mol attokatal NPU08612 Other term(s): Arylsulfatase A Amf—Chloride; subst.c. = ? mmol/l NPU09104 Lkcs(B)—Cerebroside-sulfatase; entitic cat.act. Plasma— (37 °C; proc.) = ? akat Chloride; substance concentration Cerebrospinal fluid— millimole/liter Cerebrospinal fluid; M = 35,453 g/mol clarity(after spinning; procedure) Authority: IFCC/C-BGE NPU04225 NPU01536 Csf—Cerebrospinal fluid; clarity(after spinn.; proc.) P—Chloride; subst.c. = ? mmol/l = ? Sweat— Cerebrospinal fluid— Chloride; Cerebrospinal fluid; substance concentration clarity(before spinning; procedure) millimole/liter NPU04224 M = 35,453 g/mol Csf—Cerebrospinal fluid; clarity(before spinn.; Authority: IFCC/C-BGE proc.) = ? NPU01537 Sweat—Chloride; subst.c. = ? mmol/l Cerebrospinal fluid— Cerebrospinal fluid; System(specification)— colour(procedure) Chloride; NPU17026 substance concentration Csf—Cerebrospinal fluid; colour(proc.) = ? millimole/liter M = 35,453 g/mol Cerebrospinal fluid— NPU10122 Cerebrospinal fluid; Syst(spec.)—Chloride; subst.c. = ? mmol/l property(list; procedure) NPU14911 Urine— Csf—Cerebrospinal fluid; prop.(list; proc.) Chloride; NPU01130 Csf—Albumin; subst.c. = ? µmol/l substance concentration NPU04224 Csf—Cerebrospinal fluid; clarity(before millimole/liter spinn.; proc.)= ? M = 35,45 g/mol NPU04225 Csf—Cerebrospinal fluid; clarity(after NPU08613 spinn.; proc.)= ? U—Chloride; subst.c. = ? mmol/l NPU01962 Csf—Erythrocytes; num.c. = ? × 106/l NPU02190 Csf—Glucose; subst.c. = ? mmol/l Faeces— NPU01523 Csf—Glucose; rel.subst.c.(Csf/P) = ? Chloride; NPU02594 Csf—Leukocytes; num.c. = ? × 106/l substance content NPU03276 Csf—Protein; mass c. = ? g/l millimole/kilogram NPU03816 Urine— F—Chloride; subst.cont. = ? mmol/kg Chloride; amount-of-substance(procedure) millimole

Patient(Urine)— NPU10157 Chloride; P(fPt)—Cholesterol+ester, in HDL; subst.c. = ? substance rate(procedure) mmol/l millimole/day Authority: IFCC/C-BGE Pleural fluid— NPU01535 Cholesterol+ester, in HDL; Pt(U)—Chloride; subst.rate(proc.) = ? mmol/d substance concentration millimole/liter Plasma— Other term(s): High density lipoprotein cholesterol Cholecystokinin; Note: (H)igh (D)ensity substance concentration NPU17016 picomole/liter Plf—Cholesterol+ester, in HDL; subst.c. = ? mmol/l NPU17555 P—Cholecystokinin; subst.c. = ? pmol/l Plasma— Cholesterol+ester, in LDL/Cholesterol+ester, in Plasma— HDL; Cholesterol(non ester); substance ratio substance concentration NPU04146 millimole/liter P—Cholesterol+ester, in LDL/Cholesterol+ester, in M = 386,64 g/mol HDL; subst.ratio = ? NPU01549 P—Cholesterol(non ester); subst.c. = ? mmol/l Plasma(fasting Patient)— Cholesterol+ester, in LDL/Cholesterol+ester, in Plasma— HDL; Cholesterol; substance ratio property(list; procedure) NPU10172 M = 386,64 g/mol P(fPt)—Cholesterol+ester, in LDL/ NPU17029 Cholesterol+ester, in HDL; subst.ratio = ? P—Cholesterol; prop.(list; proc.) NPU01549 P—Cholesterol(non ester); subst.c. = ? Plasma— mmol/l Cholesterol+ester, in LDL; NPU01566 P—Cholesterol+ester; subst.c. = ? substance concentration mmol/l millimole/liter NPU01567 P—Cholesterol+ester, in HDL; subst.c. = Other term(s): Low density lipoprotein cholesterol ? mmol/l Note: (L)ow (D)ensity NPU01568 P—Cholesterol+ester, in LDL; subst.c. = NPU01568 ? mmol/l P—Cholesterol+ester, in LDL; subst.c. = ? mmol/l NPU01569 P—Cholesterol+ester, in VLDL; subst.c. = ? mmol/l Plasma(fasting Patient)— NPU04146 P—Cholesterol+ester, in LDL/ Cholesterol+ester, in LDL; Cholesterol+ester, in HDL; subst.ratio = ? substance concentration NPU10293 P(fPt)—Cholesterol+ester/ millimole/liter Cholesterol+ester, in HDL; subst.ratio = ? NPU10171 P(fPt)—Cholesterol+ester, in LDL; subst.c. = ? Ascites— mmol/l Cholesterol+ester, in HDL; substance concentration Pleural fluid— millimole/liter Cholesterol+ester, in LDL; Other term(s): High density lipoprotein cholesterol substance concentration Note: (H)igh (D)ensity millimole/liter NPU17014 Other term(s): Low density lipoprotein cholesterol Asc—Cholesterol+ester, in HDL; subst.c. = ? mmol/l Note: (L)ow (D)ensity NPU17017 Plasma— Plf—Cholesterol+ester, in LDL; subst.c. = ? mmol/l Cholesterol+ester, in HDL; substance concentration Plasma— millimole/liter Cholesterol+ester, in VLDL; Other term(s): High density lipoprotein cholesterol substance concentration Note: (H)igh (D)ensity millimole/liter NPU01567 Other term(s): Very low density lipoprotein P—Cholesterol+ester, in HDL; subst.c. = ? mmol/l cholesterol Note: (V)ery (L)ow (D)ensity Plasma(fasting Patient)— NPU01569 Cholesterol+ester, in HDL; P—Cholesterol+ester, in VLDL; subst.c. = ? mmol/l substance concentration millimole/liter © 2000 IUPAC, Pure and Applied Chemistry 72, 747–972 Properties and units in general clinical chemistry 799

Plasma(fasting Patient)— M = 386,64 g/mol Cholesterol+ester, in VLDL; NPU10033 substance concentration Syst(spec.)—Cholesterol+ester; subst.c. = ? mmol/l millimole/liter Other term(s): Very low density lipoprotein Plasma— cholesterol Cholinesterase antibody; Note: (V)ery (L)ow (D)ensity arbitrary substance concentration(procedure) NPU09256 arbitrary unit/liter P(fPt)—Cholesterol+ester, in VLDL; subst.c. = ? NPU12063 mmol/l P—Cholinesterase antibody; arb.subst.c.(proc.) = ? arb.unit/l Pleural fluid— Cholesterol+ester, in VLDL; Cholinesterase(Plasma)— substance concentration Cholinesterase type; millimole/liter catalytic-activity fraction(list; 25 °C; procedure) Other term(s): Very low density lipoprotein Note: obs the sum of fractions may be >1 cholesterol NPU03565 Note: (V)ery (L)ow (D)ensity ChE(P)—Cholinesterase type; cat.fr.(list; 25 °C; NPU17019 proc.) Plf—Cholesterol+ester, in VLDL; subst.c. = ? mmol/l NPU04603 ChE(P)—Cholinesterase, cinchocaine inhibited; cat.fr.(25 °C; proc.) = ? Plasma(fasting Patient)— NPU04595 ChE(P)—Cholinesterase, dibucain Cholesterol+ester/Cholesterol+ester, in HDL; inhibited; cat.fr.(25 °C; proc.) = ? substance ratio NPU04566 ChE(P)—Cholinesterase, fluoride NPU10293 inhibited; cat.fr.(25 °C; proc.)= ? P(fPt)—Cholesterol+ester/Cholesterol+ester, in NPU04494 ChE(P)—Cholinesterase, RO-20683 HDL; subst.ratio = ? inhibited; cat.fr.(25 °C; proc.)= ? NPU04594 ChE(P)—Cholinesterase, carbamide Amniotic fluid— inhibited; cat.fr.(25 °C; proc.)= ? Cholesterol+ester; substance concentration Cholinesterase(Plasma)— millimole/liter Cholinesterase type; NPU17784 catalytic-activity fraction(list; 37 °C; procedure) Amf—Cholesterol+ester; subst.c. = ? mmol/l Note: obs the sum of fractions may be >1 NPU03792 Ascites— ChE(P)—Cholinesterase type; cat.fr.(list; 37 °C; Cholesterol+ester; proc.) substance concentration NPU04170 ChE(P)—Cholinesterase, cinchocaine millimole/liter inhibited; cat.fr.(37 °C; proc.) = ? M = 386,64 g/mol NPU04601 ChE(P)—Cholinesterase, dibucain NPU10032 inhibited; cat.fr.(37 °C; proc.)= ? Asc—Cholesterol+ester; subst.c. = ? mmol/l NPU04600 ChE(P)—Cholinesterase, fluoride inhibited; cat.fr.(37 °C; proc.)= ? Plasma— NPU04604 ChE(P)—Cholinesterase, RO-20683 Cholesterol+ester; inhibited; cat.fr.(37 °C; proc.)= ? substance concentration NPU04602 ChE(P)—Cholinesterase, carbamide millimole/liter inhibited; cat.fr.(37 °C; proc.) = ? M = 386,64 g/mol Other term(s): Cholesterol; Cholesterol, total Cholinesterase(Plasma)— NPU01566 Cholinesterase, butan-1-ol inhibited; P—Cholesterol+ester; subst.c. = ? mmol/l catalytic-activity fraction(25 °C; procedure) Note: Fraction of total activity inhibited by butan-1-ol Pleural fluid— NPU08568 Cholesterol+ester; ChE(P)—Cholinesterase, butan-1-ol inhibited; substance concentration cat.fr.(25 °C; proc.) = ? millimole/liter M = 386,64 g/mol Cholinesterase(Plasma)— Other term(s): Cholesterol; Cholesterol, total Cholinesterase, carbamide inhibited; NPU17028 catalytic-activity fraction(25 °C; procedure) Plf—Cholesterol+ester; subst.c. = ? mmol/l Note: fraction of total activity inhibited by urea NPU04594 System(specification)— ChE(P)—Cholinesterase, carbamide inhibited; Cholesterol+ester; cat.fr.(25 °C; proc.)= ? substance concentration millimole/liter

Cholinesterase(Plasma)— Note: Fraction of total activity inhibited by RO-20683 Cholinesterase, carbamide inhibited; NPU04494 catalytic-activity fraction(37 °C; procedure) ChE(P)—Cholinesterase, RO-20683 inhibited; Note: fraction of total activity inhibited by urea cat.fr.(25 °C; proc.) = ? NPU04602 ChE(P)—Cholinesterase, carbamide inhibited; Cholinesterase(Plasma)— cat.fr.(37 °C; proc.) = ? Cholinesterase, RO-20683 inhibited; catalytic-activity fraction(37 °C; procedure) Cholinesterase(Plasma)— Note: Fraction of total activity inhibited by RO-20683 Cholinesterase, cinchocaine inhibited; NPU04604 catalytic-activity fraction(25 °C; procedure) ChE(P)—Cholinesterase, RO-20683 inhibited; Other term(s): Dibucaine; Cinchoine cat.fr.(37 °C; proc.) = ? Note: Fraction of total activity inhibited by cinchocaine Plasma— NPU04603 Cholinesterase; ChE(P)—Cholinesterase, cinchocaine inhibited; catalytic-activity concentration(25 °C; cat.fr.(25 °C; proc.) = ? procedure) microkatal/liter Cholinesterase(Plasma)— Other term(s): Benzoylcholinesterase; Choline Cholinesterase, cinchocaine inhibited; esterase II; Pseudocholinesterase catalytic-activity fraction(37 °C; procedure) NPU04593 Other term(s): Dibucaine; Cinchoine P—Cholinesterase; cat.c.(25 °C; proc.) = ? µkat/l Note: Fraction of total activity inhibited by cinchocaine Amniotic fluid— NPU04170 Cholinesterase; ChE(P)—Cholinesterase, cinchocaine inhibited; catalytic-activity concentration(37 °C; cat.fr.(37 °C; proc.) = ? procedure) microkatal/liter Cholinesterase(Plasma)— NPU03914 Cholinesterase, dibucain inhibited; Amf—Cholinesterase; cat.c.(37 °C; proc.) = ? µkat/l catalytic-activity fraction(25 °C; procedure) Note: Fraction of total activity inhibited by dibucain Plasma— NPU04595 Cholinesterase; ChE(P)—Cholinesterase, dibucain inhibited; catalytic-activity concentration(37 °C; cat.fr.(25 °C; proc.) = ? procedure) microkatal/liter Cholinesterase(Plasma)— Other term(s): Benzoylcholinesterase; Choline Cholinesterase, dibucain inhibited; esterase II; Pseudocholinesterase catalytic-activity fraction(37 °C; procedure) NPU01570 Note: Fraction of total activity inhibited by dibucain P—Cholinesterase; cat.c.(37 °C; proc.) = ? µkat/l NPU04601 ChE(P)—Cholinesterase, dibucain inhibited; Plasma— cat.fr.(37 °C; proc. )= ? Cholinesterase; substance concentration Cholinesterase(Plasma)— nanomole/liter Cholinesterase, fluoride inhibited; M = 300 000 g/mol catalytic-activity fraction(25 °C; procedure) Other term(s): Benzoylcholinesterase; Choline Note: Fraction of total activity inhibited by fluoride esterase II; Pseudocholinesterase NPU04566 NPU10294 ChE(P)—Cholinesterase, fluoride inhibited; P—Cholinesterase; subst.c. = ? nmol/l cat.fr.(25 °C; proc.) = ? Urine— Cholinesterase(Plasma)— Chondroitin sulfate; Cholinesterase, fluoride inhibited; substance concentration catalytic-activity fraction(37 °C; procedure) micromole/liter Note: Fraction of total activity inhibited by fluoride M = 50 000 g/mol NPU04600 Authority: IUPAC-IUB85 ChE(P)—Cholinesterase, fluoride inhibited; NPU01571 cat.fr.(37 °C; proc.) = ? U—Chondroitin sulfate; subst.c. = ? µmol/l

Cholinesterase(Plasma)— Plasma— Cholinesterase, RO-20683 inhibited; Choriogonadotropin a-chain; catalytic-activity fraction(25 °C; procedure) arbitrary substance concentration(IRP 75/569; procedure)

international unit/liter Urine— M = 14 000 g/mol Choriogonadotropin; Recommended calibrator: WHO 1st IRP 75/569 arbitrary concentration(procedure) Other term(s): hCG alpha M = 39 000 g/mol NPU01578 Authority: IUPAC-IUB 74 P—Choriogonadotropin a-chain; arb.subst.c.(IRP NPU10394 75/569; proc.) = ? int. unit/l U—Choriogonadotropin; arb.c.(proc.) = ?

Plasma— Plasma— Choriogonadotropin a-chain; Choriogonadotropin; substance concentration arbitrary substance concentration(IS 61/6; picomole/liter procedure) M = 14 000 g/mol international unit/liter Other term(s): hCG alpha M = 39 000 g/mol NPU01579 Recommended calibrator: WHO 2nd IS 61/6 P—Choriogonadotropin a-chain; subst.c. = ? pmol/l Other term(s): hCG Authority: IUPAC-IUB 74 Plasma— NPU04003 Choriogonadotropin b-chain core fragment; P—Choriogonadotropin; arb.subst.c.(IS 61/6; proc.) substance concentration = ? int. unit/l picomole/liter Other term(s): hCG b-cf Urine— NPU08936 Choriogonadotropin; P—Choriogonadotropin b-chain core fragment; arbitrary substance concentration(IS 61/6; subst.c. = ? pmol/l procedure) international unit/liter Plasma— M = 39 000 g/mol Choriogonadotropin b-chain nicked; Recommended calibrator: WHO 2nd IS 61/6 substance concentration Other term(s): hCG picomole/liter Authority: IUPAC-IUB 74 Other term(s): hCG b-n NPU01576 NPU08938 U—Choriogonadotropin; arb.subst.c.(IS 61/6; proc.) P—Choriogonadotropin b-chain nicked; subst.c. = ? = ? int. unit/l pmol/l Plasma— Plasma— Choriogonadotropin; Choriogonadotropin b-chain; arbitrary substance concentration(IS 75/537; arbitrary substance concentration(IRP 75/551; procedure) procedure) international unit/liter international unit/liter M = 39 000 g/mol M = 25 000 g/mol Recommended calibrator: WHO 3rd IS 75/537 Recommended calibrator: WHO 1st IRP 75/551 Calibrator(s): WHO 1st IRP 75/537 (for Other term(s): hCG beta immunoassay; identical to 3rd IS NPU01580 Other term(s): hCG P—Choriogonadotropin b-chain; arb.subst.c.(IRP Authority: IUPAC-IUB 74 75/551; proc.) = ? int. unit/l NPU01572 P—Choriogonadotropin; arb.subst.c.(IS 75/537; Plasma— proc.) = ? int. unit/l Choriogonadotropin b-chain; substance concentration Urine— picomole/liter Choriogonadotropin; M = 25 000 g/mol arbitrary substance concentration(IS 75/537; Other term(s): hCG beta procedure) NPU01581 international unit/liter P—Choriogonadotropin b-chain; subst.c. = ? pmol/l M = 39 000 g/mol Recommended calibrator: 3rd IS 75/537 Plasma— Calibrator(s): 1st IRP 75/537 (identical to 3rd IS) Choriogonadotropin nicked; Authority: IUPAC-IUB 74 substance concentration NPU10034 picomole/liter U—Choriogonadotropin; arb.subst.c.(IS 75/537; Other term(s): hCGn proc.) = ? int. unit/l NPU08937 P—Choriogonadotropin nicked; subst.c. = ? pmol/l

Patient— Plasma— Choriogonadotropin; Choriomammotropin; arbitrary substance content(intramuscular substance concentration administration; arbitrary amount-of-substance/ nanomole/liter body m; procedure; IS 75/537) M = 21 600 g/mol international unit/kilogram Other term(s): Chorionic somatomammotropin; NPU10423 Chorionsomatomammotropin; Human placenta Pt—Choriogonadotropin; arb.subst.cont.(i.m.; lactogen arb.am.s./body mass; proc.; IS 75/537)= ? int. unit/ Authority: IUPAC-IUB 74 kg NPU01585 P—Choriomammotropin; subst.c. = ? nmol/l Plasma— Choriogonadotropin; Plasma— substance concentration Chromium(III); picomole/liter substance concentration M = 39 000 g/mol nanomole/liter Other term(s): hCG M = 52,00 g/mol Authority: IUPAC-IUB 74 Authority: IUPAC/VII-C-TOX NPU01573 NPU01589 P—Choriogonadotropin; subst.c. = ? pmol/l P—Chromium(III); subst.c. = ? nmol/l

Urine— Urine— Choriogonadotropin; Chromium(III); substance concentration substance concentration picomole/liter nanomole/liter M = 39 000 g/mol M = 52,00 g/mol Other term(s): hCG Authority: IUPAC/VII-C-TOX Authority: IUPAC-IUB 74 NPU01590 NPU01577 U—Chromium(III); subst.c. = ? nmol/l U—Choriogonadotropin; subst.c. = ? pmol/l Hair— Plasma— Chromium(III); Choriogonadotropin+b-chain; substance content arbitrary substance concentration(IS 75/537; micromole/kilogram procedure) M = 52,00 g/mol international unit/liter Authority: IUPAC/VII-C-TOX Recommended calibrator: WHO 3rd IS 75/537 NPU01588 Calibrator(s): 1st IRP 75/537 (identical to 3rd IS) Hair—Chromium(III); subst.cont. = ? µmol/kg NPU01582 P—Choriogonadotropin+b-chain; arb.subst.c.(IS 75/ Cells(Blood)— 537; proc.) = ? int. unit/l Chromium(III); substance content Plasma— nanomole/kilogram Choriogonadotropin+b-chain; M = 52,00 g/mol substance concentration Authority: IUPAC/VII-C-TOX picomole/liter NPU01586 NPU01583 Cells(B)—Chromium(III); subst.cont. = ? nmol/kg P—Choriogonadotropin+b-chain; subst.c. = ? pmol/l Air(specification)— Plasma— Chromium(IV); Choriomammotropin; substance concentration arbitrary substance concentration(IRP 73/545; micromole/(meter)³ procedure) M = 52,00 g/mol international unit/liter Authority: IUPAC/VII-C-TOX M = 21 600 g/mol NPU01591 Recommended calibrator: WHO 1st IRP 73/545 Air(spec.)—Chromium(IV); subst.c. = ? µmol/m³ Other term(s): Chorionic somatomammotropin; Chorionsomatomammotropin; Human placenta Kidney— lactogen Chromium-EDTA-clearance; Authority: IUPAC-IUB 74 volume rate(procedure) NPU01584 milliliter/second P—Choriomammotropin; arb.subst.c.(IRP 73/545; NPU10295 proc.) = ? int. unit/l Kidn.—Chromium-EDTA-clearance; vol.rate(proc.) = ? ml/s

Plasma— Plasma— Chromogranin A; Citrulline; arbitrary substance concentration(procedure) substance concentration arbitrary unit/liter micromole/liter NPU10614 M = 175,19 g/mol P—Chromogranin A; arb.subst.c.(proc.) = ? NPU01611 arb.unit/l P—Citrulline; subst.c. = ? µmol/l

Plasma— Urine— Chromogranin A; Citrulline; substance concentration substance concentration picomole/liter micromole/liter NPU17556 M = 175,19 g/mol P—Chromogranin A; subst.c. = ? pmol/l NPU01612 U—Citrulline; subst.c. = ? µmol/l Plasma— Chromogranin B; Patient— substance concentration Clonidine(administered); picomole/liter amount-of-substance(oral administration) NPU17557 micromole P—Chromogranin B; subst.c. = ? pmol/l M = 230,10 g/mol NPU10536 Plasma— Pt—Clonidine(administered); am.s.(p.o.) = ? µmol Chylomicrons; arbitrary concentration(procedure) Vaginal fluid— NPU10035 Clue cells; P—Chylomicrons; arb.c.(proc.) = ? arbitrary concentration(procedure) NPU14316 Faeces— Vagf—Clue cells; arb.c.(proc.) = ? Chymotrypsin; arbitrary content(procedure) Plasma— NPU04850 Coagulation, tissue factor-induced; F—Chymotrypsin; arb.cont.(proc.)= ? arbitrary substance concentration(procedure; BCR/CRM148/149R) Urine— arbitrary unit/liter Citrate; NPU14567 substance concentration P—Coagulation, tissue factor-induced; millimole/liter arb.subst.c.(proc.; BCR/CRM148/149R) = ? NPU01594 arb.unit/l U—Citrate; subst.c. = ? mmol/l Synovial fluid— Patient(Urine)— Coagulum; Citrate; arbitrary concentration(procedure) substance rate(procedure) NPU17067 millimole/day Synf—Coagulum; arb.c.(proc.) = ? NPU14263 Pt(U)—Citrate; subst.rate(proc.) = ? mmol/d Intestine, small— Cobalamin absorption; Urine— substance rate(Intrinsic factor; oral Citrulline/Creatininium; administration; list; procedure) substance ratio NPU13813 10-3 Intest., small—Cobalamin absorption; NPU14204 subst.rate(Intrinsic factor; p.o.; list; proc.) U—Citrulline/Creatininium; subst.ratio = ? × 10-3 NPU13809 Pt—Cobalamin(administered); am.s.(i.m.) = ? µmol Cerebrospinal fluid— NPU13805 Pt—57Co-Cobalamin(administered); Citrulline; am.s.(p.o.) = ? pmol substance concentration NPU13812 Pt—58Co-Cobalamin(administered); micromole/liter am.s.(p.o.) = ? pmol M = 175,19 g/mol NPU13808 Pt—57Co-Cobalamin(administered); NPU09020 radioact.(p.o.) = ? kBq Csf—Citrulline; subst.c. = ? µmol/l NPU13810 Pt—58Co-Cobalamin(administered); radioact.(p.o.) = ? kBq

NPU13807 Pt(U)—57Co-Cobalamin; rel.radioact.(U Patient— 1 d/intake) = ? 58Co- NPU13811 Pt(U)—58Co-Cobalamin; rel.radioact.(U Cobalamin(administered); 1 d/intake) = ? amount-of-substance(oral administration) picomole Intestine, small— NPU13812 Cobalamin absorption; Pt—58Co-Cobalamin(administered); am.s.(p.o.) = ? substance rate(no intrinsic factor; list; pmol procedure) NPU13804 Patient— Intest., small—Cobalamin absorption; subst.rate(no 57Co- intrinsic factor; list; proc.) Cobalamin(administered); NPU13809 Pt—Cobalamin(administered); radioactivity(oral administration) am.s.(i.m.) = ? µmol kilobecquerel NPU13805 Pt—57Co-Cobalamin(administered); NPU13808 am.s.(p.o.) = ? pmol Pt—57Co-Cobalamin(administered); radioact.(p.o.) = NPU13812 Pt—58Co-Cobalamin(administered); ? kBq am.s.(p.o.) = ? pmol NPU13808 Pt—57Co-Cobalamin(administered); Patient— radioact.(p.o.) = ? kBq 58Co- NPU13810 Pt—58Co-Cobalamin(administered); Cobalamin(administered); radioact.(p.o.) = ? kBq radioactivity(oral administration) NPU13807 Pt(U)—57Co-Cobalamin; rel.radioact.(U kilobecquerel 1 d/intake) = ? NPU13810 NPU13811 Pt(U)—58Co-Cobalamin; rel.radioact.(U Pt—58Co-Cobalamin(administered); radioact.(p.o.) = 1 d/intake) = ? ? kBq

Cobalamin(Plasma)— Patient(Urine)— Cobalamin type; 57Co- substance fraction(list; procedure) Cobalamin; 57 NPU01701 relative amount-of-substance( Co-B12 and Cobalamin(P)—Cobalamin type; subst.fr.(list; proc.) intrinsic factor, oral administration; urine 1 d/ NPU04956 Cobalamin(P)—Aquocobalamin; intake; procedure) subst.fr. = ? M = 1 355 g/mol NPU04954 Cobalamin(P)—Cyanocobalamin; Other term(s): Schilling test II subst.fr. = ? NPU01698 57 57 NPU04959 Cobalamin(P)—Deoxycobalamin; Pt(U)— Co-Cobalamin; rel.ams.( Co-B12 and IF subst.fr.= ? p.o.; U 1 d/intake; proc.) = ? NPU04955 Cobalamin(P)—Hydroxocobalamin; subst.fr. = ? Patient(Urine)— NPU04958 Cobalamin(P)—Methylcobalamin; 57Co- subst.fr.= ? Cobalamin; 57 NPU04957 Cobalamin(P)—Sulfitocobalamin; relative amount-of-substance( Co-B12, oral subst.fr. = ? administration; urine 1 d/intake; procedure) M = 1 355 g/mol Patient— Other term(s): Schilling test I Cobalamin(administered); NPU01699 57 57 amount-of-substance(intramuscular Pt(U)— Co-Cobalamin; rel.ams.( Co-B12 p.o.; U 1 administration) d/intake; proc.) = ? micromole NPU13809 Patient(Faeces)— Pt—Cobalamin(administered); am.s.(i.m.) = ? µmol 58Co- Cobalamin; 58 Patient— relative amount-of-substance( Co-B12 and 57Co- intrinsic factor, oral administration; faeces/ Cobalamin(administered); intake; procedure) amount-of-substance(oral administration) M = 1 355 g/mol picomole Other term(s): ISA-test; Incomplete Stool NPU13805 Absorption test Pt—57Co-Cobalamin(administered); am.s.(p.o.) = ? NPU01696 58 58 pmol Pt(F)— Co-Cobalamin; rel.ams.( Co-B12 and IF p.o.; F/intake; proc.) = ?

Patient(Faeces)— Urine— 58Co- Cobalt; Cobalamin; substance concentration 58 relative amount-of-substance( Co-B12, oral nanomole/liter administration; faeces/intake; procedure) M = 58,93 g/mol M = 1 355 g/mol Authority: IUPAC/VII-C-TOX Other term(s): ISA-test; Incomplete Stool NPU01705 Absorption test U—Cobalt; subst.c. = ? nmol/l NPU01695 58 58 Pt(F)— Co-Cobalamin; rel.ams.( Co-B12 p.o.; F/ Hair— intake; proc.) = ? Cobalt; substance content Patient(Urine)— micromole/kilogram 57Co- M = 58,93 g/mol Cobalamin; Authority: IUPAC/VII-C-TOX relative radioactivity(urine 1 d/intake) NPU01704 NPU13807 Hair—Cobalt; subst.cont. = ? µmol/kg Pt(U)—57Co-Cobalamin; rel.radioact.(U 1 d/intake) = ? Plasma— Coeliac disease antibody; Patient(Urine)— property(list; procedure) 58Co- NPU14503 Cobalamin; P—Coeliac disease antibody; prop.(list; proc.) relative radioactivity(urine 1 d/intake) NPU12538 P—Endomysium antibody(IgA); NPU13811 arb.c.(proc.) = ? Pt(U)—58Co-Cobalamin; rel.radioact.(U 1 d/intake) = NPU08945 P—Gliadin antibody(IgA); ? arb.subst.c.(proc.) = ? × 10³ arb.unit/l NPU08944 P—Gliadin antibody(IgG); Plasma— arb.subst.c.(proc.) = ? × 10³ arb.unit/l Cobalamin; NPU12247 P—Reticulin antibody(IgA); arb.c.(proc.) substance concentration = ? picomole/liter NPU12248 P—Reticulin antibody(IgG); arb.c.(proc.) NPU01700 = ? P—Cobalamin; subst.c. = ? pmol/l NPU17704 P—Transglutaminase antibody(IgA); arb.c.(proc.) = ? Air(specification)— NPU14566 P—Transglutaminase antibody(IgA); Cobalt; arb.subst.c.(proc.) = ? × 10³ arb.unit/l substance concentration micromole/(meter)³ Plasma— M = 58,93 g/mol Colistin; Authority: IUPAC/VII-C-TOX substance concentration NPU01702 mole/liter Air(spec.)—Cobalt; subst.c. = ? µmol/m³ NPU10297 P—Colistin; subst.c.= ? prefix ? mol/l Blood— Cobalt; Plasma— substance concentration Complement activity, antibody-induced; nanomole/liter property(erythrolysis; procedure) M = 58,93 g/mol Other term(s): Hemolytic complement titer classical Authority: IUPAC/VII-C-TOX system; CH50; AP50 NPU01703 Authority: ICW91 B—Cobalt; subst.c. = ? nmol/l NPU01715 P—Complement activity, antibody-induced; Plasma— prop.(erythrol.; proc.) = ? Cobalt; substance concentration Plasma— nanomole/liter Complement activity, cell-surface-induced; M = 58,93 g/mol property(erythrolysis; procedure) Authority: IUPAC/VII-C-TOX Other term(s): Hemolytic complement titer NPU04904 alternative system P—Cobalt; subst.c. = ? nmol/l Authority: ICW91 NPU01716 P—Complement activity, cell-surface-induced; prop.(erythrol.; proc.) = ?

Plasma— M = 462 000 g/mol Complement C1 esterase inhibitor; Authority: ICW91 arbitrary concentration(enzymatic; procedure) NPU01722 M = 105 000 g/mol P—Complement C1q; subst.c.(proc.) = ? µmol/l Other term(s): C1 Inactivator; C1 INA; C1IA; C1 esterase inhibitor; C1 INH; C1 inhibitor Plasma— Authority: ICW91 Complement C1r2-C1s2; NPU01718 arbitrary concentration(erythrolysis; procedure) P—Complement C1 esterase inhibitor; arb.c.(enz.; M = 332 000 g/mol proc.) = ? Authority: ICW91 NPU01723 Plasma— P—Complement C1r2-C1s2; arb.c.(erythrol.; proc.) Complement C1 esterase inhibitor; = ? arbitrary concentration(immunological; procedure) Plasma— M = 105 000 g/mol Complement C1r2-C1s2; Other term(s): C1 Inactivator; C1 INA; C1IA; C1 arbitrary concentration(immunological; esterase inhibitor; C1 INH; C1 inhibitor procedure) Authority: ICW91 M = 332 000 g/mol NPU01719 Authority: ICW91 P—Complement C1 esterase inhibitor; arb.c.(imm.; NPU03858 proc.) = ? P—Complement C1r2-C1s2; arb.c.(imm.; proc.) = ?

Plasma— Plasma— Complement C1 esterase inhibitor; Complement C1r2-C1s2; arbitrary substance concentration(enzymatic; substance concentration(procedure) procedure) micromole/liter NPU14340 M = 332 000 g/mol P—Complement C1 esterase inhibitor; Authority: ICW91 arb.subst.c.(enz.; proc.) = ? NPU01724 P—Complement C1r2-C1s2; subst.c.(proc.) = ? Plasma— µmol/l Complement C1 esterase inhibitor; substance concentration(procedure) Plasma— micromole/liter Complement C1s; M = 105 000 g/mol arbitrary substance Other term(s): C1 Inactivator; C1 INA; C1IA; C1 concentration(immunological; procedure) esterase inhibitor; C1 INH; C1 inhibitor arbitrary unit/liter Authority: ICW91 NPU03900 NPU01720 P—Complement C1s; arb.subst.c.(imm.; proc.) = ? P—Complement C1 esterase inhibitor; arb.unit/l subst.c.(proc.) = ? µmol/l Plasma— Plasma— Complement C2; Complement C1q; arbitrary concentration(erythrolysis; procedure) arbitrary concentration(erythrolysis; procedure) M = 102 000 g/mol M = 462 000 g/mol Authority: ICW91 Authority: ICW91 NPU01725 NPU01721 P—Complement C2; arb.c.(erythrol.; proc.) = ? P—Complement C1q; arb.c.(erythrol.; proc.) = ? Plasma— Plasma— Complement C2; Complement C1q; arbitrary concentration(immunological; arbitrary concentration(immunological; procedure) procedure) M = 102 000 g/mol M = 462 000 g/mol Authority: ICW91 Authority: ICW91 NPU03859 NPU03857 P—Complement C2; arb.c.(imm.; proc.) = ? P—Complement C1q; arb.c.(imm.; proc.) = ? Plasma— Plasma— Complement C2; Complement C1q; substance concentration(procedure) substance concentration(procedure) micromole/liter micromole/liter

M = 102 000 g/mol Plasma— Authority: ICW91 Complement C3b; NPU01726 substance concentration P—Complement C2; subst.c.(proc.) = ? µmol/l micromole/liter M = 176 000 g/mol Erythrocytes(Blood)— Authority: ICW91 Complement C3 fragment; NPU01730 arbitrary entitic number(procedure) P—Complement C3b; subst.c. = ? µmol/l Authority: ICW91 NPU01728 Erythrocytes(Blood)— Ercs(B)—Complement C3 fragment; arb.entitic Complement C3b-C4b receptor; num.(proc.) = ? arbitrary entitic number(procedure) Other term(s): Complement receptor type 1; CR 1 Erythrocytes(Blood)— NPU03869 Complement C3 fragment; Ercs(B)—Complement C3b-C4b receptor; arb.entitic entitic number(procedure) num.(proc.) = ? Authority: ICW91 NPU03885 Erythrocytes(Blood)— Ercs(B)—Complement C3 fragment; entitic Complement C3b-C4b receptor; num.(proc.) = ? entitic number(procedure) Other term(s): Complement receptor type 1; CR 1 Plasma— Authority: ICW91 Complement C3; NPU01731 arbitrary concentration(procedure) Ercs(B)—Complement C3b-C4b receptor; entitic M = 185 000 g/mol num.(proc.) = ? Other term(s): b-1-C-globulin; Factor A Authority: ICW91 Plasma— NPU03861 Complement C3c; P—Complement C3; arb.c.(proc.) = ? arbitrary concentration(procedure) M = 134 000 g/mol Plasma— Authority: ICW91 Complement C3; NPU03864 substance concentration P—Complement C3c; arb.c.(proc.) = ? micromole/liter M = 185 000 g/mol Plasma— Other term(s): beta1-C-globulin; Factor A Complement C3c; Authority: ICW91 substance concentration NPU01727 micromole/liter P—Complement C3; subst.c. = ? µmol/l M = 134 000 g/mol Authority: ICW91 Plasma— NPU01732 Complement C3a; P—Complement C3c; subst.c. = ? µmol/l arbitrary concentration(procedure) M = 9 000 g/mol Plasma— Authority: ICW91 Complement C3d,g; NPU03862 arbitrary concentration(procedure) P—Complement C3a; arb.c.(proc.) = ? M = 40 000 g/mol Authority: ICW91 Plasma— NPU01735 Complement C3a; P—Complement C3d,g; arb.c.(proc.) = ? substance concentration micromole/liter Plasma— M = 9 000 g/mol Complement C3d,g; Authority: ICW91 substance concentration NPU01729 micromole/liter P—Complement C3a; subst.c. = ? µmol/l M = 40 000 g/mol Authority: ICW91 Plasma— NPU03865 Complement C3b; P—Complement C3d,g; subst.c. = ? µmol/l arbitrary concentration(procedure) M = 176 000 g/mol Authority: ICW91 NPU03863 P—Complement C3b; arb.c.(proc.) = ?

Erythrocytes(Blood)— Plasma— Complement C3d; Complement C4a; arbitrary entitic number(procedure) arbitrary concentration(immunological; Authority: ICW91 procedure) NPU01733 M = 7 000 g/mol Ercs(B)—Complement C3d; arb.entitic num.(proc.) Authority: ICW91 = ? NPU03866 P—Complement C4a; arb.c.(imm.; proc.) = ? Plasma— Complement C3d; Plasma— arbitrary substance concentration Complement C4a; arbitrary unit/liter substance concentration(procedure) Authority: ICW91 micromole/liter NPU10298 M = 7 000 g/mol P—Complement C3d; arb.subst.c. = ? arb.unit/l Authority: ICW91 NPU01738 Erythrocytes(Blood)— P—Complement C4a; subst.c.(proc.) = ? µmol/l Complement C3d; entitic number(procedure) Plasma— Authority: ICW91 Complement C4b binding protein; NPU03886 arbitrary concentration(immunological; Ercs(B)—Complement C3d; entitic num.(proc.) = ? procedure) M = 500 000 g/mol B-lymphocytes(Blood)— Authority: ICW91 Complement C3d-C3d,g-iC3b receptor; NPU03867 arbitrary entitic number(procedure) P—Complement C4b binding protein; arb.c.(imm.; Other term(s): Complement receptor type 2; CR 2 proc.) = ? Authority: ICW91 NPU01734 Plasma— B-lymphocs(B)—Complement C3d-C3d,g-iC3b Complement C4b binding protein; receptor; arb.entitic num.(proc.) = ? substance concentration(procedure) micromole/liter Plasma— M = 500 000 g/mol Complement C4; Authority: ICW91 arbitrary concentration(adhesion; procedure) NPU01739 M = 205 000 g/mol P—Complement C4b binding protein; Authority: ICW91 subst.c.(proc.) = ? µmol/l NPU01736 P—Complement C4; arb.c.(adhesion; proc.) = ? Erythrocytes(Blood)— Complement C4d; Plasma— arbitrary entitic number(procedure) Complement C4; Authority: ICW91 arbitrary substance NPU01740 concentration(immunological; procedure) Ercs(B)—Complement C4d; arb.entitic num.(proc.) arbitrary unit/liter = ? M = 205 000 g/mol Other term(s): beta1-E-globulin Erythrocytes(Blood)— Authority: ICW91 Complement C4d; NPU03860 entitic number(procedure) P—Complement C4; arb.subst.c.(imm.; proc.) = ? Authority: ICW91 arb.unit/l NPU03887 Ercs(B)—Complement C4d; entitic num.(proc.) = ? Plasma— Complement C4; Plasma— substance concentration(procedure) Complement C5; micromole/liter arbitrary concentration(adhesion; procedure) M = 205 000 g/mol M = 190 000 g/mol Other term(s): beta1-E-globulin Other term(s): ß1-F-globulin Authority: ICW91 Authority: ICW91 NPU01737 NPU01741 P—Complement C4; subst.c.(proc.) = ? µmol/l P—Complement C5; arb.c.(adhesion; proc.) = ?

Plasma— Plasma— Complement C5; Complement C7; arbitrary substance arbitrary concentration(adhesion; procedure) concentration(immunological; procedure) M = 110 000 g/mol arbitrary unit/liter Authority: ICW91 M = 190 000 g/mol NPU01746 Other term(s): ß1-F-globulin P—Complement C7; arb.c.(adhesion; proc.) = ? Authority: ICW91 NPU03873 Plasma— P—Complement C5; arb.subst.c.(imm.; proc.) = ? Complement C7; arb.unit/l arbitrary concentration(immunological; procedure) Plasma— M = 110 000 g/mol Complement C5; Authority: ICW91 substance concentration(procedure) NPU03876 micromole/liter P—Complement C7; arb.c.(imm.; proc.) = ? M = 190 000 g/mol Other term(s): ß1-F-globulin Plasma— Authority: ICW91 Complement C7; NPU01742 substance concentration(procedure) P—Complement C5; subst.c.(proc.) = ? µmol/l micromole/liter M = 110 000 g/mol Plasma— Authority: ICW91 Complement C5a; NPU01747 arbitrary concentration(procedure) P—Complement C7; subst.c.(proc.) = ? µmol/l M = 11 000 g/mol Authority: ICW91 Plasma— NPU03874 Complement C8; P—Complement C5a; arb.c.(proc.) = ? arbitrary concentration(adhesion; procedure) M = 150 000 g/mol Plasma— Authority: ICW91 Complement C5a; NPU01748 substance concentration(procedure) P—Complement C8; arb.c.(adhesion; proc.) = ? micromole/liter M = 11 000 g/mol Plasma— Authority: ICW91 Complement C8; NPU01743 arbitrary concentration(immunological; P—Complement C5a; subst.c.(proc.) = ? µmol/l procedure) M = 150 000 g/mol Plasma— Authority: ICW91 Complement C6; NPU03877 arbitrary concentration(adhesion; procedure) P—Complement C8; arb.c.(imm.; proc.) = ? M = 120 000 g/mol Authority: ICW91 Plasma— NPU01744 Complement C8; P—Complement C6; arb.c.(adhesion; proc.) = ? substance concentration(procedure) micromole/liter Plasma— M = 150 000 g/mol Complement C6; Authority: ICW91 arbitrary concentration(immunological; NPU01749 procedure) P—Complement C8; subst.c.(proc.) = ? µmol/l M = 120 000 g/mol Authority: ICW91 Plasma— NPU03875 Complement C9; P—Complement C6; arb.c.(imm.; proc.) = ? arbitrary concentration(immunological; procedure) Plasma— M = 71 000 g/mol Complement C6; Authority: ICW91 substance concentration(procedure) NPU03878 micromole/liter P—Complement C9; arb.c.(imm.; proc.) = ? M = 120 000 g/mol Authority: ICW91 NPU01745 P—Complement C6; subst.c.(proc.) = ? µmol/l

Erythrocytes(Blood)— Plasma— Complement C9; Complement factor B; arbitrary entitic number(adhesion; procedure) arbitrary substance M = 71 000 g/mol concentration(immunological; procedure) Authority: ICW91 arbitrary unit/liter NPU01750 NPU12891 Ercs(B)—Complement C9; arb.entitic P—Complement factor B; arb.subst.c.(imm.; proc.) num.(adhesion; proc.) = ? = ? arb.unit/l

Plasma— Plasma— Complement C9; Complement factor B; substance concentration(procedure) substance concentration(procedure) micromole/liter micromole/liter M = 71 000 g/mol M = 92 000 g/mol Authority: ICW91 Other term(s): C3 proactivator; Complement C3 NPU01751 proactivator+activator; Glycine-rich b-glycoprotein; P—Complement C9; subst.c.(proc.) = ? µmol/l Heat labile factor Authority: ICW91 Erythrocytes(Blood)— NPU01754 Complement decay accelerating factor; P—Complement factor B; subst.c.(proc.) = ? µmol/l arbitrary entitic number(immunological; procedure) Plasma— Other term(s): DAF; Cluster of differentiation 55; CD Complement factor Ba; 55 arbitrary concentration(immunological; Authority: ICW91 procedure) NPU03879 M = 33 000 g/mol Ercs(B)—Complement decay accelerating factor; Authority: ICW91 arb.entitic num.(imm.; proc.) = ? NPU03881 P—Complement factor Ba; arb.c.(imm.; proc.) = ? Erythrocytes(Blood)— Complement decay accelerating factor; Plasma— entitic number(immunological; procedure) Complement factor Ba; Other term(s): DAF substance concentration(procedure) Authority: ICW91 micromole/liter Note: Other name: Cluster of differentiation 55; CD M = 33 000 g/mol 55 Authority: ICW91 NPU01752 NPU01755 Ercs(B)—Complement decay accelerating factor; P—Complement factor Ba; subst.c.(proc.) = ? entitic num.(imm.; proc.) = ? µmol/l

Plasma— Plasma— Complement factor B; Complement factor Bb; arbitrary concentration(adhesion; procedure) arbitrary concentration(immunological; M = 92 000 g/mol procedure) Other term(s): C3 proactivator; Complement C3 M = 60 000 g/mol proactivator+activator; Glycine-rich b-glycoprotein; Authority: ICW91 Heat labile factor NPU03882 Authority: ICW91 P—Complement factor Bb; arb.c.(imm.; proc.) = ? NPU01753 P—Complement factor B; arb.c.(adhesion; proc.) = Plasma— ? Complement factor Bb; substance concentration(procedure) Plasma— micromole/liter Complement factor B; M = 60 000 g/mol arbitrary concentration(immunological; Authority: ICW91 procedure) NPU01756 M = 92 000 g/mol P—Complement factor Bb; subst.c.(proc.) = ? µmol/ Other term(s): C3 proactivator; Complement C3 proactivator+activator; Glycine-rich b-glycoprotein; Heat labile factor Authority: ICW91 NPU03880 P—Complement factor B; arb.c.(imm.; proc.) = ?

Plasma— Other term(s): C3b inactivator; C4b inactivator; KAF Complement factor D; NPU01762 arbitrary concentration(adhesion; procedure) P—Complement factor I; subst.c.(proc.) = ? µmol/l M = 24 000 g/mol Other term(s): C3 proactivator convertase; GBGase Plasma— Authority: ICW91 Complement factor P; NPU01757 arbitrary concentration(immunological; P—Complement factor D; arb.c.(adhesion; proc.) = procedure) ? M = 220 000 g/mol Other term(s): Properdin Plasma— Authority: ICW91 Complement factor D; NPU01763 arbitrary concentration(immunological; P—Complement factor P; arb.c.(imm.; proc.) = ? procedure) M = 24 000 g/mol Plasma— Other term(s): C3 proactivator convertase; GBGase Complement factor P; Authority: ICW91 substance concentration(procedure) NPU03889 micromole/liter P—Complement factor D; arb.c.(imm.; proc.) = ? M = 220 000 g/mol Other term(s): Properdin Plasma— Authority: ICW91 Complement factor D; NPU01764 substance concentration(procedure) P—Complement factor P; subst.c.(proc.) = ? µmol/l micromole/liter M = 24 000 g/mol Plasma— Other term(s): C3 proactivator convertase; GBGase Complement iC3; Authority: ICW91 arbitrary concentration(procedure) NPU01758 M = 174 000 g/mol P—Complement factor D; subst.c.(proc.) = ? µmol/l Authority: ICW91 NPU03883 Plasma— P—Complement iC3; arb.c.(proc.) = ? Complement factor H; arbitrary concentration(immunological; Plasma— procedure) Complement iC3; M = 150 000 g/mol substance concentration Other term(s): beta1H; C3bINA accelerator micromole/liter Authority: ICW91 M = 174 000 g/mol NPU01759 Authority: ICW91 P—Complement factor H; arb.c.(imm.; proc.) = ? NPU01765 P—Complement iC3; subst.c. = ? µmol/l Plasma— Complement factor H; Granulocytes(Blood)— substance concentration(procedure) Complement iC3b receptor; micromole/liter arbitrary entitic number(procedure) M = 150 000 g/mol M = 260 000 g/mol Other term(s): beta1H; C3bINA accelerator Authority: ICW91 Authority: ICW91 NPU03871 NPU01760 Granulocytes(B)—Complement iC3b receptor; P—Complement factor H; subst.c.(proc.) = ? µmol/l arb.entitic num.(proc.) = ?

Plasma— Granulocytes(Blood)— Complement factor I; Complement iC3b receptor; arbitrary concentration(immunological; entitic number(procedure) procedure) M = 260 000 g/mol M = 88 000 g/mol Authority: ICW91 Other term(s): C3b inactivator; C4b inactivator; KAF NPU01766 NPU01761 Granulocytes(B)—Complement iC3b receptor; P—Complement factor I; arb.c.(imm.; proc.) = ? entitic num.(proc.) = ?

Plasma— Complement factor I; substance concentration(procedure) micromole/liter M = 88 000 g/mol

Plasma— NPU01773 Complement membrane attack complex(C5b-C6-C7- P—Copper; subst.c. = ? µmol/l C8-C9n); arbitrary concentration(immunological; Urine— procedure) Copper; Other term(s): MAC substance concentration Authority: ICW91 micromole/liter Note: M: 1-2 x 10E6 M = 63,55 g/mol NPU01767 Authority: IUPAC/VII-C-TOX P—Complement membrane attack complex(C5b- NPU01774 C6-C7-C8-C9n); arb.c.(imm.; proc.) = ? U—Copper; subst.c. = ? µmol/l

B-lymphocytes(Blood)— Cells(Blood)— Complement membrane C3b-C4b cofactor protein; Copper; arbitrary entitic number(procedure) substance content Authority: ICW91 micromole/kilogram Note: M: 45 000-70 000 M = 63,55 g/mol NPU01768 Authority: IUPAC/VII-C-TOX B-lymphocs(B)—Complement membrane C3b-C4b NPU04905 cofactor protein; arb.entitic num.(proc.) = ? Cells(B)—Copper; subst.cont. = ? µmol/kg

B-lymphocytes(Blood)— Chorionic villus cell protein— Complement membrane C3b-C4b cofactor protein; Copper; entitic number substance content Authority: ICW91 micromole/kilogram Note: M: 45 000-70 000 M = 63,55 g/mol NPU03888 NPU01771 B-lymphocs(B)—Complement membrane C3b-C4b Chor.villus cell prot.—Copper; subst.cont. = ? µmol/ cofactor protein; entitic num. = ? kg

Erythrocytes(Blood)— Hair— Complement+Immunoglobulin; Copper; arbitrary entitic number(adhesion; procedure) substance content Other term(s): Coomb’s direct test; Anti globulin micromole/kilogram reaction M = 63,55 g/mol Authority: ICW91 Authority: IUPAC/VII-C-TOX NPU01717 NPU01772 Ercs(B)—Complement+Immunoglobulin; arb.entitic Hair—Copper; subst.cont. = ? µmol/kg num.(adhesion; proc.) = ? Patient(Urine)— Erythrocytes(Blood)— Copper; Complement+Immunoglobulin; substance rate(procedure) entitic number(procedure) micromole/day Other term(s): Coomb’s direct test; Anti globulin NPU08976 reaction Pt(U)—Copper; subst.rate(proc.) = ? µmol/d Authority: ICW91 NPU03868 Urine— Ercs(B)—Complement+Immunoglobulin; entitic Coproporphyrin; num.(proc.) = ? substance concentration nanomole/liter Urine— NPU10300 Copper; U—Coproporphyrin; subst.c. = ? nmol/l amount-of-substance(procedure) micromole Faeces— M = 63,55 g/mol Coproporphyrin; NPU08635 substance content U—Copper; am.s.(proc.) = ? µmol micromole/kilogram NPU10299 Plasma— F—Coproporphyrin; subst.cont. = ? µmol/kg Copper; substance concentration Patient— micromole/liter Corticoliberin(administered); M = 63,55 g/mol amount-of-substance(intravenous Authority: IUPAC/VII-C-TOX administration) nanomole

Other term(s): Corticotropin-releasing factor; CRF; NPU10487 P—Corticotropin; subst.c.(5 min) = ? Corticotropin releasing hormone; CRH pmol/l NPU10484 NPU10623 P—Corticotropin; subst.c.(10 min) = ? Pt—Corticoliberin(administered); am.s.(i.v.) = ? pmol/l nmol NPU10624 P—Corticotropin; subst.c.(15 min) = ? pmol/l Patient— NPU10625 P—Corticotropin; subst.c.(20 min) = ? Corticoliberin(administered); pmol/l substance content(intravenous administration; NPU10488 P—Corticotropin; subst.c.(30 min) = ? amount-of-substance/body mass) pmol/l nanomole/kilogram NPU10626 P—Corticotropin; subst.c.(40 min) = ? Other term(s): Corticotropin-releasing factor; CRF; pmol/l Corticotropin releasing hormone; CRH NPU10489 P—Corticotropin; subst.c.(45 min) = ? NPU10483 pmol/l Pt—Corticoliberin(administered); subst.cont.(i.v.; NPU10490 P—Corticotropin; subst.c.(60 min) = ? am.s./body mass) = ? nmol/kg pmol/l NPU10627 P—Cortisol; subst.c.(-15 min) = ? nmol/l Plasma(fasting Patient)— NPU04139 P—Cortisol; subst.c.(0 min) = ? nmol/l Corticoliberin; NPU10409 P—Cortisol; subst.c.(1 min) = ? nmol/l substance concentration NPU10410 P—Cortisol; subst.c.(5 min) = ? nmol/l picomole/liter NPU10628 P—Cortisol; subst.c.(10 min) = ? nmol/l Other term(s): Corticotropin-releasing factor; CRF; NPU04966 P—Cortisol; subst.c.(15 min) = ? nmol/l Corticotropin releasing hormone; CRH NPU04140 P—Cortisol; subst.c.(30 min) = ? nmol/l NPU14068 NPU10631 P—Cortisol; subst.c.(40 min) = ? nmol/l P(fPt)—Corticoliberin; subst.c. = ? pmol/l NPU04967 P—Cortisol; subst.c.(45 min) = ? nmol/l NPU04968 P—Cortisol; subst.c.(60 min) = ? nmol/l Urine— Corticoliberin; Patient— substance concentration Corticotropin secretion; picomole/liter substance rate(insulin, intravenous Other term(s): Corticotropin-releasing factor; CRF; administration; list; procedure) Corticotropin releasing hormone; CRH Note: M (insulin) = 5 807,65 g/mol; M (corticotropin) NPU14069 = 4 542 g/mol U—Corticoliberin; subst.c. = ? pmol/l NPU10554 Pt—Corticotropin secretion; subst.rate(insulin i.v.; Patient(Urine)— list; proc.) Corticoliberin; NPU10547 Pt—Insulin(administered); substance rate subst.cont.(i.v.; am.s./body mass) = ? µmol/kg picomole/day NPU10548 Pt—Insulin(administered); Other term(s): Corticotropin-releasing factor; CRF; arb.subst.cont.(i.v.; arb.am.s./body mass; proc.) = ? Corticotropin releasing hormone; CRH int. unit/kg NPU14070 NPU10485 P—Corticotropin; subst.c.(0 min) = ? Pt(U)—Corticoliberin; subst.rate = ? pmol/d pmol/l NPU10488 P—Corticotropin; subst.c.(30 min) = ? Patient— pmol/l Corticotropin secretion; NPU10489 P—Corticotropin; subst.c.(45 min) = ? substance rate(corticoliberin, intravenous pmol/l administration; list; procedure) NPU10490 P—Corticotropin; subst.c.(60 min) = ? Other term(s): CRH test pmol/l Note: M (corticotropin releasing hormone) = 4 NPU10553 P—Corticotropin; subst.c.(90 min) = ? 757,5 g/mol; M (corticotropin) = 4 542 g/mol pmol/l NPU10482 NPU10641 P—Corticotropin; subst.c.(120 min) = ? Pt—Corticotropin secretion; subst.rate(corticoliberin pmol/l i.v.; list; proc.) NPU04173 P—Glucose; subst.c.(0 min) = ? mmol/l NPU10484 Pt—Corticoliberin(administered); NPU04186 P—Glucose; subst.c.(15 min) = ? am.s.(i.v.) = ? nmol mmol/l NPU10483 Pt—Corticoliberin(administered); NPU04174 P—Glucose; subst.c.(30 min) = ? subst.cont.(i.v.; am.s./body mass) = ? nmol/kg mmol/l NPU10622 P—Corticotropin; subst.c.(-15 min) = ? NPU04187 P—Glucose; subst.c.(45 min) = ? pmol/l mmol/l NPU10485 P—Corticotropin; subst.c.(0 min) = ? NPU04175 P—Glucose; subst.c.(60 min) = ? pmol/l mmol/l NPU10486 P—Corticotropin; subst.c.(1 min) = ? NPU04965 P—Glucose; subst.c.(75 min) = ? pmol/l mmol/l

NPU04176 P—Glucose; subst.c.(90 min) = ? Plasma— mmol/l Corticotropin; NPU04177 P—Glucose; subst.c.(120 min) = ? substance concentration(15 minutes before mmol/l challenge) NPU04179 P—Glucose; subst.c.(180 min) = ? picomole/liter mmol/l NPU10622 NPU04981 P—Glucose; subst.c.(min.; proc.) = ? P—Corticotropin; subst.c.(-15 min) = ? pmol/l mmol/l Plasma— Patient— Corticotropin; Corticotropin(administered); substance concentration(0 minutes after amount-of-substance(intramuscular challenge) administration) picomole/liter nanomole NPU10485 M = 4 542 g/mol P—Corticotropin; subst.c.(0 min) = ? pmol/l Other term(s): ACTH; Adrenocorticotropic hormone Authority: IUPAC-IUB 74 Plasma— NPU10375 Corticotropin; Pt—Corticotropin(administered); am.s.(i.m.) = ? substance concentration(1 minute after nmol challenge) picomole/liter Patient— NPU10486 Corticotropin(administered); P—Corticotropin; subst.c.(1 min) = ? pmol/l amount-of-substance(intravenous administration) Plasma— nanomole Corticotropin; M = 4 542 g/mol substance concentration(5 minutes after Other term(s): ACTH; Adrenocorticotropic hormone challenge) Authority: IUPAC-IUB 74 picomole/liter NPU10531 NPU10487 Pt—Corticotropin(administered); am.s.(i.v.) = ? nmol P—Corticotropin; subst.c.(5 min) = ? pmol/l

Patient— Plasma— Corticotropin(administered); Corticotropin; substance rate(intramuscular administration; 3 substance concentration(10 minutes after days) challenge) nanomole/day picomole/liter M = 4 542 g/mol NPU10623 Other term(s): ACTH; Adrenocorticotropic hormone P—Corticotropin; subst.c.(10 min) = ? pmol/l Authority: IUPAC-IUB 74 NPU10556 Plasma— Pt—Corticotropin(administered); subst.rate(i.m.; 3 Corticotropin; d) = ? nmol/d substance concentration(15 minutes after challenge) Urine— picomole/liter Corticotropin; NPU10624 arbitrary concentration(procedure) P—Corticotropin; subst.c.(15 min) = ? pmol/l M = 4 542 g/mol Other term(s): ACTH; Adrenocorticotropic hormone Plasma— NPU04892 Corticotropin; U—Corticotropin; arb.c.(proc.) = ? substance concentration(20 minutes after challenge) Plasma— picomole/liter Corticotropin; NPU10625 arbitrary substance concentration(procedure) P—Corticotropin; subst.c.(20 min) = ? pmol/l arbitrary unit/liter M = 4 542 g/mol Plasma— Other term(s): ACTH; Adrenocorticotropic hormone Corticotropin; Authority: IUPAC-IUB 74 substance concentration(30 minutes after NPU01784 challenge) P—Corticotropin; arb.subst.c.(proc.) = ? arb.unit/l picomole/liter NPU10488 P—Corticotropin; subst.c.(30 min) = ? pmol/l

Plasma— Plasma— Corticotropin; Corticotropin; substance concentration(40 minutes after substance concentration challenge) picomole/liter picomole/liter M = 4 542 g/mol NPU10626 Other term(s): ACTH; Adrenocorticotropic hormone P—Corticotropin; subst.c.(40 min) = ? pmol/l Authority: IUPAC-IUB 74 NPU01785 Plasma— P—Corticotropin; subst.c. = ? pmol/l Corticotropin; substance concentration(45 minutes after Urine— challenge) Corticotropin; picomole/liter substance concentration NPU10489 picomole/liter P—Corticotropin; subst.c.(45 min) = ? pmol/l M = 4 542 g/mol Other term(s): ACTH; Adrenocorticotropic hormone Plasma— Authority: IFCC/C-LDA Corticotropin; NPU04895 substance concentration(60 minutes after U—Corticotropin; subst.c. = ? pmol/l challenge) picomole/liter Adrenal cortex— NPU10490 Cortisol secretion; P—Corticotropin; subst.c.(60 min) = ? pmol/l substance rate(corticotropin, intramuscular administration; list; procedure) Plasma— Note: M(corticotropin) = 4 542 g/mol Corticotropin; NPU10555 substance concentration(90 minutes after Adrenal cortex—Cortisol secretion; challenge) subst.rate(corticotropin i.m.; list; proc.) picomole/liter NPU10375 Pt—Corticotropin(administered); NPU10553 am.s.(i.m.) = ? nmol P—Corticotropin; subst.c.(90 min) = ? pmol/l NPU10556 Pt—Corticotropin(administered); subst.rate(i.m.; 3 d) = ? nmol/d Plasma— NPU04139 P—Cortisol; subst.c.(0 min) = ? nmol/l Corticotropin; NPU04140 P—Cortisol; subst.c.(30 min) = ? nmol/l substance concentration(120 minutes after NPU04968 P—Cortisol; subst.c.(60 min) = ? nmol/l challenge) NPU04972 P—Cortisol; subst.c.(480 min) = ? picomole/liter nmol/l NPU10641 NPU10533 P—Cortisol; subst.c.(1 d) = ? nmol/l P—Corticotropin; subst.c.(120 min) = ? pmol/l NPU10593 P—Cortisol; subst.c.(1,5 d) = ? nmol/l NPU10588 P—Cortisol; subst.c.(2 d) = ? nmol/l Plasma— NPU04973 U—Cortisol; am.s.(-1d - 0 d) = ? nmol Corticotropin; NPU04974 U—Cortisol; am.s.(0-1 d) = ? nmol substance concentration(135 minutes after NPU04975 U—Cortisol; am.s.(1-2 d) = ? nmol challenge) NPU04976 U—Cortisol; am.s.(2-3 d) = ? nmol picomole/liter NPU10557 U—Creatininium; am.s.(-1d - 0 d) = ? NPU10642 mmol P—Corticotropin; subst.c.(135 min) = ? pmol/l NPU10558 U—Creatininium; am.s.(0-1 d) = ? mmol NPU10559 U—Creatininium; am.s.(1-2 d) = ? mmol Plasma— NPU10560 U—Creatininium; am.s.(2-3 d) = ? mmol Corticotropin; substance concentration(150 minutes after Adrenal cortex— challenge) Cortisol secretion; picomole/liter substance rate(dexamethasone, oral NPU10643 administration; list; procedure) P—Corticotropin; subst.c.(150 min) = ? pmol/l Note: M(dexamethasone) = 392,5 g/mol; M (cortisol) = 362,47 g/mol Plasma— NPU01792 Corticotropin; Adrenal cortex—Cortisol secretion; substance concentration(180 minutes after subst.rate(dexamethasone p.o.; list; proc.) challenge) NPU10532 Pt—Dexamethasone(administered); picomole/liter am.s.(single dose p.o.) = ? µmol NPU10644 NPU04139 P—Cortisol; subst.c.(0 min) = ? nmol/l P—Corticotropin; subst.c.(180 min) = ? pmol/l NPU04972 P—Cortisol; subst.c.(480 min) = ? nmol/l

NPU10533 P—Cortisol; subst.c.(1 d) = ? nmol/l Note: M (metyrapone) = 226,27 g/mol; M (cortisol) = NPU10588 P—Cortisol; subst.c.(2 d) = ? nmol/l 362,47 g/mol NPU10587 P—Cortisol; subst.c.(3 d) = ? nmol/l NPU10530 NPU04973 U—Cortisol; am.s.(-1d - 0 d) = ? nmol Adrenal cortex—Cortisol secretion; NPU04974 U—Cortisol; am.s.(0-1 d) = ? nmol subst.rate(metyrapone p.o.; list; proc.) NPU04975 U—Cortisol; am.s.(1-2 d) = ? nmol NPU09113 Pt—Metyrapone(administered); number NPU04976 U—Cortisol; am.s.(2-3 d) = ? nmol of doses = ? NPU10557 U—Creatininium; am.s.(-1d - 0 d) = ? NPU09114 Pt—Metyrapone(administered); time mmol int.(between doses) = ? min NPU10558 U—Creatininium; am.s.(0-1 d) = ? mmol NPU10524 Pt—Metyrapone(administered); NPU10559 U—Creatininium; am.s.(1-2 d) = ? mmol am.s.(p.o.) = ? mmol NPU10560 U—Creatininium; am.s.(2-3 d) = ? mmol NPU04139 P—Cortisol; subst.c.(0 min) = ? nmol/l NPU10408 P—Cortisol; subst.c.(240 min) = ? Adrenal cortex— nmol/l Cortisol secretion; NPU04972 P—Cortisol; subst.c.(480 min) = ? substance rate(insulin, intravenous nmol/l administration; list; procedure) NPU10589 P—Cortisol; subst.c.(540 min) = ? Other term(s): Insulin hypoglycemic test; ITT nmol/l Note: M(insulin) = 5 807,65 g/mol; M (cortisol) = NPU10533 P—Cortisol; subst.c.(1 d) = ? nmol/l 362,47 g/mol NPU10526 P—Cortodoxone; subst.c.(0 min) = ? NPU01790 nmol/l Adrenal cortex—Cortisol secretion; NPU10527 P—Cortodoxone; subst.c.(240 min) = ? subst.rate(insulin i.v.; list; proc.) nmol/l NPU10547 Pt—Insulin(administered); NPU10528 P—Cortodoxone; subst.c.(480 min) = ? subst.cont.(i.v.; am.s./body mass) = ? µmol/kg nmol/l NPU10548 Pt—Insulin(administered); NPU10529 P—Cortodoxone; subst.c.(540 min) = ? arb.subst.cont.(i.v.; arb.am.s./body mass; proc.) = ? nmol/l int. unit/kg NPU10632 P—Cortodoxone; subst.c.(1 d) = ? NPU04139 P—Cortisol; subst.c.(0 min) = ? nmol/l nmol/l NPU04966 P—Cortisol; subst.c.(15 min) = ? nmol/l NPU04140 P—Cortisol; subst.c.(30 min) = ? nmol/l Adrenal cortex— NPU04967 P—Cortisol; subst.c.(45 min) = ? nmol/l Cortisol secretion; NPU04968 P—Cortisol; subst.c.(60 min) = ? nmol/l substance rate(tetracosactide, intramuscular NPU04969 P—Cortisol; subst.c.(75 min) = ? nmol/l administration; list; procedure) NPU04970 P—Cortisol; subst.c.(90 min) = ? nmol/l Note: M(tetracosactide) = 2 933,57 g/mol; M NPU04971 P—Cortisol; subst.c.(120 min) = ? (cortisol) = 362,47 g/mol nmol/l NPU01791 NPU08711 P—Cortisol; subst.c.(max.; proc.) = ? Adrenal cortex—Cortisol secretion; nmol/l subst.rate(tetracosactide i.m.; list; proc.) NPU04173 P—Glucose; subst.c.(0 min) = ? mmol/l NPU10534 Pt—Tetracosactide(administered); NPU04186 P—Glucose; subst.c.(15 min) = ? am.s.(i.m.) = ? nmol mmol/l NPU10671 U—Cortisol; am.s.(-2 d - -1d) = ? nmol NPU04174 P—Glucose; subst.c.(30 min) = ? NPU04973 U—Cortisol; am.s.(-1d - 0 d) = ? nmol mmol/l NPU04974 U—Cortisol; am.s.(0-1 d) = ? nmol NPU04187 P—Glucose; subst.c.(45 min) = ? NPU04975 U—Cortisol; am.s.(1-2 d) = ? nmol mmol/l NPU04976 U—Cortisol; am.s.(2-3 d) = ? nmol NPU04175 P—Glucose; subst.c.(60 min) = ? NPU10672 U—Creatininium; am.s.(-2 d - -1d) = ? mmol/l mmol NPU04965 P—Glucose; subst.c.(75 min) = ? NPU10557 U—Creatininium; am.s.(-1d - 0 d) = ? mmol/l mmol NPU04176 P—Glucose; subst.c.(90 min) = ? NPU10558 U—Creatininium; am.s.(0-1 d) = ? mmol mmol/l NPU10559 U—Creatininium; am.s.(1-2 d) = ? mmol NPU04177 P—Glucose; subst.c.(120 min) = ? NPU10560 U—Creatininium; am.s.(2-3 d) = ? mmol mmol/l NPU04179 P—Glucose; subst.c.(180 min) = ? Adrenal cortex— mmol/l Cortisol secretion; NPU04981 P—Glucose; subst.c.(min.; proc.) = ? substance rate(tetracosactide, intravenous mmol/l administration; list; procedure) Other term(s): ACTH test Adrenal cortex— Note: M (tetracosactide) = 2 933,57 g/mol; M Cortisol secretion; (cortisol) = 362,47 g/mol substance rate(metyrapone, oral administration; NPU01789 list; procedure) Adrenal cortex—Cortisol secretion;

subst.rate(tetracosactide i.v.; list; proc.) Urine— NPU10534 Pt—Tetracosactide(administered); Cortisol; am.s.(i.m.) = ? nmol amount-of-substance(2-3 days after challenge) NPU04139 P—Cortisol; subst.c.(0 min) = ? nmol/l nanomole NPU04966 P—Cortisol; subst.c.(15 min) = ? nmol/l NPU04976 NPU04140 P—Cortisol; subst.c.(30 min) = ? nmol/l U—Cortisol; am.s.(2-3 d) = ? nmol NPU04967 P—Cortisol; subst.c.(45 min) = ? nmol/l NPU04968 P—Cortisol; subst.c.(60 min) = ? nmol/l Urine— NPU04969 P—Cortisol; subst.c.(75 min) = ? nmol/l Cortisol; NPU04970 P—Cortisol; subst.c.(90 min) = ? nmol/l amount-of-substance(procedure) NPU04971 P—Cortisol; subst.c.(120 min) = ? nanomole nmol/l NPU17629 NPU10673 P—Cortisol; subst.c.incr.(max. c. minus U—Cortisol; am.s.(proc.) =? nmol 0 min c.; proc.) = ? nmol/l Plasma— Plasma— Cortisol; Cortisol(free); substance concentration(15 minutes before substance concentration challenge) nanomole/liter nanomole/liter M = 362,47 g/mol NPU10627 Other term(s): Compound F P—Cortisol; subst.c.(-15 min) = ? nmol/l Authority: IUPAC-IUB 89 NPU10301 Plasma— P—Cortisol(free); subst.c. = ? nmol/l Cortisol; substance concentration(0 minutes after Patient(Urine)— challenge) Cortisol(free); nanomole/liter substance rate(procedure) NPU04139 nanomole/day P—Cortisol; subst.c.(0 min) = ? nmol/l Authority: IUPAC-IUB 89 NPU14495 Plasma— Pt(U)—Cortisol(free); subst.rate(proc.) = ? nmol/d Cortisol; substance concentration(1 minute after Urine— challenge) Cortisol; nanomole/liter amount-of-substance(2 days to 1 day before NPU10409 challenge) P—Cortisol; subst.c.(1 min) = ? nmol/l nanomole NPU10671 Plasma— U—Cortisol; am.s.(-2 d - -1d) = ? nmol Cortisol; substance concentration(5 minutes after Urine— challenge) Cortisol; nanomole/liter amount-of-substance(1 day to 0 day before NPU10410 challenge) P—Cortisol; subst.c.(5 min) = ? nmol/l nanomole NPU04973 Plasma— U—Cortisol; am.s.(-1d - 0 d) = ? nmol Cortisol; substance concentration(10 minutes after Urine— challenge) Cortisol; nanomole/liter amount-of-substance(0-1 day after challenge) NPU10628 nanomole P—Cortisol; subst.c.(10 min) = ? nmol/l NPU04974 U—Cortisol; am.s.(0-1 d) = ? nmol Plasma— Cortisol; Urine— substance concentration(15 minutes after Cortisol; challenge) amount-of-substance(1-2 days after challenge) nanomole/liter nanomole NPU04966 NPU04975 P—Cortisol; subst.c.(15 min) = ? nmol/l U—Cortisol; am.s.(1-2 d) = ? nmol

Plasma— Plasma— Cortisol; Cortisol; substance concentration(20 minutes after substance concentration(135 minutes after challenge) challenge) nanomole/liter nanomole/liter NPU10630 NPU10645 P—Cortisol; subst.c.(20 min) = ? nmol/l P—Cortisol; subst.c.(135 min) = ? nmol/l

Plasma— Plasma— Cortisol; Cortisol; substance concentration(30 minutes after substance concentration(150 minutes after challenge) challenge) nanomole/liter nanomole/liter NPU04140 NPU10224 P—Cortisol; subst.c.(30 min) = ? nmol/l P—Cortisol; subst.c.(150 min) = ? nmol/l

Plasma— Plasma— Cortisol; Cortisol; substance concentration(40 minutes after substance concentration(180 minutes after challenge) challenge) nanomole/liter nanomole/liter NPU10631 NPU10222 P—Cortisol; subst.c.(40 min) = ? nmol/l P—Cortisol; subst.c.(180 min) = ? nmol/l

Plasma— Plasma— Cortisol; Cortisol; substance concentration(45 minutes after substance concentration(240 minutes after challenge) challenge) nanomole/liter nanomole/liter NPU04967 NPU10408 P—Cortisol; subst.c.(45 min) = ? nmol/l P—Cortisol; subst.c.(240 min) = ? nmol/l

Plasma— Plasma— Cortisol; Cortisol; substance concentration(60 minutes after substance concentration(300 minutes after challenge) challenge) nanomole/liter nanomole/liter NPU04968 NPU10223 P—Cortisol; subst.c.(60 min) = ? nmol/l P—Cortisol; subst.c.(300 min) = ? nmol/l

Plasma— Plasma— Cortisol; Cortisol; substance concentration(75 minutes after substance concentration(480 minutes after challenge) challenge) nanomole/liter nanomole/liter NPU04969 NPU04972 P—Cortisol; subst.c.(75 min) = ? nmol/l P—Cortisol; subst.c.(480 min) = ? nmol/l

Plasma— Plasma— Cortisol; Cortisol; substance concentration(90 minutes after substance concentration(540 minutes after challenge) challenge) nanomole/liter nanomole/liter NPU04970 NPU10589 P—Cortisol; subst.c.(90 min) = ? nmol/l P—Cortisol; subst.c.(540 min) = ? nmol/l

Plasma— Plasma— Cortisol; Cortisol; substance concentration(120 minutes after substance concentration(570 minutes after challenge) challenge) nanomole/liter nanomole/liter NPU04971 NPU10590 P—Cortisol; subst.c.(120 min) = ? nmol/l P—Cortisol; subst.c.(570 min) = ? nmol/l

Plasma— Saliva— Cortisol; Cortisol; substance concentration(1 day after challenge) substance concentration nanomole/liter nanomole/liter NPU10533 M = 362,47 g/mol P—Cortisol; subst.c.(1 d) = ? nmol/l Other term(s): Compound F Authority: IUPAC-IUB 89 Plasma— NPU01788 Cortisol; Saliva—Cortisol; subst.c. = ? nmol/l substance concentration(1,5 days after challenge) Urine— nanomole/liter Cortisol; NPU10593 substance concentration P—Cortisol; subst.c.(1,5 d) = ? nmol/l nanomole/liter M = 362,47 g/mol Plasma— Other term(s): Compound F; Hydrocortisone Cortisol; Authority: IFCC/C-LDA; INN substance concentration(2 days after challenge) NPU04360 nanomole/liter U—Cortisol; subst.c. = ? nmol/l NPU10588 P—Cortisol; subst.c.(2 d) = ? nmol/l Patient(Urine)— Cortisol; Plasma— substance rate(procedure) Cortisol; nanomole/day substance concentration(3 days after challenge) Authority: IUPAC-IUB 89 nanomole/liter NPU01786 NPU10587 Pt(U)—Cortisol; subst.rate(proc.) = ? nmol/d P—Cortisol; subst.c.(3 d) = ? nmol/l Plasma— Plasma— Cortisone; Cortisol; substance concentration substance concentration(maximum; procedure) mole/liter nanomole/liter M = 360,46 g/mol NPU08711 Authority: IFCC/C-LDA; INN P—Cortisol; subst.c.(max.; proc.) = ? nmol/l NPU04363 P—Cortisone; subst.c.= ? prefix ? mol/l Plasma— Cortisol; Urine— substance concentration(minimum; procedure) Cortisone; nanomole/liter substance concentration NPU08733 mole/liter P—Cortisol; subst.c.(min.; proc.) = ? nmol/l M = 360,46 g/mol Authority: IFCC/C-LDA; INN Plasma— NPU04362 Cortisol; U—Cortisone; subst.c.= ? prefix ? mol/l substance concentration increment(maximum concentration minus 0 minutes concentration; Plasma— procedure) Cortodoxone; nanomole/liter substance concentration(0 minutes after NPU10673 challenge) P—Cortisol; subst.c.incr.(max. c. minus 0 min c.; nanomole/liter proc.) = ? nmol/l NPU10526 P—Cortodoxone; subst.c.(0 min) = ? nmol/l Plasma— Cortisol; Plasma— substance concentration Cortodoxone; nanomole/liter substance concentration(240 minutes after M = 362,47 g/mol challenge) Other term(s): Compound F nanomole/liter Authority: IUPAC-IUB 89 NPU10527 NPU01787 P—Cortodoxone; subst.c.(240 min) = ? nmol/l P—Cortisol; subst.c. = ? nmol/l

Plasma— Creatine kinase(Plasma)— Cortodoxone; Creatine kinase BB; substance concentration(480 minutes after catalytic-activity fraction(37 °C; procedure) challenge) Other term(s): Creatin kinase 3 (IUPAC-IUB76) nanomole/liter Note: M(uscle); B(rain) NPU10528 NPU01146 P—Cortodoxone; subst.c.(480 min) = ? nmol/l CK(P)—Creatine kinase BB; cat.fr.(37 °C; proc.) = ?

Plasma— Plasma— Cortodoxone; Creatine kinase BB; substance concentration(540 minutes after substance concentration challenge) mole/liter nanomole/liter Other term(s): Creatin kinase 3 (IUPAC-IUB76) NPU10529 Note: M(uscle); B(rain) P—Cortodoxone; subst.c.(540 min) = ? nmol/l NPU01800 P—Creatine kinase BB; subst.c.= ? prefix ? mol/l Plasma— Cortodoxone; Plasma— substance concentration(1 day after challenge) Creatine kinase MB; nanomole/liter catalytic-activity concentration(37 °C; NPU10632 procedure) P—Cortodoxone; subst.c.(1 d) = ? nmol/l microkatal/liter Other term(s): Creatin kinase 2 (IUPAC-IUB76) Plasma— Note: M(uscle); B(rain) Cortodoxone; NPU01801 substance concentration P—Creatine kinase MB; cat.c.(37 °C; proc.) = ? nanomole/liter µkat/l M = 346,47 g/mol Other term(s): Compound S; Cortexolone Creatine kinase(Plasma)— NPU01856 Creatine kinase MB; P—Cortodoxone; subst.c. = ? nmol/l catalytic-activity fraction(37 °C; procedure) Other term(s): Creatin kinase 2 (IUPAC-IUB76) Plasma— Note: M(uscle); B(rain) C-reactive protein; NPU03996 arbitrary substance concentration(IS 85/506; CK(P)—Creatine kinase MB; cat.fr.(37 °C; proc.) = ? procedure) international unit/liter Plasma— M = 105 000 g/mol Creatine kinase MB; Recommended calibrator: WHO 1st IS 85/506 substance concentration NPU01422 mole/liter P—C-reactive protein; arb.subst.c.(IS 85/506; proc.) Other term(s): Creatin kinase 2 (IUPAC-IUB76) = ? int. unit/l Note: M(uscle); B(rain) NPU01802 Plasma— P—Creatine kinase MB; subst.c.= ? prefix ? mol/l C-reactive protein; substance concentration Plasma— nanomole/liter Creatine kinase MB+BB; M = 105 000 g/mol catalytic-activity concentration(37 °C; NPU01423 procedure) P—C-reactive protein; subst.c. = ? nmol/l microkatal/liter Note: M(uscle); B(rain) Plasma— NPU01798 Creatine kinase BB; P—Creatine kinase MB+BB; cat.c.(37 °C; proc.) = ? catalytic-activity concentration(37 °C; µkat/l procedure) microkatal/liter Creatine kinase(Plasma)— Other term(s): Creatin kinase 3 (IUPAC-IUB76) Creatine kinase MB+BB; Note: M(uscle); B(rain) catalytic-activity fraction(37 °C; procedure) NPU01799 Note: M(uscle); B(rain) P—Creatine kinase BB; cat.c.(37 °C; proc.) = ? NPU17127 µkat/l CK(P)—Creatine kinase MB+BB; cat.fr.(37 °C; proc.) = ?

Plasma— Amniotic fluid— Creatine kinase MM; Creatine kinase; catalytic-activity concentration(37 °C; catalytic-activity concentration(37 °C; procedure) procedure) microkatal/liter microkatal/liter Other term(s): Creatin kinase 1 (IUPAC-IUB76) NPU03912 Note: M(uscle); B(rain) Amf—Creatine kinase; cat.c.(37 °C; proc.) = ? µkat/l NPU01803 P—Creatine kinase MM; cat.c.(37 °C; proc.) = ? Plasma— µkat/l Creatine kinase; catalytic-activity concentration(37 °C; Creatine kinase(Plasma)— procedure) Creatine kinase MM; microkatal/liter catalytic-activity fraction(37 °C; procedure) Other term(s): Creatine phosphokinase Other term(s): Creatin kinase 1 (IUPAC-IUB76) NPU01796 Note: M(uscle); B(rain) P—Creatine kinase; cat.c.(37 °C; proc.) = ? µkat/l NPU01977 CK(P)—Creatine kinase MM; cat.fr.(37 °C; proc.) = Patient(Urine)— ? Creatine; substance rate(procedure) Plasma— millimole/day Creatine kinase MM; M = 131,1 g/mol substance concentration NPU01795 mole/liter Pt(U)—Creatine; subst.rate(proc.) = ? mmol/d Other term(s): Creatin kinase 1 (IUPAC-IUB 76) Note: M(uscle); B(rain) Kidney— NPU01804 Creatininium clearance; P—Creatine kinase MM; subst.c.= ? prefix ? mol/l volume rate(list; procedure) NPU17160 Plasma— Kidn.—Creatininium clearance; vol.rate(list; proc.) Creatine kinase type; NPU14048 Kidn.—Creatininium clearance; catalytic-activity concentration(list; 37 °C; vol.rate(proc.) = ? ml/min procedure) NPU01809 Kidn.—Creatininium clearance; Note: M(uscle); B(rain) vol.rate(proc.) = ? ml/s NPU01978 NPU01808 U—Creatininium; subst.c. = ? µmol/l P—Creatine kinase type; cat.c.(list; 37 °C; proc.) NPU09102 U—Creatininium; subst.c. = ? mmol/l NPU01799 P—Creatine kinase BB; cat.c.(37 °C; NPU04998 P—Creatininium; subst.c.(enz.) = ? proc.) = ? µkat/l µmol/l NPU01801 P—Creatine kinase MB; cat.c.(37 °C; NPU01807 P—Creatininium; subst.c.(Jaffé) = ? proc.) = ? µkat/l µmol/l NPU01798 P—Creatine kinase MB+BB; cat.c. NPU09101 P—Creatininium; subst.c.(Jaffé) = ? (37 °C; proc.) = ? µkat/l mmol/l NPU01803 P—Creatine kinase MM; cat.c.(37 °C; NPU03794 Pt—Body; height = ? m proc.) = ? µkat/l NPU03804 Pt—Body; mass = ? kg NPU03695 Pt—Urine; vol.(proc.) = ? ml Creatine kinase(Plasma)— NPU10380 Pt—Urine sampling; duration = ? d Creatine kinase type; NPU10379 Pt—Urine sampling; duration = ? h catalytic-activity fraction(list; 37 °C; procedure) NPU10323 Pt—Urine sampling; duration = ? h:min Other term(s): Creatine kinase isoenzymes NPU10324 Pt—Urine sampling; duration = ? min Note: M(uscle); B(rain) NPU01805 Kidney— CK(P)—Creatine kinase type; cat.fr.(list; 37 °C; Creatininium clearance; proc.) volume rate(procedure) NPU01146 CK(P)—Creatine kinase BB; cat.fr. milliliter/minute (37 °C; proc.) = ? Note: calculated from (b × c)/(a × d) NPU03996 CK(P)—Creatine kinase MB; cat.fr. a: [NPU01807] P—Creatininium; subst.c. = ? mmol/l (37 °C; proc.) = ? b: [NPU01808] U—Creatininium; subst.c. = ? mmol/l NPU17127 CK(P)—Creatine kinase MB+BB; c: [NPU03695] Pt—Urine; vol.(proc.) = ? ml cat.fr.(37 °C; proc.) = ? d: [NPU10380] U—Sampling period; time = ? d NPU01977 CK(P)—Creatine kinase MM; cat.fr. NPU14048 (37 °C; proc.) = ? Kidn.—Creatininium clearance; vol.rate(proc.) = ? ml/min

Kidney— NPU08617 Creatininium clearance; Syst(spec.)—Creatininium; am.s.(proc.) = ? mmol volume rate(procedure) milliliter/second Urine— Note: calculated from (b × c)/(a × d) Creatininium; a: [NPU01807] P—Creatininium; subst.c. = ? mmol/l amount-of-substance(procedure) b: [NPU01808] U—Creatininium; subst.c. = ? mmol/l millimole c: [NPU03695] Pt—Urine; vol.(proc.) = ? ml NPU17540 d: [NPU10380] U—Sampling period; time = ? d U—Creatininium; am.s.(proc.) = ? mmol NPU01809 Kidn.—Creatininium clearance; vol.rate(proc.) = ? Plasma— ml/s Creatininium; substance concentration(enzymatic) Urine— micromole/liter Creatininium; M = 113,12 g/mol amount-of-substance(2 days to 1 day before NPU04998 challenge) P—Creatininium; subst.c.(enz.) = ? µmol/l millimole NPU10672 Plasma— U—Creatininium; am.s.(-2 d - -1d) = ? mmol Creatininium; substance concentration(Jaffé) Urine— micromole/liter Creatininium; M = 113,12 g/mol amount-of-substance(1 day to 0 day before NPU01807 challenge) P—Creatininium; subst.c.(Jaffé) = ? µmol/l millimole NPU10557 Plasma— U—Creatininium; am.s.(-1d - 0 d) = ? mmol Creatininium; substance concentration(Jaffé) Urine— millimole/liter Creatininium; M = 113,12 g/mol amount-of-substance(0-1 day after challenge) NPU09101 millimole P—Creatininium; subst.c.(Jaffé) = ? mmol/l NPU10558 U—Creatininium; am.s.(0-1 d) = ? mmol Amniotic fluid— Creatininium; Urine— substance concentration Creatininium; micromole/liter amount-of-substance(1-2 days after challenge) M = 113,12 g/mol millimole NPU01806 NPU10559 Amf—Creatininium; subst.c. = ? µmol/l U—Creatininium; am.s.(1-2 d) = ? mmol Dialysis solution— Urine— Creatininium; Creatininium; substance concentration amount-of-substance(2-3 days after challenge) micromole/liter millimole M = 113,12 g/mol NPU10560 NPU10043 U—Creatininium; am.s.(2-3 d) = ? mmol Dialysis solution—Creatininium; subst.c. = ? µmol/l

Ascites— Urine— Creatininium; Creatininium; amount-of-substance(procedure) substance concentration millimole micromole/liter M = 113,12 g/mol M = 113,12 g/mol NPU08616 NPU01808 Asc—Creatininium; am.s.(proc.) = ? mmol U—Creatininium; subst.c. = ? µmol/l

System(specification)— Amniotic fluid— Creatininium; Creatininium; amount-of-substance(procedure) substance concentration millimole millimole/liter M = 113,12 g/mol M = 113,12 g/mol

NPU09100 Patient(Urine)— Amf—Creatininium; subst.c. = ? mmol/l Creatininium; substance rate(procedure) Ascites— millimole/day Creatininium; NPU03800 substance concentration Pt(U)—Creatininium; subst.rate(proc.) = ? mmol/d millimole/liter M = 113,12 g/mol Plasma— NPU08614 Cryoglobulins; Asc—Creatininium; subst.c. = ? mmol/l arbitrary concentration(procedure) NPU01816 Cerebrospinal fluid— P—Cryoglobulins; arb.c.(proc.) = ? Creatininium; substance concentration Urine— millimole/liter Crystals; M = 113,12 g/mol arbitrary concentration(procedure) NPU09348 NPU08761 Csf—Creatininium; subst.c. = ? mmol/l U—Crystals; arb.c.(proc.) = ?

Drain fluid(specification)— Urine— Creatininium; Crystals; substance concentration number concentration(procedure) millimole/liter 106/liter NPU17048 NPU10511 Drain fluid(spec.)—Creatininium; subst.c. = ? mmol/l U—Crystals; num.c.(proc.) = ? × 106/l

Plasma— Synovial fluid(specification)— Creatininium; Crystals; substance concentration taxon(procedure) millimole/liter Note: Example of values: urate; pyrophosphate NPU17559 NPU04127 P—Creatininium; subst.c. = ? mmol/l Synf(spec.)—Crystals; taxon(proc.) = ?

Secretion(Conjunctiva; specification)— Blood— Creatininium; Cyanide; substance concentration substance concentration millimole/liter micromole/liter M = 113,12 g/mol NPU04780 NPU09352 B—Cyanide; subst.c.= ? µmol/l Secr(Conj; spec.)—Creatininium; subst.c. = ? mmol/l Cobalamin(Plasma)— Cyanocobalamin; System(specification)— substance fraction Creatininium; NPU04954 substance concentration Cobalamin(P)—Cyanocobalamin; subst.fr. = ? millimole/liter M = 113,12 g/mol Urine— NPU08615 Cyclic AMP/Creatininium; Syst(spec.)—Creatininium; subst.c. = ? mmol/l substance ratio 10-6 Urine— NPU10260 Creatininium; U—Cyclic AMP/Creatininium; subst.ratio = ? × 10-6 substance concentration millimole/liter Plasma— M = 113,12 g/mol Cyclic AMP; NPU09102 substance concentration U—Creatininium; subst.c. = ? mmol/l nanomole/liter NPU10258 Patient(Urine)— P—Cyclic AMP; subst.c. = ? nmol/l Creatininium; substance rate(procedure) Urine— micromole/hour Cyclic AMP; NPU03801 substance concentration Pt(U)—Creatininium; subst.rate(proc.) = ? µmol/h nanomole/liter NPU10259 U—Cyclic AMP; subst.c. = ? nmol/l © 2000 IUPAC, Pure and Applied Chemistry 72, 747–972 824 H. OLESEN et al.

Patient(Urine)— Other term(s): Cylinders, cereous type Cyclic AMP; NPU01819 substance rate U—Cylinder, hyaline type; arb.c.(proc.) = ? millimole/day NPU14341 Urine— Pt(U)—Cyclic AMP; subst.rate = ? mmol/d Cylinder, hyaline type; number concentration(procedure) Urine— 106/liter Cylinder type; Other term(s): Cylinders, cereous type arbitrary concentration(list; procedure) NPU10510 NPU03856 U—Cylinder, hyaline type; num.c.(proc.) = ? × 106/l U—Cylinder type; arb.c.(list; proc.) NPU01817 U—Cylinder, erythrocyte type; Urine— arb.c.(proc.) = ? Cystathionine/Creatininium; NPU01818 U—Cylinder, granular type; arb.c.(proc.) substance ratio = ? 10-3 NPU01819 U—Cylinder, hyaline type; arb.c.(proc.) = NPU14205 ? U—Cystathionine/Creatininium; subst.ratio = ? × 10-3 Urine— Cylinder type; Plasma— number concentration(list; procedure) Cystathionine; NPU09257 substance concentration U—Cylinder type; num.c.(list; proc.) micromole/liter NPU10508 U—Cylinder, erythrocyte type; M = 222,28 g/mol num.c.(proc.) = ? × 106/l NPU01820 NPU10509 U—Cylinder, granular type; P—Cystathionine; subst.c. = ? µmol/l num.c.(proc.) = ? × 106/l NPU10510 U—Cylinder, hyaline type; num.c.(proc.) Urine— = ? × 106/l Cystathionine; substance concentration Urine— micromole/liter Cylinder, erythrocyte type; M = 222,28 g/mol arbitrary concentration(procedure) NPU01821 NPU01817 U—Cystathionine; subst.c. = ? µmol/l U—Cylinder, erythrocyte type; arb.c.(proc.) = ? Plasma— Urine— Cystatin C; Cylinder, erythrocyte type; substance concentration number concentration(procedure) mole/liter 106/liter NPU10302 NPU10508 P—Cystatin C; subst.c.= ? prefix ? mol/l U—Cylinder, erythrocyte type; num.c.(proc.) = ? × 106/l Urine— Cysteine+Cystine; Urine— substance concentration Cylinder, granular type; micromole/liter arbitrary concentration(procedure) NPU14319 Other term(s): Cylinders, leukocyte type U—Cysteine+Cystine; subst.c. = ? µmol/l NPU01818 U—Cylinder, granular type; arb.c.(proc.) = ? Urine— Cysteine-L-homocysteine disulfide/Creatininium; Urine— substance ratio Cylinder, granular type; 10-3 number concentration(procedure) NPU14206 106/liter U—Cysteine-L-homocysteine disulfide/Creatininium; Other term(s): Cylinders, leukocyte type subst.ratio = ? × 10-3 NPU10509 U—Cylinder, granular type; num.c.(proc.) = ? × 106/l Plasma— Cysteine-L-homocysteine disulfide; Urine— substance concentration Cylinder, hyaline type; micromole/liter arbitrary concentration(procedure) NPU01823

P—Cysteine-L-homocysteine disulfide; subst.c. = ? Plasma— µmol/l Cystine; substance concentration Urine— micromole/liter Cysteine-L-homocysteine disulfide; NPU01826 substance concentration P—Cystine; subst.c. = ? µmol/l micromole/liter NPU01824 Urine— U—Cysteine-L-homocysteine disulfide; subst.c. = ? Cystine; µmol/l substance concentration micromole/liter Urine— NPU01828 Cysteinyldopa/Creatininium; U—Cystine; subst.c. = ? µmol/l substance ratio 10-6 Leukocyte protein— Note: Cysteinyldopa = 5-S-Cysteinyldopa Cystine; NPU09007 substance content U—Cysteinyldopa/Creatininium; subst.ratio = ? × micromole/kilogram 10-6 NPU01825 Lkc prot.—Cystine; subst.cont. = ? µmol/kg Urine— Cysteinyldopa; Calculus(Urine)— substance concentration Cystine; nanomole/liter substance content Other term(s): 5-S-Cysteinyldopa mole/kilogram NPU09107 NPU01827 U—Cysteinyldopa; subst.c. = ? nmol/l Calculus(U)—Cystine; subst.cont. = ? mol/kg

Patient(Urine)— Patient(Urine)— Cysteinyldopa; Cystine; substance rate substance rate(procedure) nanomole/day micromole/day Other term(s): 5-S-Cysteinyldopa NPU04161 NPU09108 Pt(U)—Cystine; subst.rate(proc.) = ? µmol/d Pt(U)—Cysteinyldopa; subst.rate = ? nmol/d Plasma— Urine— Cytoplasma antibody(Immunoglobulin G); Cystine/Creatininium; arbitrary concentration(procedure) substance ratio NPU16391 10-3 P—Cytoplasma antibody(IgG); arb.c.(proc.) = ? NPU14207 U—Cystine/Creatininium; subst.ratio = ? × 10-3 Plasma— Cytoplasma antibody(Immunoglobulin G); Urine— arbitrary substance concentration(procedure) Cystine; 10³ arbitrary unit/liter arbitrary concentration(procedure) NPU16392 NPU04782 P—Cytoplasma antibody(IgG); arb.subst.c.(proc.) = U—Cystine; arb.c.(proc.)= ? ? × 10³ arb.unit/l

Calculus(Urine)— Plasma— Cystine; Cytosol aminopeptidase; arbitrary content(procedure) catalytic-activity concentration(37 °C; NPU10367 procedure) Calculus(U)—Cystine; arb.cont.(proc.) = ? microkatal/liter Other term(s): Leucine aminopeptidase Cerebrospinal fluid— NPU01847 Cystine; P—Cytosol aminopeptidase; cat.c.(37 °C; proc.) = ? substance concentration µkat/l micromole/liter NPU09021 Urine— Csf—Cystine; subst.c. = ? µmol/l Dehydrochloromethyl testosterone; arbitrary concentration(procedure) M = 334,87 g/mol NPU04449 U—Dehydrochloromethyl testosterone; arb.c.(proc.) = ? © 2000 IUPAC, Pure and Applied Chemistry 72, 747–972 826 H. OLESEN et al.

Urine— NPU09098 Dehydrochloromethyl testosterone; U—Deoxypyridinoline/Creatininium; subst.ratio = ? substance concentration × 10-6 nanomole/liter M = 334,87 g/mol Urine— NPU01851 Dermatan sulfate; U—Dehydrochloromethyl testosterone; subst.c. = ? substance concentration nmol/l micromole/liter M = 50 000 g/mol Plasma— Authority: IUPAC-IUB85 Dehydroepiandrosterone sulfate; NPU01857 substance concentration U—Dermatan sulfate; subst.c. = ? µmol/l micromole/liter NPU04121 Patient— P—Dehydroepiandrosterone sulfate; subst.c. = ? Desmopressin(administered); µmol/l amount-of-substance(intranasal administration) micromole Urine— M = 1069,23 g/mol Dehydroepiandrosterone sulfate; NPU12875 substance concentration Pt—Desmopressin(administered); am.s.(i.n.) = ? micromole/liter µmol NPU04124 U—Dehydroepiandrosterone sulfate; subst.c. = ? Patient— µmol/l Desmopressin(administered); amount-of-substance(intranasal administration) Plasma— nanomole Dehydroepiandrosterone sulfate; M = 1069,23 g/mol substance concentration NPU09117 nanomole/liter Pt—Desmopressin(administered); am.s.(i.n.) = ? NPU14568 nmol P—Dehydroepiandrosterone sulfate; subst.c. = ? nmol/l Patient— Desmopressin(administered); Cobalamin(Plasma)— substance content(intranasal administration; Deoxycobalamin; amount-of-substance/body mass) substance fraction nanomole/kilogram NPU04959 M = 1069,23 g/mol Cobalamin(P)—Deoxycobalamin; subst.fr.= ? NPU09118 Pt—Desmopressin(administered); subst.cont.(i.n.; Haemoglobin(deoxy+oxy; arterial Blood)— am.s./body mass) = ? nmol/kg Deoxyhaemoglobin; substance fraction Plasma— Authority: IFCC/C-BGE Desoxycortone; NPU08754 substance concentration Hb(deoxy+oxy; aB)—Deoxyhaemoglobin; subst.fr. = mole/liter ? M = 330,45 g/mol Other term(s): Deoxycorticosterone; 11- Haemoglobin(total; arterial Blood)— Hydroxyprogesterone Deoxyhaemoglobin; Authority: INN substance fraction NPU04369 Authority: IFCC/C-BGE P—Desoxycortone; subst.c.= ? prefix ? mol/l Note: “total” includes dyshaemoglobin, carboxihaemoglobin, methaemoglobin, Urine— sulfhaemoglobin Desoxycortone; NPU08753 substance concentration Hb(tot.; aB)—Deoxyhaemoglobin; subst.fr. = ? mole/liter M = 330,45 g/mol Urine— Other term(s): Deoxycorticosterone; 11- Deoxypyridinoline/Creatininium; Hydroxyprogesterone substance ratio Authority: INN 10-6 NPU04368 Note: M (deoxypyridinoline) = ? g/mol; M U—Desoxycortone; subst.c.= ? prefix ? mol/l (creatininium) = 113,12

Patient— NPU10112 Dialysis solution—Glucose; subst.c. = ? Dexamethasone(administered); mmol/l amount-of-substance(single dose oral NPU10165 Dialysis solution—Hydrogen carbonate; administration) subst.c.(actual) = ? mmol/l micromole NPU14922 Dialysis solution—Hydrogen ion; M = 392,45 g/mol subst.c. = ? nmol/l NPU10532 NPU14355 Dialysis solution—Hydrogen ion; pH = ? Pt—Dexamethasone(administered); am.s.(single NPU10168 Dialysis solution—Potassium ion; dose p.o.) = ? µmol subst.c. = ? mmol/l NPU10182 Dialysis solution—Lithium ion; Patient— subst.c.(therapy) = ? mmol/l Dexamethasone(administered); NPU10192 Dialysis solution—Sodium ion; subst.c. number of doses = ? mmol/l NPU09115 Pt—Dexamethasone(administered); number of Patient(Peritoneum)— doses = ? Dialysis solution; property(list; procedure) Patient— NPU17070 Dexamethasone(administered); Pt(Peritoneum)—Dialysis solution; prop.(list; proc.) time interval(between doses) NPU10018 Dialysis solution—Albumin; subst.c. = ? minute µmol/l NPU09116 NPU17172 Dialysis solution—Calcium(II; total); Pt—Dexamethasone(administered); time subst.c. = ? mmol/l int.(between doses) = ? min NPU10026 Dialysis solution—Carbamide; subst.c. = ? mmol/l Patient— NPU10043 Dialysis solution—Creatininium; subst.c. Dialysis solution; = ? µmol/l property(list; procedure) NPU10112 Dialysis solution—Glucose; subst.c. = ? NPU14913 mmol/l Pt—Dialysis solution; prop.(list; proc.) NPU10165 Dialysis solution—Hydrogen carbonate; NPU10018 Dialysis solution—Albumin; subst.c. = ? subst.c.(actual) = ? mmol/l µmol/l NPU14355 Dialysis solution—Hydrogen ion; pH = ? NPU10026 Dialysis solution—Carbamide; subst.c. = NPU14922 Dialysis solution—Hydrogen ion; ? mmol/l subst.c. = ? nmol/l NPU17172 Dialysis solution—Calcium(II; total); NPU10168 Dialysis solution—Potassium ion; subst.c. = ? mmol/l subst.c. = ? mmol/l NPU10043 Dialysis solution—Creatininium; subst.c. NPU10182 Dialysis solution—Lithium ion; = ? µmol/l subst.c.(therapy) = ? mmol/l NPU10112 Dialysis solution—Glucose; subst.c. = ? NPU10192 Dialysis solution—Sodium ion; subst.c. mmol/l = ? mmol/l NPU10165 Dialysis solution—Hydrogen carbonate; subst.c.(actual) = ? mmol/l Plasma—

NPU14922 Dialysis solution—Hydrogen ion; Dicarboxylic acid C6C8C10; subst.c. = ? nmol/l substance concentration NPU14355 Dialysis solution—Hydrogen ion; pH = ? micromole/liter NPU10168 Dialysis solution—Potassium ion; NPU01881

subst.c. = ? mmol/l P—Dicarboxylic acid C6C8C10; subst.c. = ? µmol/l NPU10182 Dialysis solution—Lithium ion; subst.c.(therapy) = ? mmol/l Urine—

NPU10192 Dialysis solution—Sodium ion; subst.c. Dicarboxylic acid C6C8C10; = ? mmol/l substance concentration micromole/liter Patient(Blood)— NPU01882

Dialysis solution; U—Dicarboxylic acid C6C8C10; subst.c. = ? µmol/l property(list; procedure) NPU17054 Erythrocytes(Blood)— Pt(B)—Dialysis solution; prop.(list; proc.) 2,3- NPU10018 Dialysis solution—Albumin; subst.c. = ? Diphosphoglycerate; µmol/l substance concentration NPU10026 Dialysis solution—Carbamide; subst.c. = millimole/liter ? mmol/l Other term(s): Glycerate 2,3-biphosphate NPU17172 Dialysis solution—Calcium(II; total); NPU01907 subst.c. = ? mmol/l Ercs(B)—2,3-Diphosphoglycerate; subst.c. = ? NPU10043 Dialysis solution—Creatininium; subst.c. mmol/l = ? µmol/l

Plasma— Urine— DNA(double coil) antibody(Immunoglobulin G); Dopamine; arbitrary concentration(procedure) substance concentration Other term(s): DNA(double coil) antibody micromole/liter NPU04172 M = 153,18 g/mol P—DNA(double coil) antibody(IgG); arb.c.(proc.) = NPU01915 ? U—Dopamine; subst.c. = ? µmol/l

Plasma— Drain fluid(specification)— DNA(double coil) antibody(Immunoglobulin G); Drain fluid; arbitrary substance concentration(procedure) property(list; procedure) arbitrary unit/liter NPU17126 NPU12038 Drain fluid(spec.)—Drain fluid; prop.(list; proc.) P—DNA(double coil) antibody(IgG); NPU17046 Drain fluid(spec.)—Albumin; subst.c. = ? arb.subst.c.(proc.) = ? arb.unit/l µmol/l NPU08590 Drain fluid(spec.)—Amylase, pancreatic Plasma— type 3+4+5; cat.c.(37 °C; proc.) = ? µkat/l DNA(double coil) antibody(Immunoglobulin G); NPU17195 Drain fluid(spec.)—Amylase; cat.c. arbitrary substance concentration(WHO (37 °C; proc.) = ? µkat/l calibrator; procedure) NPU17043 Drain fluid(spec.)—Bilirubins(tot.); 10³ international unit/liter subst.c. = ? µmol/l NPU16393 NPU17047 Drain fluid(spec.)—Carbamide; subst.c. P—DNA(double coil) antibody(IgG); = ? mmol/l arb.subst.c.(WHO calib.; proc.) = ? × 10³ int.unit/l NPU17050 Drain fluid(spec.)—Glucose; subst.c. = ? mmol/l Plasma— NPU17048 Drain fluid(spec.)—Creatininium; DNA(double coil) antibody; subst.c. = ? mmol/l arbitrary concentration(procedure) NPU17051 Drain fluid(spec.)—Haemoglobin(Fe); Other term(s): DNA(double coil) antibody(IgG) arb.c.(proc.) = ? NPU01913 NPU17052 Drain fluid(spec.)—Haemoglobin(Fe); P—DNA(double coil) antibody; arb.c.(proc.) = ? subst.c. = ? µmol/l NPU17049 Drain fluid(spec.)—Potassium ion; Plasma— subst.c. = ? mmol/l DNA(double coil) antibody; NPU17178 Drain fluid(spec.)—Leukocytes; num.c. = mass concentration ? × 106/l milligram/liter NPU17045 Drain fluid(spec.)—Sodium ion; subst.c. Other term(s): DNA(double coil) antibody(IgG) = ? mmol/l NPU10751 NPU17042 Drain fluid(spec.)—Protein; mass c. = ? P—DNA(double coil) antibody; mass c. = ? mg/l g/l

Plasma— Blood— DNA-ase B antibody; Echinocytes; arbitrary substance concentration(procedure) arbitrary concentration(procedure) arbitrary unit/liter NPU17083 Other term(s): ASH B—Echinocytes; arb.c.(proc.) = ? NPU13794 P—DNA-ase B antibody; arb.subst.c.(proc.) = ? Plasma— arb.unit/l Endomysium antibody(Immunoglobulin A); arbitrary concentration(procedure) Plasma— NPU12538 DNP antibody; P—Endomysium antibody(IgA); arb.c.(proc.) = ? arbitrary concentration(procedure) NPU01914 Plasma— P—DNP antibody; arb.c.(proc.) = ? Endomysium antibody(Immunoglobulin G); arbitrary substance concentration(procedure) Urine— arbitrary unit Dopamine; NPU14342 amount-of-substance(procedure) P—Endomysium antibody(IgG); arb.subst.c.(proc.) micromole = ? arb.unit M = 153,18 g/mol NPU08619 Plasma— U—Dopamine; am.s.(proc.) = ? µmol b- Endorphin; substance concentration picomole/liter

NPU10606 Secretion(Nasopharynx)— P—b-Endorphin; subst.c. = ? pmol/l Eosinophilocytes; arbitrary concentration(procedure) Plasma— NPU10142 Entactin antibody(Immunoglobulin G); Secr(Nasoph)—Eosinophilocytes; arb.c.(proc.) = ? arbitrary concentration(procedure) NPU12549 Secretion(specification)— P—Entactin antibody(IgG); arb.c.(proc.) = ? Eosinophilocytes; arbitrary concentration(procedure) Plasma— NPU01935 Entactin antibody(Immunoglobulin G); Secr(spec.)—Eosinophilocytes; arb.c.(proc.) = ? arbitrary substance concentration(procedure) 10³ arbitrary unit/liter Blood— NPU12550 Eosinophilocytes; P—Entactin antibody(IgG); arb.subst.c.(proc.) = ? × number concentration(mechanical) 10³ arb.unit/l 109/liter NPU01933 Plasma— B—Eosinophilocytes; num.c.(mech.) = ? × 109/l Entactin antibody(Immunoglobulin M); arbitrary concentration(procedure) Blood— NPU12547 Eosinophilocytes; P—Entactin antibody(IgM); arb.c.(proc.) = ? number concentration(microscopic) 109/liter Plasma— NPU17562 Entactin antibody(Immunoglobulin M); B—Eosinophilocytes; num.c.(micr.) = ? × 109/l arbitrary substance concentration(procedure) 10³ arbitrary unit/liter Secretion(Nasopharynx)— NPU12551 Eosinophilocytes; P—Entactin antibody(IgM); arb.subst.c.(proc.) = ? × number concentration 10³ arb.unit/l 106/liter NPU10220 Plasma— Secr(Nasoph)—Eosinophilocytes; num.c. = ? × 106/l Entactin antibody; arbitrary concentration(list; procedure) Blood fraction(specification)— NPU17102 Eosinophilocytes; P—Entactin antibody; arb.c.(list; proc.) number concentration NPU12549 P—Entactin antibody(IgG); arb.c.(proc.) 109/liter = ? NPU17561 NPU12547 P—Entactin antibody(IgM); arb.c.(proc.) B fract.(spec.)—Eosinophilocytes; num.c. = ? × 109/l = ? Bone marrow— Plasma— Eosinophilocytes; Entactin antibody; number concentration arbitrary substance concentration(list; 109/liter procedure) NPU04671 NPU17103 Marrow—Eosinophilocytes; num.c. = ? × 109/l P—Entactin antibody; arb.subst.c.(list; proc.) NPU12550 P—Entactin antibody(IgG); Leukocytes(Blood)— arb.subst.c.(proc.) = ? × 10³ arb.unit/l Eosinophilocytes; NPU12551 P—Entactin antibody(IgM); number fraction arb.subst.c.(proc.) = ? × 10³ arb.unit/l NPU03967 Lkcs(B)—Eosinophilocytes; num.fr. = ? Plasma— Entactin; Leukocytes(Bone marrow)— arbitrary substance concentration(procedure) Eosinophilocytes; arbitrary unit/liter number fraction NPU12119 NPU04672 P—Entactin; arb.subst.c.(proc.) = ? arb.unit/l Lkcs(Marrow)—Eosinophilocytes; num.fr. = ?

Expectorate— Urine— Eosinophilocytes; Epitestosterone; arbitrary concentration(procedure) substance concentration NPU01934 nanomole/liter Ex—Eosinophilocytes; arb.c.(proc.) = ? M = 288,43 g/mol NPU01941 U—Epitestosterone; subst.c. = ? nmol/l © 2000 IUPAC, Pure and Applied Chemistry 72, 747–972 830 H. OLESEN et al.

Pleural fluid(specification)— Blood— Epithelial cells; Erythroblasts(orthochrome); arbitrary concentration(procedure) number concentration NPU10307 109/liter Plf(spec.)—Epithelial cells; arb.c.(proc.) = ? NPU04692 B—Erythroblasts(orthochrome); num.c. = ? × 109/l Synovial fluid(specification)— Epithelial cells; Blood fraction(specification)— arbitrary concentration(procedure) Erythroblasts(orthochrome); NPU10308 number concentration Synf(spec.)—Epithelial cells; arb.c.(proc.) = ? 109/liter NPU17599 System(specification)— B fract.(spec.)—Erythroblasts(orthochrome); num.c. Epithelial cells; = ? × 109/l arbitrary concentration(procedure) NPU10306 Bone marrow— Syst(spec.)—Epithelial cells; arb.c.(proc.) = ? Erythroblasts(orthochrome); number concentration Urine— 109/liter Epithelial cells; NPU03799 arbitrary concentration(procedure) Marrow—Erythroblasts(orthochrome); num.c. = ? × NPU03986 109/l U—Epithelial cells; arb.c.(proc.) = ? Leukocytes(Blood)— Urine— Erythroblasts(orthochrome); Epithelial cells; number fraction number concentration(procedure) NPU04694 106/liter Lkcs(B)—Erythroblasts(orthochrome); num.fr. = ? NPU10507 U—Epithelial cells; num.c.(proc.) = ? × 106/l Leukocytes(Bone marrow)— Erythroblasts(orthochrome); Blood— number fraction Erythroblasts(basophil); NPU04993 number concentration Lkcs(Marrow)—Erythroblasts(orthochrome); num.fr. 109/liter = ? NPU04690 B—Erythroblasts(basophil); num.c. = ? × 109/l Blood— Erythroblasts(polychrome); Blood fraction(specification)— number concentration Erythroblasts(basophil); 109/liter number concentration NPU04695 109/liter B—Erythroblasts(polychrome); num.c. = ? × 109/l NPU17598 B fract.(spec.)—Erythroblasts(basophil); num.c. = ? Blood fraction(specification)— × 109/l Erythroblasts(polychrome); number concentration Bone marrow— 109/liter Erythroblasts(basophil); NPU17600 number concentration B fract.(spec.)—Erythroblasts(polychrome); num.c. 109/liter = ? × 109/l NPU03798 Marrow—Erythroblasts(basophil); num.c. = ? × 109/l Bone marrow— Erythroblasts(polychrome); Leukocytes(Blood)— number concentration Erythroblasts(basophil); 109/liter number fraction NPU03806 NPU04691 Marrow—Erythroblasts(polychrome); num.c. = ? × Lkcs(B)—Erythroblasts(basophil); num.fr. = ? 109/l

Leukocytes(Bone marrow)— Leukocytes(Blood)— Erythroblasts(basophil); Erythroblasts(polychrome); number fraction number fraction NPU04991 NPU04696 Lkcs(Marrow)—Erythroblasts(basophil); num.fr. = ? Lkcs(B)—Erythroblasts(polychrome); num.fr. = ?

Leukocytes(Bone marrow)— Blood— Erythroblasts(polychrome); Erythrocytes(basophilic punctured); number fraction arbitrary concentration(procedure) NPU04992 NPU17081 Lkcs(Marrow)—Erythroblasts(polychrome); num.fr. B—Erythrocytes(baso punct.); arb.c.(proc.) = ? = ? Erythrocytes(Blood)— Blood— Erythrocytes(basophilic punctured); Erythroblasts; number fraction arbitrary concentration(procedure) NPU14349 NPU17086 Ercs(B)—Erythrocytes(baso punct.); num.fr. = ? B—Erythroblasts; arb.c.(proc.) = ? Blood— Blood— Erythrocytes(Howell-Jolly bodies); Erythroblasts; arbitrary concentration(procedure) number concentration NPU17090 109/liter B—Erythrocytes(Howell-Jolly); arb.c.(proc.) = ? NPU01943 B—Erythroblasts; num.c. = ? × 109/l Erythrocytes(Blood)— Erythrocytes(Howell-Jolly bodies); Blood fraction(specification)— number fraction Erythroblasts; NPU14269 number concentration Ercs(B)—Erythrocytes(Howell-Jolly); num.fr. = ? 109/liter NPU17601 Blood— B fract.(spec.)—Erythroblasts; num.c. = ? × 109/l Erythrocytes(hyperchrome); arbitrary concentration(procedure) Leukocytes(Blood)— NPU17091 Erythroblasts; B—Erythrocytes(hyperchrome); arb.c.(proc.) = ? number concentration 109/liter Erythrocytes(Blood)— NPU09110 Erythrocytes(hyperchrome); Lkcs(B)—Erythroblasts; num.c. = ? × 109/l number fraction NPU14350 Erythrocytes(Blood)— Ercs(B)—Erythrocytes(hyperchrome); num.fr. = ? Erythroblasts; number fraction Blood— NPU14347 Erythrocytes(hypochromic); Ercs(B)—Erythroblasts; num.fr. = ? arbitrary concentration(procedure) NPU17092 Leukocytes(Blood)— B—Erythrocytes(hypochromic); arb.c.(proc.) = ? Erythroblasts; number fraction Erythrocytes(Blood)— NPU10143 Erythrocytes(hypochromic); Lkcs(B)—Erythroblasts; num.fr. = ? number fraction NPU14111 Patient(Blood)— Ercs(B)—Erythrocytes(hypochromic); num.fr. = ? Erythrocyte elimination; half-life(procedure) Blood— day Erythrocytes(polychrome); NPU04150 arbitrary concentration(procedure) Pt(B)—Erythrocyte elimination; half-life(proc.) = ? d NPU14275 B—Erythrocytes(polychrome); arb.c.(proc.) = ? Blood— Erythrocyte surface; Erythrocytes(Amniotic fluid)— entitic area Erythrocytes, haemoglobin F containing; micro(meter)² number fraction NPU04074 NPU01963 B—Erythrocyte surface; entitic area = ? µm² Ercs(Amf)—Erythrocytes, haemoglobin F containing; num.fr. = ? Blood— Erythrocytes(Anisocytosis); arbitrary concentration(procedure) NPU14259 B—Erythrocytes(Anisoc.); arb.c.(proc.) = ?

Erythrocytes(Blood)— NPU17090 B—Erythrocytes(Howell-Jolly); Erythrocytes, haemoglobin F containing; arb.c.(proc.) = ? number fraction NPU14350 Ercs(B)—Erythrocytes(hyperchrome); NPU01964 num.fr. = ? Ercs(B)—Erythrocytes, haemoglobin F containing; NPU17091 B—Erythrocytes(hyperchrome); num.fr. = ? arb.c.(proc.) = ? NPU14111 Ercs(B)—Erythrocytes(hypochromic); Erythrocytes(vaginal Blood)— num.fr. = ? Erythrocytes, haemoglobin F containing; NPU17092 B—Erythrocytes(hypochromic); number fraction arb.c.(proc.) = ? NPU01965 NPU14275 B—Erythrocytes(polychrome); Ercs(vagB)—Erythrocytes, haemoglobin F arb.c.(proc.) = ? containing; num.fr. = ? NPU17088 B—Helmet cells; arb.c.(proc.) = ? NPU14270 Ercs(B)—Megalocytes; num.fr. = ? Urine— NPU17094 B—Megalocytes; arb.c.(proc.) = ? Erythrocytes; NPU14371 Ercs(B)—Megaloblasts; num.fr. = ? arbitrary concentration(procedure) NPU17093 B—Megaloblasts; arb.c.(proc.) = ? NPU03963 NPU14271 Ercs(B)—Microcytes; num.fr. = ? U—Erythrocytes; arb.c.(proc.) = ? NPU17095 B—Microcytes; arb.c.(proc.) = ? NPU17096 B—Rouleau formation; arb.c.(proc.) = ? Blood— NPU14274 B—Poikilocytosis; arb.c.(proc.) = ? Erythrocytes; NPU17097 B—Schistocytes; arb.c.(proc.) = ? entitic diameter NPU14272 Ercs(B)—Sickle cells; num.fr. = ? micrometer NPU17098 B—Sickle cells; arb.c.(proc.) = ? NPU04060 NPU14110 Ercs(B)—spherocytic; num.fr. = ? B—Erythrocytes; entitic diameter = ? µm NPU17099 B—spherocytic; arb.c.(proc.) = ? NPU17130 B—Smudge cells; arb.c.(proc.) = ? Blood— NPU17100 B—Stomatocytes; arb.c.(proc.) = ? Erythrocytes; NPU14273 Ercs(B)—Target cells; num.fr. = ? entitic volume difference(maximum-minimum; NPU17101 B—Target cells; arb.c.(proc.) = ? erythrocyte distribution width; procedure) femtoliter Blood— Other term(s): MCV Erythrocytes; NPU14143 morphology(procedure) B—Erythrocytes; entitic vol.diff.?(max.-min.; RDW; NPU04221 proc.) = ? fl B—Erythrocytes; morphology(proc.) = ?

Blood— Urine— Erythrocytes; Erythrocytes; entitic volume number of entities(procedure) femtoliter 106 Other term(s): MCV Note: f.ex. Addis 1949; 3 d NPU01944 NPU03843 B—Erythrocytes; entitic vol. = ? fl U—Erythrocytes; num.(proc.) = ? × 106

Blood— Blood— Erythrocytes; Erythrocytes; morphology(list; procedure) number concentration(microscopic) NPU14139 1012/liter B—Erythrocytes; morphology(list; proc.) NPU17564 NPU14348 Ercs(B)—Acanthocytes; num.fr. = ? B—Erythrocytes; num.c.(micr.) = ? × 1012/l NPU17074 B—Acanthocytes; arb.c.(proc.) = ? NPU17078 B—Annulocytes; arb.c.(proc.) = ? Urine— NPU17083 B—Echinocytes; arb.c.(proc.) = ? Erythrocytes; NPU14347 Ercs(B)—Erythroblasts; num.fr. = ? number concentration(procedure) NPU17086 B—Erythroblasts; arb.c.(proc.) = ? 106/liter NPU14259 B—Erythrocytes(Anisoc.); arb.c.(proc.) NPU03842 = ? U—Erythrocytes; num.c.(proc.) = ? × 106/l NPU14349 Ercs(B)—Erythrocytes(baso punct.); num.fr. = ? Blood— NPU17081 B—Erythrocytes(baso punct.); Erythrocytes; arb.c.(proc.) = ? number concentration NPU14269 Ercs(B)—Erythrocytes(Howell-Jolly); 1012/liter num.fr. = ? NPU01960 B—Erythrocytes; num.c. = ? × 1012/l

Blood fraction(specification)— System(specification)— Erythrocytes; Erythrocytes; number concentration number concentration 1012/liter 109/liter NPU17563 NPU10129 B fract.(spec.)—Erythrocytes; num.c. = ? × 1012/l Syst(spec.)—Erythrocytes; num.c. = ? × 109/l

Synovial fluid(specification)— Patient(Blood)— Erythrocytes; Erythrocytes; number concentration volume(procedure) 1012/liter liter NPU14080 NPU04168 Synf(spec.)—Erythrocytes; num.c. = ? × 1012/l Pt(B)—Erythrocytes; vol.(proc.)=? l

Amniotic fluid— Blood— Erythrocytes; Erythrocytes; number concentration volume fraction 106/liter NPU01961 NPU08967 B—Erythrocytes; vol.fr. = ? Amf—Erythrocytes; num.c. = ? × 106/l Blood fraction(specification)— Ascites— Erythrocytes; Erythrocytes; volume fraction number concentration NPU17565 106/liter B fract.(spec.)—Erythrocytes; vol.fr. = ? NPU08934 Asc—Erythrocytes; num.c. = ? × 106/l Plasma— Erythrolysine, biphasical(Immunoglobulin G); Cerebrospinal fluid— arbitrary substance concentration(procedure) Erythrocytes; arbitrary unit/liter number concentration Other term(s): Biphasic hemolysine; Donath- 106/liter Landsteiner antibody NPU01962 NPU17110 Csf—Erythrocytes; num.c. = ? × 106/l P—Erythrolysine, biphasical(IgG); arb.subst.c.(proc.) = ? arb.unit/l Pleural fluid(specification)— Erythrocytes; Plasma— number concentration Erythrolysine, biphasical; 106/liter arbitrary concentration(procedure) NPU10145 Other term(s): Biphasic hemolysine; Donath- Plf(spec.)—Erythrocytes; num.c. = ? × 106/l Landsteiner antibody NPU01966 Semen— P—Erythrolysine, biphasical; arb.c.(proc.) = ? Erythrocytes; number concentration Plasma— 106/liter Erythrolysine, cold(Immunoglobulin M); NPU10146 arbitrary substance concentration(procedure) Sem—Erythrocytes; num.c. = ? × 106/l arbitrary unit/liter Other term(s): Cold hemolysine Synovial fluid(specification)— NPU17107 Erythrocytes; P—Erythrolysine, cold(IgM); arb.subst.c.(proc.) = ? number concentration arb.unit/l 106/liter NPU08933 Plasma— Synf(spec.)—Erythrocytes; num.c. = ? × 106/l Erythrolysine, cold; arbitrary concentration(procedure) System(specification)— Other term(s): Cold hemolysine Erythrocytes; NPU01967 number concentration P—Erythrolysine, cold; arb.c.(proc.) = ? 106/liter NPU10144 Syst(spec.)—Erythrocytes; num.c. = ? × 106/l

Plasma— Recommended calibrator: WHO 2nd IRP 67/343 Erythrolysine, heat; Authority: IUPAC-IUB 74 arbitrary concentration(procedure) NPU04012 Other term(s): Heat hemolysine P—Erythropoietin; arb.subst.c.(one-site NPU01968 immunoassay; IRP 67/343; proc.) = ? int. unit/l P—Erythrolysine, heat; arb.c.(proc.) = ? Plasma— Plasma— Erythropoietin; Erythropoietin; arbitrary substance concentration(one-site arbitrary substance concentration(in-vitro immunoassay; IS 87/684; procedure) bioassay; IRP 67/343; procedure) international unit/liter international unit/liter M = 30 000 g/mol M = 30 000 g/mol Recommended calibrator: 1st IS 87/684 Recommended calibrator: WHO 2nd IRP 67/343 Calibrator(s): 1st IRP; 2nd IRP 67/343 Authority: IUPAC-IUB 74 Authority: IUPAC-IUB 74 NPU04011 NPU03829 P—Erythropoietin; arb.subst.c.(in-vitro bioassay; P—Erythropoietin; arb.subst.c.(one-site IRP 67/343; proc.) = ? int. unit/l immunoassay; IS 87/684; proc.) = ? int. unit/l

Plasma— Plasma— Erythropoietin; Erythropoietin; arbitrary substance concentration(in-vitro arbitrary substance concentration(two-site bioassay; IS 87/684; procedure) immunoassay; IRP 67/343; procedure) international unit/liter international unit/liter M = 30 000 g/mol M = 30 000 g/mol Recommended calibrator: 1st IS 87/684 Recommended calibrator: WHO 2nd IRP 67/343 Calibrator(s): 1st IRP; 2nd IRP 67/343 Authority: IUPAC-IUB 74 Authority: IUPAC-IUB 74 NPU04013 NPU03828 P—Erythropoietin; arb.subst.c.(two-site P—Erythropoietin; arb.subst.c.(in-vitro bioassay; IS immunoassay; IRP 67/343; proc.) = ? int. unit/l 87/684; proc.) = ? int. unit/l Plasma— Plasma— Erythropoietin; Erythropoietin; arbitrary substance concentration(two-site arbitrary substance concentration(in-vivo immunoassay; IS 87/684; procedure) bioassay; IRP 67/343; procedure) international unit/liter international unit/liter M = 30 000 g/mol M = 30 000 g/mol Recommended calibrator: 1st IS 87/684 Recommended calibrator: 2nd IRP 67/343 Calibrator(s): 1st IRP; 2nd IRP 67/343 Authority: IUPAC-IUB 74 Authority: IUPAC-IUB 74 NPU04010 NPU03830 P—Erythropoietin; arb.subst.c.(in-vivo bioassay; P—Erythropoietin; arb.subst.c.(two-site IRP 67/343; proc.) = ? int. unit/l immunoassay; IS 87/684; proc.) = ? int. unit/l

Plasma— Plasma— Erythropoietin; Erythropoietin; arbitrary substance concentration(in-vivo substance concentration bioassay; IS 87/684; procedure) mole/liter international unit/liter M = 30 000 g/mol M = 30 000 g/mol Authority: IUPAC-IUB 74 Recommended calibrator: WHO 1st IS 87/684 NPU01970 Calibrator(s): WHO 1st IRP; 2nd IRP 67/343 P—Erythropoietin; subst.c.= ? prefix ? mol/l Authority: IUPAC-IUB 74 NPU01969 Plasma— P—Erythropoietin; arb.subst.c.(in-vivo bioassay; IS Estradiol(free); 87/684; proc.) = ? int. unit/l substance concentration nanomole/liter Plasma— M = 272,37 g/mol Erythropoietin; Other term(s): Free E2 arbitrary substance concentration(one-site Authority: IUPAC-IUB 89 immunoassay; IRP 67/343; procedure) NPU01974 international unit/liter P—Estradiol(free); subst.c. = ? nmol/l M = 30 000 g/mol

Plasma— Mammary cytosol protein— Estradiol(free); Estradiol-receptor(free); substance concentration substance content picomole/liter nanomole/kilogram M = 272,37 g/mol NPU01976 Other term(s): Free E2 Mammary cytosol prot.—Estradiol-receptor(free); Authority: IUPAC-IUB 89 subst.cont. = ? nmol/kg NPU14569 P—Estradiol(free); subst.c. = ? pmol/l Mammary cytosol protein— Estradiol-receptor(total); Plasma— substance content Estradiol(non sexual-hormone-binding-globulin nanomole/kilogram bound); NPU01975 substance concentration Mammary cytosol prot.—Estradiol-receptor(tot.); nanomole/liter subst.cont. = ? nmol/kg NPU12124 P—Estradiol(non SHBG bound); subst.c. = ? nmol/l Plasma— Estriol(total); Plasma— substance concentration Estradiol(non sexual-hormone-binding-globulin nanomole/liter bound); Other term(s): Estriol+estriolglucuronate+estriol substance concentration sulphate; Total estriols; Unconjugated+conjugated picomole/liter estriol NPU14570 NPU01980 P—Estradiol(non SHBG bound); subst.c. = ? pmol/l P—Estriol(tot.); subst.c. = ? nmol/l

Cystic fluid(specification)— Urine— Estradiol(total); Estriol(total); substance concentration substance concentration nanomole/liter nanomole/liter NPU08760 Other term(s): Estriol+estriolglucuronate+estriol Cystf(spec.)—Estradiol(tot.); subst.c. = ? nmol/l sulphate; Total estriols; Unconjugated+conjugated estriol Plasma— NPU01981 Estradiol(total); U—Estriol(tot.); subst.c. = ? nmol/l substance concentration nanomole/liter Plasma— M = 272,37 g/mol Estriol(total); Authority: IUPAC-IUB 89 which is Estradiol-17-beta. substance concentration Here 17-beta is omitted as 17-alpha does not occur picomole/liter in human plasma; CAS50-28-2 Other term(s): Estriol+estriolglucuronate+estriol NPU01972 sulphate; Total estriols; Unconjugated+conjugated P—Estradiol(tot.); subst.c. = ? nmol/l estriol NPU14571 Saliva— P—Estriol(tot.); subst.c. = ? pmol/l Estradiol(total); substance concentration Plasma— nanomole/liter Estriol; M = 272,37 g/mol substance concentration Authority: IUPAC-IUB 89 which is Estradiol-17-beta. nanomole/liter Here 17-beta is omitted as 17-alpha does not occur M = 288,37 g/mol in human plasma; CAS50-28-2 Other term(s): Unconjugated estriol NPU01973 Authority: IUPAC-IUB 89 Saliva—Estradiol(tot.); subst.c. = ? nmol/l NPU01979 P—Estriol; subst.c. = ? nmol/l Plasma— Estradiol(total); Plasma— substance concentration Estriol; picomole/liter substance concentration M = 272,37 g/mol picomole/liter Authority: IUPAC-IUB 89 which is Estradiol-17-beta. M = 288,37 g/mol Here 17-beta is omitted as 17-alpha does not occur Other term(s): Unconjugated estriol in human plasma; CAS50-28-2 Authority: IUPAC-IUB 89 NPU09357 NPU14572 P—Estradiol(tot.); subst.c. = ? pmol/l P—Estriol; subst.c. = ? pmol/l

Plasma— Plasma— Estrogen; Extractable nuclear-antigen antibody; substance concentration(list; procedure) arbitrary substance concentration(list; NPU12122 procedure) P—Estrogen; subst.c.(list; proc.) NPU12022 NPU01974 P—Estradiol(free); subst.c. = ? nmol/l P—Extractable nuclear-antigen antibody; NPU14569 P—Estradiol(free); subst.c. = ? pmol/l arb.subst.c.(list; proc.) NPU12124 P—Estradiol(non SHBG bound); NPU14504 P—Ribonucleoprotein antibody(IgG); subst.c. = ? nmol/l arb.subst.c.(proc.) = ? arb.unit/l NPU14570 P—Estradiol(non SHBG bound); NPU14505 P—Ribonucleoprotein(U1) subst.c. = ? pmol/l antibody(IgG); arb.subst.c.(proc.) = ? × 10³ arb.unit/l NPU01972 P—Estradiol(tot.); subst.c. = ? nmol/l NPU12024 P—Smith’s antibody; arb.subst.c.(proc.) NPU09357 P—Estradiol(tot.); subst.c. = ? pmol/l = ? arb.unit/l NPU01980 P—Estriol(tot.); subst.c. = ? nmol/l NPU01982 P—Estrone; subst.c. = ? pmol/l Patient— NPU12123 P—Estrone sulphate; subst.c. = ? pmol/l Faeces; NPU03419 P—Sexual-hormone-binding-globulin; mass rate(procedure) subst.c. = ? nmol/l gram/day NPU03813 Plasma— Pt—Faeces; mass rate(proc.) = ? g/d Estrone sulphate; substance concentration Patient— picomole/liter Faeces; NPU12123 mass(procedure) P—Estrone sulphate; subst.c. = ? pmol/l gram NPU10221 Plasma— Pt—Faeces; mass(proc.) = ? g Estrone; substance concentration Plasma— picomole/liter Ferritin; M = 270,36 g/mol substance concentration Authority: IUPAC-IUB 89 picomole/liter NPU01982 M = 450 000 g/mol P—Estrone; subst.c. = ? pmol/l NPU03899 P—Ferritin; subst.c. = ? pmol/l Urine— Ethanolamine/Creatininium; Plasma— substance ratio Ferroxidase; 10-3 substance concentration NPU14208 micromole/liter U—Ethanolamine/Creatininium; subst.ratio = ? × M = 134 000 g/mol 10-3 Other term(s): Ceruloplasmin; Coeruloplasmin Authority: IUB 84; E.C. 1.16.3.1 Plasma— NPU02041 Ethylene glycol; P—Ferroxidase; subst.c. = ? µmol/l substance concentration millimole/liter a-1-Fetoprotein— M = 62,07 g/mol a-1- NPU09008 Fetoprotein(non con-A reactive); P—Ethylene glycol; subst.c. = ? mmol/l substance fraction(IS 72/225; procedure) NPU17674 Urine— a-1-Fetoprotein—a-1-Fetoprotein(non con-A Etiocholanolone; reactive); subst.fr.(IS 72/225; proc.) = ? substance concentration micromole/liter Amniotic fluid— M = 290,4 g/mol a-1- NPU02013 Fetoprotein; U—Etiocholanolone; subst.c. = ? µmol/l arbitrary substance concentration(IS 72/225) 10³ international unit/liter Patient(Urine)— NPU17685 Etiocholanolone; Amf—a-1-Fetoprotein; arb.subst.c.(IS 72/225) = ? × substance rate 10³ int.unit/l micromole/day NPU10134 Pt(U)—Etiocholanolone; subst.rate = ? µmol/d

Plasma— NPU02063 a-1- Pt(U)—Fluoride; subst.rate(proc.) = ? µmol/d Fetoprotein; arbitrary substance concentration(IS 72/225; Plasma— procedure) Folate; 10³ international unit/liter substance concentration M = 69 000 g/mol nanomole/liter Recommended calibrator: WHO 1st IS 72/225 M = 441,40 g/mol NPU02043 NPU02070 P—a-1-Fetoprotein; arb.subst.c.(IS 72/225; proc.) = P—Folate; subst.c. = ? nmol/l ? × 10³ int.unit/l Erythrocytes(Blood)— Amniotic fluid— Folates(total); a-1- substance concentration Fetoprotein; micromole/liter arbitrary substance concentration(IS 72/225; Other term(s): Pteroylpolyglutamic Acids for Folates procedure) NPU17169 international unit/liter Ercs(B)—Folates(tot.); subst.c. = ? µmol/l M = 69 000 g/mol Recommended calibrator: WHO 1st IS 72/225 Blood— NPU02042 Folates(total); Amf—a-1-Fetoprotein; arb.subst.c.(IS 72/225; proc.) substance concentration = ? int. unit/l nanomole/liter Other term(s): Pteroylpolyglutamic Acids for Folates Amniotic fluid— NPU14326 a-1- B—Folates(tot.); subst.c. = ? nmol/l Fetoprotein; substance concentration Erythrocytes(Blood)— nanomole/liter Folates(total); M = 69 000 g/mol substance concentration NPU03925 nanomole/liter Amf—a-1-Fetoprotein; subst.c. = ? nmol/l Other term(s): Pteroylpolyglutamic Acids for Folates NPU02071 Plasma— Ercs(B)—Folates(tot.); subst.c. = ? nmol/l a-1- Fetoprotein; Plasma— substance concentration Follitropin a-chain; nanomole/liter substance concentration M = 69 000 g/mol picomole/liter NPU03924 M = 14 000 g/mol P—a-1-Fetoprotein; subst.c. = ? nmol/l NPU02074 P—Follitropin a-chain; subst.c. = ? pmol/l Plasma— Fluoride; Plasma— substance concentration Follitropin b-chain; micromole/liter substance concentration M = 19,00 g/mol picomole/liter Authority: IUPAC/VII-C-TOX M = 19 000 g/mol NPU04882 NPU02075 P—Fluoride; subst.c. = ? µmol/l P—Follitropin b-chain; subst.c. = ? pmol/l

Urine— Pituitary gland— Fluoride; Follitropin secretion; substance concentration substance rate(gonadorelin, intravenous micromole/liter administration; list; procedure) M = 19,00 g/mol Other term(s): Gonadorelin test; Gonadoliberin test; Authority: IUPAC/VII-C-TOX Luliberin test; Gonadotropin-releasing hormone test; NPU10152 GRH test U—Fluoride; subst.c. = ? µmol/l Note: M(gonadorelin) = 1 182,3 g/mol NPU10570 Patient(Urine)— PitGl—Follitropin secretion; subst.rate(gonadorelin Fluoride; i.v.; list; proc.) substance rate(procedure) NPU10561 Pt—Gonadorelin(administered); micromole/day am.s.(i.v.) = ? nmol

NPU10674 P—Follitropin; arb.subst.c.(IRP 78/549; - Plasma— 60 min; proc.) = ? int. unit/l Follitropin; NPU10675 P—Follitropin; arb.subst.c.(IRP 78/549; - arbitrary substance concentration(IRP 78/549; 15 min; proc.) = ? int. unit/l 30 minutes after challenge; procedure) NPU10562 P—Follitropin; arb.subst.c.(IRP 78/549; international unit/liter 0 min; proc.) = ? int. unit/l NPU10564 NPU10563 P—Follitropin; arb.subst.c.(IRP 78/549; P—Follitropin; arb.subst.c.(IRP 78/549; 30 min; 15 min; proc.) = ? int. unit/l proc.) = ? int. unit/l NPU10564 P—Follitropin; arb.subst.c.(IRP 78/549; 30 min; proc.) = ? int. unit/l Plasma— NPU10565 P—Follitropin; arb.subst.c.(IRP 78/549; Follitropin; 60 min; proc.) = ? int. unit/l arbitrary substance concentration(IRP 78/549; NPU10566 P—Follitropin; arb.subst.c.(IRP 78/549; 60 minutes after challenge; procedure) 75 min; proc.) = ? int. unit/l international unit/liter NPU10567 P—Follitropin; arb.subst.c.(IRP 78/549; NPU10565 90 min; proc.) = ? int. unit/l P—Follitropin; arb.subst.c.(IRP 78/549; 60 min; NPU10568 P—Follitropin; arb.subst.c.(IRP 78/549; proc.) = ? int. unit/l 105 min; proc.) = ? int. unit/l NPU10569 P—Follitropin; arb.subst.c.(IRP 78/549; Plasma— 120 min; proc.) = ? int. unit/l Follitropin; arbitrary substance concentration(IRP 78/549; Plasma— 60 minutes before challenge; procedure) Follitropin; international unit/liter arbitrary substance concentration(IRP 78/549; 0 NPU10674 minutes after challenge; procedure) P—Follitropin; arb.subst.c.(IRP 78/549; -60 min; international unit/liter proc.) = ? int. unit/l NPU10562 P—Follitropin; arb.subst.c.(IRP 78/549; 0 min; proc.) Plasma— = ? int. unit/l Follitropin; arbitrary substance concentration(IRP 78/549; Plasma— 75 minutes after challenge; procedure) Follitropin; international unit/liter arbitrary substance concentration(IRP 78/549; NPU10566 105 minutes after challenge; procedure) P—Follitropin; arb.subst.c.(IRP 78/549; 75 min; international unit/liter proc.) = ? int. unit/l NPU10568 P—Follitropin; arb.subst.c.(IRP 78/549; 105 min; Plasma— proc.) = ? int. unit/l Follitropin; arbitrary substance concentration(IRP 78/549; Plasma— 90 minutes after challenge; procedure) Follitropin; international unit/liter arbitrary substance concentration(IRP 78/549; NPU10567 120 minutes after challenge; procedure) P—Follitropin; arb.subst.c.(IRP 78/549; 90 min; international unit/liter proc.) = ? int. unit/l NPU10569 P—Follitropin; arb.subst.c.(IRP 78/549; 120 min; Plasma— proc.) = ? int. unit/l Follitropin; arbitrary substance concentration(IRP 78/549; Plasma— procedure) Follitropin; international unit/liter arbitrary substance concentration(IRP 78/549; M = 33 000 g/mol 15 minutes after challenge; procedure) Recommended calibrator: WHO 2nd IRP 78/549 international unit/liter Other term(s): Follicle-stimulating hormone; FSH NPU10563 Authority: IUPAC-IUB 74 P—Follitropin; arb.subst.c.(IRP 78/549; 15 min; NPU04014 proc.) = ? int. unit/l P—Follitropin; arb.subst.c.(IRP 78/549; proc.) = ? int. unit/l Plasma— Follitropin; Plasma— arbitrary substance concentration(IRP 78/549; Follitropin; 15 minutes before challenge; procedure) arbitrary substance concentration(IS 83/575; international unit/liter procedure) NPU10675 international unit/liter P—Follitropin; arb.subst.c.(IRP 78/549; -15 min; proc.) = ? int. unit/l

M = 33 000 g/mol Patient— Recommended calibrator: WHO 1st IS 83/575 Fructose(administered); Calibrator(s): WHO 2nd IRP 78/549 amount-of-substance(oral administration) Other term(s): Follicle-stimulating hormone; FSH millimole Authority: IUPAC-IUB 74 M = 180,16 g/mol NPU02072 Other term(s): D-Fructose; D-Levulose P—Follitropin; arb.subst.c.(IS 83/575; proc.) = ? int. NPU10498 unit/l Pt—Fructose(administered); am.s.(p.o.) = ? mmol

Plasma— Patient— Follitropin; Fructose(administered); substance concentration substance content(oral administration; amount- mole/liter of-substance/body mass) M = 33 000 g/mol millimole/kilogram Other term(s): Follicle-stimulating hormone; FSH M = 180,16 g/mol Authority: IUPAC-IUB 74 Other term(s): D-Fructose; D-Levulose NPU02073 NPU10499 P—Follitropin; subst.c.= ? prefix ? mol/l Pt—Fructose(administered); subst.cont.(p.o.; am.s./ body mass) = ? mmol/kg Plasma— Follitropin+Lutropin; Urine— arbitrary substance concentration(list; Fructose; procedure) substance concentration NPU17672 mole/liter P—Follitropin+Lutropin; arb.subst.c.(list; proc.) M = 180,16 g/mol NPU04014 P—Follitropin; arb.subst.c.(IRP 78/549; Other term(s): Levulose proc.) = ? int. unit/l NPU02098 NPU02618 P—Lutropin; arb.subst.c.(IS 80/552; U—Fructose; subst.c.= ? prefix ? mol/l proc.) = ? int. unit/l Patient— Patient— Fructose+glucose tolerance; Food ingestion; property(fructose+glucose, oral administration; mass rate(procedure) list; procedure) gram/day Note: M (fructose) = 180,16 g/mol; M (glucose) = NPU04077 180,16 g/mol Pt—Food ingestion; mass rate(proc.) = ? g/d NPU02099 Pt—Fructose+glucose tolerance; Urine— prop.(fructose+glucose p.o.; list; proc.) Formiminoglutamate; NPU10498 Pt—Fructose(administered); am.s.(p.o.) amount-of-substance(0-540 minutes after = ? mmol histidine, oral administration; procedure) NPU10499 Pt—Fructose(administered); micromole subst.cont.(p.o.; am.s./body mass) = ? mmol/kg Other term(s): FIGLU test NPU10574 Pt—Glucose(administered); am.s.(p.o.) NPU02086 = ? mmol U—Formiminoglutamate; am.s.(0-540 min after NPU10575 Pt—Glucose(administered); histidine p.o.; proc.)= ? µmol subst.cont.(p.o.; am.s./body mass) = ? mmol/kg NPU08503 B—Glucose; subst.c.(0 min) = ? mmol/l Plasma— NPU08516 B—Glucose; subst.c.(15 min) = ? Freezing point; mmol/l Celsius temperature increment(Water-Plasma) NPU08504 B—Glucose; subst.c.(30 min) = ? degree Celsius mmol/l NPU04035 NPU08517 B—Glucose; subst.c.(45 min) = ? P—Freezing point; temp.incr.(Water-Plasma) = ? °C mmol/l NPU08501 B—Glucose; subst.c.(60 min) = ? Plasma— mmol/l Fructosamine; NPU08518 B—Glucose; subst.c.(75 min) = ? substance concentration mmol/l micromole/liter NPU08506 B—Glucose; subst.c.(90 min) = ? NPU02096 mmol/l P—Fructosamine; subst.c. = ? µmol/l NPU08507 B—Glucose; subst.c.(120 min) = ? mmol/l NPU08500 B—Glucose; subst.c.(180 min) = ? mmol/l

NPU08515 B—Glucose; subst.c.(360 min) = ? Note: M(galactose) = 180,16 g/mol mmol/l NPU10336 NPU08502 B—Glucose; subst.c.incr.(max. c. minus Pt—Galactose tolerance; prop.(galactose i.v.; list; 0 min c.; proc.) = ? mmol/l proc.) NPU04173 P—Glucose; subst.c.(0 min) = ? mmol/l NPU10344 Pt—Galactose(administered); am.s.(i.v.) NPU04186 P—Glucose; subst.c.(15 min) = ? = ? mmol mmol/l NPU10345 Pt—Galactose(administered); NPU04174 P—Glucose; subst.c.(30 min) = ? subst.cont.(i.v.; am.s./body mass) = ? mmol/kg mmol/l NPU14914 Pt—Galactose elimination; NPU04187 P—Glucose; subst.c.(45 min) = ? subst.rate(proc.) = ? mmol/s mmol/l NPU17700 Pt(P)—Galactose elimination; subst.rate NPU04175 P—Glucose; subst.c.(60 min) = ? ratio(galactose i.v.; actual/norm; proc.) = ? mmol/l NPU10337 B—Galactose; subst.c.(0 min) = ? NPU04965 P—Glucose; subst.c.(75 min) = ? mmol/l mmol/l NPU10338 B—Galactose; subst.c.(10 min) = ? NPU04176 P—Glucose; subst.c.(90 min) = ? mmol/l mmol/l NPU09241 B—Galactose; subst.c.(25 min) = ? NPU04177 P—Glucose; subst.c.(120 min) = ? mmol/l mmol/l NPU10340 B—Galactose; subst.c.(30 min) = ? NPU04179 P—Glucose; subst.c.(180 min) = ? mmol/l mmol/l NPU09242 B—Galactose; subst.c.(35 min) = ? NPU04185 P—Glucose; subst.c.(360 min) = ? mmol/l mmol/l NPU09243 B—Galactose; subst.c.(45 min) = ? NPU03841 P—Glucose; subst.c.incr.(max. c. minus mmol/l 0 min c.; proc.) = ? mmol/l NPU10343 B—Galactose; subst.c.(60 min) = ? mmol/l Urine— NPU10495 B—Galactose; subst.c.(90 min) = ? Fumarate; mmol/l substance concentration NPU10496 B—Galactose; subst.c.(120 min) = ? mole/liter mmol/l M = 116,07 g/mol NPU14128 B(cB)—Galactose; subst.c.(0 min) = ? NPU02118 mmol/l U—Fumarate; subst.c.= ? prefix ? mol/l NPU14130 B(cB)—Galactose; subst.c.(25 min) = ? mmol/l Patient— NPU14131 B(cB)—Galactose; subst.c.(30 min) = ? Furosemide(administered); mmol/l amount-of-substance(oral administration) NPU14132 B(cB)—Galactose; subst.c.(35 min) = ? micromole mmol/l M = 330,75 g/mol NPU14133 B(cB)—Galactose; subst.c.(45 min) = ? NPU10419 mmol/l Pt—Furosemide(administered); am.s.(p.o.) = ? µmol NPU14134 B(cB)—Galactose; subst.c.(60 min) = ? mmol/l Patient(Plasma)— NPU14135 B(cB)—Galactose; subst.c.(90 min) = ? Galactose elimination; mmol/l substance rate ratio(galactose, intravenous NPU14129 B(cB)—Galactose; subst.c.(120 min) = ? administration; actual/norm; procedure) mmol/l NPU17700 Pt(P)—Galactose elimination; subst.rate Patient— ratio(galactose i.v.; actual/norm; proc.) = ? Galactose tolerance; property(galactose, oral administration; list; Patient— procedure) Galactose elimination; Note: M(galactose) = 180,16 g/mol substance rate(procedure) NPU10573 millimole/second Pt—Galactose tolerance; prop.(galactose p.o.; list; NPU14914 proc.) Pt—Galactose elimination; subst.rate(proc.) = ? NPU10572 Pt—Galactose(administered); mmol/s am.s.(p.o.) = ? mmol NPU10497 Pt—Galactose(administered); Patient— subst.cont.(p.o.; am.s./body mass) = ? mmol/kg Galactose tolerance; NPU10337 B—Galactose; subst.c.(0 min) = ? property(galactose, intravenous administration; mmol/l list; procedure) NPU10338 B—Galactose; subst.c.(10 min) = ? Other term(s): Galactose elimination capacity test mmol/l

NPU09241 B—Galactose; subst.c.(25 min) = ? millimole mmol/l M = 180,16 g/mol NPU10340 B—Galactose; subst.c.(30 min) = ? NPU10344 mmol/l Pt—Galactose(administered); am.s.(i.v.) = ? mmol NPU09242 B—Galactose; subst.c.(35 min) = ? mmol/l Patient— NPU09243 B—Galactose; subst.c.(45 min) = ? Galactose(administered); mmol/l amount-of-substance(oral administration) NPU10343 B—Galactose; subst.c.(60 min) = ? millimole mmol/l M = 180,16 g/mol NPU10495 B—Galactose; subst.c.(90 min) = ? NPU10572 mmol/l Pt—Galactose(administered); am.s.(p.o.) = ? mmol NPU10496 B—Galactose; subst.c.(120 min) = ? mmol/l Patient— NPU08503 B—Glucose; subst.c.(0 min) = ? mmol/l Galactose(administered); NPU08504 B—Glucose; subst.c.(30 min) = ? substance content(intravenous administration; mmol/l amount-of-substance/body mass) NPU08501 B—Glucose; subst.c.(60 min) = ? millimole/kilogram mmol/l M = 180,16 g/mol NPU08506 B—Glucose; subst.c.(90 min) = ? NPU10345 mmol/l Pt—Galactose(administered); subst.cont.(i.v.; am.s./ NPU08507 B—Glucose; subst.c.(120 min) = ? body mass) = ? mmol/kg mmol/l NPU14128 B(cB)—Galactose; subst.c.(0 min) = ? Patient— mmol/l Galactose(administered); NPU14130 B(cB)—Galactose; subst.c.(25 min) = ? substance content(oral administration; amount- mmol/l of-substance/body mass) NPU14131 B(cB)—Galactose; subst.c.(30 min) = ? millimole/kilogram mmol/l M = 180,16 g/mol NPU14132 B(cB)—Galactose; subst.c.(35 min) = ? NPU10497 mmol/l Pt—Galactose(administered); subst.cont.(p.o.; NPU14133 B(cB)—Galactose; subst.c.(45 min) = ? am.s./body mass) = ? mmol/kg mmol/l NPU14134 B(cB)—Galactose; subst.c.(60 min) = ? Urine— mmol/l Galactose; NPU14135 B(cB)—Galactose; subst.c.(90 min) = ? relative amount-of-substance(urine 300 minutes/ mmol/l intake; procedure) NPU14129 B(cB)—Galactose; subst.c.(120 min) = ? NPU02152 mmol/l U—Galactose; rel.ams.(U 300 min/intake; proc.) = ? NPU10047 B(cB)—Glucose; subst.c.(0 min) = ? mmol/l Blood— NPU10048 B(cB)—Glucose; subst.c.(30 min) = ? Galactose; mmol/l substance concentration(0 minutes after NPU10045 B(cB)—Glucose; subst.c.(60 min) = ? challenge) mmol/l millimole/liter NPU10050 B(cB)—Glucose; subst.c.(90 min) = ? NPU10337 mmol/l B—Galactose; subst.c.(0 min) = ? mmol/l NPU10051 B(cB)—Glucose; subst.c.(120 min) = ? mmol/l Blood(capillary Blood)— NPU04173 P—Glucose; subst.c.(0 min) = ? mmol/l Galactose; NPU04174 P—Glucose; subst.c.(30 min) = ? substance concentration(0 minutes after mmol/l challenge) NPU04175 P—Glucose; subst.c.(60 min) = ? millimole/liter mmol/l NPU14128 NPU04176 P—Glucose; subst.c.(90 min) = ? B(cB)—Galactose; subst.c.(0 min) = ? mmol/l mmol/l NPU04177 P—Glucose; subst.c.(120 min) = ? Blood— mmol/l Galactose; NPU02152 U—Galactose; rel.ams.(U 300 min/ substance concentration(10 minutes after intake; proc.) = ? challenge) millimole/liter Patient— NPU10338 Galactose(administered); B—Galactose; subst.c.(10 min) = ? mmol/l amount-of-substance(intravenous administration)

Blood— Blood— Galactose; Galactose; substance concentration(20 minutes after substance concentration(45 minutes after challenge) challenge) millimole/liter millimole/liter NPU10339 NPU09243 B—Galactose; subst.c.(20 min) = ? mmol/l B—Galactose; subst.c.(45 min) = ? mmol/l

Blood— Blood(capillary Blood)— Galactose; Galactose; substance concentration(25 minutes after substance concentration(45 minutes after challenge) challenge) millimole/liter millimole/liter NPU09241 NPU14133 B—Galactose; subst.c.(25 min) = ? mmol/l B(cB)—Galactose; subst.c.(45 min) = ? mmol/l

Blood(capillary Blood)— Blood— Galactose; Galactose; substance concentration(25 minutes after substance concentration(50 minutes after challenge) challenge) millimole/liter millimole/liter NPU14130 NPU10342 B(cB)—Galactose; subst.c.(25 min) = ? mmol/l B—Galactose; subst.c.(50 min) = ? mmol/l

Blood— Blood— Galactose; Galactose; substance concentration(30 minutes after substance concentration(60 minutes after challenge) challenge) millimole/liter millimole/liter NPU10340 NPU10343 B—Galactose; subst.c.(30 min) = ? mmol/l B—Galactose; subst.c.(60 min) = ? mmol/l

Blood(capillary Blood)— Blood(capillary Blood)— Galactose; Galactose; substance concentration(30 minutes after substance concentration(60 minutes after challenge) challenge) millimole/liter millimole/liter NPU14131 NPU14134 B(cB)—Galactose; subst.c.(30 min) = ? mmol/l B(cB)—Galactose; subst.c.(60 min) = ? mmol/l

Blood— Blood— Galactose; Galactose; substance concentration(35 minutes after substance concentration(90 minutes after challenge) challenge) millimole/liter millimole/liter NPU09242 NPU10495 B—Galactose; subst.c.(35 min) = ? mmol/l B—Galactose; subst.c.(90 min) = ? mmol/l

Blood(capillary Blood)— Blood(capillary Blood)— Galactose; Galactose; substance concentration(35 minutes after substance concentration(90 minutes after challenge) challenge) millimole/liter millimole/liter NPU14132 NPU14135 B(cB)—Galactose; subst.c.(35 min) = ? mmol/l B(cB)—Galactose; subst.c.(90 min) = ? mmol/l

Blood— Blood— Galactose; Galactose; substance concentration(40 minutes after substance concentration(120 minutes after challenge) challenge) millimole/liter millimole/liter NPU10341 NPU10496 B—Galactose; subst.c.(40 min) = ? mmol/l B—Galactose; subst.c.(120 min) = ? mmol/l

Blood(capillary Blood)— NPU08501 B—Glucose; subst.c.(60 min) = ? Galactose; mmol/l substance concentration(120 minutes after NPU08506 B—Glucose; subst.c.(90 min) = ? challenge) mmol/l millimole/liter NPU08507 B—Glucose; subst.c.(120 min) = ? NPU14129 mmol/l B(cB)—Galactose; subst.c.(120 min) = ? mmol/l NPU08502 B—Glucose; subst.c.incr.(max. c. minus 0 min c.; proc.) = ? mmol/l Blood— NPU10047 B(cB)—Glucose; subst.c.(0 min) = ? Galactose; mmol/l substance concentration(55 minutes after NPU10059 B(cB)—Glucose; subst.c.(15 min) = ? challenge) mmol/l millimole/liter NPU10048 B(cB)—Glucose; subst.c.(30 min) = ? NPU09244 mmol/l B—Galactose; subst.c.(550 min) = ? mmol/l NPU10060 B(cB)—Glucose; subst.c.(45 min) = ? mmol/l Blood(capillary Blood)— NPU10045 B(cB)—Glucose; subst.c.(60 min) = ? Galactose; mmol/l substance concentration NPU10050 B(cB)—Glucose; subst.c.(90 min) = ? millimole/liter mmol/l M = 180,16 g/mol NPU10051 B(cB)—Glucose; subst.c.(120 min) = ? NPU10611 mmol/l B(cB)—Galactose; subst.c. = ? mmol/l NPU10046 B(cB)—Glucose; subst.c.incr.(max. c. minus 0 min c.; proc.) = ? mmol/l Plasma— NPU04173 P—Glucose; subst.c.(0 min) = ? mmol/l Galactose; NPU04186 P—Glucose; subst.c.(15 min) = ? substance concentration mmol/l millimole/liter NPU04174 P—Glucose; subst.c.(30 min) = ? M = 180,16 g/mol mmol/l NPU02150 NPU04187 P—Glucose; subst.c.(45 min) = ? P—Galactose; subst.c. = ? mmol/l mmol/l NPU04175 P—Glucose; subst.c.(60 min) = ? Urine— mmol/l Galactose; NPU04176 P—Glucose; subst.c.(90 min) = ? substance concentration mmol/l millimole/liter NPU04177 P—Glucose; subst.c.(120 min) = ? M = 180,16 g/mol mmol/l NPU02151 NPU03841 P—Glucose; subst.c.incr.(max. c. minus U—Galactose; subst.c. = ? mmol/l 0 min c.; proc.) = ? mmol/l

Patient— Erythrocytes(Blood)— Galactose+glucose tolerance; Galactose-1-phosphate; property(galactose+glucose, oral entitic amount-of-substance administration; list; procedure) attomole Note: M (galactose) = 180,16 g/mol; M (glucose) = M = 260,14 g/mol 180,16 g/mol NPU02153 NPU08697 Ercs(B)—Galactose-1-phosphate; entitic am.s. = ? Pt—Galactose+glucose tolerance; amol prop.(galactose+glucose p.o.; list; proc.) NPU10572 Pt—Galactose(administered); Plasma— am.s.(p.o.) = ? mmol Gall canaliculus antibody; NPU10497 Pt—Galactose(administered); arbitrary concentration(procedure) subst.cont.(p.o.; am.s./body mass) = ? mmol/kg NPU02158 NPU10574 Pt—Glucose(administered); am.s.(p.o.) P—Gall canaliculus antibody; arb.c.(proc.) = ? = ? mmol NPU10575 Pt—Glucose(administered); Urine— subst.cont.(p.o.; am.s./body mass) = ? mmol/kg Gallium; NPU08503 B—Glucose; subst.c.(0 min) = ? mmol/l substance concentration NPU08516 B—Glucose; subst.c.(15 min) = ? picomole/liter mmol/l M = 69,72 g/mol NPU08504 B—Glucose; subst.c.(30 min) = ? NPU02159 mmol/l U—Gallium; subst.c. = ? pmol/l NPU08517 B—Glucose; subst.c.(45 min) = ? mmol/l

Plasma— arb.subst.c.(proc.) = ? × 10³ arb.unit/l Gamma-globulin; NPU12895 P—Gangliosid(GM1) antibody(IgM); mass concentration arb.subst.c.(proc.) = ? × 10³ arb.unit/l gram/liter NPU04653 Alveolar gas— P—Gamma-globulin; mass c. = ? g/l Gas; pressure Cerebrospinal fluid— kilopascal Gamma-globulin; NPU04033 mass concentration Alveolar gas—Gas; pr. = ? kPa milligram/liter NPU04661 Plasma— Csf—Gamma-globulin; mass c. = ? mg/l Gastric parietal cell antibody; arbitrary concentration(procedure) Urine— NPU02160 Gamma-globulin; P—Gastric parietal cell antibody; arb.c.(proc.) = ? mass concentration milligram/liter Patient— NPU04657 Gastrin secretion; U—Gamma-globulin; mass c. = ? mg/l substance rate(secretin, intravenous administration; list; procedure) Protein(Cerebrospinal fluid)— Note: M (secretin) = 3 056 g/mol. Gamma-globulin; NPU10522 mass fraction Pt—Gastrin secretion; subst.rate(secretin i.v.; list; NPU04953 proc.) Prot.(Csf)—Gamma-globulin; mass fr. = ? NPU10512 Pt—Secretin(administered); am.s.(i.v.) = ? nmol Protein(Plasma)— NPU10513 Pt—Secretin(administered); Gamma-globulin; subst.cont.(i.v.; am.s./body mass) = ? pmol/kg mass fraction NPU10514 P—Gastrin; subst.c.(0 min) = ? pmol/l NPU04943 NPU10515 P—Gastrin; subst.c.(5 min) = ? pmol/l Prot.(P)—Gamma-globulin; mass fr. = ? NPU10516 P—Gastrin; subst.c.(10 min) = ? pmol/l NPU10517 P—Gastrin; subst.c.(15 min) = ? pmol/l Protein(Urine)— NPU10518 P—Gastrin; subst.c.(20 min) = ? pmol/l Gamma-globulin; NPU10519 P—Gastrin; subst.c.(25 min) = ? pmol/l mass fraction NPU10520 P—Gastrin; subst.c.(30 min) = ? pmol/l NPU04948 NPU10521 P—Gastrin; subst.c.(max.; proc.) = ? Prot.(U)—Gamma-globulin; mass fr. = ? pmol/l

Plasma— Plasma— Gangliosid(GM1) antibody(Immunoglobulin G); Gastrin; arbitrary substance concentration(procedure) substance concentration(0 minutes after 10³ arbitrary unit/liter challenge) NPU14506 picomole/liter P—Gangliosid(GM1) antibody(IgG); NPU10514 arb.subst.c.(proc.) = ? × 10³ arb.unit/l P—Gastrin; subst.c.(0 min) = ? pmol/l

Plasma— Plasma— Gangliosid(GM1) antibody(Immunoglobulin M); Gastrin; arbitrary substance concentration(procedure) substance concentration(5 minutes after 10³ arbitrary unit/liter challenge) NPU12895 picomole/liter P—Gangliosid(GM1) antibody(IgM); NPU10515 arb.subst.c.(proc.) = ? × 10³ arb.unit/l P—Gastrin; subst.c.(5 min) = ? pmol/l

Plasma— Plasma— Gangliosid(GM1) antibody; Gastrin; arbitrary substance concentration(list; substance concentration(10 minutes after procedure) challenge) NPU17004 picomole/liter P—Gangliosid(GM1) antibody; arb.subst.c.(list; NPU10516 proc.) P—Gastrin; subst.c.(10 min) = ? pmol/l NPU14506 P—Gangliosid(GM1) antibody(IgG);

Plasma— Authority: IUPAC-IUB74 Gastrin; NPU14003 substance concentration(15 minutes after U—Gastrin; subst.c. = ? pmol/l challenge) picomole/liter Patient(Urine)— NPU10517 Gastrin; P—Gastrin; subst.c.(15 min) = ? pmol/l substance rate picomole/day Plasma— M = 2 080 g/mol Gastrin; NPU14004 substance concentration(20 minutes after Pt(U)—Gastrin; subst.rate = ? pmol/d challenge) picomole/liter Urine— NPU10518 Germanium; P—Gastrin; subst.c.(20 min) = ? pmol/l substance concentration picomole/liter Plasma— M = 72,61 g/mol Gastrin; NPU02165 substance concentration(25 minutes after U—Germanium; subst.c. = ? pmol/l challenge) picomole/liter Patient— NPU10519 Gestation period; P—Gastrin; subst.c.(25 min) = ? pmol/l duration Week(s) Plasma— NPU09355 Gastrin; Pt—Gestation period; duration= ? Week(s) substance concentration(30 minutes after challenge) Plasma— picomole/liter Gliadin antibody(Immunoglobulin A); NPU10520 arbitrary concentration(procedure) P—Gastrin; subst.c.(30 min) = ? pmol/l NPU12539 P—Gliadin antibody(IgA); arb.c.(proc.) = ? Plasma— Gastrin; Plasma— substance concentration(maximum; procedure) Gliadin antibody(Immunoglobulin A); picomole/liter arbitrary substance concentration(procedure) NPU10521 10³ arbitrary unit/liter P—Gastrin; subst.c.(max.; proc.) = ? pmol/l NPU08945 P—Gliadin antibody(IgA); arb.subst.c.(proc.) = ? × Plasma— 10³ arb.unit/l Gastrin; substance concentration Plasma— picomole/liter Gliadin antibody(Immunoglobulin G); M = 2 080 g/mol arbitrary concentration(procedure) Recommended calibrator: Non sulphated gastrin-17 NPU12537 Authority: IUPAC-IUB74 P—Gliadin antibody(IgG); arb.c.(proc.) = ? NPU02161 P—Gastrin; subst.c. = ? pmol/l Plasma— Gliadin antibody(Immunoglobulin G); Plasma(fasting Patient)— arbitrary substance concentration(procedure) Gastrin; 10³ arbitrary unit/liter substance concentration NPU08944 picomole/liter P—Gliadin antibody(IgG); arb.subst.c.(proc.) = ? × M = 2 080 g/mol 10³ arb.unit/l NPU04152 P(fPt)—Gastrin; subst.c. = ? pmol/l Plasma— Gliadin antibody; Urine— arbitrary concentration(list; procedure) Gastrin; NPU14050 substance concentration P—Gliadin antibody; arb.c.(list; proc.) picomole/liter NPU12539 P—Gliadin antibody(IgA); arb.c.(proc.) = M = 2 080 g/mol ? Recommended calibrator: Non sulphated gastrin-17 NPU12537 P—Gliadin antibody(IgG); arb.c.(proc.) = ?

Plasma— M = 3 482,8 g/mol Gliadin antibody; Other term(s): Hyperglycaemic factor arbitrary substance concentration(list; Authority: IUPAC-IUB 74 procedure) NPU10690 NPU14051 Pt—Glucagon(administered); subst.cont.(i.m.; P—Gliadin antibody; arb.subst.c.(list; proc.) am.s./body mass) = ? nmol/kg NPU08945 P—Gliadin antibody(IgA); arb.subst.c.(proc.) = ? × 10³ arb.unit/l Patient— NPU08944 P—Gliadin antibody(IgG); Glucagon(administered); arb.subst.c.(proc.) = ? × 10³ arb.unit/l substance content(intravenous administration; amount-of-substance/body mass) Plasma— nanomole/kilogram Glomerulus membrane antibody(Immunoglobulin M = 3 482,8 g/mol G); Other term(s): Hyperglycaemic factor arbitrary concentration(procedure) Authority: IUPAC-IUB 74 NPU12542 NPU10691 P—Glomerulus membrane antibody(IgG); Pt—Glucagon(administered); subst.cont.(i.v.; am.s./ arb.c.(proc.) = ? body mass) = ? nmol/kg

Plasma— Plasma— Glomerulus membrane antibody(Immunoglobulin Glucagon(total); G); substance concentration arbitrary substance concentration(procedure) picomole/liter 10³ arbitrary unit/liter M = 3 482,8 g/mol NPU12552 Other term(s): Hyperglycaemic factor P—Glomerulus membrane antibody(IgG); Authority: IUPAC-IUB 74 arb.subst.c.(proc.) = ? × 10³ arb.unit/l NPU02169 P—Glucagon(tot.); subst.c. = ? pmol/l Plasma— Glomerulus membrane antibody; Plasma— arbitrary concentration(procedure) Glucagon, pancreatic type; NPU02167 substance concentration P—Glomerulus membrane antibody; arb.c.(proc.) = picomole/liter ? M = 3 482,8 g/mol NPU08656 Patient— P—Glucagon, pancreatic type; subst.c. = ? pmol/l Glucagon(administered); amount-of-substance(intramuscular Plasma— administration) Glucagon; nanomole arbitrary substance concentration(IS 69/194; M = 3 482,8 g/mol procedure) Other term(s): Hyperglycaemic factor international unit/liter Authority: IUPAC-IUB 74 M = 3 482,8 g/mol NPU10662 Recommended calibrator: WHO 1st IS 69/194 Pt—Glucagon(administered); am.s.(i.m.) = ? nmol (porcine) Other term(s): Hyperglycaemic factor Patient— Authority: IUPAC-IUB 74 Glucagon(administered); NPU02168 amount-of-substance(intravenous P—Glucagon; arb.subst.c.(IS 69/194; proc.) = ? int. administration) unit/l nanomole M = 3 482,8 g/mol Plasma— Other term(s): Hyperglycaemic factor Glucagon+proglucagon(1-61); Authority: IUPAC-IUB 74 substance concentration NPU10389 picomole/liter Pt—Glucagon(administered); am.s.(i.v.) = ? nmol Recommended calibrator: Glucagon NPU02170 Patient— P—Glucagon+proglucagon(1-61); subst.c. = ? Glucagon(administered); pmol/l substance content(intramuscular administration; amount-of-substance/body Patient— mass) Glucose tolerance; nanomole/kilogram property(glucose, intravenous administration;

list; procedure) NPU10050 B(cB)—Glucose; subst.c.(90 min) = ? Note: M (glucose) = 180,16 g/mol mmol/l NPU08505 NPU10051 B(cB)—Glucose; subst.c.(120 min) = ? Pt—Glucose tolerance; prop.(glucose i.v.; list; proc.) mmol/l NPU10406 Pt—Glucose(administered); am.s.(i.v.) = NPU10052 B(cB)—Glucose; subst.c.(150 min) = ? ? mmol mmol/l NPU10407 Pt—Glucose(administered); NPU10044 B(cB)—Glucose; subst.c.(180 min) = ? subst.cont.(i.v.; am.s./body mass) = ? mmol/kg mmol/l NPU04173 P—Glucose; subst.c.(0 min) = ? mmol/l NPU10053 B(cB)—Glucose; subst.c.(210 min) = ? NPU08657 P—Glucose; subst.c.(1 min) = ? mmol/l mmol/l NPU08658 P—Glucose; subst.c.(3 min) = ? mmol/l NPU10054 B(cB)—Glucose; subst.c.(240 min) = ? NPU08659 P—Glucose; subst.c.(5 min) = ? mmol/l mmol/l NPU08660 P—Glucose; subst.c.(10 min) = ? mmol/l Patient— NPU04175 P—Glucose; subst.c.(60 min) = ? Glucose tolerance; mmol/l property(glucose, oral administration; list; (0 30 NPU04176 P—Glucose; subst.c.(90 min) = ? 60 90 120 150 180) minutes after challenge) mmol/l NPU14387 Pt—Glucose tolerance; prop.(glucose p.o.; list; (0 30 Patient— 60 90 120 150 180) min) Glucose tolerance; NPU10574 Pt—Glucose(administered); am.s.(p.o.) property(glucose, oral administration; list; (0 = ? mmol 120) minutes after challenge) NPU10575 Pt—Glucose(administered); NPU14383 subst.cont.(p.o.; am.s./body mass) = ? mmol/kg Pt—Glucose tolerance; prop.(glucose p.o.; list; (0 NPU08503 B—Glucose; subst.c.(0 min) = ? mmol/l 120) min) NPU08504 B—Glucose; subst.c.(30 min) = ? NPU10574 Pt—Glucose(administered); am.s.(p.o.) mmol/l = ? mmol NPU08501 B—Glucose; subst.c.(60 min) = ? NPU10575 Pt—Glucose(administered); mmol/l subst.cont.(p.o.; am.s./body mass) = ? mmol/kg NPU08506 B—Glucose; subst.c.(90 min) = ? NPU08503 B—Glucose; subst.c.(0 min) = ? mmol/l mmol/l NPU08507 B—Glucose; subst.c.(120 min) = ? NPU08507 B—Glucose; subst.c.(120 min) = ? mmol/l mmol/l NPU10047 B(cB)—Glucose; subst.c.(0 min) = ? NPU08508 B—Glucose; subst.c.(150 min) = ? mmol/l mmol/l NPU10051 B(cB)—Glucose; subst.c.(120 min) = ? NPU08500 B—Glucose; subst.c.(180 min) = ? mmol/l mmol/l NPU04173 P—Glucose; subst.c.(0 min) = ? mmol/l NPU10047 B(cB)—Glucose; subst.c.(0 min) = ? NPU04177 P—Glucose; subst.c.(120 min) = ? mmol/l mmol/l NPU10048 B(cB)—Glucose; subst.c.(30 min) = ? NPU08768 U—Glucose; subst.c.(0 min) = ? mmol/l mmol/l NPU08770 U—Glucose; subst.c.(120 min) = ? NPU10045 B(cB)—Glucose; subst.c.(60 min) = ? mmol/l mmol/l NPU10050 B(cB)—Glucose; subst.c.(90 min) = ? Patient— mmol/l Glucose tolerance; NPU10051 B(cB)—Glucose; subst.c.(120 min) = ? property(glucose, oral administration; list; (0 30 mmol/l 45 60 90 120 150 180 210 240) minutes after NPU10052 B(cB)—Glucose; subst.c.(150 min) = ? challenge) mmol/l NPU17071 NPU10044 B(cB)—Glucose; subst.c.(180 min) = ? Pt—Glucose tolerance; prop.(glucose p.o.; list; (0 30 mmol/l 45 60 90 120 150 180 210 240) min) NPU04173 P—Glucose; subst.c.(0 min) = ? mmol/l NPU10574 Pt—Glucose(administered); am.s.(p.o.) NPU04174 P—Glucose; subst.c.(30 min) = ? = ? mmol mmol/l NPU10575 Pt—Glucose(administered); NPU04175 P—Glucose; subst.c.(60 min) = ? subst.cont.(p.o.; am.s./body mass) = ? mmol/kg mmol/l NPU10047 B(cB)—Glucose; subst.c.(0 min) = ? NPU04176 P—Glucose; subst.c.(90 min) = ? mmol/l mmol/l NPU10048 B(cB)—Glucose; subst.c.(30 min) = ? NPU04177 P—Glucose; subst.c.(120 min) = ? mmol/l mmol/l NPU10060 B(cB)—Glucose; subst.c.(45 min) = ? NPU04178 P—Glucose; subst.c.(150 min) = ? mmol/l mmol/l NPU10045 B(cB)—Glucose; subst.c.(60 min) = ? NPU04179 P—Glucose; subst.c.(180 min) = ? mmol/l mmol/l

NPU08768 U—Glucose; subst.c.(0 min) = ? mmol/l NPU08770 U—Glucose; subst.c.(120 min) = ? NPU10581 U—Glucose; subst.c.(30 min) = ? mmol/l mmol/l NPU08769 U—Glucose; subst.c.(60 min) = ? Patient— mmol/l Glucose tolerance; NPU10582 U—Glucose; subst.c.(90 min) = ? property(glucose, oral administration; list; (0 30 mmol/l 60 90 120) minutes after challenge) NPU08770 U—Glucose; subst.c.(120 min) = ? NPU14915 mmol/l Pt—Glucose tolerance; prop.(glucose p.o.; list; (0 30 NPU08771 U—Glucose; subst.c.(180 min) = ? 60 90 120) min) mmol/l NPU10574 Pt—Glucose(administered); am.s.(p.o.) = ? mmol Patient— NPU10575 Pt—Glucose(administered); Glucose tolerance; subst.cont.(p.o.; am.s./body mass) = ? mmol/kg property(glucose, oral administration; list; (0 30 NPU10047 B(cB)—Glucose; subst.c.(0 min) = ? 60 90 120 150) minutes after challenge) mmol/l NPU14386 NPU10048 B(cB)—Glucose; subst.c.(30 min) = ? Pt—Glucose tolerance; prop.(glucose p.o.; list; (0 30 mmol/l 60 90 120 150) min) NPU10045 B(cB)—Glucose; subst.c.(60 min) = ? NPU10574 Pt—Glucose(administered); am.s.(p.o.) mmol/l = ? mmol NPU10050 B(cB)—Glucose; subst.c.(90 min) = ? NPU10575 Pt—Glucose(administered); mmol/l subst.cont.(p.o.; am.s./body mass) = ? mmol/kg NPU10051 B(cB)—Glucose; subst.c.(120 min) = ? NPU08503 B—Glucose; subst.c.(0 min) = ? mmol/l mmol/l NPU08504 B—Glucose; subst.c.(30 min) = ? mmol/l Patient— NPU08501 B—Glucose; subst.c.(60 min) = ? Glucose tolerance; mmol/l property(glucose, oral administration; list; (0 60 NPU08506 B—Glucose; subst.c.(90 min) = ? 120 150 180 210 240) minutes after challenge) mmol/l NPU14916 NPU08507 B—Glucose; subst.c.(120 min) = ? Pt—Glucose tolerance; prop.(glucose p.o.; list; (0 60 mmol/l 120 150 180 210 240) min) NPU08508 B—Glucose; subst.c.(150 min) = ? NPU10574 Pt—Glucose(administered); am.s.(p.o.) mmol/l = ? mmol NPU10047 B(cB)—Glucose; subst.c.(0 min) = ? NPU10575 Pt—Glucose(administered); mmol/l subst.cont.(p.o.; am.s./body mass) = ? mmol/kg NPU10048 B(cB)—Glucose; subst.c.(30 min) = ? NPU10047 B(cB)—Glucose; subst.c.(0 min) = ? mmol/l mmol/l NPU10045 B(cB)—Glucose; subst.c.(60 min) = ? NPU10045 B(cB)—Glucose; subst.c.(60 min) = ? mmol/l mmol/l NPU10050 B(cB)—Glucose; subst.c.(90 min) = ? NPU10051 B(cB)—Glucose; subst.c.(120 min) = ? mmol/l mmol/l NPU10051 B(cB)—Glucose; subst.c.(120 min) = ? NPU10052 B(cB)—Glucose; subst.c.(150 min) = ? mmol/l mmol/l NPU10052 B(cB)—Glucose; subst.c.(150 min) = ? NPU10044 B(cB)—Glucose; subst.c.(180 min) = ? mmol/l mmol/l NPU04173 P—Glucose; subst.c.(0 min) = ? mmol/l NPU10053 B(cB)—Glucose; subst.c.(210 min) = ? NPU04174 P—Glucose; subst.c.(30 min) = ? mmol/l mmol/l NPU10054 B(cB)—Glucose; subst.c.(240 min) = ? NPU04175 P—Glucose; subst.c.(60 min) = ? mmol/l mmol/l NPU04176 P—Glucose; subst.c.(90 min) = ? Patient— mmol/l Glucose tolerance; NPU04177 P—Glucose; subst.c.(120 min) = ? property(glucose, oral administration; list; (0 60 mmol/l 120 180 240) minutes after challenge) NPU04178 P—Glucose; subst.c.(150 min) = ? NPU14388 mmol/l Pt—Glucose tolerance; prop.(glucose p.o.; list; (0 60 NPU08768 U—Glucose; subst.c.(0 min) = ? mmol/l 120 180 240) min) NPU10581 U—Glucose; subst.c.(30 min) = ? NPU10574 Pt—Glucose(administered); am.s.(p.o.) mmol/l = ? mmol NPU08769 U—Glucose; subst.c.(60 min) = ? NPU10575 Pt—Glucose(administered); mmol/l subst.cont.(p.o.; am.s./body mass) = ? mmol/kg NPU10582 U—Glucose; subst.c.(90 min) = ? NPU08503 B—Glucose; subst.c.(0 min) = ? mmol/l mmol/l NPU08501 B—Glucose; subst.c.(60 min) = ? mmol/l

NPU08507 B—Glucose; subst.c.(120 min) = ? NPU08768 U—Glucose; subst.c.(0 min) = ? mmol/l mmol/l NPU08769 U—Glucose; subst.c.(60 min) = ? NPU08500 B—Glucose; subst.c.(180 min) = ? mmol/l mmol/l NPU08770 U—Glucose; subst.c.(120 min) = ? NPU08511 B—Glucose; subst.c.(240 min) = ? mmol/l mmol/l NPU10047 B(cB)—Glucose; subst.c.(0 min) = ? Patient— mmol/l Glucose tolerance; NPU10045 B(cB)—Glucose; subst.c.(60 min) = ? property(glucose, oral administration; list; (0 60) mmol/l minutes after challenge) NPU10051 B(cB)—Glucose; subst.c.(120 min) = ? NPU14384 mmol/l Pt—Glucose tolerance; prop.(glucose p.o.; list; (0 NPU10044 B(cB)—Glucose; subst.c.(180 min) = ? 60) min) mmol/l NPU10574 Pt—Glucose(administered); am.s.(p.o.) NPU10054 B(cB)—Glucose; subst.c.(240 min) = ? = ? mmol mmol/l NPU10575 Pt—Glucose(administered); NPU04173 P—Glucose; subst.c.(0 min) = ? mmol/l subst.cont.(p.o.; am.s./body mass) = ? mmol/kg NPU04175 P—Glucose; subst.c.(60 min) = ? NPU08503 B—Glucose; subst.c.(0 min) = ? mmol/l mmol/l NPU08501 B—Glucose; subst.c.(60 min) = ? NPU04177 P—Glucose; subst.c.(120 min) = ? mmol/l mmol/l NPU10047 B(cB)—Glucose; subst.c.(0 min) = ? NPU04179 P—Glucose; subst.c.(180 min) = ? mmol/l mmol/l NPU10045 B(cB)—Glucose; subst.c.(60 min) = ? NPU04181 P—Glucose; subst.c.(240 min) = ? mmol/l mmol/l NPU04173 P—Glucose; subst.c.(0 min) = ? mmol/l NPU08768 U—Glucose; subst.c.(0 min) = ? mmol/l NPU04175 P—Glucose; subst.c.(60 min) = ? NPU08769 U—Glucose; subst.c.(60 min) = ? mmol/l mmol/l NPU08768 U—Glucose; subst.c.(0 min) = ? mmol/l NPU08770 U—Glucose; subst.c.(120 min) = ? NPU08769 U—Glucose; subst.c.(60 min) = ? mmol/l mmol/l NPU08771 U—Glucose; subst.c.(180 min) = ? mmol/l Patient— NPU10583 U—Glucose; subst.c.(240 min) = ? Glucose tolerance; mmol/l property(glucose, oral administration; list; procedure) Patient— Note: M (glucose) = 180,16 g/mol Glucose tolerance; NPU02196 property(glucose, oral administration; list; (0 60 Pt—Glucose tolerance; prop.(glucose p.o.; list; 120) minutes after challenge) proc.) NPU14385 NPU10574 Pt—Glucose(administered); am.s.(p.o.) Pt—Glucose tolerance; prop.(glucose p.o.; list; (0 60 = ? mmol 120) min) NPU10575 Pt—Glucose(administered); NPU10574 Pt—Glucose(administered); am.s.(p.o.) subst.cont.(p.o.; am.s./body mass) = ? mmol/kg = ? mmol NPU08503 B—Glucose; subst.c.(0 min) = ? mmol/l NPU10575 Pt—Glucose(administered); NPU08516 B—Glucose; subst.c.(15 min) = ? subst.cont.(p.o.; am.s./body mass) = ? mmol/kg mmol/l NPU08503 B—Glucose; subst.c.(0 min) = ? mmol/l NPU08504 B—Glucose; subst.c.(30 min) = ? NPU08501 B—Glucose; subst.c.(60 min) = ? mmol/l mmol/l NPU08517 B—Glucose; subst.c.(45 min) = ? NPU08507 B—Glucose; subst.c.(120 min) = ? mmol/l mmol/l NPU08501 B—Glucose; subst.c.(60 min) = ? NPU10047 B(cB)—Glucose; subst.c.(0 min) = ? mmol/l mmol/l NPU08518 B—Glucose; subst.c.(75 min) = ? NPU10045 B(cB)—Glucose; subst.c.(60 min) = ? mmol/l mmol/l NPU08506 B—Glucose; subst.c.(90 min) = ? NPU10051 B(cB)—Glucose; subst.c.(120 min) = ? mmol/l mmol/l NPU08507 B—Glucose; subst.c.(120 min) = ? NPU04173 P—Glucose; subst.c.(0 min) = ? mmol/l mmol/l NPU04175 P—Glucose; subst.c.(60 min) = ? NPU08508 B—Glucose; subst.c.(150 min) = ? mmol/l mmol/l NPU04177 P—Glucose; subst.c.(120 min) = ? NPU08500 B—Glucose; subst.c.(180 min) = ? mmol/l mmol/l

NPU08510 B—Glucose; subst.c.(210 min) = ? NPU04178 P—Glucose; subst.c.(150 min) = ? mmol/l mmol/l NPU08511 B—Glucose; subst.c.(240 min) = ? NPU04179 P—Glucose; subst.c.(180 min) = ? mmol/l mmol/l NPU08512 B—Glucose; subst.c.(270 min) = ? NPU04180 P—Glucose; subst.c.(210 min) = ? mmol/l mmol/l NPU08513 B—Glucose; subst.c.(300 min) = ? NPU04181 P—Glucose; subst.c.(240 min) = ? mmol/l mmol/l NPU08514 B—Glucose; subst.c.(330 min) = ? NPU04182 P—Glucose; subst.c.(270 min) = ? mmol/l mmol/l NPU08515 B—Glucose; subst.c.(360 min) = ? NPU04183 P—Glucose; subst.c.(300 min) = ? mmol/l mmol/l NPU08735 B—Glucose; subst.c.(max.; proc.) = ? NPU04184 P—Glucose; subst.c.(330 min) = ? mmol/l mmol/l NPU10047 B(cB)—Glucose; subst.c.(0 min) = ? NPU04185 P—Glucose; subst.c.(360 min) = ? mmol/l mmol/l NPU10059 B(cB)—Glucose; subst.c.(15 min) = ? NPU08734 P—Glucose; subst.c.(max.; proc.) = ? mmol/l mmol/l NPU10048 B(cB)—Glucose; subst.c.(30 min) = ? NPU08768 U—Glucose; subst.c.(0 min) = ? mmol/l mmol/l NPU10581 U—Glucose; subst.c.(30 min) = ? NPU10060 B(cB)—Glucose; subst.c.(45 min) = ? mmol/l mmol/l NPU08769 U—Glucose; subst.c.(60 min) = ? NPU10045 B(cB)—Glucose; subst.c.(60 min) = ? mmol/l mmol/l NPU10582 U—Glucose; subst.c.(90 min) = ? NPU10061 B(cB)—Glucose; subst.c.(75 min) = ? mmol/l mmol/l NPU08770 U—Glucose; subst.c.(120 min) = ? NPU10050 B(cB)—Glucose; subst.c.(90 min) = ? mmol/l mmol/l NPU08771 U—Glucose; subst.c.(180 min) = ? NPU10051 B(cB)—Glucose; subst.c.(120 min) = ? mmol/l mmol/l NPU10583 U—Glucose; subst.c.(240 min) = ? NPU10052 B(cB)—Glucose; subst.c.(150 min) = ? mmol/l mmol/l NPU10571 U—Glucose; subst.c.(300 min) = ? NPU10044 B(cB)—Glucose; subst.c.(180 min) = ? mmol/l mmol/l NPU10584 U—Glucose; subst.c.(360 min) = ? NPU10053 B(cB)—Glucose; subst.c.(210 min) = ? mmol/l mmol/l NPU10054 B(cB)—Glucose; subst.c.(240 min) = ? Patient— mmol/l Glucose(administered); NPU10055 B(cB)—Glucose; subst.c.(270 min) = ? amount-of-substance(intravenous mmol/l administration) NPU10056 B(cB)—Glucose; subst.c.(300 min) = ? millimole mmol/l M = 180,16 g/mol NPU10057 B(cB)—Glucose; subst.c.(330 min) = ? NPU10406 mmol/l Pt—Glucose(administered); am.s.(i.v.) = ? mmol NPU10058 B(cB)—Glucose; subst.c.(360 min) = ? mmol/l Patient— NPU10111 B(cB)—Glucose; subst.c.(max.; proc.) = Glucose(administered); ? mmol/l amount-of-substance(oral administration) NPU04173 P—Glucose; subst.c.(0 min) = ? mmol/l millimole NPU04186 P—Glucose; subst.c.(15 min) = ? M = 180,16 g/mol mmol/l NPU10574 NPU04174 P—Glucose; subst.c.(30 min) = ? Pt—Glucose(administered); am.s.(p.o.) = ? mmol mmol/l NPU04187 P—Glucose; subst.c.(45 min) = ? Patient— mmol/l Glucose(administered); NPU04175 P—Glucose; subst.c.(60 min) = ? substance content(intravenous administration; mmol/l amount-of-substance/body mass) NPU04965 P—Glucose; subst.c.(75 min) = ? millimole/kilogram mmol/l M = 180,16 g/mol NPU04176 P—Glucose; subst.c.(90 min) = ? NPU10407 mmol/l Pt—Glucose(administered); subst.cont.(i.v.; am.s./ NPU04177 P—Glucose; subst.c.(120 min) = ? body mass) = ? mmol/kg mmol/l

Patient— Plasma— Glucose(administered); Glucose; substance content(oral administration; amount- substance concentration(5 minutes before of-substance/body mass) challenge) millimole/kilogram millimole/liter M = 180,16 g/mol NPU08665 NPU10575 P—Glucose; subst.c.(-5 min) = ? mmol/l Pt—Glucose(administered); subst.cont.(p.o.; am.s./ body mass) = ? mmol/kg Blood— Glucose; Ascites— substance concentration(0 minutes after Glucose; challenge) amount-of-substance(procedure) millimole/liter millimole NPU08503 M = 180,16 g/mol B—Glucose; subst.c.(0 min) = ? mmol/l NPU08624 Asc—Glucose; am.s.(proc.) = ? mmol Blood(capillary Blood)— Glucose; Urine— substance concentration(0 minutes after Glucose; challenge) amount-of-substance millimole/liter millimole NPU10047 NPU17566 B(cB)—Glucose; subst.c.(0 min) = ? mmol/l U—Glucose; am.s. = ? mmol Plasma— Urine— Glucose; Glucose; substance concentration(0 minutes after arbitrary concentration(procedure) challenge) M = 180,16 g/mol millimole/liter NPU04207 NPU04173 U—Glucose; arb.c.(proc.) = ? P—Glucose; subst.c.(0 min) = ? mmol/l

Urine— Urine— Glucose; Glucose; relative amount-of-substance(urine 300 minutes/ substance concentration(0 minutes after intake; procedure) challenge) NPU10491 millimole/liter U—Glucose; rel.ams.(U 300 min/intake; proc.) = ? NPU08768 U—Glucose; subst.c.(0 min) = ? mmol/l Cerebrospinal fluid— Glucose; Plasma— relative substance concentration(Cerebrospinal Glucose; fluid/Plasma) substance concentration(1 minute after M = 180,16 g/mol challenge) NPU01523 millimole/liter Csf—Glucose; rel.subst.c.(Csf/P) = ? NPU08657 P—Glucose; subst.c.(1 min) = ? mmol/l Synovial fluid(specification)— Glucose; Plasma— relative substance concentration(Synovial fluid/ Glucose; Plasma) substance concentration(3 minutes after M = 180,16 g/mol challenge) NPU04232 millimole/liter Synf(spec.)—Glucose; rel.subst.c.(Synf/P) = ? NPU08658 P—Glucose; subst.c.(3 min) = ? mmol/l Plasma— Glucose; Blood— substance concentration(10 minutes before Glucose; challenge) substance concentration(5 minutes after millimole/liter challenge) NPU08666 millimole/liter P—Glucose; subst.c.(-10 min) = ? mmol/l NPU14352 B—Glucose; subst.c.(5 min) = ? mmol/l

Blood(capillary Blood)— Plasma— Glucose; Glucose; substance concentration(5 minutes after substance concentration(20 minutes after challenge) challenge) millimole/liter millimole/liter NPU14353 NPU08661 B(cB)—Glucose; subst.c.(5 min) = ? mmol/l P—Glucose; subst.c.(20 min) = ? mmol/l

Plasma— Blood— Glucose; Glucose; substance concentration(5 minutes after substance concentration(30 minutes after challenge) challenge) millimole/liter millimole/liter NPU08659 NPU08504 P—Glucose; subst.c.(5 min) = ? mmol/l B—Glucose; subst.c.(30 min) = ? mmol/l

Blood— Blood(capillary Blood)— Glucose; Glucose; substance concentration(6 minutes after substance concentration(30 minutes after challenge) challenge) millimole/liter millimole/liter NPU10655 NPU10048 B—Glucose; subst.c.(6 min) = ? mmol/l B(cB)—Glucose; subst.c.(30 min) = ? mmol/l

Blood— Plasma— Glucose; Glucose; substance concentration(10 minutes after substance concentration(30 minutes after challenge) challenge) millimole/liter millimole/liter NPU10117 NPU04174 B—Glucose; subst.c.(10 min) = ? mmol/l P—Glucose; subst.c.(30 min) = ? mmol/l

Plasma— Urine— Glucose; Glucose; substance concentration(10 minutes after substance concentration(30 minutes after challenge) challenge) millimole/liter millimole/liter NPU08660 NPU10581 P—Glucose; subst.c.(10 min) = ? mmol/l U—Glucose; subst.c.(30 min) = ? mmol/l

Blood— Plasma— Glucose; Glucose; substance concentration(15 minutes after substance concentration(40 minutes after challenge) challenge) millimole/liter millimole/liter NPU08516 NPU08662 B—Glucose; subst.c.(15 min) = ? mmol/l P—Glucose; subst.c.(40 min) = ? mmol/l

Blood(capillary Blood)— Blood— Glucose; Glucose; substance concentration(15 minutes after substance concentration(45 minutes after challenge) challenge) millimole/liter millimole/liter NPU10059 NPU08517 B(cB)—Glucose; subst.c.(15 min) = ? mmol/l B—Glucose; subst.c.(45 min) = ? mmol/l

Plasma— Blood(capillary Blood)— Glucose; Glucose; substance concentration(15 minutes after substance concentration(45 minutes after challenge) challenge) millimole/liter millimole/liter NPU04186 NPU10060 P—Glucose; subst.c.(15 min) = ? mmol/l B(cB)—Glucose; subst.c.(45 min) = ? mmol/l

Plasma— Plasma— Glucose; Glucose; substance concentration(45 minutes after substance concentration(75 minutes after challenge) challenge) millimole/liter millimole/liter NPU04187 NPU04965 P—Glucose; subst.c.(45 min) = ? mmol/l P—Glucose; subst.c.(75 min) = ? mmol/l

Plasma— Blood— Glucose; Glucose; substance concentration(50 minutes after substance concentration(90 minutes after challenge) challenge) millimole/liter millimole/liter NPU08663 NPU08506 P—Glucose; subst.c.(50 min) = ? mmol/l B—Glucose; subst.c.(90 min) = ? mmol/l

Blood— Blood(capillary Blood)— Glucose; Glucose; substance concentration(60 minutes after substance concentration(90 minutes after challenge) challenge) millimole/liter millimole/liter NPU08501 NPU10050 B—Glucose; subst.c.(60 min) = ? mmol/l B(cB)—Glucose; subst.c.(90 min) = ? mmol/l

Blood(capillary Blood)— Plasma— Glucose; Glucose; substance concentration(60 minutes after substance concentration(90 minutes after challenge) challenge) millimole/liter millimole/liter NPU10045 NPU04176 B(cB)—Glucose; subst.c.(60 min) = ? mmol/l P—Glucose; subst.c.(90 min) = ? mmol/l

Plasma— Urine— Glucose; Glucose; substance concentration(60 minutes after substance concentration(90 minutes after challenge) challenge) millimole/liter millimole/liter NPU04175 NPU10582 P—Glucose; subst.c.(60 min) = ? mmol/l U—Glucose; subst.c.(90 min) = ? mmol/l

Urine— Blood— Glucose; Glucose; substance concentration(60 minutes after substance concentration(105 minutes after challenge) challenge) millimole/liter millimole/liter NPU08769 NPU10764 U—Glucose; subst.c.(60 min) = ? mmol/l B—Glucose; subst.c.(105 min) = ? mmol/l

Blood— Plasma— Glucose; Glucose; substance concentration(75 minutes after substance concentration(105 minutes after challenge) challenge) millimole/liter millimole/liter NPU08518 NPU08664 B—Glucose; subst.c.(75 min) = ? mmol/l P—Glucose; subst.c.(105 min) = ? mmol/l

Blood(capillary Blood)— Blood— Glucose; Glucose; substance concentration(75 minutes after substance concentration(110 minutes after challenge) challenge) millimole/liter millimole/liter NPU10061 NPU10696 B(cB)—Glucose; subst.c.(75 min) = ? mmol/l B—Glucose; subst.c.(110 min) = ? mmol/l

Plasma— Blood(capillary Blood)— Glucose; Glucose; substance concentration(110 minutes after substance concentration(150 minutes after challenge) challenge) millimole/liter millimole/liter NPU10652 NPU10052 P—Glucose; subst.c.(110 min) = ? mmol/l B(cB)—Glucose; subst.c.(150 min) = ? mmol/l

Blood— Plasma— Glucose; Glucose; substance concentration(120 minutes after substance concentration(150 minutes after challenge) challenge) millimole/liter millimole/liter NPU08507 NPU04178 B—Glucose; subst.c.(120 min) = ? mmol/l P—Glucose; subst.c.(150 min) = ? mmol/l

Blood(capillary Blood)— Urine— Glucose; Glucose; substance concentration(120 minutes after substance concentration(150 minutes after challenge) challenge) millimole/liter millimole/liter NPU10051 NPU14165 B(cB)—Glucose; subst.c.(120 min) = ? mmol/l U—Glucose; subst.c.(150 min) = ? mmol/l

Plasma— Blood— Glucose; Glucose; substance concentration(120 minutes after substance concentration(180 minutes after challenge) challenge) millimole/liter millimole/liter NPU04177 NPU08500 P—Glucose; subst.c.(120 min) = ? mmol/l B—Glucose; subst.c.(180 min) = ? mmol/l

Urine— Blood(capillary Blood)— Glucose; Glucose; substance concentration(120 minutes after substance concentration(180 minutes after challenge) challenge) millimole/liter millimole/liter NPU08770 NPU10044 U—Glucose; subst.c.(120 min) = ? mmol/l B(cB)—Glucose; subst.c.(180 min) = ? mmol/l

Blood— Plasma— Glucose; Glucose; substance concentration(135 minutes after substance concentration(180 minutes after challenge) challenge) millimole/liter millimole/liter NPU10697 NPU04179 B—Glucose; subst.c.(135 min) = ? mmol/l P—Glucose; subst.c.(180 min) = ? mmol/l

Plasma— Urine— Glucose; Glucose; substance concentration(135 minutes after substance concentration(180 minutes after challenge) challenge) millimole/liter millimole/liter NPU10653 NPU08771 P—Glucose; subst.c.(135 min) = ? mmol/l U—Glucose; subst.c.(180 min) = ? mmol/l

Blood— Blood— Glucose; Glucose; substance concentration(150 minutes after substance concentration(210 minutes after challenge) challenge) millimole/liter millimole/liter NPU08508 NPU08510 B—Glucose; subst.c.(150 min) = ? mmol/l B—Glucose; subst.c.(210 min) = ? mmol/l

Blood(capillary Blood)— Blood(capillary Blood)— Glucose; Glucose; substance concentration(210 minutes after substance concentration(270 minutes after challenge) challenge) millimole/liter millimole/liter NPU10053 NPU10055 B(cB)—Glucose; subst.c.(210 min) = ? mmol/l B(cB)—Glucose; subst.c.(270 min) = ? mmol/l

Plasma— Plasma— Glucose; Glucose; substance concentration(210 minutes after substance concentration(270 minutes after challenge) challenge) millimole/liter millimole/liter NPU04180 NPU04182 P—Glucose; subst.c.(210 min) = ? mmol/l P—Glucose; subst.c.(270 min) = ? mmol/l

Urine— Urine— Glucose; Glucose; substance concentration(210 minutes after substance concentration(270 minutes after challenge) challenge) millimole/liter millimole/liter NPU14166 NPU14167 U—Glucose; subst.c.(210 min) = ? mmol/l U—Glucose; subst.c.(270 min) = ? mmol/l

Blood— Blood— Glucose; Glucose; substance concentration(240 minutes after substance concentration(300 minutes after challenge) challenge) millimole/liter millimole/liter NPU08511 NPU08513 B—Glucose; subst.c.(240 min) = ? mmol/l B—Glucose; subst.c.(300 min) = ? mmol/l

Blood(capillary Blood)— Blood(capillary Blood)— Glucose; Glucose; substance concentration(240 minutes after substance concentration(300 minutes after challenge) challenge) millimole/liter millimole/liter NPU10054 NPU10056 B(cB)—Glucose; subst.c.(240 min) = ? mmol/l B(cB)—Glucose; subst.c.(300 min) = ? mmol/l

Plasma— Plasma— Glucose; Glucose; substance concentration(240 minutes after substance concentration(300 minutes after challenge) challenge) millimole/liter millimole/liter NPU04181 NPU04183 P—Glucose; subst.c.(240 min) = ? mmol/l P—Glucose; subst.c.(300 min) = ? mmol/l

Urine— Urine— Glucose; Glucose; substance concentration(240 minutes after substance concentration(300 minutes after challenge) challenge) millimole/liter millimole/liter NPU10583 NPU10571 U—Glucose; subst.c.(240 min) = ? mmol/l U—Glucose; subst.c.(300 min) = ? mmol/l

Blood— Blood— Glucose; Glucose; substance concentration(270 minutes after substance concentration(330 minutes after challenge) challenge) millimole/liter millimole/liter NPU08512 NPU08514 B—Glucose; subst.c.(270 min) = ? mmol/l B—Glucose; subst.c.(330 min) = ? mmol/l

Blood(capillary Blood)— Blood— Glucose; Glucose; substance concentration(330 minutes after substance concentration(480 minutes after challenge) challenge) millimole/liter millimole/liter NPU10057 NPU10119 B(cB)—Glucose; subst.c.(330 min) = ? mmol/l B—Glucose; subst.c.(480 min) = ? mmol/l

Plasma— Blood— Glucose; Glucose; substance concentration(330 minutes after substance concentration(540 minutes after challenge) challenge) millimole/liter millimole/liter NPU04184 NPU10120 P—Glucose; subst.c.(330 min) = ? mmol/l B—Glucose; subst.c.(540 min) = ? mmol/l

Urine— Blood— Glucose; Glucose; substance concentration(330 minutes after substance concentration(600 minutes after challenge) challenge) millimole/liter millimole/liter NPU14168 NPU10121 U—Glucose; subst.c.(330 min) = ? mmol/l B—Glucose; subst.c.(600 min) = ? mmol/l

Blood— Blood— Glucose; Glucose; substance concentration(360 minutes after substance concentration(list; time; procedure) challenge) M = 180,16 g/mol millimole/liter NPU08572 NPU08515 B—Glucose; subst.c.(list; time; proc.) B—Glucose; subst.c.(360 min) = ? mmol/l NPU08520 B—Glucose; subst.c.(T00) = ? mmol/l NPU08869 B—Glucose; subst.c.(T00:30) = ? Blood(capillary Blood)— mmol/l Glucose; NPU08521 B—Glucose; subst.c.(T01) = ? mmol/l substance concentration(360 minutes after NPU08870 B—Glucose; subst.c.(T01:30) = ? challenge) mmol/l millimole/liter NPU08522 B—Glucose; subst.c.(T02) = ? mmol/l NPU10058 NPU08871 B—Glucose; subst.c.(T02:30) = ? B(cB)—Glucose; subst.c.(360 min) = ? mmol/l mmol/l NPU08523 B—Glucose; subst.c.(T03) = ? mmol/l Plasma— NPU08872 B—Glucose; subst.c.(T03:30) = ? Glucose; mmol/l substance concentration(360 minutes after NPU08524 B—Glucose; subst.c.(T04) = ? mmol/l challenge) NPU08873 B—Glucose; subst.c.(T04:30) = ? millimole/liter mmol/l NPU04185 NPU08525 B—Glucose; subst.c.(T05) = ? mmol/l P—Glucose; subst.c.(360 min) = ? mmol/l NPU08874 B—Glucose; subst.c.(T05:30) = ? mmol/l Urine— NPU08526 B—Glucose; subst.c.(T06) = ? mmol/l Glucose; NPU08875 B—Glucose; subst.c.(T06:30) = ? substance concentration(360 minutes after mmol/l challenge) NPU08527 B—Glucose; subst.c.(T07) = ? mmol/l millimole/liter NPU08876 B—Glucose; subst.c.(T07:30) = ? NPU10584 mmol/l U—Glucose; subst.c.(360 min) = ? mmol/l NPU08528 B—Glucose; subst.c.(T08) = ? mmol/l NPU08877 B—Glucose; subst.c.(T08:30) = ? Blood— mmol/l Glucose; NPU08529 B—Glucose; subst.c.(T09) = ? mmol/l substance concentration(420 minutes after NPU08878 B—Glucose; subst.c.(T09:30) = ? challenge) mmol/l millimole/liter NPU08530 B—Glucose; subst.c.(T10) = ? mmol/l NPU10118 NPU08879 B—Glucose; subst.c.(T10:30) = ? B—Glucose; subst.c.(420 min) = ? mmol/l mmol/l

NPU08531 B—Glucose; subst.c.(T11) = ? mmol/l NPU08550 P—Glucose; subst.c.(T06) = ? mmol/l NPU08880 B—Glucose; subst.c.(T11:30) = ? NPU08899 P—Glucose; subst.c.(T06:30) = ? mmol/l mmol/l NPU08532 B—Glucose; subst.c.(T12) = ? mmol/l NPU08551 P—Glucose; subst.c.(T07) = ? mmol/l NPU08881 B—Glucose; subst.c.(T12:30) = ? NPU08900 P—Glucose; subst.c.(T07:30) = ? mmol/l mmol/l NPU08533 B—Glucose; subst.c.(T13) = ? mmol/l NPU08552 P—Glucose; subst.c.(T08) = ? mmol/l NPU08882 B—Glucose; subst.c.(T13:30) = ? NPU08901 P—Glucose; subst.c.(T08:30) = ? mmol/l mmol/l NPU08534 B—Glucose; subst.c.(T14) = ? mmol/l NPU08553 P—Glucose; subst.c.(T09) = ? mmol/l NPU08883 B—Glucose; subst.c.(T14:30) = ? NPU08902 P—Glucose; subst.c.(T09:30) = ? mmol/l mmol/l NPU08535 B—Glucose; subst.c.(T15) = ? mmol/l NPU08554 P—Glucose; subst.c.(T10) = ? mmol/l NPU08884 B—Glucose; subst.c.(T15:30) = ? NPU08903 P—Glucose; subst.c.(T10:30) = ? mmol/l mmol/l NPU08536 B—Glucose; subst.c.(T16) = ? mmol/l NPU08555 P—Glucose; subst.c.(T11) = ? mmol/l NPU08885 B—Glucose; subst.c.(T16:30) = ? NPU08904 P—Glucose; subst.c.(T11:30) = ? mmol/l mmol/l NPU08537 B—Glucose; subst.c.(T17) = ? mmol/l NPU08556 P—Glucose; subst.c.(T12) = ? mmol/l NPU08886 B—Glucose; subst.c.(T17:30) = ? NPU08905 P—Glucose; subst.c.(T12:30) = ? mmol/l mmol/l NPU08538 B—Glucose; subst.c.(T18) = ? mmol/l NPU08557 P—Glucose; subst.c.(T13) = ? mmol/l NPU08887 B—Glucose; subst.c.(T18:30) = ? NPU08906 P—Glucose; subst.c.(T13:30) = ? mmol/l mmol/l NPU08539 B—Glucose; subst.c.(T19) = ? mmol/l NPU08558 P—Glucose; subst.c.(T14) = ? mmol/l NPU08888 B—Glucose; subst.c.(T19:30) = ? NPU08907 P—Glucose; subst.c.(T14:30) = ? mmol/l mmol/l NPU08540 B—Glucose; subst.c.(T20) = ? mmol/l NPU08559 P—Glucose; subst.c.(T15) = ? mmol/l NPU08889 B—Glucose; subst.c.(T20:30) = ? NPU08908 P—Glucose; subst.c.(T15:30) = ? mmol/l mmol/l NPU08541 B—Glucose; subst.c.(T21) = ? mmol/l NPU08560 P—Glucose; subst.c.(T16) = ? mmol/l NPU08890 B—Glucose; subst.c.(T21:30) = ? NPU08909 P—Glucose; subst.c.(T16:30) = ? mmol/l mmol/l NPU08542 B—Glucose; subst.c.(T22) = ? mmol/l NPU08561 P—Glucose; subst.c.(T17) = ? mmol/l NPU08891 B—Glucose; subst.c.(T22:30) = ? NPU08910 P—Glucose; subst.c.(T17:30) = ? mmol/l mmol/l NPU08543 B—Glucose; subst.c.(T23) = ? mmol/l NPU08562 P—Glucose; subst.c.(T18) = ? mmol/l NPU08892 B—Glucose; subst.c.(T23:30) = ? NPU08911 P—Glucose; subst.c.(T18:30) = ? mmol/l mmol/l NPU08563 P—Glucose; subst.c.(T19) = ? mmol/l Plasma— NPU08912 P—Glucose; subst.c.(T19:30) = ? Glucose; mmol/l substance concentration(list; time; procedure) NPU08564 P—Glucose; subst.c.(T20) = ? mmol/l M = 180,16 g/mol NPU08913 P—Glucose; subst.c.(T20:30) = ? NPU08571 mmol/l P—Glucose; subst.c.(list; time; proc.) NPU08565 P—Glucose; subst.c.(T21) = ? mmol/l NPU08544 P—Glucose; subst.c.(T00) = ? mmol/l NPU08914 P—Glucose; subst.c.(T21:30) = ? NPU08893 P—Glucose; subst.c.(T00:30) = ? mmol/l mmol/l NPU08566 P—Glucose; subst.c.(T22) = ? mmol/l NPU08545 P—Glucose; subst.c.(T01) = ? mmol/l NPU08915 P—Glucose; subst.c.(T22:30) = ? NPU08894 P—Glucose; subst.c.(T01:30) = ? mmol/l mmol/l NPU08567 P—Glucose; subst.c.(T23) = ? mmol/l NPU08546 P—Glucose; subst.c.(T02) = ? mmol/l NPU08916 P—Glucose; subst.c.(T23:30) = ? NPU08895 P—Glucose; subst.c.(T02:30) = ? mmol/l mmol/l NPU08547 P—Glucose; subst.c.(T03) = ? mmol/l Blood— NPU08896 P—Glucose; subst.c.(T03:30) = ? Glucose; mmol/l substance concentration(maximum; procedure) NPU08548 P—Glucose; subst.c.(T04) = ? mmol/l millimole/liter NPU08897 P—Glucose; subst.c.(T04:30) = ? NPU08735 mmol/l B—Glucose; subst.c.(max.; proc.) = ? mmol/l NPU08549 P—Glucose; subst.c.(T05) = ? mmol/l NPU08898 P—Glucose; subst.c.(T05:30) = ? mmol/l

Blood(capillary Blood)— Plasma— Glucose; Glucose; substance concentration(maximum; procedure) substance concentration(T00) millimole/liter millimole/liter NPU10111 NPU08544 B(cB)—Glucose; subst.c.(max.; proc.) = ? mmol/l P—Glucose; subst.c.(T00) = ? mmol/l

Plasma— Blood— Glucose; Glucose; substance concentration(maximum; procedure) substance concentration(T00:30) millimole/liter millimole/liter NPU08734 NPU08869 P—Glucose; subst.c.(max.; proc.) = ? mmol/l B—Glucose; subst.c.(T00:30) = ? mmol/l

Blood— Blood(capillary Blood)— Glucose; Glucose; substance concentration(minimum; procedure) substance concentration(T00:30) millimole/liter millimole/liter NPU08519 NPU10087 B—Glucose; subst.c.(min.; proc.) = ? mmol/l B(cB)—Glucose; subst.c.(T00:30) = ? mmol/l

Blood(capillary Blood)— Plasma— Glucose; Glucose; substance concentration(minimum; procedure) substance concentration(T00:30) millimole/liter millimole/liter NPU10062 NPU08893 B(cB)—Glucose; subst.c.(min.; proc.) = ? mmol/l P—Glucose; subst.c.(T00:30) = ? mmol/l

Plasma— Blood— Glucose; Glucose; substance concentration(minimum; procedure) substance concentration(T01) millimole/liter millimole/liter NPU04981 NPU08521 P—Glucose; subst.c.(min.; proc.) = ? mmol/l B—Glucose; subst.c.(T01) = ? mmol/l

Blood(capillary Blood)— Blood(capillary Blood)— Glucose; Glucose; substance concentration(procedure) substance concentration(T01) millimole/liter millimole/liter M = 180,16 g/mol NPU10064 NPU10114 B(cB)—Glucose; subst.c.(T01) = ? mmol/l B(cB)—Glucose; subst.c.(proc.) = ? mmol/l Plasma— Urine— Glucose; Glucose; substance concentration(T01) substance concentration(procedure) millimole/liter millimole/liter NPU08545 M = 180,16 g/mol P—Glucose; subst.c.(T01) = ? mmol/l NPU02194 U—Glucose; subst.c.(proc.) = ? mmol/l Blood— Glucose; Blood— substance concentration(T01:30) Glucose; millimole/liter substance concentration(T00) NPU08870 millimole/liter B—Glucose; subst.c.(T01:30) = ? mmol/l NPU08520 B—Glucose; subst.c.(T00) = ? mmol/l Blood(capillary Blood)— Glucose; Blood(capillary Blood)— substance concentration(T01:30) Glucose; millimole/liter substance concentration(T00) NPU10088 millimole/liter B(cB)—Glucose; subst.c.(T01:30) = ? mmol/l NPU10063 B(cB)—Glucose; subst.c.(T00) = ? mmol/l

Plasma— Plasma— Glucose; Glucose; substance concentration(T01:30) substance concentration(T03) millimole/liter millimole/liter NPU08894 NPU08547 P—Glucose; subst.c.(T01:30) = ? mmol/l P—Glucose; subst.c.(T03) = ? mmol/l

Blood— Blood— Glucose; Glucose; substance concentration(T02) substance concentration(T03:30) millimole/liter millimole/liter NPU08522 NPU08872 B—Glucose; subst.c.(T02) = ? mmol/l B—Glucose; subst.c.(T03:30) = ? mmol/l

Blood(capillary Blood)— Blood(capillary Blood)— Glucose; Glucose; substance concentration(T02) substance concentration(T03:30) millimole/liter millimole/liter NPU10065 NPU10090 B(cB)—Glucose; subst.c.(T02) = ? mmol/l B(cB)—Glucose; subst.c.(T03:30) = ? mmol/l

Plasma— Plasma— Glucose; Glucose; substance concentration(T02) substance concentration(T03:30) millimole/liter millimole/liter NPU08546 NPU08896 P—Glucose; subst.c.(T02) = ? mmol/l P—Glucose; subst.c.(T03:30) = ? mmol/l

Blood— Blood— Glucose; Glucose; substance concentration(T02:30) substance concentration(T04) millimole/liter millimole/liter NPU08871 NPU08524 B—Glucose; subst.c.(T02:30) = ? mmol/l B—Glucose; subst.c.(T04) = ? mmol/l

Blood(capillary Blood)— Blood(capillary Blood)— Glucose; Glucose; substance concentration(T02:30) substance concentration(T04) millimole/liter millimole/liter NPU10089 NPU10067 B(cB)—Glucose; subst.c.(T02:30) = ? mmol/l B(cB)—Glucose; subst.c.(T04) = ? mmol/l

Plasma— Plasma— Glucose; Glucose; substance concentration(T02:30) substance concentration(T04) millimole/liter millimole/liter NPU08895 NPU08548 P—Glucose; subst.c.(T02:30) = ? mmol/l P—Glucose; subst.c.(T04) = ? mmol/l

Blood— Blood— Glucose; Glucose; substance concentration(T03) substance concentration(T04:30) millimole/liter millimole/liter NPU08523 NPU08873 B—Glucose; subst.c.(T03) = ? mmol/l B—Glucose; subst.c.(T04:30) = ? mmol/l

Blood(capillary Blood)— Blood(capillary Blood)— Glucose; Glucose; substance concentration(T03) substance concentration(T04:30) millimole/liter millimole/liter NPU10066 NPU10091 B(cB)—Glucose; subst.c.(T03) = ? mmol/l B(cB)—Glucose; subst.c.(T04:30) = ? mmol/l

Plasma— Plasma— Glucose; Glucose; substance concentration(T04:30) substance concentration(T06) millimole/liter millimole/liter NPU08897 NPU08550 P—Glucose; subst.c.(T04:30) = ? mmol/l P—Glucose; subst.c.(T06) = ? mmol/l

Blood— Blood— Glucose; Glucose; substance concentration(T05) substance concentration(T06:30) millimole/liter millimole/liter NPU08525 NPU08875 B—Glucose; subst.c.(T05) = ? mmol/l B—Glucose; subst.c.(T06:30) = ? mmol/l

Blood(capillary Blood)— Blood(capillary Blood)— Glucose; Glucose; substance concentration(T05) substance concentration(T06:30) millimole/liter millimole/liter NPU10068 NPU10093 B(cB)—Glucose; subst.c.(T05) = ? mmol/l B(cB)—Glucose; subst.c.(T06:30) = ? mmol/l

Plasma— Plasma— Glucose; Glucose; substance concentration(T05) substance concentration(T06:30) millimole/liter millimole/liter NPU08549 NPU08899 P—Glucose; subst.c.(T05) = ? mmol/l P—Glucose; subst.c.(T06:30) = ? mmol/l

Blood— Blood— Glucose; Glucose; substance concentration(T05:30) substance concentration(T07) millimole/liter millimole/liter NPU08874 NPU08527 B—Glucose; subst.c.(T05:30) = ? mmol/l B—Glucose; subst.c.(T07) = ? mmol/l

Blood(capillary Blood)— Blood(capillary Blood)— Glucose; Glucose; substance concentration(T05:30) substance concentration(T07) millimole/liter millimole/liter NPU10092 NPU10070 B(cB)—Glucose; subst.c.(T05:30) = ? mmol/l B(cB)—Glucose; subst.c.(T07) = ? mmol/l

Plasma— Plasma— Glucose; Glucose; substance concentration(T05:30) substance concentration(T07) millimole/liter millimole/liter NPU08898 NPU08551 P—Glucose; subst.c.(T05:30) = ? mmol/l P—Glucose; subst.c.(T07) = ? mmol/l

Blood— Blood— Glucose; Glucose; substance concentration(T06) substance concentration(T07:30) millimole/liter millimole/liter NPU08526 NPU08876 B—Glucose; subst.c.(T06) = ? mmol/l B—Glucose; subst.c.(T07:30) = ? mmol/l

Blood(capillary Blood)— Blood(capillary Blood)— Glucose; Glucose; substance concentration(T06) substance concentration(T07:30) millimole/liter millimole/liter NPU10069 NPU10094 B(cB)—Glucose; subst.c.(T06) = ? mmol/l B(cB)—Glucose; subst.c.(T07:30) = ? mmol/l

Blood(fasting Patient)— Blood(capillary Blood)— Glucose; Glucose; substance concentration(T07:30) substance concentration(T09) millimole/liter millimole/liter NPU08509 NPU10072 B(fPt)—Glucose; subst.c.(T07:30) = ? mmol/l B(cB)—Glucose; subst.c.(T09) = ? mmol/l

Plasma— Plasma— Glucose; Glucose; substance concentration(T07:30) substance concentration(T09) millimole/liter millimole/liter NPU08900 NPU08553 P—Glucose; subst.c.(T07:30) = ? mmol/l P—Glucose; subst.c.(T09) = ? mmol/l

Blood— Blood— Glucose; Glucose; substance concentration(T08) substance concentration(T09:30) millimole/liter millimole/liter NPU08528 NPU08878 B—Glucose; subst.c.(T08) = ? mmol/l B—Glucose; subst.c.(T09:30) = ? mmol/l

Blood(capillary Blood)— Blood(capillary Blood)— Glucose; Glucose; substance concentration(T08) substance concentration(T09:30) millimole/liter millimole/liter NPU10071 NPU10096 B(cB)—Glucose; subst.c.(T08) = ? mmol/l B(cB)—Glucose; subst.c.(T09:30) = ? mmol/l

Plasma— Plasma— Glucose; Glucose; substance concentration(T08) substance concentration(T09:30) millimole/liter millimole/liter NPU08552 NPU08902 P—Glucose; subst.c.(T08) = ? mmol/l P—Glucose; subst.c.(T09:30) = ? mmol/l

Blood— Blood— Glucose; Glucose; substance concentration(T08:30) substance concentration(T10) millimole/liter millimole/liter NPU08877 NPU08530 B—Glucose; subst.c.(T08:30) = ? mmol/l B—Glucose; subst.c.(T10) = ? mmol/l

Blood(capillary Blood)— Blood(capillary Blood)— Glucose; Glucose; substance concentration(T08:30) substance concentration(T10) millimole/liter millimole/liter NPU10095 NPU10073 B(cB)—Glucose; subst.c.(T08:30) = ? mmol/l B(cB)—Glucose; subst.c.(T10) = ? mmol/l

Plasma— Plasma— Glucose; Glucose; substance concentration(T08:30) substance concentration(T10) millimole/liter millimole/liter NPU08901 NPU08554 P—Glucose; subst.c.(T08:30) = ? mmol/l P—Glucose; subst.c.(T10) = ? mmol/l

Blood— Blood— Glucose; Glucose; substance concentration(T09) substance concentration(T10:30) millimole/liter millimole/liter NPU08529 NPU08879 B—Glucose; subst.c.(T09) = ? mmol/l B—Glucose; subst.c.(T10:30) = ? mmol/l

Blood(capillary Blood)— Blood(capillary Blood)— Glucose; Glucose; substance concentration(T10:30) substance concentration(T12) millimole/liter millimole/liter NPU10097 NPU10075 B(cB)—Glucose; subst.c.(T10:30) = ? mmol/l B(cB)—Glucose; subst.c.(T12) = ? mmol/l

Plasma— Plasma— Glucose; Glucose; substance concentration(T10:30) substance concentration(T12) millimole/liter millimole/liter NPU08903 NPU08556 P—Glucose; subst.c.(T10:30) = ? mmol/l P—Glucose; subst.c.(T12) = ? mmol/l

Blood— Blood— Glucose; Glucose; substance concentration(T11) substance concentration(T12:30) millimole/liter millimole/liter NPU08531 NPU08881 B—Glucose; subst.c.(T11) = ? mmol/l B—Glucose; subst.c.(T12:30) = ? mmol/l

Blood(capillary Blood)— Blood(capillary Blood)— Glucose; Glucose; substance concentration(T11) substance concentration(T12:30) millimole/liter millimole/liter NPU10074 NPU10099 B(cB)—Glucose; subst.c.(T11) = ? mmol/l B(cB)—Glucose; subst.c.(T12:30) = ? mmol/l

Plasma— Plasma— Glucose; Glucose; substance concentration(T11) substance concentration(T12:30) millimole/liter millimole/liter NPU08555 NPU08905 P—Glucose; subst.c.(T11) = ? mmol/l P—Glucose; subst.c.(T12:30) = ? mmol/l

Blood— Blood— Glucose; Glucose; substance concentration(T11:30) substance concentration(T13) millimole/liter millimole/liter NPU08880 NPU08533 B—Glucose; subst.c.(T11:30) = ? mmol/l B—Glucose; subst.c.(T13) = ? mmol/l

Blood(capillary Blood)— Blood(capillary Blood)— Glucose; Glucose; substance concentration(T11:30) substance concentration(T13) millimole/liter millimole/liter NPU10098 NPU10076 B(cB)—Glucose; subst.c.(T11:30) = ? mmol/l B(cB)—Glucose; subst.c.(T13) = ? mmol/l

Plasma— Plasma— Glucose; Glucose; substance concentration(T11:30) substance concentration(T13) millimole/liter millimole/liter NPU08904 NPU08557 P—Glucose; subst.c.(T11:30) = ? mmol/l P—Glucose; subst.c.(T13) = ? mmol/l

Blood— Blood— Glucose; Glucose; substance concentration(T12) substance concentration(T13:30) millimole/liter millimole/liter NPU08532 NPU08882 B—Glucose; subst.c.(T12) = ? mmol/l B—Glucose; subst.c.(T13:30) = ? mmol/l

Blood(capillary Blood)— Blood(capillary Blood)— Glucose; Glucose; substance concentration(T13:30) substance concentration(T15) millimole/liter millimole/liter NPU10100 NPU10078 B(cB)—Glucose; subst.c.(T13:30) = ? mmol/l B(cB)—Glucose; subst.c.(T15) = ? mmol/l

Plasma— Plasma— Glucose; Glucose; substance concentration(T13:30) substance concentration(T15) millimole/liter millimole/liter NPU08906 NPU08559 P—Glucose; subst.c.(T13:30) = ? mmol/l P—Glucose; subst.c.(T15) = ? mmol/l

Blood— Blood— Glucose; Glucose; substance concentration(T14) substance concentration(T15:30) millimole/liter millimole/liter NPU08534 NPU08884 B—Glucose; subst.c.(T14) = ? mmol/l B—Glucose; subst.c.(T15:30) = ? mmol/l

Blood(capillary Blood)— Blood(capillary Blood)— Glucose; Glucose; substance concentration(T14) substance concentration(T15:30) millimole/liter millimole/liter NPU10077 NPU10102 B(cB)—Glucose; subst.c.(T14) = ? mmol/l B(cB)—Glucose; subst.c.(T15:30) = ? mmol/l

Plasma— Plasma— Glucose; Glucose; substance concentration(T14) substance concentration(T15:30) millimole/liter millimole/liter NPU08558 NPU08908 P—Glucose; subst.c.(T14) = ? mmol/l P—Glucose; subst.c.(T15:30) = ? mmol/l

Blood— Blood— Glucose; Glucose; substance concentration(T14:30) substance concentration(T16) millimole/liter millimole/liter NPU08883 NPU08536 B—Glucose; subst.c.(T14:30) = ? mmol/l B—Glucose; subst.c.(T16) = ? mmol/l

Blood(capillary Blood)— Blood(capillary Blood)— Glucose; Glucose; substance concentration(T14:30) substance concentration(T16) millimole/liter millimole/liter NPU10101 NPU10079 B(cB)—Glucose; subst.c.(T14:30) = ? mmol/l B(cB)—Glucose; subst.c.(T16) = ? mmol/l

Plasma— Plasma— Glucose; Glucose; substance concentration(T14:30) substance concentration(T16) millimole/liter millimole/liter NPU08907 NPU08560 P—Glucose; subst.c.(T14:30) = ? mmol/l P—Glucose; subst.c.(T16) = ? mmol/l

Blood— Blood— Glucose; Glucose; substance concentration(T15) substance concentration(T16:30) millimole/liter millimole/liter NPU08535 NPU08885 B—Glucose; subst.c.(T15) = ? mmol/l B—Glucose; subst.c.(T16:30) = ? mmol/l

Blood(capillary Blood)— Blood(capillary Blood)— Glucose; Glucose; substance concentration(T16:30) substance concentration(T18) millimole/liter millimole/liter NPU10103 NPU10081 B(cB)—Glucose; subst.c.(T16:30) = ? mmol/l B(cB)—Glucose; subst.c.(T18) = ? mmol/l

Plasma— Plasma— Glucose; Glucose; substance concentration(T16:30) substance concentration(T18) millimole/liter millimole/liter NPU08909 NPU08562 P—Glucose; subst.c.(T16:30) = ? mmol/l P—Glucose; subst.c.(T18) = ? mmol/l

Blood— Blood— Glucose; Glucose; substance concentration(T17) substance concentration(T18:30) millimole/liter millimole/liter NPU08537 NPU08887 B—Glucose; subst.c.(T17) = ? mmol/l B—Glucose; subst.c.(T18:30) = ? mmol/l

Blood(capillary Blood)— Blood(capillary Blood)— Glucose; Glucose; substance concentration(T17) substance concentration(T18:30) millimole/liter millimole/liter NPU10080 NPU10105 B(cB)—Glucose; subst.c.(T17) = ? mmol/l B(cB)—Glucose; subst.c.(T18:30) = ? mmol/l

Plasma— Plasma— Glucose; Glucose; substance concentration(T17) substance concentration(T18:30) millimole/liter millimole/liter NPU08561 NPU08911 P—Glucose; subst.c.(T17) = ? mmol/l P—Glucose; subst.c.(T18:30) = ? mmol/l

Blood— Blood— Glucose; Glucose; substance concentration(T17:30) substance concentration(T19) millimole/liter millimole/liter NPU08886 NPU08539 B—Glucose; subst.c.(T17:30) = ? mmol/l B—Glucose; subst.c.(T19) = ? mmol/l

Blood(capillary Blood)— Blood(capillary Blood)— Glucose; Glucose; substance concentration(T17:30) substance concentration(T19) millimole/liter millimole/liter NPU10104 NPU10082 B(cB)—Glucose; subst.c.(T17:30) = ? mmol/l B(cB)—Glucose; subst.c.(T19) = ? mmol/l

Plasma— Plasma— Glucose; Glucose; substance concentration(T17:30) substance concentration(T19) millimole/liter millimole/liter NPU08910 NPU08563 P—Glucose; subst.c.(T17:30) = ? mmol/l P—Glucose; subst.c.(T19) = ? mmol/l

Blood— Blood— Glucose; Glucose; substance concentration(T18) substance concentration(T19:30) millimole/liter millimole/liter NPU08538 NPU08888 B—Glucose; subst.c.(T18) = ? mmol/l B—Glucose; subst.c.(T19:30) = ? mmol/l

Blood(capillary Blood)— Blood(capillary Blood)— Glucose; Glucose; substance concentration(T19:30) substance concentration(T21) millimole/liter millimole/liter NPU10106 NPU10084 B(cB)—Glucose; subst.c.(T19:30) = ? mmol/l B(cB)—Glucose; subst.c.(T21) = ? mmol/l

Plasma— Plasma— Glucose; Glucose; substance concentration(T19:30) substance concentration(T21) millimole/liter millimole/liter NPU08912 NPU08565 P—Glucose; subst.c.(T19:30) = ? mmol/l P—Glucose; subst.c.(T21) = ? mmol/l

Blood— Blood— Glucose; Glucose; substance concentration(T20) substance concentration(T21:30) millimole/liter millimole/liter NPU08540 NPU08890 B—Glucose; subst.c.(T20) = ? mmol/l B—Glucose; subst.c.(T21:30) = ? mmol/l

Blood(capillary Blood)— Blood(capillary Blood)— Glucose; Glucose; substance concentration(T20) substance concentration(T21:30) millimole/liter millimole/liter NPU10083 NPU10108 B(cB)—Glucose; subst.c.(T20) = ? mmol/l B(cB)—Glucose; subst.c.(T21:30) = ? mmol/l

Plasma— Plasma— Glucose; Glucose; substance concentration(T20) substance concentration(T21:30) millimole/liter millimole/liter NPU08564 NPU08914 P—Glucose; subst.c.(T20) = ? mmol/l P—Glucose; subst.c.(T21:30) = ? mmol/l

Blood— Blood— Glucose; Glucose; substance concentration(T20:30) substance concentration(T22) millimole/liter millimole/liter NPU08889 NPU08542 B—Glucose; subst.c.(T20:30) = ? mmol/l B—Glucose; subst.c.(T22) = ? mmol/l

Blood(capillary Blood)— Blood(capillary Blood)— Glucose; Glucose; substance concentration(T20:30) substance concentration(T22) millimole/liter millimole/liter NPU10107 NPU10085 B(cB)—Glucose; subst.c.(T20:30) = ? mmol/l B(cB)—Glucose; subst.c.(T22) = ? mmol/l

Plasma— Plasma— Glucose; Glucose; substance concentration(T20:30) substance concentration(T22) millimole/liter millimole/liter NPU08913 NPU08566 P—Glucose; subst.c.(T20:30) = ? mmol/l P—Glucose; subst.c.(T22) = ? mmol/l

Blood— Blood— Glucose; Glucose; substance concentration(T21) substance concentration(T22:30) millimole/liter millimole/liter NPU08541 NPU08891 B—Glucose; subst.c.(T21) = ? mmol/l B—Glucose; subst.c.(T22:30) = ? mmol/l

Blood(capillary Blood)— Blood(capillary Blood)— Glucose; Glucose; substance concentration(T22:30) substance concentration increment(maximum millimole/liter concentration minus 0 minutes concentration; NPU10109 procedure) B(cB)—Glucose; subst.c.(T22:30) = ? mmol/l millimole/liter NPU10046 Plasma— B(cB)—Glucose; subst.c.incr.(max. c. minus 0 min Glucose; c.; proc.) = ? mmol/l substance concentration(T22:30) millimole/liter Plasma— NPU08915 Glucose; P—Glucose; subst.c.(T22:30) = ? mmol/l substance concentration increment(maximum concentration minus 0 minutes concentration; Blood— procedure) Glucose; millimole/liter substance concentration(T23) NPU03841 millimole/liter P—Glucose; subst.c.incr.(max. c. minus 0 min c.; NPU08543 proc.) = ? mmol/l B—Glucose; subst.c.(T23) = ? mmol/l Amniotic fluid— Blood(capillary Blood)— Glucose; Glucose; substance concentration substance concentration(T23) millimole/liter millimole/liter M = 180,16 g/mol NPU10086 NPU08623 B(cB)—Glucose; subst.c.(T23) = ? mmol/l Amf—Glucose; subst.c. = ? mmol/l

Plasma— Ascites— Glucose; Glucose; substance concentration(T23) substance concentration millimole/liter millimole/liter NPU08567 M = 180,16 g/mol P—Glucose; subst.c.(T23) = ? mmol/l NPU04072 Asc—Glucose; subst.c. = ? mmol/l Blood— Glucose; Blood— substance concentration(T23:30) Glucose; millimole/liter substance concentration NPU08892 millimole/liter B—Glucose; subst.c.(T23:30) = ? mmol/l M = 180,16 g/mol NPU02187 Blood(capillary Blood)— B—Glucose; subst.c. = ? mmol/l Glucose; substance concentration(T23:30) Blood(arterial Blood)— millimole/liter Glucose; NPU10110 substance concentration B(cB)—Glucose; subst.c.(T23:30) = ? mmol/l millimole/liter M = 180,16 g/mol Plasma— NPU04092 Glucose; B(aB)—Glucose; subst.c.=? mmol/l substance concentration(T23:30) millimole/liter Blood(capillary Blood)— NPU08916 Glucose; P—Glucose; subst.c.(T23:30) = ? mmol/l substance concentration millimole/liter Blood— M = 180,16 g/mol Glucose; NPU10113 substance concentration increment(maximum B(cB)—Glucose; subst.c. = ? mmol/l concentration minus 0 minutes concentration; procedure) Blood(capillary Blood; fasting Patient)— millimole/liter Glucose; NPU08502 substance concentration B—Glucose; subst.c.incr.(max. c. minus 0 min c.; millimole/liter proc.) = ? mmol/l

M = 180,16 g/mol NPU02193 NPU02188 P(cB; fPt)—Glucose; subst.c. = ? mmol/l B(cB; fPt)—Glucose; subst.c. = ? mmol/l Pleural fluid(specification)— Blood(fasting Patient)— Glucose; Glucose; substance concentration substance concentration millimole/liter millimole/liter M = 180,16 g/mol M = 180,16 g/mol NPU10115 NPU08972 Plf(spec.)—Glucose; subst.c. = ? mmol/l B(fPt)—Glucose; subst.c. = ? mmol/l Plasma(venous Blood; fasting Patient)— Blood(venous Blood)— Glucose; Glucose; substance concentration substance concentration millimole/liter millimole/liter M = 180,16 g/mol M = 180,16 g/mol NPU02195 NPU04093 P(vB; fPt)—Glucose; subst.c. = ? mmol/l B(vB)—Glucose; subst.c.=? mmol/l Secretion(Conjunctiva; specification)— Blood(venous Blood; fasting Patient)— Glucose; Glucose; substance concentration substance concentration millimole/liter millimole/liter M = 180,16 g/mol M = 180,16 g/mol NPU09350 NPU02189 Secr(Conj; spec.)—Glucose; subst.c. = ? mmol/l B(vB; fPt)—Glucose; subst.c. = ? mmol/l Synovial fluid(specification)— Cerebrospinal fluid— Glucose; Glucose; substance concentration substance concentration millimole/liter millimole/liter M = 180,16 g/mol M = 180,16 g/mol NPU08622 NPU02190 Synf(spec.)—Glucose; subst.c. = ? mmol/l Csf—Glucose; subst.c. = ? mmol/l System(specification)— Dialysis solution— Glucose; Glucose; substance concentration substance concentration millimole/liter millimole/liter M = 180,16 g/mol M = 180,16 g/mol NPU10127 NPU10112 Syst(spec.)—Glucose; subst.c. = ? mmol/l Dialysis solution—Glucose; subst.c. = ? mmol/l Urine— Drain fluid(specification)— Glucose; Glucose; substance concentration substance concentration millimole/liter millimole/liter M = 180,16 g/mol NPU17050 NPU03936 Drain fluid(spec.)—Glucose; subst.c. = ? mmol/l U—Glucose; subst.c. = ? mmol/l

Plasma— Patient(Urine)— Glucose; Glucose; substance concentration substance rate(procedure) millimole/liter millimole/day M = 180,16 g/mol NPU02191 NPU02192 Pt(U)—Glucose; subst.rate(proc.) = ? mmol/d P—Glucose; subst.c. = ? mmol/l Biopsy(specification)— Plasma(capillary Blood; fasting Patient)— a- Glucose; Glucosidase; substance concentration catalytic-activity content(37 °C; procedure) millimole/liter katal/kilogram M = 180,16 g/mol NPU10183 Biopsy(spec.)—a-Glucosidase; cat.cont.(37 °C; proc.)= ? prefix ? kat/kg © 2000 IUPAC, Pure and Applied Chemistry 72, 747–972 868 H. OLESEN et al.

Urine— Amniotic fluid— b- Glutamate dehydrogenase(NADP+); Glucuronidase; catalytic-activity concentration(37 °C; catalytic-activity concentration(37 °C; procedure) procedure) microkatal/liter microkatal/liter NPU03905 NPU02227 Amf—Glutamate dehydrogenase(NADP+); cat.c. U—b-Glucuronidase; cat.c.(37 °C; proc.) = ? µkat/l (37 °C; proc.) = ? µkat/l

Plasma— Urine— Glutamate decarboxylase(gad65) Glutamate/Creatininium; antibody(Immunoglobulin G); substance ratio arbitrary concentration(procedure) 10-3 NPU12544 NPU14209 P—Glutamate decarboxylase(gad65) antibody(IgG); U—Glutamate/Creatininium; subst.ratio = ? × 10-3 arb.c.(proc.) = ? Cerebrospinal fluid— Plasma— Glutamate; Glutamate decarboxylase(gad65) substance concentration antibody(Immunoglobulin G); micromole/liter arbitrary substance concentration(ELISA; NPU02228 procedure) Csf—Glutamate; subst.c. = ? µmol/l 10³ arbitrary unit/liter NPU12546 Plasma— P—Glutamate decarboxylase(gad65) antibody(IgG); Glutamate; arb.subst.c.(ELISA; proc.) = ? × 10³ arb.unit/l substance concentration micromole/liter Plasma— NPU02229 Glutamate decarboxylase(gad65) P—Glutamate; subst.c. = ? µmol/l antibody(Immunoglobulin G); arbitrary substance Urine— concentration(Radioimmunoassay; procedure) Glutamate; 10³ arbitrary unit/liter substance concentration NPU16484 micromole/liter P—Glutamate decarboxylase(gad65) antibody(IgG); NPU02230 arb.subst.c.(RIA; proc.) = ? × 10³ arb.unit/l U—Glutamate; subst.c. = ? µmol/l

Amniotic fluid— Urine— Glutamate dehydrogenase(NAD(P)+); Glutamine/Creatininium; catalytic-activity concentration(37 °C; substance ratio procedure) 10-3 microkatal/liter NPU14210 NPU03904 U—Glutamine/Creatininium; subst.ratio = ? × 10-3 Amf—Glutamate dehydrogenase(NAD(P)+); cat.c.(37 °C; proc.) = ? µkat/l Cerebrospinal fluid— Glutamine; Plasma— substance concentration Glutamate dehydrogenase(NAD(P)+); micromole/liter catalytic-activity concentration(37 °C; M = 146,15 g/mol procedure) NPU09022 microkatal/liter Csf—Glutamine; subst.c. = ? µmol/l NPU02247 P—Glutamate dehydrogenase(NAD(P)+); cat.c. Plasma— (37 °C; proc.) = ? µkat/l Glutamine; substance concentration Plasma— micromole/liter Glutamate dehydrogenase(NADP+); M = 146,15 g/mol catalytic-activity concentration(37 °C; NPU02249 procedure) P—Glutamine; subst.c. = ? µmol/l katal/liter NPU02248 Urine— P—Glutamate dehydrogenase(NADP+); cat.c. Glutamine; (37 °C; proc.)= ? prefix ? kat/l substance concentration micromole/liter M = 146,15 g/mol

NPU02250 Urine— U—Glutamine; subst.c. = ? µmol/l Glycerate; substance concentration Amniotic fluid— mole/liter g- NPU02279 Glutamyltransferase; U—Glycerate; subst.c.= ? prefix ? mol/l catalytic-activity concentration(37 °C; procedure) Plasma— microkatal/liter Glycerol; Other term(s): Glutamyl transpeptidase substance concentration NPU03907 millimole/liter Amf—g-Glutamyltransferase; cat.c.(37 °C; proc.) = ? NPU08973 µkat/l P—Glycerol; subst.c. = ? mmol/l

Plasma— Urine— g- Glycine/Creatininium; Glutamyltransferase; substance ratio catalytic-activity concentration(37 °C; 10-3 procedure) NPU14211 microkatal/liter U—Glycine/Creatininium; subst.ratio = ? × 10-3 Other term(s): Glutamyl transpeptidase NPU02251 Cerebrospinal fluid— P—g-Glutamyltransferase; cat.c.(37 °C; proc.) = ? Glycine; µkat/l substance concentration micromole/liter Urine— M = 75,07 g/mol g- NPU02288 Glutamyltransferase; Csf—Glycine; subst.c. = ? µmol/l catalytic-activity concentration(37 °C; procedure) Plasma— microkatal/liter Glycine; Other term(s): Glutamyl transpeptidase substance concentration NPU10312 micromole/liter U—g-Glutamyltransferase; cat.c.(37 °C; proc.) = ? NPU02289 µkat/l P—Glycine; subst.c. = ? µmol/l

Urine— Urine— Glutarate; Glycine; substance concentration substance concentration micromole/liter micromole/liter NPU02252 NPU02290 U—Glutarate; subst.c. = ? µmol/l U—Glycine; subst.c. = ? µmol/l

Erythrocytes(Blood)— Haemoglobin(Fe; Blood)— Glutathione peroxidase; Glycohaemoglobin(Fe); entitic catalytic activity(37 °C; procedure) substance fraction attokatal M = 16 700 g/mol NPU04801 Other term(s): glycosylated haemoglobin Ercs(B)—Glutathione peroxidase; entitic cat.act.(37 Authority: IUPAC-IUB85 °C; proc.)= ? akat NPU02307 Hb(Fe; B)—Glycohaemoglobin(Fe); subst.fr. = ? Erythrocytes(Blood)— Glutathione reductase (NAD(P)H); Urine— arbitrary catalytic activity(procedure) Glycolate/Creatininium; NPU17109 substance ratio Ercs(B)—Glutathione reductase (NAD(P)H); 10-3 arb.cat.act.(proc.) = ? NPU14212 U—Glycolate/Creatininium; subst.ratio = ? × 10-3 Plasma— Glutathione reductase (NAD(P)H); Plasma— arbitrary catalytic activity(procedure) Glycolate; NPU14354 substance concentration P—Glutathione reductase (NAD(P)H); mole/liter arb.cat.act.(proc.) = ? NPU02308 P—Glycolate; subst.c.= ? prefix ? mol/l

Urine— Synovial fluid(specification)— Glycolate; Gold; substance concentration substance concentration(therapy) mole/liter micromole/liter NPU02309 M = 196,97 g/mol U—Glycolate; subst.c.= ? prefix ? mol/l NPU10769 Synf(spec.)—Gold; subst.c.(therapy) = ? µmol/l Plasma— b-2- Blood— Glycoprotein I antibody(Immunoglobulin G); Gold; arbitrary concentration(procedure) substance concentration NPU14508 picomole/liter P—b-2-Glycoprotein I antibody(IgG); arb.c.(proc.) = M = 196,97 g/mol ? Authority: IUPAC/VII-C-TOX NPU02310 Plasma— B—Gold; subst.c. = ? pmol/l b-2- Glycoprotein I antibody(Immunoglobulin G); Plasma— arbitrary substance concentration(procedure) Gold; 10³ arbitrary unit/liter substance concentration NPU16397 picomole/liter P—b-2-Glycoprotein I antibody(IgG); M = 196,97 g/mol arb.subst.c.(proc.) = ? × 10³ arb.unit/l Authority: IUPAC/VII-C-TOX NPU02312 Plasma— P—Gold; subst.c. = ? pmol/l b-2- Glycoprotein I antibody(Immunoglobulin M); Urine— arbitrary concentration(procedure) Gold; NPU14509 substance concentration P—b-2-Glycoprotein I antibody(IgM); arb.c.(proc.) = picomole/liter ? M = 196,97 g/mol Authority: IUPAC/VII-C-TOX Plasma— NPU02313 b-2- U—Gold; subst.c. = ? pmol/l Glycoprotein I antibody(Immunoglobulin M); arbitrary substance concentration(procedure) Hair— 10³ arbitrary unit/liter Gold; NPU16398 substance content P—b-2-Glycoprotein I antibody(IgM); nanomole/kilogram arb.subst.c.(proc.) = ? × 10³ arb.unit/l M = 196,97 g/mol Authority: IUPAC/VII-C-TOX Plasma— NPU02311 b-2- Hair—Gold; subst.cont. = ? nmol/kg Glycoprotein I antibody; arbitrary substance concentration(list; Patient(Urine)— procedure) Gold; NPU17671 substance rate(therapy) P—b-2-Glycoprotein I antibody; arb.subst.c.(list; micromole/day proc.) M = 196,97 g/mol NPU16397 P—b-2-Glycoprotein I antibody(IgG); NPU10313 arb.subst.c.(proc.) = ? × 10³ arb.unit/l Pt(U)—Gold; subst.rate(therapy) = ? µmol/d NPU16398 P—b-2-Glycoprotein I antibody(IgM); arb.subst.c.(proc.) = ? × 10³ arb.unit/l Patient— Gonadorelin(administered); Plasma— amount-of-substance(intravenous a-2-HS- administration) Glycoprotein; nanomole substance concentration NPU10561 micromole/liter Pt—Gonadorelin(administered); am.s.(i.v.) = ? nmol NPU10274 P—a-2-HS-Glycoprotein; subst.c. = ? µmol/l Haemoglobin(Fe; Blood)— Haemoglobin A(Fe); substance fraction M = 16 500 g/mol

NPU04610 Haemoglobin(Fe; Blood)— Hb(Fe; B)—Haemoglobin A(Fe); subst.fr.= ? Haemoglobin F+Haemoglobin F1; substance fraction Haemoglobin(Fe; Blood)— NPU10160 Haemoglobin A1(Fe); Hb(Fe; B)—Haemoglobin F+Haemoglobin F1; substance fraction subst.fr.= ? M = 16 500 g/mol NPU04994 Haemoglobin(Fe; Blood)— Hb(Fe; B)—Haemoglobin A1(Fe); subst.fr.= ? Haemoglobin F1(Fe); substance fraction Haemoglobin(Fe; Blood)— M = 16 500 g/mol Haemoglobin A1c(Fe); NPU04614 substance fraction Hb(Fe; B)—Haemoglobin F1(Fe); subst.fr.= ? M = 16 500 g/mol NPU03835 Haemoglobin(Fe; Blood)— Hb(Fe; B)—Haemoglobin A1c(Fe); subst.fr. = ? Haemoglobin S(Fe); substance fraction Haemoglobin(Fe; Blood)— NPU10158 Haemoglobin A2(Fe); Hb(Fe; B)—Haemoglobin S(Fe); subst.fr.= ? substance fraction M = 16 500 g/mol Haemoglobin(Blood)— NPU04611 Haemoglobin type; Hb(Fe; B)—Haemoglobin A2(Fe); subst.fr.= ? property(list; procedure) NPU17703 Haemoglobin(Fe; Blood)— Hb(B)—Haemoglobin type; prop.(list; proc.) Haemoglobin A3(Fe); NPU04610 Hb(Fe; B)—Haemoglobin A(Fe); substance fraction subst.fr.= ? M = 16 500 g/mol NPU04994 Hb(Fe; B)—Haemoglobin A1(Fe); NPU04612 subst.fr.= ? Hb(Fe; B)—Haemoglobin A3(Fe); subst.fr.= ? NPU04611 Hb(Fe; B)—Haemoglobin A2(Fe); subst.fr.= ? Haemoglobin(Fe; Blood)— NPU04612 Hb(Fe; B)—Haemoglobin A3(Fe); Haemoglobin C(Fe); subst.fr.= ? substance fraction NPU04613 Hb(Fe; B)—Haemoglobin F(Fe); NPU10161 subst.fr.= ? Hb(Fe; B)—Haemoglobin C(Fe); subst.fr.= ? NPU04614 Hb(Fe; B)—Haemoglobin F1(Fe); subst.fr.= ? Haemoglobin(Fe; Blood)— NPU04984 Hb(Fe; B)—Haemoglobin, other(Fe; Haemoglobin D(Fe); spec.); subst.fr.= ? substance fraction NPU09034 Hb(Fe; B)—Haemoglobin, heat NPU10163 unstable(Fe); arb.c.(proc.) = ? Hb(Fe; B)—Haemoglobin D(Fe); subst.fr.= ? NPU02327 Hb(Fe; B)—Haemoglobin, heat unstable(Fe); subst.fr.(proc.) = ? Haemoglobin(Fe; Blood)— NPU02725 Hb(Fe; B)—Methaemoglobin(Fe); Haemoglobin E(Fe); subst.fr. = ? substance fraction NPU10159 Haemoglobin(Blood)— Hb(Fe; B)—Haemoglobin E(Fe); subst.fr.= ? Haemoglobin type; substance fraction(list; procedure) Haemoglobin(Fe; Amniotic fluid)— NPU02326 Haemoglobin F(Fe); Hb(B)—Haemoglobin type; subst.fr.(list; proc.) substance fraction NPU04610 Hb(Fe; B)—Haemoglobin A(Fe); M = 16 500 g/mol subst.fr.= ? NPU02325 NPU04994 Hb(Fe; B)—Haemoglobin A1(Fe); Hb(Fe; Amf)—Haemoglobin F(Fe); subst.fr. = ? subst.fr.= ? NPU04611 Hb(Fe; B)—Haemoglobin A2(Fe); Haemoglobin(Fe; Blood)— subst.fr.= ? Haemoglobin F(Fe); NPU04612 Hb(Fe; B)—Haemoglobin A3(Fe); substance fraction subst.fr.= ? M = 16 500 g/mol NPU04613 Hb(Fe; B)—Haemoglobin F(Fe); NPU04613 subst.fr.= ? Hb(Fe; B)—Haemoglobin F(Fe); subst.fr.= ? NPU04614 Hb(Fe; B)—Haemoglobin F1(Fe); subst.fr.= ?

NPU04984 Hb(Fe; B)—Haemoglobin, other(Fe; Blood fraction(specification)— spec.); subst.fr.= ? Haemoglobin(Fe); NPU02725 Hb(Fe; B)—Methaemoglobin(Fe); substance concentration subst.fr. = ? micromole/liter NPU17569 Drain fluid(specification)— B fract.(spec.)—Haemoglobin(Fe); subst.c. = ? Haemoglobin(Fe); µmol/l arbitrary concentration(procedure) NPU17051 Cerebrospinal fluid— Drain fluid(spec.)—Haemoglobin(Fe); arb.c.(proc.) = Haemoglobin(Fe); ? substance concentration micromole/liter System(specification)— M = 16 500 g/mol Haemoglobin(Fe); NPU17030 arbitrary concentration(procedure) Csf—Haemoglobin(Fe); subst.c. = ? µmol/l M = 16 500 g/mol NPU10314 Drain fluid(specification)— Syst(spec.)—Haemoglobin(Fe); arb.c.(proc.) = ? Haemoglobin(Fe); substance concentration Erythrocytes(Blood)— micromole/liter Haemoglobin(Fe); NPU17052 entitic amount-of-substance Drain fluid(spec.)—Haemoglobin(Fe); subst.c. = ? femtomole µmol/l M = 16 500 g/mol Other term(s): MCH Plasma— NPU02320 Haemoglobin(Fe); Ercs(B)—Haemoglobin(Fe); entitic am.s. = ? fmol substance concentration micromole/liter Reticulocytes(Blood)— M = 16 500 g/mol Haemoglobin(Fe); NPU02322 entitic amount-of-substance P—Haemoglobin(Fe); subst.c. = ? µmol/l femtomole M = 16 500 g/mol Blood— Other term(s): MCH Haemoglobin(Fe); NPU17007 substance concentration Rtcs(B)—Haemoglobin(Fe); entitic am.s. = ? fmol millimole/liter M = 16 500 g/mol System(specification)— NPU02319 Haemoglobin(Fe); B—Haemoglobin(Fe); subst.c. = ? mmol/l substance concentration(procedure) nanomole/liter Blood fraction(specification)— M = 16 500 g/mol Haemoglobin(Fe); NPU10287 substance concentration Syst(spec.)—Haemoglobin(Fe); subst.c.(proc.) = ? millimole/liter nmol/l NPU17570 B fract.(spec.)—Haemoglobin(Fe); subst.c. = ? Urine— mmol/l Haemoglobin(Fe); substance concentration(procedure) Blood(cord Blood)— nanomole/liter Haemoglobin(Fe); M = 16 500 g/mol substance concentration NPU02323 millimole/liter U—Haemoglobin(Fe); subst.c.(proc.) = ? nmol/l NPU10162 B(cordB)—Haemoglobin(Fe); subst.c. = ? mmol/l Urine(cell free)— Haemoglobin(Fe); Erythrocytes(Blood)— substance concentration(procedure) Haemoglobin(Fe); nanomole/liter substance concentration M = 16 500 g/mol millimole/liter NPU02324 M = 16 500 g/mol U(cell free)—Haemoglobin(Fe); subst.c.(proc.) = ? Other term(s): MCHC nmol/l NPU02321 Ercs(B)—Haemoglobin(Fe); subst.c. = ? mmol/l

Lavage fluid(specification)— Cerebrospinal fluid(cell free)— Haemoglobin(Fe); Haemoglobin+derivative; substance concentration arbitrary concentration(procedure) millimole/liter NPU08626 NPU14358 Csf(cell free)—Haemoglobin+derivative; Lavagef(spec.)—Haemoglobin(Fe); subst.c. = ? arb.c.(proc.) = ? mmol/l Plasma— Pleural fluid— Haemopexin; Haemoglobin(Fe); substance concentration substance concentration micromole/liter millimole/liter M = 57 000 g/mol M = 16 500 g/mol NPU02328 NPU17022 P—Haemopexin; subst.c. = ? µmol/l Plf—Haemoglobin(Fe); subst.c. = ? mmol/l Urine— Reticulocytes(Blood)— Haemosiderin; Haemoglobin(Fe); arbitrary concentration(procedure) substance concentration NPU04209 millimole/liter U—Haemosiderin; arb.c.(proc.)= ? NPU17008 Rtcs(B)—Haemoglobin(Fe); subst.c. = ? mmol/l Plasma— Haptocorrin(free); Haemoglobin(Fe; Blood)— substance concentration Haemoglobin, heat unstable(Fe); picomole/liter arbitrary concentration(procedure) M = 70 000 g/mol M = 16 500 g/mol Other term(s): Transcobalamin I(free) NPU09034 NPU08569 Hb(Fe; B)—Haemoglobin, heat unstable(Fe); P—Haptocorrin(free); subst.c. = ? pmol/l arb.c.(proc.) = ? Plasma— Haemoglobin(Fe; Blood)— Haptocorrin(total); Haemoglobin, heat unstable(Fe); substance concentration substance fraction(procedure) picomole/liter M = 16 500 g/mol M = 70 000 g/mol NPU02327 Other term(s): Transcobalamin I(total) Hb(Fe; B)—Haemoglobin, heat unstable(Fe); NPU02317 subst.fr.(proc.) = ? P—Haptocorrin(tot.); subst.c. = ? pmol/l

Haemoglobin(Fe; Blood)— Plasma— Haemoglobin, other(Fe; specification); Haptoglobin; substance fraction substance concentration M = 16 500 g/mol micromole/liter NPU04984 M = 100 000 g/mol Hb(Fe; B)—Haemoglobin, other(Fe; spec.); NPU02318 subst.fr.= ? P—Haptoglobin; subst.c. = ? µmol/l

Haemoglobin(Blood)— Blood— Haemoglobin, unusual; Helmet cells; taxon(procedure) arbitrary concentration(procedure) NPU03988 NPU17088 Hb(B)—Haemoglobin, unusual; taxon(proc.) = ? B—Helmet cells; arb.c.(proc.) = ?

Urine— Urine— Haemoglobin; Heparan sulfate; arbitrary concentration(procedure) substance concentration NPU04208 mole/liter U—Haemoglobin; arb.c.(proc.) = ? Authority: IUPAC-IUB85 NPU02329 Faeces— U—Heparan sulfate; subst.c.= ? prefix ? mol/l Haemoglobin; arbitrary content(procedure) NPU01393 F—Haemoglobin; arb.cont.(proc.) = ?

Erythrocytes(Ascites)— Plasma— Hexokinase; Histidine-tRNA ligase antibody(Immunoglobulin G); entitic catalytic-activity content arbitrary concentration(procedure) attokatal Other term(s): Jo-1 antibody NPU17567 NPU12568 Ercs(Asc)—Hexokinase; entitic cat.cont. = ? akat P—Histidine-tRNA ligase antibody(IgG); arb.c.(proc.) = ? Urine— Hexose(reducing); Plasma— arbitrary concentration(procedure) Histidine-tRNA ligase antibody; NPU14142 arbitrary concentration(procedure) U—Hexose(reducing); arb.c.(proc.) = ? Other term(s): Jo-1 antibody; histidyl tRNA syntetase antibody Patient(Urine)— NPU12040 Hippurate; P—Histidine-tRNA ligase antibody; arb.c.(proc.) = ? substance rate(procedure) micromole/day Plasma— NPU02371 Histidine—tRNA-synthetase(Jo 1) Pt(U)—Hippurate; subst.rate(proc.) = ? µmol/d antibody(Immunoglobulin G); arbitrary concentration(procedure) Blood— NPU14511 Histamine; P—Histidine—tRNA-synthetase(Jo 1) substance concentration antibody(IgG); arb.c.(proc.) = ? micromole/liter NPU04805 Plasma— B—Histamine; subst.c.= ? µmol/l Histone; arbitrary substance concentration(procedure) Patient(Urine)— arbitrary unit/liter Histamine; NPU12904 substance rate(procedure) P—Histone; arb.subst.c.(proc.) = ? arb.unit/l micromole/day NPU04812 Plasma— Pt(U)—Histamine; subst.rate(proc.)= ? µmol/d Histone antibody(Immunoglobulin G); arbitrary concentration(procedure) Urine— NPU12560 Histidine/Creatininium; P—Histone antibody(IgG); arb.c.(proc.) = ? substance ratio 10-3 Plasma— NPU14213 Histone antibody(Immunoglobulin G); U—Histidine/Creatininium; subst.ratio = ? × 10-3 arbitrary substance concentration(procedure) 10³ arbitrary unit/liter Cerebrospinal fluid— NPU12559 Histidine; P—Histone antibody(IgG); arb.subst.c.(proc.) = ? × substance concentration 10³ arb.unit/l micromole/liter M = 195,16 g/mol Plasma— NPU09023 Histone antibody; Csf—Histidine; subst.c. = ? µmol/l arbitrary concentration(procedure) NPU02385 Plasma— P—Histone antibody; arb.c.(proc.) = ? Histidine; substance concentration Plasma— micromole/liter Histone antibody; M = 155,16 g/mol arbitrary substance concentration(procedure) NPU02373 arbitrary unit/liter P—Histidine; subst.c. = ? µmol/l NPU12034 P—Histone antibody; arb.subst.c.(proc.) = ? Urine— arb.unit/l Histidine; substance concentration Urine— micromole/liter Homoarginine/Creatininium; M = 155,16 g/mol substance ratio NPU02374 10-3 U—Histidine; subst.c. = ? µmol/l NPU14214

U—Homoarginine/Creatininium; subst.ratio = ? × Urine— 10-3 Homocystine; substance concentration Urine— micromole/liter Homoarginine; M = 268,36 g/mol substance concentration NPU02398 micromole/liter U—Homocystine; subst.c. = ? µmol/l M = 189,2 g/mol NPU02386 Urine— U—Homoarginine; subst.c. = ? µmol/l Homogentisate; substance concentration Urine— micromole/liter Homocarnosine/Creatininium; NPU02399 substance ratio U—Homogentisate; subst.c. = ? µmol/l 10-3 NPU14215 Urine— U—Homocarnosine/Creatininium; subst.ratio = ? × Homoserine/Creatininium; 10-3 substance ratio 10-3 Cerebrospinal fluid— NPU14218 Homocarnosine; U—Homoserine/Creatininium; subst.ratio = ? × 10-3 substance concentration micromole/liter Urine— M = 240,26 g/mol Homoserine; NPU02387 substance concentration Csf—Homocarnosine; subst.c. = ? µmol/l micromole/liter M = 119,1 g/mol Urine— NPU02400 Homocitrulline/Creatininium; U—Homoserine; subst.c. = ? µmol/l substance ratio 10-3 Urine— NPU14216 Homovanillate/Creatininium; U—Homocitrulline/Creatininium; subst.ratio = ? × substance ratio 10-3 10-3 NPU10164 Urine— U—Homovanillate/Creatininium; subst.ratio = ? × Homocitrulline; 10-3 substance concentration micromole/liter Urine— NPU02388 Homovanillate; U—Homocitrulline; subst.c. = ? µmol/l amount-of-substance micromole Plasma— NPU17568 Homocysteine(total); U—Homovanillate; am.s. = ? µmol substance concentration micromole/liter Cerebrospinal fluid— NPU04073 Homovanillate; P—Homocysteine(tot.); subst.c. = ? µmol/l substance concentration micromole/liter Urine— NPU02401 Homocystine/Creatininium; Csf—Homovanillate; subst.c. = ? µmol/l substance ratio 10-3 Urine— NPU14217 Homovanillate; U—Homocystine/Creatininium; subst.ratio = ? × 10-3 substance concentration micromole/liter Plasma— NPU02402 Homocystine; U—Homovanillate; subst.c. = ? µmol/l substance concentration micromole/liter Patient(Urine)— M = 268,36 g/mol Homovanillate; NPU02397 substance rate(procedure) P—Homocystine; subst.c. = ? µmol/l micromole/day NPU04814 Pt(U)—Homovanillate; subst.rate(proc.)= ? µmol/d

Dialysis solution— Plasma(venous Blood)— Hydrogen carbonate; Hydrogen carbonate; substance concentration(actual) substance concentration(actual) millimole/liter millimole/liter Authority: IFCC/C-BGE Authority: IFCC/C-BGE NPU10165 NPU14266 Dialysis solution—Hydrogen carbonate; P(vB)—Hydrogen carbonate; subst.c.(actual) = ? subst.c.(actual) = ? mmol/l mmol/l

Plasma(arterial Blood)— System(specification)— Hydrogen carbonate; Hydrogen carbonate; substance concentration(actual) substance concentration(actual) millimole/liter millimole/liter Authority: IFCC/C-BGE Authority: IFCC/C-BGE NPU02409 NPU10286 P(aB)—Hydrogen carbonate; subst.c.(actual) = ? Syst(spec.)—Hydrogen carbonate; subst.c.(actual) mmol/l = ? mmol/l

Plasma(capillary Blood)— Plasma— Hydrogen carbonate; Hydrogen carbonate;

substance concentration(actual) substance concentration(pCO2 = 5,3 kPa; 37 °C) millimole/liter millimole/liter Authority: IFCC/C-BGE Other term(s): Standard bicarbonate NPU14264 Authority: IFCC/C-BGE

P(cB)—Hydrogen carbonate; subst.c.(actual) = ? Note: standard: blood; pCO2 = 5,3 kPa; 37 °C mmol/l NPU02410

P—Hydrogen carbonate; subst.c.(pCO2 = 5,3 kPa; Plasma(cord Blood)— 37 °C) = ? mmol/l Hydrogen carbonate; substance concentration(actual) Plasma(arterial Blood)— millimole/liter Hydrogen carbonate;

Authority: IFCC/C-BGE substance concentration(pCO2 = 5,3 kPa; 37 °C) NPU14265 millimole/liter P(cordB)—Hydrogen carbonate; subst.c.(actual) = ? Authority: IFCC/C-BGE

mmol/l Note: standard: blod; pCO2 = 5,3 kPa; 37 °C NPU14176

Plasma(cord Blood; arterial Blood)— P(aB)—Hydrogen carbonate; subst.c.(pCO2 = 5,3 Hydrogen carbonate; kPa; 37 °C) = ? mmol/l substance concentration(actual) millimole/liter Plasma(capillary Blood)— Authority: IFCC/C-BGE Hydrogen carbonate;

NPU17145 substance concentration(pCO2 = 5,3 kPa; 37 °C) P(cordB; aB)—Hydrogen carbonate; subst.c.(actual) millimole/liter = ? mmol/l Authority: IFCC/C-BGE

Note: standard: blod; pCO2 = 5,3 kPa; 37 °C Plasma(cord Blood; venous Blood)— NPU14279

Hydrogen carbonate; P(cB)—Hydrogen carbonate; subst.c.(pCO2 = 5,3 substance concentration(actual) kPa; 37 °C) = ? mmol/l millimole/liter Authority: IFCC/C-BGE Plasma(cord Blood)— NPU17146 Hydrogen carbonate;

P(cordB; vB)—Hydrogen carbonate; subst.c.(actual) substance concentration(pCO2 = 5,3 kPa; 37 °C) = ? mmol/l millimole/liter Authority: IFCC/C-BGE

Plasma(mixed Blood)— Note: standard: blod; pCO2 = 5,3 kPa; 37 °C Hydrogen carbonate; NPU10166

substance concentration(actual) P(cordB)—Hydrogen carbonate; subst.c.(pCO2 = millimole/liter 5,3 kPa; 37 °C) = ? mmol/l Authority: IFCC/C-BGE NPU09209 Plasma(venous Blood)— P(mixB)—Hydrogen carbonate; subst.c.(actual) = ? Hydrogen carbonate;

mmol/l substance concentration(pCO2 = 5,3 kPa; 37 °C) millimole/liter

Authority: IFCC/C-BGE Plasma(mixed Blood)—

Note: standard: blod; pCO2 = 5,3 kPa; 37 °C Hydrogen ion; NPU09360 pH(patient body temperature)

P(vB)—Hydrogen carbonate; subst.c.(pCO2 = 5,3 Authority: IFCC/C-BGE kPa; 37 °C) = ? mmol/l Note: See also P—Hydrogen ion; subst.c. NPU09211 Plasma(arterial Blood)— P(mixB)—Hydrogen ion; pH(body temp.) = ? Hydrogen ion; pH(37 °C) Plasma(venous Blood)— NPU12474 Hydrogen ion; P(aB)—Hydrogen ion; pH(37 °C) = ? pH(patient body temperature) NPU12492 Plasma(capillary Blood)— P(vB)—Hydrogen ion; pH(body temp.) = ? Hydrogen ion; pH(37 °C) Faeces— NPU12490 Hydrogen ion; P(cB)—Hydrogen ion; pH(37 °C) = ? pH(procedure) Authority: IFCC/C-BGE Plasma(mixed Blood)— NPU10318 Hydrogen ion; F—Hydrogen ion; pH(proc.) = ? pH(37 °C) NPU09210 Urine— P(mixB)—Hydrogen ion; pH(37 °C) = ? Hydrogen ion; pH(procedure) Plasma(venous Blood)— Authority: IFCC/C-BGE Hydrogen ion; NPU02415 pH(37 °C) U—Hydrogen ion; pH(proc.) = ? NPU12489 P(vB)—Hydrogen ion; pH(37 °C) = ? Amniotic fluid— Hydrogen ion; Plasma(arterial Blood)— pH Hydrogen ion; Authority: IFCC/C-BGE pH(patient body temperature) NPU10209 Authority: IFCC/C-BGE Amf—Hydrogen ion; pH = ? Note: See also P—Hydrogen ion; subst.c. NPU02412 Dialysis solution— P(aB)—Hydrogen ion; pH(body temp.) = ? Hydrogen ion; pH Plasma(capillary Blood)— NPU14355 Hydrogen ion; Dialysis solution—Hydrogen ion; pH = ? pH(patient body temperature) NPU12491 Duodenal fluid— P(cB)—Hydrogen ion; pH(body temp.) = ? Hydrogen ion; pH Plasma(cord Blood)— NPU14356 Hydrogen ion; Duodf—Hydrogen ion; pH = ? pH(patient body temperature) NPU12493 Plasma(capillary Blood)— P(cordB)—Hydrogen ion; pH(body temp.) = ? Hydrogen ion; pH Plasma(cord Blood; arterial Blood)— NPU10212 Hydrogen ion; P(cB)—Hydrogen ion; pH = ? pH(patient body temperature) NPU17149 Plasma(cord Blood)— P(cordB; aB)—Hydrogen ion; pH(body temp.) = ? Hydrogen ion; pH Plasma(cord Blood; venous Blood)— NPU10016 Hydrogen ion; P(cordB)—Hydrogen ion; pH = ? pH(patient body temperature) NPU17150 Plasma(cord Blood; arterial Blood)— P(cordB; vB)—Hydrogen ion; pH(body temp.) = ? Hydrogen ion; pH NPU17147 P(cordB; aB)—Hydrogen ion; pH = ?

Plasma(cord Blood; venous Blood)— Plasma(venous Blood)— Hydrogen ion; Hydrogen ion; pH substance concentration(37 °C) NPU17148 nanomole/liter P(cordB; vB)—Hydrogen ion; pH = ? NPU12495 P(vB)—Hydrogen ion; subst.c.(37 °C) = ? nmol/l Plasma(venous Blood)— Hydrogen ion; Plasma(arterial Blood)— pH Hydrogen ion; Authority: IFCC/C-BGE substance concentration(patient body NPU03995 temperature) P(vB)—Hydrogen ion; pH = ? nanomole/liter Authority: IFCC/C-BGE System(specification)— NPU02413 Hydrogen ion; P(aB)—Hydrogen ion; subst.c.(body temp.) = ? pH nmol/l NPU10126 Syst(spec.)—Hydrogen ion; pH = ? Plasma(capillary Blood)— Hydrogen ion; Plasma(arterial Blood)— substance concentration(patient body Hydrogen ion; temperature) substance concentration(37 °C) nanomole/liter nanomole/liter NPU12497 NPU12475 P(cB)—Hydrogen ion; subst.c.(body temp.) = ? P(aB)—Hydrogen ion; subst.c.(37 °C) = ? nmol/l nmol/l

Plasma(capillary Blood)— Plasma(cord Blood)— Hydrogen ion; Hydrogen ion; substance concentration(37 °C) substance concentration(patient body nanomole/liter temperature) NPU12494 nanomole/liter P(cB)—Hydrogen ion; subst.c.(37 °C) = ? nmol/l NPU12499 P(cordB)—Hydrogen ion; subst.c.(body temp.) = ? Plasma(cord Blood)— nmol/l Hydrogen ion; substance concentration(37 °C) Plasma(cord Blood; arterial Blood)— nanomole/liter Hydrogen ion; NPU12496 substance concentration(patient body P(cordB)—Hydrogen ion; subst.c.(37 °C) = ? nmol/l temperature) nanomole/liter Plasma(cord Blood; arterial Blood)— NPU17153 Hydrogen ion; P(cordB; aB)—Hydrogen ion; subst.c.(body temp.) = substance concentration(37 °C) ? nmol/l nanomole/liter NPU17151 Plasma(cord Blood; venous Blood)— P(cordB; aB)—Hydrogen ion; subst.c.(37 °C) = ? Hydrogen ion; nmol/l substance concentration(patient body temperature) Plasma(cord Blood; venous Blood)— nanomole/liter Hydrogen ion; NPU17154 substance concentration(37 °C) P(cordB; vB)—Hydrogen ion; subst.c.(body temp.) = nanomole/liter ? nmol/l NPU17152 P(cordB; vB)—Hydrogen ion; subst.c.(37 °C) = ? Plasma(mixed Blood)— nmol/l Hydrogen ion; substance concentration(patient body Plasma(mixed Blood)— temperature) Hydrogen ion; nanomole/liter substance concentration(37 °C) Authority: IFCC/C-BGE nanomole/liter NPU09213 NPU09212 P(mixB)—Hydrogen ion; subst.c.(body temp.) = ? P(mixB)—Hydrogen ion; subst.c.(37 °C) = ? nmol/l nmol/l

Plasma(venous Blood)— Urine— Hydrogen ion; 11-b- substance concentration(patient body Hydroxyandrosterone; temperature) substance concentration nanomole/liter micromole/liter NPU12498 M = 306,43 g/mol P(vB)—Hydrogen ion; subst.c.(body temp.) = ? NPU02422 nmol/l U—11-b-Hydroxyandrosterone; subst.c. = ? µmol/l

Dialysis solution— Urine— Hydrogen ion; 3- substance concentration Hydroxyasparagine/Creatininium; nanomole/liter substance ratio Authority: IFCC/C-BGE 10-3 NPU14922 NPU14222 Dialysis solution—Hydrogen ion; subst.c. = ? nmol/l U—3-Hydroxyasparagine/Creatininium; subst.ratio = ? × 10-3 Urine— Hydrogen ion; Urine— substance concentration 3- nanomole/liter Hydroxyasparagine; Authority: IFCC/C-BGE substance concentration NPU03848 mole/liter U—Hydrogen ion; subst.c. = ? nmol/l NPU02423 U—3-Hydroxyasparagine; subst.c.= ? prefix ? mol/l Stomach fluid— Hydrogen ion; Urine— substance rate(procedure) a- millimole/day Hydroxy-b-chito-g-aminobutyrate/Creatininium; NPU14357 substance ratio Stomf—Hydrogen ion; subst.rate(proc.) = ? mmol/d 10-3 NPU14221 Cobalamin(Plasma)— U—a-Hydroxy-b-chito-g-aminobutyrate/ Hydroxocobalamin; Creatininium; subst.ratio = ? × 10-3 substance fraction NPU04955 Urine— Cobalamin(P)—Hydroxocobalamin; subst.fr. = ? a- Hydroxy-b-chito-g-aminobutyrate; Urine— substance concentration 3- mole/liter Hydroxy-3-carboxy-n-propylthio-cystine/ NPU02418 Creatininium; U—a-Hydroxy-b-chito-g-aminobutyrate; subst.c.= ? substance ratio prefix ? mol/l 10-3 NPU14220 Plasma— U—3-Hydroxy-3-carboxy-n-propylthio-cystine/ 3- Creatininium; subst.ratio = ? × 10-3 Hydroxybutyrate; substance concentration Urine— millimole/liter 3- NPU02424 Hydroxy-3-carboxy-n-propylthio-cystine; P—3-Hydroxybutyrate; subst.c. = ? mmol/l substance concentration mole/liter Urine— NPU02416 4- U—3-Hydroxy-3-carboxy-n-propylthio-cystine; Hydroxybutyrate; subst.c.= ? prefix ? mol/l substance concentration millimole/liter Urine— NPU02425 3- U—4-Hydroxybutyrate; subst.c. = ? mmol/l Hydroxy-3-methylglutarate; substance concentration mole/liter NPU02417 U—3-Hydroxy-3-methylglutarate; subst.c.= ? prefix ? mol/l

Cerebrospinal fluid— NPU10443 U—17-Hydroxycorticosteroid; am.s.(-1d b- - 0 d) = ? µmol Hydroxybutyrate; NPU10444 U—17-Hydroxycorticosteroid; am.s.(0-1 substance concentration d) = ? µmol millimole/liter NPU10445 U—17-Hydroxycorticosteroid; am.s.(1-2 NPU02426 d) = ? µmol Csf—b-Hydroxybutyrate; subst.c. = ? mmol/l NPU10446 U—17-Hydroxycorticosteroid; am.s.(2-3 d) = ? µmol Plasma— b- Urine— Hydroxybutyrate; 17- substance concentration Hydroxycorticosteroid; millimole/liter amount-of-substance(1 day to 0 day before NPU02427 challenge) P—b-Hydroxybutyrate; subst.c. = ? mmol/l micromole NPU10443 Plasma— U—17-Hydroxycorticosteroid; am.s.(-1d - 0 d) = ? (24R)- µmol Hydroxycalcidiol; substance concentration Urine— nanomole/liter 17- M = 416,3 g/mol Hydroxycorticosteroid; Authority: IUPAC-IUB81 amount-of-substance(0-1 day after challenge) NPU02428 micromole P—(24R)-Hydroxycalcidiol; subst.c. = ? nmol/l NPU10444 U—17-Hydroxycorticosteroid; am.s.(0-1 d) = ? µmol Adrenal cortex— 17- Urine— Hydroxycorticosteroid secretion; 17- substance rate(dexamethasone, oral Hydroxycorticosteroid; administration; list; procedure) amount-of-substance(1-2 days after challenge) Note: M (dexamethasone) = 392,5 g/mol micromole NPU10442 NPU10445 Adrenal cortex—17-Hydroxycorticosteroid U—17-Hydroxycorticosteroid; am.s.(1-2 d) = ? µmol secretion; subst.rate(dexamethasone p.o.; list; proc.) Urine— NPU09115 Pt—Dexamethasone(administered); 17- number of doses = ? Hydroxycorticosteroid; NPU09116 Pt—Dexamethasone(administered); amount-of-substance(2-3 days after challenge) time int.(between doses) = ? min micromole NPU10532 Pt—Dexamethasone(administered); NPU10446 am.s.(single dose p.o.) = ? µmol U—17-Hydroxycorticosteroid; am.s.(2-3 d) = ? µmol NPU10443 U—17-Hydroxycorticosteroid; am.s.(-1d - 0 d) = ? µmol Patient(Urine)— NPU10444 U—17-Hydroxycorticosteroid; am.s.(0-1 17- d) = ? µmol Hydroxycorticosteroid; NPU10445 U—17-Hydroxycorticosteroid; am.s.(1-2 substance rate(procedure) d) = ? µmol micromole/day NPU10446 U—17-Hydroxycorticosteroid; am.s.(2-3 NPU09094 d) = ? µmol Pt(U)—17-Hydroxycorticosteroid; subst.rate(proc.) = ? µmol/d Adrenal cortex— 17- Urine— Hydroxycorticosteroid secretion; 5- substance rate(tetracosactide, intramuscular Hydroxyindolylacetate; administration; list; procedure) amount-of-substance(procedure) Note: M (tetracosactide) = 2 933,57 g/mol; M (17- micromole hydroxycorticosteroid) = ? g/mol NPU17541 NPU10447 U—5-Hydroxyindolylacetate; am.s.(proc.) = ? µmol Adrenal cortex—17-Hydroxycorticosteroid secretion; subst.rate(tetracosactide i.m.; list; proc.) Urine— NPU10534 Pt—Tetracosactide(administered); 5- am.s.(i.m.) = ? nmol Hydroxyindolylacetate; arbitrary concentration(procedure) NPU10014 U—5-Hydroxyindolylacetate; arb.c.(proc.) = ? © 2000 IUPAC, Pure and Applied Chemistry 72, 747–972 Properties and units in general clinical chemistry 881

Urine— Urine— 5- 5- Hydroxyindolylacetate; Hydroxylysine/Creatininium; substance concentration substance ratio micromole/liter 10-3 Other term(s): 5-HIAA NPU14225 NPU02430 U—5-Hydroxylysine/Creatininium; subst.ratio = ? × U—5-Hydroxyindolylacetate; subst.c. = ? µmol/l 10-3

Cerebrospinal fluid— Plasma— 5- 5- Hydroxyindolylacetate; Hydroxylysine; substance concentration substance concentration nanomole/liter micromole/liter Other term(s): 5-HIAA M = 162,1 g/mol NPU02429 NPU02433 Csf—5-Hydroxyindolylacetate; subst.c. = ? nmol/l P—5-Hydroxylysine; subst.c. = ? µmol/l

Patient(Urine)— Urine— 5- 5- Hydroxyindolylacetate; Hydroxylysine; substance rate(procedure) substance concentration micromole/day micromole/liter Other term(s): 5-HIAA-excretion M = 162,1 g/mol NPU03939 NPU02434 Pt(U)—5-Hydroxyindolylacetate; subst.rate(proc.) = U—5-Hydroxylysine; subst.c. = ? µmol/l ? µmol/d Adrenal cortex— Urine— 17- 3- Hydroxyprogesterone secretion; Hydroxyisovalerate/Creatininium; substance rate(tetracosactide, intravenous substance ratio administration; list; procedure) 10-3 Note: M (tetracosactide) = 2 933,57 g/mol; M NPU14223 (hydroxyprogesterone) = 330,47 g/mol U—3-Hydroxyisovalerate/Creatininium; subst.ratio = NPU02461 ? × 10-3 Adrenal cortex—17-Hydroxyprogesterone secretion; subst.rate(tetracosactide i.v.; list; proc.) Urine— NPU10688 Pt—Tetracosactide(administered); 3- am.s.(i.v.) = ? nmol Hydroxyisovalerate; NPU10689 Pt—Tetracosactide(administered); substance concentration subst.cont.(i.v.; am.s./body mass) = ? nmol/kg mole/liter NPU04977 P—17-Hydroxyprogesterone; subst.c.(0 NPU02431 min) = ? nmol/l U—3-Hydroxyisovalerate; subst.c.= ? prefix ? mol/l NPU04978 P—17-Hydroxyprogesterone; subst.c.(30 min) = ? nmol/l Urine— 3- Plasma— Hydroxykynurenine/Creatininium; 17- substance ratio Hydroxyprogesterone; 10-3 substance concentration(0 minutes after NPU14224 challenge) U—3-Hydroxykynurenine/Creatininium; subst.ratio = nanomole/liter ? × 10-3 NPU04977 P—17-Hydroxyprogesterone; subst.c.(0 min) = ? Urine— nmol/l 3- Hydroxykynurenine; Plasma— substance concentration 17- mole/liter Hydroxyprogesterone; M = 224,2 g/mol substance concentration(30 minutes after NPU02432 challenge) U—3-Hydroxykynurenine; subst.c.= ? prefix ? mol/l nanomole/liter NPU04978 P—17-Hydroxyprogesterone; subst.c.(30 min) = ? nmol/l

Plasma— Plasma— 17- 3- Hydroxyprogesterone; Hydroxyproline; substance concentration substance concentration nanomole/liter micromole/liter M = 330,47 g/mol M = 131,13 g/mol Authority: IUPAC-IUB NPU02463 NPU02460 P—3-Hydroxyproline; subst.c. = ? µmol/l P—17-Hydroxyprogesterone; subst.c. = ? nmol/l Urine— Patient(Urine)— 3- Hydroxyproline(free); Hydroxyproline; substance rate(procedure) substance concentration micromole/day micromole/liter NPU02462 M = 131,13 g/mol Pt(U)—Hydroxyproline(free); subst.rate(proc.) = ? NPU09024 µmol/d U—3-Hydroxyproline; subst.c. = ? µmol/l

Patient(Urine)— Cerebrospinal fluid— Hydroxyproline(total); 4- substance rate(procedure) Hydroxyproline; micromole/day substance concentration NPU02466 micromole/liter Pt(U)—Hydroxyproline(tot.); subst.rate(proc.) = ? M = 131,13 g/mol µmol/d NPU09026 Csf—4-Hydroxyproline; subst.c. = ? µmol/l Urine— 3- Plasma— Hydroxyproline/Creatininium; 4- substance ratio Hydroxyproline; 10-3 substance concentration NPU14228 micromole/liter U—3-Hydroxyproline/Creatininium; subst.ratio = ? × M = 131,13 g/mol 10-3 NPU02464 P—4-Hydroxyproline; subst.c. = ? µmol/l Urine— 4- Urine— Hydroxyproline/Creatininium; 4- substance ratio Hydroxyproline; 10-3 substance concentration NPU14226 micromole/liter U—4-Hydroxyproline/Creatininium; subst.ratio = ? × M = 131,13 g/mol 10-3 NPU02465 U—4-Hydroxyproline; subst.c. = ? µmol/l Urine— Hydroxyproline/Creatininium; Plasma— substance ratio L- 10-3 Iditol dehydrogenase; NPU04210 catalytic-activity concentration(37 °C; U—Hydroxyproline/Creatininium; subst.ratio= ? × procedure) 10-3 katal/liter Other term(s): Polyol dehydrogenase; Sorbitol Cerebrospinal fluid— dehydrogenase 3- NPU02469 Hydroxyproline; P—L-Iditol dehydrogenase; cat.c.(37 °C; proc.)= ? substance concentration prefix ? kat/l micromole/liter M = 131,13 g/mol Amniotic fluid— NPU09025 L- Csf—3-Hydroxyproline; subst.c. = ? µmol/l Iditol dehydrogenase; catalytic-activity concentration(37 °C; procedure) microkatal/liter NPU03909

Amf—L-Iditol dehydrogenase; cat.c.(37 °C; proc.) = micromole/liter ? µkat/l M = 160 000 g/mol NPU09336 Plasma— Csf—Immunoglobulin A; subst.c. = ? µmol/l Immune complexes(C1q binding); arbitrary concentration(procedure) Plasma— Authority: ICW91 Immunoglobulin A; NPU02474 substance concentration P—Immune complexes(C1q bind.); arb.c.(proc.) = ? micromole/liter M = 160 000 g/mol Plasma— NPU02476 Immunoglobulin A antibody(Immunoglobulin G); P—Immunoglobulin A; subst.c. = ? µmol/l arbitrary substance concentration(procedure) 10³ arbitrary unit/liter Saliva— NPU14512 Immunoglobulin A; P—Immunoglobulin A antibody(IgG); substance concentration arb.subst.c.(proc.) = ? × 10³ arb.unit/l micromole/liter M = 160 000 g/mol Plasma— NPU02477 Immunoglobulin A antibody(Immunoglobulin M); Saliva—Immunoglobulin A; subst.c. = ? µmol/l arbitrary substance concentration(procedure) 10³ arbitrary unit/liter Plasma— NPU14513 Immunoglobulin D; P—Immunoglobulin A antibody(IgM); arbitrary substance concentration arb.subst.c.(proc.) = ? × 10³ arb.unit/l arbitrary unit/liter M = 170 000 g/mol Plasma— NPU14663 Immunoglobulin A antibody; P—Immunoglobulin D; arb.subst.c. = ? arb.unit/l arbitrary substance concentration(list; procedure) Plasma— NPU17669 Immunoglobulin D; P—Immunoglobulin A antibody; arb.subst.c.(list; substance concentration proc.) micromole/liter NPU14512 P—Immunoglobulin A antibody(IgG); M = 170 000 g/mol arb.subst.c.(proc.) = ? × 10³ arb.unit/l NPU02479 NPU14513 P—Immunoglobulin A antibody(IgM); P—Immunoglobulin D; subst.c. = ? µmol/l arb.subst.c.(proc.) = ? × 10³ arb.unit/l Central nervous system— Central nervous system— Immunoglobulin G production; Immunoglobulin A production; arbitrary rate(procedure) arbitrary rate(procedure) Other term(s): IgG Index NPU17680 Note1: M(albumin) = 66 000 g/mol; Cns—Immunoglobulin A production; arb.rate(proc.) M(immunglobulin G) = 160 000 g/mol = ? Note2: calculated from (a × d)/(b × c) a: [NPU01132] P—Albumin; subst.c. = ? µmol/l Plasma— b: [NPU01130] Csf—Albumin; subst.c. = ? µmol/l Immunoglobulin A; c: [NPU02481] P—Immunoglobulin G; subst.c. = ? arbitrary concentration(procedure) µmol/l NPU02478 d: [NPU04099] Csf—Immunoglobulin G; subst.c.= ? P—Immunoglobulin A; arb.c.(proc.) = ? µmol/l NPU02485 Cerebrospinal fluid— Cns—Immunoglobulin G production; arb.rate(proc.) Immunoglobulin A; = ? relative substance concentration(Cerebrospinal fluid/Plasma) Central nervous system— M = 160 000 g/mol Immunoglobulin G production; Note: Calculated from: NPU09336 and NPU02476 property(list; procedure) NPU09337 NPU17072 Csf—Immunoglobulin A; rel.subst.c.(Csf/P) = ? Cns—Immunoglobulin G production; prop.(list; proc.) Cerebrospinal fluid— NPU02485 Cns—Immunoglobulin G production; Immunoglobulin A; arb.rate(proc.) = ? substance concentration NPU17076 Csf—Immunoglobulin oligocloni; arb.c.(proc.) = ?

Plasma— Plasma— Immunoglobulin G subclasses; Immunoglobulin G; substance concentration(list; procedure) substance concentration Note: M (IgG1) = 146 000; M (IgG2) =146 000; M micromole/liter (IgG3) = 170 000; M (IgG4) = 146 000 g/mol M = 160 000 g/mol NPU02486 NPU02481 P—Immunoglobulin G subclasses; subst.c.(list; P—Immunoglobulin G; subst.c. = ? µmol/l proc.) NPU10500 P—Immunoglobulin G1; subst.c. = ? Urine— µmol/l Immunoglobulin G; NPU10501 P—Immunoglobulin G2; subst.c. = ? substance concentration µmol/l micromole/liter NPU10502 P—Immunoglobulin G3; subst.c. = ? M = 160 000 g/mol µmol/l NPU04101 NPU10503 P—Immunoglobulin G4; subst.c. = ? U—Immunoglobulin G; subst.c.= ? µmol/l µmol/l Plasma— Plasma— Immunoglobulin G1; Immunoglobulin G subclasses; substance concentration taxon(procedure) micromole/liter NPU10608 M = 146 000 g/mol P—Immunoglobulin G subclasses; taxon(proc.) = ? NPU10500 P—Immunoglobulin G1; subst.c. = ? µmol/l Cerebrospinal fluid— Immunoglobulin G/Albumin; Plasma— relative substance ratio(Cerebrospinal fluid/ Immunoglobulin G2; Plasma) substance concentration NPU04029 micromole/liter Csf—Immunoglobulin G/Albumin; M = 146 000 g/mol rel.subst.ratio(Csf/P) = ? NPU10501 P—Immunoglobulin G2; subst.c. = ? µmol/l Erythrocytes(Blood)— Immunoglobulin G; Plasma— arbitrary entitic number(procedure) Immunoglobulin G3; M = 160 000 g/mol substance concentration Other term(s): IgG micromole/liter NPU04070 M = 170 000 g/mol Ercs(B)—Immunoglobulin G; arb.entitic num.(proc.) NPU10502 = ? P—Immunoglobulin G3; subst.c. = ? µmol/l

Erythrocytes(Blood)— Plasma— Immunoglobulin G; Immunoglobulin G4; entitic number(procedure) substance concentration M = 160 000 g/mol micromole/liter Other term(s): IgG M = 146 000 g/mol NPU01948 NPU10503 Ercs(B)—Immunoglobulin G; entitic num.(proc.) = ? P—Immunoglobulin G4; subst.c. = ? µmol/l

Cerebrospinal fluid— Central nervous system— Immunoglobulin G; Immunoglobulin M production; relative substance concentration(Cerebrospinal arbitrary rate(procedure) fluid/Plasma) NPU17681 M = 160 000 g/mol Cns—Immunoglobulin M production; arb.rate(proc.) Note: Calculated from: NPU04099 and NPU2481 = ? NPU09335 Csf—Immunoglobulin G; rel.subst.c.(Csf/P) = ? Cerebrospinal fluid— Immunoglobulin M; Cerebrospinal fluid— relative substance concentration(Cerebrospinal Immunoglobulin G; fluid/Plasma) substance concentration M = 950 000 g/mol micromole/liter Note: Calculated from: NPU09338 and NPU02488 M = 160 000 g/mol NPU09339 NPU04099 Csf—Immunoglobulin M; rel.subst.c.(Csf/P) = ? Csf—Immunoglobulin G; subst.c.= ? µmol/l

Cerebrospinal fluid— NPU10690 Pt—Glucagon(administered); Immunoglobulin M; subst.cont.(i.m.; am.s./body mass) = ? nmol/kg substance concentration NPU08715 P—Insulin; subst.c.(0 min) = ? pmol/l micromole/liter NPU10656 P—Insulin; subst.c.(6 min) = ? pmol/l M = 950 000 g/mol NPU08702 P—Insulin; subst.c.(15 min) = ? pmol/l NPU09338 NPU08705 P—Insulin; subst.c.(60 min) = ? pmol/l Csf—Immunoglobulin M; subst.c. = ? µmol/l NPU08707 P—Insulin; subst.c.(90 min) = ? pmol/l NPU08708 P—Insulin; subst.c.(120 min) = ? pmol/l Plasma— NPU10657 P—Insulin; arb.subst.c.(IRP 66/304; 0 Immunoglobulin M; min; proc.) = ? × 10-3 int.unit/l substance concentration NPU10658 P—Insulin; arb.subst.c.(IRP 66/304; 6 micromole/liter min; proc.) = ? × 10-3 int.unit/l M = 950 000 g/mol NPU10659 P—Insulin; arb.subst.c.(IRP 66/304; 15 NPU02488 min; proc.) = ? × 10-3 int.unit/l P—Immunoglobulin M; subst.c. = ? µmol/l NPU10660 P—Insulin; arb.subst.c.(IRP 66/304; 60 min; proc.) = ? × 10-3 int.unit/l Urine— NPU10692 P—Insulin; arb.subst.c.(IRP 66/304; 90 Immunoglobulin M; min; proc.) = ? × 10-3 int.unit/l substance concentration NPU10661 P—Insulin; arb.subst.c.(IRP 66/304; 120 micromole/liter min; proc.) = ? × 10-3 int.unit/l M = 950 000 g/mol NPU08503 B—Glucose; subst.c.(0 min) = ? mmol/l NPU08573 NPU10655 B—Glucose; subst.c.(6 min) = ? mmol/l U—Immunoglobulin M; subst.c. = ? µmol/l NPU08516 B—Glucose; subst.c.(15 min) = ? mmol/l Cerebrospinal fluid— NPU08501 B—Glucose; subst.c.(60 min) = ? Immunoglobulin oligocloni; mmol/l arbitrary concentration(procedure) NPU08506 B—Glucose; subst.c.(90 min) = ? NPU17076 mmol/l Csf—Immunoglobulin oligocloni; arb.c.(proc.) = ? NPU08507 B—Glucose; subst.c.(120 min) = ? mmol/l Plasma— Inhibin; Pancreatic b-cell— substance concentration Insulin secretion; picomole/liter substance rate(glucose, oral administration; list; M = 32 000 g/mol procedure) NPU02492 Note: M (glucose) = 180,16 g/mol; M (insulin) = 5 P—Inhibin; subst.c. = ? pmol/l 807,65 g/mol NPU10471 Plasma— Pancreatic b-cell—Insulin secretion; Insulin antibody(Immunoglobulin G); subst.rate(glucose p.o.; list; proc.) arbitrary substance concentration(procedure) NPU10574 Pt—Glucose(administered); am.s.(p.o.) arbitrary unit/liter = ? mmol NPU12039 NPU08715 P—Insulin; subst.c.(0 min) = ? pmol/l P—Insulin antibody(IgG); arb.subst.c.(proc.) = ? NPU08703 P—Insulin; subst.c.(30 min) = ? pmol/l arb.unit/l NPU08705 P—Insulin; subst.c.(60 min) = ? pmol/l NPU08708 P—Insulin; subst.c.(120 min) = ? pmol/l Plasma— NPU08709 P—Insulin; subst.c.(180 min) = ? pmol/l Insulin antibody; NPU10469 P—Insulin; subst.c.(240 min) = ? pmol/l arbitrary substance concentration(procedure) NPU10470 P—Insulin; subst.c.(300 min) = ? pmol/l 10³ arbitrary unit/liter NPU08710 P—Insulin; subst.c.(360 min) = ? pmol/l NPU14359 NPU08756 P—Insulin; subst.c.(max.; proc.) = ? P—Insulin antibody; arb.subst.c.(proc.) = ? × 10³ pmol/l arb.unit/l Pancreatic b-cell— Pancreatic b-cell— Insulin secretion; Insulin secretion; substance rate(leucine, oral administration; list; substance rate(glucagon, intramuscular procedure) administration; list; procedure) Note: M (leucine) = 131,17 g/mol; M (insulin) = 5 Note: M (glucagon) = 3 482,8 g/mol; M (insulin) = 5 807,65 g/mol 807,65 g/mol NPU02591 NPU10663 Pancreatic b-cell—Insulin secretion; Pancreatic b-cell—Insulin secretion; subst.rate(leucine p.o.; list; proc.) subst.rate(glucagon i.m.; list; proc.) NPU10598 Pt—Leucine(administered); am.s.(p.o.) = NPU10662 Pt—Glucagon(administered); am.s.(i.m.) ? mmol = ? nmol

NPU10599 Pt—Leucine(administered); Pt—Insulin(administered); arb.subst.cont.(i.v.; subst.cont.(p.o.; am.s./body mass) = ? mmol/kg arb.am.s./body mass; proc.) = ? int. unit/kg NPU08715 P—Insulin; subst.c.(0 min) = ? pmol/l NPU08702 P—Insulin; subst.c.(15 min) = ? pmol/l Patient— NPU08703 P—Insulin; subst.c.(30 min) = ? pmol/l Insulin(administered); NPU08704 P—Insulin; subst.c.(45 min) = ? pmol/l substance content(intravenous administration; NPU08705 P—Insulin; subst.c.(60 min) = ? pmol/l amount-of-substance/body mass) NPU08706 P—Insulin; subst.c.(75 min) = ? pmol/l micromole/kilogram NPU08707 P—Insulin; subst.c.(90 min) = ? pmol/l M = 5 807,65 g/mol NPU08708 P—Insulin; subst.c.(120 min) = ? pmol/l NPU10547 NPU08709 P—Insulin; subst.c.(180 min) = ? pmol/l Pt—Insulin(administered); subst.cont.(i.v.; am.s./ NPU08710 P—Insulin; subst.c.(360 min) = ? pmol/l body mass) = ? µmol/kg NPU08756 P—Insulin; subst.c.(max.; proc.) = ? pmol/l Plasma— NPU04173 P—Glucose; subst.c.(0 min) = ? mmol/l Insulin; NPU04186 P—Glucose; subst.c.(15 min) = ? arbitrary substance concentration(IRP 66/304; 0 mmol/l minutes after challenge; procedure) NPU04174 P—Glucose; subst.c.(30 min) = ? 10-3 international unit/liter mmol/l NPU10657 NPU04187 P—Glucose; subst.c.(45 min) = ? P—Insulin; arb.subst.c.(IRP 66/304; 0 min; proc.) = mmol/l ? × 10-3 int.unit/l NPU04175 P—Glucose; subst.c.(60 min) = ? mmol/l Plasma— NPU04965 P—Glucose; subst.c.(75 min) = ? Insulin; mmol/l arbitrary substance concentration(IRP 66/304; NPU04176 P—Glucose; subst.c.(90 min) = ? 120 minutes after challenge; procedure) mmol/l 10-3 international unit/liter NPU04177 P—Glucose; subst.c.(120 min) = ? NPU10661 mmol/l P—Insulin; arb.subst.c.(IRP 66/304; 120 min; proc.) NPU04179 P—Glucose; subst.c.(180 min) = ? = ? × 10-3 int.unit/l mmol/l NPU04185 P—Glucose; subst.c.(360 min) = ? Plasma— mmol/l Insulin; NPU04981 P—Glucose; subst.c.(min.; proc.) = ? arbitrary substance concentration(IRP 66/304; mmol/l 15 minutes after challenge; procedure) 10-3 international unit/liter Pancreatic b-cell— NPU10659 Insulin secretion; P—Insulin; arb.subst.c.(IRP 66/304; 15 min; proc.) = substance rate(tolbutamide, intravenous ? × 10-3 int.unit/l administration; list; procedure) Note: M (tolbutamide) = 270,34 g/mol; M (insulin) = Plasma— 5 807,65 g/mol Insulin; NPU10468 arbitrary substance concentration(IRP 66/304; 6 Pancreatic b-cell—Insulin secretion; minutes after challenge; procedure) subst.rate(tolbutamide i.v.; list; proc.) 10-3 international unit/liter NPU10467 Pt—Tolbutamide(administered); NPU10658 am.s.(i.v.) = ? mmol P—Insulin; arb.subst.c.(IRP 66/304; 6 min; proc.) = NPU13487 Pt—Tolbutamide(administered); ? × 10-3 int.unit/l subst.cont.(i.v.; am.s./body mass) = ? µmol/kg NPU08715 P—Insulin; subst.c.(0 min) = ? pmol/l Plasma— NPU08703 P—Insulin; subst.c.(30 min) = ? pmol/l Insulin; NPU08705 P—Insulin; subst.c.(60 min) = ? pmol/l arbitrary substance concentration(IRP 66/304; NPU08707 P—Insulin; subst.c.(90 min) = ? pmol/l 60 minutes after challenge; procedure) NPU08708 P—Insulin; subst.c.(120 min) = ? pmol/l 10-3 international unit/liter NPU10235 P—Insulin; subst.c.(150 min) = ? pmol/l NPU10660 NPU08709 P—Insulin; subst.c.(180 min) = ? pmol/l P—Insulin; arb.subst.c.(IRP 66/304; 60 min; proc.) = ? × 10-3 int.unit/l Patient— Insulin(administered); Plasma— arbitrary substance content(intravenous Insulin; administration; arbitrary amount-of-substance/ arbitrary substance concentration(IRP 66/304; body m; procedure) 90 minutes after challenge; procedure) international unit/kilogram 10-3 international unit/liter M = 5 807,65 g/mol NPU10692 NPU10548

P—Insulin; arb.subst.c.(IRP 66/304; 90 min; proc.) = NPU08706 ? × 10-3 int.unit/l P—Insulin; subst.c.(75 min) = ? pmol/l

Plasma— Plasma— Insulin; Insulin; arbitrary substance concentration(IRP 66/304; substance concentration(90 minutes after procedure) challenge) 10-3 international unit/liter picomole/liter NPU02496 NPU08707 P—Insulin; arb.subst.c.(IRP 66/304; proc.) = ? × 10- P—Insulin; subst.c.(90 min) = ? pmol/l 3 int.unit/l Plasma— Plasma— Insulin; Insulin; substance concentration(120 minutes after substance concentration(0 minutes after challenge) challenge) picomole/liter picomole/liter NPU08708 NPU08715 P—Insulin; subst.c.(120 min) = ? pmol/l P—Insulin; subst.c.(0 min) = ? pmol/l Plasma— Plasma— Insulin; Insulin; substance concentration(150 minutes after substance concentration(6 minutes after challenge) challenge) picomole/liter picomole/liter NPU10235 NPU10656 P—Insulin; subst.c.(150 min) = ? pmol/l P—Insulin; subst.c.(6 min) = ? pmol/l Plasma— Plasma— Insulin; Insulin; substance concentration(180 minutes after substance concentration(15 minutes after challenge) challenge) picomole/liter picomole/liter NPU08709 NPU08702 P—Insulin; subst.c.(180 min) = ? pmol/l P—Insulin; subst.c.(15 min) = ? pmol/l Plasma— Plasma— Insulin; Insulin; substance concentration(240 minutes after substance concentration(30 minutes after challenge) challenge) picomole/liter picomole/liter NPU10469 NPU08703 P—Insulin; subst.c.(240 min) = ? pmol/l P—Insulin; subst.c.(30 min) = ? pmol/l Plasma— Plasma— Insulin; Insulin; substance concentration(300 minutes after substance concentration(45 minutes after challenge) challenge) picomole/liter picomole/liter NPU10470 NPU08704 P—Insulin; subst.c.(300 min) = ? pmol/l P—Insulin; subst.c.(45 min) = ? pmol/l Plasma— Plasma— Insulin; Insulin; substance concentration(360 minutes after substance concentration(60 minutes after challenge) challenge) picomole/liter picomole/liter NPU08710 NPU08705 P—Insulin; subst.c.(360 min) = ? pmol/l P—Insulin; subst.c.(60 min) = ? pmol/l Plasma— Plasma— Insulin; Insulin; substance concentration(maximum; procedure) substance concentration(75 minutes after picomole/liter challenge) NPU08756 picomole/liter P—Insulin; subst.c.(max.; proc.) = ? pmol/l

Plasma— Plasma— Insulin; Interferon beta antibody; substance concentration increment(maximum arbitrary substance concentration(procedure) concentration minus 0 minutes concentration) arbitrary unit/liter picomole/liter NPU12890 NPU04979 P—Interferon beta antibody; arb.subst.c.(proc.) = ? P—Insulin; subst.c.incr.(max. c. minus 0 min c.) = ? arb.unit/l pmol/l Plasma— Plasma(fasting Patient)— Interferon; Insulin; arbitrary substance concentration(procedure) substance concentration arbitrary unit/liter picomole/liter M = 20 000 g/mol M = 5 807,65 g/mol NPU09121 Authority: IUPAC-IUB 74 P—Interferon; arb.subst.c.(proc.) = ? arb.unit/l NPU02497 P(fPt)—Insulin; subst.c. = ? pmol/l Plasma— Interferon; Plasma— substance concentration Insulin-like growth factor I; mole/liter arbitrary substance concentration(IRR 87/518; M = 20 000 g/mol procedure) NPU09120 international unit/liter P—Interferon; subst.c.= ? prefix ? mol/l M = 7 649 g/mol Recommended calibrator: WHO 1st IRR 87/518 Plasma— Other term(s): Somatomedin C Intrinsic factor antibody; NPU02498 arbitrary concentration(procedure) P—Insulin-like growth factor I; arb.subst.c.(IRR 87/ NPU02503 518; proc.) = ? int. unit/l P—Intrinsic factor antibody; arb.c.(proc.) = ?

Plasma— Patient— Insulin-like growth factor I; Intrinsic factor secretion; substance concentration substance rate(pentagastrin, subcutaneous nanomole/liter administration; list; procedure) M = 7 649 g/mol Note: M (intrinsic factor) = 50 000 g/mol; M Other term(s): Somatomedin C (pentagastrin) = 767,9 g/mol NPU02499 NPU14031 P—Insulin-like growth factor I; subst.c. = ? nmol/l Pt—Intrinsic factor secretion; subst.rate(pentagastrin s.c.; list; proc.) Plasma— NPU10477 Pt—Pentagastrin(administered); Insulin-like growth factor II; subst.cont.(i.v.; am.s./body mass) = ? nmol/kg substance concentration NPU14032 Stomf—Intrinsic factor; am.s.(0-60 min) nanomole/liter = ? nmol M = 7 471 g/mol NPU14033 Stomf—Intrinsic factor; am.s.(60-120 Other term(s): Somatomedin MSA min) = ? nmol NPU02500 NPU14034 Stomf—Intrinsic factor; am.s.(120-180 P—Insulin-like growth factor II; subst.c. = ? nmol/l min) = ? nmol

Plasma— Stomach fluid— Insulinlike growthfactor-binding protein 3; Intrinsic factor; substance concentration amount-of-substance(0-60 minutes after nanomole/liter challenge) NPU10381 nanomole P—Insulinlike growthfactor-binding protein 3; NPU14032 subst.c. = ? nmol/l Stomf—Intrinsic factor; am.s.(0-60 min) = ? nmol

Plasma— Stomach fluid— Inter alpha inhibitor; Intrinsic factor; substance concentration amount-of-substance(60-120 minutes after mole/liter challenge) NPU02501 nanomole P—Inter alpha inhibitor; subst.c.= ? prefix ? mol/l NPU14033 Stomf—Intrinsic factor; am.s.(60-120 min) = ? nmol

Stomach fluid— NPU04192 Intrinsic factor; Pt(P)—Iron elimination; half-life(proc.)= ? min amount-of-substance(120-180 minutes after challenge) Patient(Plasma)— nanomole Iron turnover; NPU14034 substance rate Stomf—Intrinsic factor; am.s.(120-180 min) = ? micromole/day nmol NPU04193 Pt(P)—Iron turnover; subst.rate= ? µmol/d Stomach fluid— Intrinsic factor; Plasma— amount-of-substance(procedure) Iron; nanomole substance concentration Note: M (intrinsic factor) = 50 000 g/mol; M micromole/liter (pentagastrin) = ? g/mol M = 55,85 g/mol NPU02504 Authority: IUPAC/VII-C-TOX Stomf—Intrinsic factor; am.s.(proc.) = ? nmol NPU02508 P—Iron; subst.c. = ? µmol/l Stomach fluid— Intrinsic factor; Plasma(fasting Patient)— substance concentration Iron; nanomole/liter substance concentration M = 50 000 g/mol micromole/liter NPU02502 M = 55,85 g/mol Stomf—Intrinsic factor; subst.c. = ? nmol/l Authority: IUPAC/VII-C-TOX NPU10153 Urine— P(fPt)—Iron; subst.c. = ? µmol/l Iodine; substance concentration Urine— micromole/liter Iron; M = 126,90 g/mol substance concentration Authority: IUPAC/VII-C-TOX micromole/liter NPU04884 M = 55,85 g/mol U—Iodine; subst.c. = ? µmol/l Authority: IUPAC/VII-C-TOX NPU03940 Patient(Urine)— U—Iron; subst.c. = ? µmol/l Iodine; substance rate(procedure) Hair— micromole/day Iron; M = 126,90 g/mol substance content Authority: IUPAC/VII-C-TOX micromole/kilogram NPU02505 M = 55,85 g/mol Pt(U)—Iodine; subst.rate(proc.) = ? µmol/d Authority: IUPAC/VII-C-TOX NPU02506 Plasma— Hair—Iron; subst.cont. = ? µmol/kg Iron binding capacity(Fe; free); substance concentration Transferrin(Fe-binding sites; Plasma)— micromole/liter Iron; NPU04132 substance fraction P—Iron binding capacity(Fe; free); subst.c.= ? NPU04191 µmol/l Transferrin(Fe-binding sites; P)—Iron; subst.fr.= ?

Plasma— Patient(Urine)— Iron binding capacity(total); Iron; substance concentration substance rate(procedure) micromole/liter micromole/day Other term(s): TIBC M = 55,85 g/mol NPU04133 Authority: IUPAC/VII-C-TOX P—Iron binding capacity(tot.); subst.c.= ? µmol/l NPU02507 Pt(U)—Iron; subst.rate(proc.) = ? µmol/d Patient(Plasma)— Iron elimination; half-life(procedure) minute

Urine— Plasma- Isoleucine/Creatininium; Keratine antibody(Immunoglobulin G); substance ratio arbitrary substance concentration(procedure) 10-3 10³ arbitrary unit/liter NPU14229 NPU16399 U—Isoleucine/Creatininium; subst.ratio = ? × 10-3 P-Keratine antibody(IgG); arb.subst.c.(proc.) = ? × 10³ arb.unit/l Cerebrospinal fluid— Isoleucine; Plasma- substance concentration Keratine antibody; micromole/liter arbitrary concentration(procedure) M = 131,17 g/mol NPU02522 NPU09027 P-Keratine antibody; arb.c.(proc.) = ? Csf—Isoleucine; subst.c. = ? µmol/l Plasma- Plasma— Kidney+liver microsome antibody(Immunoglobulin Isoleucine; G); substance concentration arbitrary concentration(procedure) micromole/liter NPU12997 M = 131,17 g/mol P-Kidney+liver microsome antibody(IgG); NPU02510 arb.c.(proc.) = ? P—Isoleucine; subst.c. = ? µmol/l Urine- Urine— Kynurenine/Creatininium; Isoleucine; substance ratio substance concentration 10-3 micromole/liter NPU14230 M = 131,17 g/mol U-Kynurenine/Creatininium; subst.ratio = ? × 10-3 NPU02511 U—Isoleucine; subst.c. = ? µmol/l Urine- Kynurenine; Urine— substance concentration Kappa chain(Ig); mole/liter arbitrary concentration(procedure) M = 208,2 g/mol NPU04095 NPU02537 U—Kappa chain(Ig); arb.c.(proc.) = ? U-Kynurenine; subst.c.= ? prefix ? mol/l

Plasma— Plasma- Kappa chain(Ig); Lactate dehydrogenase H2M2; substance concentration catalytic-activity concentration(37 °C; micromole/liter procedure) NPU08634 microkatal/liter P—Kappa chain(Ig); subst.c.=? µmol/l Other term(s): LDH-3 Note: H(eart); M(uscle) Urine— NPU04104 Kappa chain(Ig); P-Lactate dehydrogenase H2M2; cat.c.(37 °C; substance concentration proc.)= ? µkat/l micromole/liter NPU04096 Lactate dehydrogenase(Plasma)- U—Kappa chain(Ig); subst.c.=? µmol/l Lactate dehydrogenase H2M2; catalytic-activity fraction(37 °C; procedure) Urine— Other term(s): LDH-3 Keratan sulfate; Note: H(eart); M(uscle) substance concentration NPU04109 mole/liter LDH(P)-Lactate dehydrogenase H2M2; cat.fr.(37 °C; Authority: IUPAC-IUB85 proc.)= ? NPU02521 U—Keratan sulfate; subst.c.= ? prefix ? mol/l Plasma— Lactate dehydrogenase H3M; Plasma- catalytic-activity concentration(37 °C; Keratine antibody(Immunoglobulin G); procedure) arbitrary concentration(procedure) microkatal/liter NPU12540 Other term(s): LDH-2 P-Keratine antibody(IgG); arb.c.(proc.) = ?

Note: H(eart); M(uscle) Lactate dehydrogenase(Plasma)— NPU04103 Lactate dehydrogenase M4; P—Lactate dehydrogenase H3M; cat.c.(37 °C; catalytic-activity fraction(37 °C; procedure) proc.)= ? µkat/l Other term(s): LDH-5 Note: H(eart); M(uscle) Lactate dehydrogenase(Plasma)— NPU04111 Lactate dehydrogenase H3M; LDH(P)—Lactate dehydrogenase M4; cat.fr.(37 °C; catalytic-activity fraction(37 °C; procedure) proc.)= ? Other term(s): LDH-2 Note: H(eart); M(uscle) Plasma— NPU04108 Lactate dehydrogenase type; LDH(P)—Lactate dehydrogenase H3M; cat.fr.(37 catalytic-activity concentration(list; 37 °C; °C; proc.)= ? procedure) Other term(s): H4 formerly coded LD1 (from anode) Plasma— or LD5 (from side of application) Lactate dehydrogenase H4; Note: H(eart); M(uscle) catalytic-activity concentration(37 °C; NPU02547 procedure) P—Lactate dehydrogenase type; cat.c.(list; 37 °C; microkatal/liter proc.) Other term(s): LDH-1 NPU02546 P—Lactate dehydrogenase; cat.c.(37 Note: H(eart); M(uscle) °C; proc.) = ? µkat/l NPU04102 NPU04102 P—Lactate dehydrogenase H4; P—Lactate dehydrogenase H4; cat.c.(37 °C; proc.)= cat.c.(37 °C; proc.)= ? µkat/l ? µkat/l NPU04103 P—Lactate dehydrogenase H3M; cat.c.(37 °C; proc.)= ? µkat/l Lactate dehydrogenase(Plasma)— NPU04104 P—Lactate dehydrogenase H2M2; Lactate dehydrogenase H4; cat.c.(37 °C; proc.)= ? µkat/l catalytic-activity fraction(37 °C; procedure) NPU04105 P—Lactate dehydrogenase HM3; Other term(s): LDH-1 cat.c.(37 °C; proc.)= ? µkat/l NPU04107 NPU04106 P—Lactate dehydrogenase M4; LDH(P)—Lactate dehydrogenase H4; cat.fr.(37 °C; cat.c.(37 °C; proc.)= ? µkat/l proc.)= ? Lactate dehydrogenase(Plasma)— Plasma— Lactate dehydrogenase type; Lactate dehydrogenase HM3; catalytic-activity fraction(list; 37 °C; procedure) catalytic-activity concentration(37 °C; Other term(s): H4 formerly coded LD1 (from anode) procedure) or LD5 (from side of application) microkatal/liter Note: H(eart); M(uscle) Other term(s): LDH-4 NPU02822 Note: H(eart); M(uscle) LDH(P)—Lactate dehydrogenase type; cat.fr.(list; NPU04105 37 °C; proc.) P—Lactate dehydrogenase HM3; cat.c.(37 °C; NPU04107 LDH(P)—Lactate dehydrogenase H4; proc.)= ? µkat/l cat.fr.(37 °C; proc.)= ? NPU04108 LDH(P)—Lactate dehydrogenase H3M; Lactate dehydrogenase(Plasma)— cat.fr.(37 °C; proc.)= ? Lactate dehydrogenase HM3; NPU04109 LDH(P)—Lactate dehydrogenase H2M2; catalytic-activity fraction(37 °C; procedure) cat.fr.(37 °C; proc.)= ? Other term(s): LDH-4 NPU04110 LDH(P)—Lactate dehydrogenase HM3; Note: H(eart); M(uscle) cat.fr.(37 °C; proc.)= ? NPU04110 NPU04111 LDH(P)—Lactate dehydrogenase M4; LDH(P)—Lactate dehydrogenase HM3; cat.fr.(37 cat.fr.(37 °C; proc.)= ? °C; proc.) = ? Amniotic fluid— Plasma— Lactate dehydrogenase; Lactate dehydrogenase M4; catalytic-activity concentration(37 °C; catalytic-activity concentration(37 °C; procedure) procedure) microkatal/liter microkatal/liter NPU03910 Other term(s): LDH-5 Amf—Lactate dehydrogenase; cat.c.(37 °C; proc.) = Note: H(eart); M(uscle) ? µkat/l NPU04106 P—Lactate dehydrogenase M4; cat.c.(37 °C; proc.)= ? µkat/l

Plasma— NPU10757 Lactate dehydrogenase; U—Lactate; subst.c. = ? mmol/l catalytic-activity concentration(37 °C; procedure) Patient(Urine)— microkatal/liter Lactate; Other term(s): Lactic acid dehydrogenase substance rate(procedure) NPU02546 micromole/day P—Lactate dehydrogenase; cat.c.(37 °C; proc.) = ? NPU17793 µkat/l Pt(U)—Lactate; subst.rate(proc.) = ? µmol/d

System(specification)— Plasma— Lactate dehydrogenase; Lactescence; catalytic-activity concentration(37 °C; arbitrary concentration(procedure) procedure) NPU17021 microkatal/liter P—Lactescence; arb.c.(proc.)= ? NPU10124 Syst(spec.)—Lactate dehydrogenase; cat.c.(37 °C; Plasma(fasting Patient)— proc.) = ? µkat/l Lactescence; arbitrary concentration(procedure) Plasma(fasting Patient)— NPU04194 Lactate; P(fPt)—Lactescence; arb.c.(proc.)= ? substance concentration micromole/liter Plasma— NPU17791 Lactoferrin antibody(Immunoglobulin G); P(fPt)—Lactate; subst.c. = ? µmol/l arbitrary concentration(procedure) NPU12577 Blood(arterial Blood)— P—Lactoferrin antibody(IgG); arb.c.(proc.) = ? Lactate; substance concentration Intestine, small— millimole/liter Lactose tolerance; NPU02544 property(lactose, oral administration; list; B(aB)—Lactate; subst.c. = ? mmol/l procedure) Note: M (lactose) = 342,30 g/mol Blood(venous Blood)— NPU02542 Lactate; Intest., small—Lactose tolerance; prop.(lactose p.o.; substance concentration list; proc.) millimole/liter NPU10576 Pt—Lactose(administered); am.s.(p.o.) = NPU03942 ? mmol B(vB)—Lactate; subst.c. = ? mmol/l NPU10577 Pt—Lactose(administered); subst.cont.(p.o.; am.s./body mass) = ? mmol/kg Cerebrospinal fluid— NPU08503 B—Glucose; subst.c.(0 min) = ? mmol/l Lactate; NPU08516 B—Glucose; subst.c.(15 min) = ? substance concentration mmol/l millimole/liter NPU08504 B—Glucose; subst.c.(30 min) = ? NPU02545 mmol/l Csf—Lactate; subst.c. = ? mmol/l NPU08517 B—Glucose; subst.c.(45 min) = ? mmol/l Plasma(arterial Blood)— NPU08501 B—Glucose; subst.c.(60 min) = ? Lactate; mmol/l substance concentration NPU08518 B—Glucose; subst.c.(75 min) = ? millimole/liter mmol/l NPU03943 NPU08506 B—Glucose; subst.c.(90 min) = ? P(aB)—Lactate; subst.c. = ? mmol/l mmol/l NPU08507 B—Glucose; subst.c.(120 min) = ? Plasma(venous Blood)— mmol/l Lactate; NPU08500 B—Glucose; subst.c.(180 min) = ? substance concentration mmol/l millimole/liter NPU08515 B—Glucose; subst.c.(360 min) = ? NPU03944 mmol/l P(vB)—Lactate; subst.c. = ? mmol/l NPU08502 B—Glucose; subst.c.incr.(max. c. minus 0 min c.; proc.) = ? mmol/l Urine— NPU10463 B—Lactose; subst.c.(0 min) = ? mmol/l Lactate; NPU10464 B—Lactose; subst.c.(30 min) = ? mmol/l substance concentration millimole/liter

NPU10465 B—Lactose; subst.c.(60 min) = ? mmol/l millimole/kilogram NPU10466 B—Lactose; subst.c.(120 min) = ? M = 342,30 g/mol mmol/l NPU10577 NPU10047 B(cB)—Glucose; subst.c.(0 min) = ? Pt—Lactose(administered); subst.cont.(p.o.; am.s./ mmol/l body mass) = ? mmol/kg NPU10059 B(cB)—Glucose; subst.c.(15 min) = ? mmol/l Blood— NPU10048 B(cB)—Glucose; subst.c.(30 min) = ? Lactose; mmol/l substance concentration(0 minutes after NPU10060 B(cB)—Glucose; subst.c.(45 min) = ? challenge) mmol/l millimole/liter NPU10045 B(cB)—Glucose; subst.c.(60 min) = ? NPU10463 mmol/l B—Lactose; subst.c.(0 min) = ? mmol/l NPU10050 B(cB)—Glucose; subst.c.(90 min) = ? mmol/l Blood— NPU10051 B(cB)—Glucose; subst.c.(120 min) = ? Lactose; mmol/l substance concentration(30 minutes after NPU10044 B(cB)—Glucose; subst.c.(180 min) = ? challenge) mmol/l millimole/liter NPU10058 B(cB)—Glucose; subst.c.(360 min) = ? NPU10464 mmol/l B—Lactose; subst.c.(30 min) = ? mmol/l NPU10046 B(cB)—Glucose; subst.c.incr.(max. c. minus 0 min c.; proc.) = ? mmol/l Blood— NPU04173 P—Glucose; subst.c.(0 min) = ? mmol/l Lactose; NPU04186 P—Glucose; subst.c.(15 min) = ? substance concentration(60 minutes after mmol/l challenge) NPU04174 P—Glucose; subst.c.(30 min) = ? millimole/liter mmol/l NPU10465 NPU04187 P—Glucose; subst.c.(45 min) = ? B—Lactose; subst.c.(60 min) = ? mmol/l mmol/l NPU04175 P—Glucose; subst.c.(60 min) = ? Blood— mmol/l Lactose; NPU04965 P—Glucose; subst.c.(75 min) = ? substance concentration(120 minutes after mmol/l challenge) NPU04176 P—Glucose; subst.c.(90 min) = ? millimole/liter mmol/l NPU10466 NPU04177 P—Glucose; subst.c.(120 min) = ? B—Lactose; subst.c.(120 min) = ? mmol/l mmol/l NPU04179 P—Glucose; subst.c.(180 min) = ? Urine— mmol/l Lambda chain(Ig); NPU04185 P—Glucose; subst.c.(360 min) = ? arbitrary concentration(procedure) mmol/l NPU04097 NPU03841 P—Glucose; subst.c.incr.(max. c. minus U—Lambda chain(Ig); arb.c.(proc.) = ? 0 min c.; proc.) = ? mmol/l NPU10581 U—Glucose; subst.c.(30 min) = ? Plasma— mmol/l Lambda chain(Ig); NPU08769 U—Glucose; subst.c.(60 min) = ? substance concentration mmol/l micromole/liter NPU08770 U—Glucose; subst.c.(120 min) = ? NPU08636 mmol/l P—Lambda chain(Ig); subst.c.=? µmol/l NPU14908 Pt—Stomach pain; prop.(proc.) = ? Urine— Patient— Lambda chain(Ig); Lactose(administered); substance concentration amount-of-substance(oral administration) micromole/liter millimole NPU04098 M = 342,30 g/mol U—Lambda chain(Ig); subst.c.=? µmol/l NPU10576 Pt—Lactose(administered); am.s.(p.o.) = ? mmol Blood— Large unstained cells; Patient— number concentration Lactose(administered); 109/liter substance content(oral administration; amount- NPU14267 of-substance/body mass) B—Large unstained cells; num.c. = ? × 109/l

Blood fraction(specification)— Authority: IUPAC/VII-C-TOX Large unstained cells; NPU10288 number concentration Pt(U)—Lead; subst.rate = ? µmol/d 109/liter NPU17617 Patient— B fract.(spec.)—Large unstained cells; num.c. = ? × Leucine(administered); 109/l amount-of-substance(oral administration) millimole Leukocytes(Blood)— M = 131,17 g/mol Large unstained cells; Other term(s): L-Leucine number fraction NPU10598 NPU04153 Pt—Leucine(administered); am.s.(p.o.) = ? mmol Lkcs(B)—Large unstained cells; num.fr. = ? Patient— Blood— Leucine(administered); Lead; substance content(oral administration; amount- substance concentration of-substance/body mass) micromole/liter millimole/kilogram M = 207,2 g/mol M = 131,17 g/mol Authority: IUPAC VII/C-TOX Other term(s): L-Leucine NPU02572 NPU10599 B—Lead; subst.c. = ? µmol/l Pt—Leucine(administered); subst.cont.(p.o.; am.s./ body mass) = ? mmol/kg Plasma— Lead; Urine— substance concentration Leucine/Creatininium; micromole/liter substance ratio M = 207,2 g/mol 10-3 Authority: IUPAC/VII-C-TOX NPU14231 NPU04887 U—Leucine/Creatininium; subst.ratio = ? × 10-3 P—Lead; subst.c. = ? µmol/l Cerebrospinal fluid— Urine— Leucine; Lead; substance concentration substance concentration micromole/liter micromole/liter M = 131,17 g/mol M = 207,2 g/mol NPU09028 Authority: IUPAC/VII-C-TOX Csf—Leucine; subst.c. = ? µmol/l NPU02575 U—Lead; subst.c. = ? µmol/l Plasma— Leucine; Cells(Blood)— substance concentration Lead; micromole/liter substance content M = 131,17 g/mol micromole/kilogram NPU02589 M = 207,2 g/mol P—Leucine; subst.c. = ? µmol/l Authority: IUPAC/VII-C-TOX NPU02573 Urine— Cells(B)—Lead; subst.cont. = ? µmol/kg Leucine; substance concentration Hair— micromole/liter Lead; M = 131,17 g/mol substance content NPU02590 micromole/kilogram U—Leucine; subst.c. = ? µmol/l M = 207,2 g/mol Authority: IUPAC VII/C-TOX Plasma— NPU02574 Leukocyte antibody; Hair—Lead; subst.cont. = ? µmol/kg arbitrary concentration(procedure) NPU04130 Patient(Urine)— P—Leukocyte antibody; arb.c.(proc.)= ? Lead; substance rate Plasma— micromole/day Leukocyte elastase; M = 207,2 g/mol catalytic-activity concentration(37 °C; procedure)

katal/liter NPU17598 B fract.(spec.)—Erythroblasts(basophil); Other term(s): Lysosomal elastase; Neutrophil num.c. = ? × 109/l elastase NPU17599 B fract.(spec.)— NPU02592 Erythroblasts(orthochrome); num.c. = ? × 109/l P—Leukocyte elastase; cat.c.(37 °C; proc.)= ? NPU17600 B fract.(spec.)— prefix ? kat/l Erythroblasts(polychrome); num.c. = ? × 109/l NPU17601 B fract.(spec.)—Erythroblasts; num.c. = Blood— ? × 109/l Leukocyte type; NPU17602 B fract.(spec.)—Leukocytes(Auer number concentration(list; microscopic; bodies); num.c. = ? × 109/l procedure) NPU17603 B fract.(spec.)—Leukocytes(Pelger- NPU17580 Huët); num.c. = ? × 109/l B—Leukocyte type; num.c.(list; micr.; proc.) NPU17604 B fract.(spec.)— NPU01349 B—Basophilocytes; num.c. = ? × 109/l Leukocytes(unspecified); num.c. = ? × 109/l NPU17562 B—Eosinophilocytes; num.c.(micr.) = ? NPU17578 B fract.(spec.)—Leukocytes; num.c. = ? × 109/l × 109/l NPU04690 B—Erythroblasts(basophil); num.c. = ? NPU17605 B fract.(spec.)—Lymphoblasts; num.c. = × 109/l ? × 109/l NPU04692 B—Erythroblasts(orthochrome); num.c. NPU17581 B fract.(spec.)—Lymphocytes; num.c. = = ? × 109/l ? × 109/l NPU04695 B—Erythroblasts(polychrome); num.c. = NPU17606 B fract.(spec.)—Megaloblasts; num.c. = ? × 109/l ? × 109/l NPU01943 B—Erythroblasts; num.c. = ? × 109/l NPU17607 B fract.(spec.)—Metamyelocytes; num.c. NPU14360 B—Leukocytes(Auer bodies); num.c. = ? = ? × 109/l × 109/l NPU17582 B fract.(spec.)—Monocytes; num.c. = ? NPU14367 B—Leukocytes(Pelger-Huët); num.c. = ? × 109/l × 109/l NPU17608 B fract.(spec.)—Myeloblasts; num.c. = ? NPU17053 B—Leukocytes(unspecified); num.c. = ? × 109/l × 109/l NPU17609 B fract.(spec.)—Myelocytes(eosinophil); NPU02593 B—Leukocytes; num.c. = ? × 109/l num.c. = ? × 109/l NPU04996 B—Lymphoblasts; num.c. = ? × 109/l NPU17610 B fract.(spec.)—Myelocytes(neutrophil); NPU02636 B—Lymphocytes; num.c. = ? × 109/l num.c. = ? × 109/l NPU14345 B—Megaloblasts; num.c. = ? × 109/l NPU17611 B fract.(spec.)—Myelocytes; num.c. = ? NPU03978 B—Metamyelocytes; num.c. = ? × 109/l × 109/l NPU02840 B—Monocytes; num.c. = ? × 109/l NPU17612 B fract.(spec.)— NPU03970 B—Myeloblasts; num.c. = ? × 109/l Neutrophilocytes(segmented); num.c. = ? × 109/l NPU04704 B—Myelocytes(eosinophil); num.c. = ? × NPU17613 B fract.(spec.)—Neutrophilocytes(band); 109/l num.c. = ? × 109/l NPU04706 B—Myelocytes(neutrophil); num.c. = ? × NPU17584 B fract.(spec.)—Neutrophilocytes; 109/l num.c. = ? × 109/l NPU03976 B—Myelocytes; num.c. = ? × 109/l NPU17630 B fract.(spec.)—Naked nuclei; num.c. = NPU03982 B—Neutrophilocytes(segmented); ? × 109/l num.c. = ? × 109/l NPU17614 B fract.(spec.)—Plasmocytes; num.c. = NPU03980 B—Neutrophilocytes(band); num.c. = ? ? × 109/l × 109/l NPU17615 B fract.(spec.)—Promyelocytes; num.c. NPU02902 B—Neutrophilocytes; num.c. = ? × 109/l = ? × 109/l NPU17597 B—Naked nuclei; num.c. = ? × 109/l NPU17616 B fract.(spec.)—Blast cells; num.c. = ? × NPU04708 B—Plasmocytes; num.c. = ? × 109/l 109/l NPU03974 B—Promyelocytes; num.c. = ? × 109/l NPU17617 B fract.(spec.)—Large unstained cells; NPU03972 B—Blast cells; num.c. = ? × 109/l num.c. = ? × 109/l NPU14267 B—Large unstained cells; num.c. = ? × NPU17618 B fract.(spec.)—Virocytes; num.c. = ? × 109/l 109/l NPU08686 B—Virocytes; num.c. = ? × 109/l Bone marrow— Blood fraction(specification)— Leukocyte type; Leukocyte type; number concentration(list; procedure) number concentration(list; procedure) Note: The concept Leukocyte in this case also NPU17596 comprises erythrocyte precursors B fract.(spec.)—Leukocyte type; num.c.(list; proc.) NPU04997 NPU17547 B fract.(spec.)—Basophilocytes; num.c. Marrow—Leukocyte type; num.c.(list; proc.) = ? × 109/l NPU03619 Marrow—Leukocytes; num.c. = ? × 109/l NPU17561 B fract.(spec.)—Eosinophilocytes; NPU04664 Marrow—Basophilocytes; num.c. = ? × num.c. = ? × 109/l 109/l

NPU04671 Marrow—Eosinophilocytes; num.c. = ? × NPU02593 B—Leukocytes; num.c. = ? × 109/l 109/l NPU04996 B—Lymphoblasts; num.c. = ? × 109/l NPU03798 Marrow—Erythroblasts(basophil); NPU02636 B—Lymphocytes; num.c. = ? × 109/l num.c. = ? × 109/l NPU14345 B—Megaloblasts; num.c. = ? × 109/l NPU14346 Marrow—Megaloblasts; num.c. = ? × NPU03978 B—Metamyelocytes; num.c. = ? × 109/l 109/l NPU02840 B—Monocytes; num.c. = ? × 109/l NPU03799 Marrow—Erythroblasts(orthochrome); NPU03970 B—Myeloblasts; num.c. = ? × 109/l num.c. = ? × 109/l NPU04704 B—Myelocytes(eosinophil); num.c. = ? × NPU03806 Marrow—Erythroblasts(polychrome); 109/l num.c. = ? × 109/l NPU04706 B—Myelocytes(neutrophil); num.c. = ? × NPU14361 Marrow—Leukocytes(Auer bodies); 109/l num.c. = ? × 109/l NPU03976 B—Myelocytes; num.c. = ? × 109/l NPU14368 Marrow—Leukocytes(Pelger-Huët); NPU03982 B—Neutrophilocytes(segmented); num.c. = ? × 109/l num.c. = ? × 109/l NPU04688 Marrow—Lymphoblasts; num.c. = ? × NPU03980 B—Neutrophilocytes(band); num.c. = ? 109/l × 109/l NPU04673 Marrow—Lymphocytes; num.c. = ? × NPU02902 B—Neutrophilocytes; num.c. = ? × 109/l 109/l NPU17597 B—Naked nuclei; num.c. = ? × 109/l NPU04675 Marrow—Metamyelocytes; num.c. = ? × NPU04708 B—Plasmocytes; num.c. = ? × 109/l 109/l NPU03974 B—Promyelocytes; num.c. = ? × 109/l NPU04677 Marrow—Monocytes; num.c. = ? × 109/l NPU03972 B—Blast cells; num.c. = ? × 109/l NPU04679 Marrow—Myeloblasts; num.c. = ? × 109/l NPU14267 B—Large unstained cells; num.c. = ? × NPU14381 Marrow—Myelocytes; num.c. = ? × 109/l 109/l NPU03994 Marrow—Myelocytes(eosinophil); num.c. NPU08686 B—Virocytes; num.c. = ? × 109/l = ? × 109/l NPU04089 Marrow—Myelocytes(neutrophil); num.c. Leukocytes(Blood)— = ? × 109/l Leukocyte type; NPU04681 Marrow—Neutrophilocytes(segmented); number fraction(list; mechanical; procedure) num.c. = ? × 109/l Note: The concept Leukocyte in this case also NPU04683 Marrow—Neutrophilocytes(band); comprises erythrocyte precursors num.c. = ? × 109/l NPU02596 NPU04090 Marrow—Plasmocytes; num.c. = ? × Lkcs(B)—Leukocyte type; num.fr.(list; mech.; proc.) 109/l NPU03968 Lkcs(B)—Basophilocytes; num.fr. = ? NPU04091 Marrow—Promyelocytes; num.c. = ? × NPU03967 Lkcs(B)—Eosinophilocytes; num.fr. = ? 109/l NPU04691 Lkcs(B)—Erythroblasts(basophil); NPU04134 Marrow—Reticulum cells; num.c. = ? × num.fr. = ? 109/l NPU04694 Lkcs(B)—Erythroblasts(orthochrome); NPU04667 Marrow—Blast cells; num.c. = ? × 109/l num.fr. = ? NPU04696 Lkcs(B)—Erythroblasts(polychrome); Blood— num.fr. = ? Leukocyte type; NPU10143 Lkcs(B)—Erythroblasts; num.fr. = ? number concentration(list; mechanical; NPU14362 Lkcs(B)—Leukocytes(Auer bodies); procedure) num.fr. = ? Note: The concept Leukocyte in this case also NPU14365 Lkcs(B)—Leukocytes(Pelger-Huët); comprises erythrocyte precursors num.fr. = ? NPU04100 NPU03984 Lkcs(B)—Leukocytes(unspecified); B—Leukocyte type; num.c.(list; mech.; proc.) num.fr. = ? NPU01349 B—Basophilocytes; num.c. = ? × 109/l NPU04995 Lkcs(B)—Lymphoblasts; num.fr. = ? NPU01933 B—Eosinophilocytes; num.c.(mech.) = ? NPU03965 Lkcs(B)—Lymphocytes; num.fr. = ? × 109/l NPU14343 Lkcs(B)—Megaloblasts; num.fr. = ? NPU04690 B—Erythroblasts(basophil); num.c. = ? NPU03977 Lkcs(B)—Metamyelocytes; num.fr. = ? × 109/l NPU03966 Lkcs(B)—Monocytes; num.fr. = ? NPU04692 B—Erythroblasts(orthochrome); num.c. NPU03969 Lkcs(B)—Myeloblasts; num.fr. = ? = ? × 109/l NPU04705 Lkcs(B)—Myelocytes(eosinophil); NPU04695 B—Erythroblasts(polychrome); num.c. = num.fr. = ? ? × 109/l NPU04707 Lkcs(B)—Myelocytes(neutrophil); NPU01943 B—Erythroblasts; num.c. = ? × 109/l num.fr. = ? NPU14360 B—Leukocytes(Auer bodies); num.c. = ? NPU03975 Lkcs(B)—Myelocytes; num.fr. = ? × 109/l NPU03981 Lkcs(B)—Neutrophilocytes(segmented); NPU14367 B—Leukocytes(Pelger-Huët); num.c. = ? num.fr. = ? × 109/l NPU03979 Lkcs(B)—Neutrophilocytes(band); NPU17053 B—Leukocytes(unspecified); num.c. = ? num.fr. = ? × 109/l NPU03983 Lkcs(B)—Neutrophilocytes; num.fr. = ?

NPU17619 Lkcs(B)—Naked nuclei; num.fr. = ? NPU10756 Lkcs(Asc)—Neutrophilocytes; num.fr.= ? NPU04709 Lkcs(B)—Plasmocytes; num.fr. = ? NPU10178 Lkcs(Asc)—Leukocytes(polynucl.); NPU03973 Lkcs(B)—Promyelocytes; num.fr. = ? num.fr. = ? NPU03971 Lkcs(B)—Blast cells; num.fr. = ? NPU04153 Lkcs(B)—Large unstained cells; num.fr. Leukocytes(Cerebrospinal fluid)— = ? Leukocyte type; NPU17620 Lkcs(B)—Virocytes; num.fr. = ? number fraction(list; procedure) NPU02597 Leukocytes(Blood)— Lkcs(Csf)—Leukocyte type; num.fr.(list; proc.) Leukocyte type; NPU04227 Lkcs(Csf)—Leukocytes(mononucl.); number fraction(list; microscopic; procedure) num.fr.= ? Note: The concept Leukocyte in this case also NPU10213 Lkcs(Csf)—Leukocytes(polynucl.); comprises erythrocyte precursors num.fr. = ? NPU17027 NPU04226 Lkcs(Csf)—Neutrophilocytes; num.fr.= ? Lkcs(B)—Leukocyte type; num.fr.(list; micr.; proc.) NPU17035 Lkcs(Csf)—Leukocytes(unspecified); NPU03968 Lkcs(B)—Basophilocytes; num.fr. = ? num.fr. = ? NPU03967 Lkcs(B)—Eosinophilocytes; num.fr. = ? NPU04691 Lkcs(B)—Erythroblasts(basophil); Leukocytes(Drain fluid; specification)— num.fr. = ? Leukocyte type; NPU04694 Lkcs(B)—Erythroblasts(orthochrome); number fraction(list; procedure) num.fr. = ? NPU17038 NPU04696 Lkcs(B)—Erythroblasts(polychrome); Lkcs(Drain fluid; spec.)—Leukocyte type; num.fr. = ? num.fr.(list; proc.) NPU10143 Lkcs(B)—Erythroblasts; num.fr. = ? NPU17039 Lkcs(Drain fluid; spec.)— NPU14362 Lkcs(B)—Leukocytes(Auer bodies); Leukocytes(mononucl.); num.fr. = ? num.fr. = ? NPU17040 Lkcs(Drain fluid; spec.)— NPU14365 Lkcs(B)—Leukocytes(Pelger-Huët); Leukocytes(polynucl.); num.fr. = ? num.fr. = ? NPU17041 Lkcs(Drain fluid; spec.)— NPU03984 Lkcs(B)—Leukocytes(unspecified); Leukocytes(unspecified); num.fr. = ? num.fr. = ? NPU04995 Lkcs(B)—Lymphoblasts; num.fr. = ? Leukocytes(Bone marrow)— NPU03965 Lkcs(B)—Lymphocytes; num.fr. = ? Leukocyte type; NPU14343 Lkcs(B)—Megaloblasts; num.fr. = ? number fraction(list; procedure) NPU03977 Lkcs(B)—Metamyelocytes; num.fr. = ? Note: The concept Leukocyte in this case also NPU03966 Lkcs(B)—Monocytes; num.fr. = ? comprises erythrocyte precursors NPU03969 Lkcs(B)—Myeloblasts; num.fr. = ? NPU04720 NPU04705 Lkcs(B)—Myelocytes(eosinophil); Lkcs(Marrow)—Leukocyte type; num.fr.(list; proc.) num.fr. = ? NPU04666 Lkcs(Marrow)—Basophilocytes; num.fr. NPU04707 Lkcs(B)—Myelocytes(neutrophil); = ? num.fr. = ? NPU04672 Lkcs(Marrow)—Eosinophilocytes; NPU03975 Lkcs(B)—Myelocytes; num.fr. = ? num.fr. = ? NPU03981 Lkcs(B)—Neutrophilocytes(segmented); NPU04991 Lkcs(Marrow)—Erythroblasts(basophil); num.fr. = ? num.fr. = ? NPU03979 Lkcs(B)—Neutrophilocytes(band); NPU14344 Lkcs(Marrow)—Megaloblasts; num.fr. = num.fr. = ? ? NPU03983 Lkcs(B)—Neutrophilocytes; num.fr. = ? NPU04993 Lkcs(Marrow)— NPU17619 Lkcs(B)—Naked nuclei; num.fr. = ? Erythroblasts(orthochrome); num.fr. = ? NPU04709 Lkcs(B)—Plasmocytes; num.fr. = ? NPU04992 Lkcs(Marrow)— NPU03973 Lkcs(B)—Promyelocytes; num.fr. = ? Erythroblasts(polychrome); num.fr. = ? NPU03971 Lkcs(B)—Blast cells; num.fr. = ? NPU14363 Lkcs(Marrow)—Leukocytes(Auer NPU04153 Lkcs(B)—Large unstained cells; num.fr. bodies); num.fr. = ? = ? NPU14366 Lkcs(Marrow)—Leukocytes(Pelger- NPU17620 Lkcs(B)—Virocytes; num.fr. = ? Huët); num.fr. = ? NPU04663 Lkcs(Marrow)— Leukocytes(Ascites)— Leukocytes(unspecified); num.fr. = ? Leukocyte type; NPU04689 Lkcs(Marrow)—Lymphoblasts; num.fr. = number fraction(list; procedure) ? Note: The concept Leukocyte in this case also NPU04674 Lkcs(Marrow)—Lymphocytes; num.fr. = comprises erythrocyte precursors ? NPU14113 NPU04676 Lkcs(Marrow)—Metamyelocytes; num.fr. Lkcs(Asc)—Leukocyte type; num.fr.(list; proc.) = ? NPU10176 Lkcs(Asc)—Leukocytes(mononucl.); NPU04678 Lkcs(Marrow)—Monocytes; num.fr. = ? num.fr. = ? NPU04680 Lkcs(Marrow)—Myeloblasts; num.fr. = ?

NPU14380 Lkcs(Marrow)—Myelocytes; num.fr. = ? Blood— NPU04987 Lkcs(Marrow)—Myelocytes(eosinophil); Leukocytes(Auer bodies); num.fr. = ? number concentration NPU04986 Lkcs(Marrow)—Myelocytes(neutrophil); 109/liter num.fr. = ? NPU14360 NPU04682 Lkcs(Marrow)— B—Leukocytes(Auer bodies); num.c. = ? × 109/l Neutrophilocytes(segmented); num.fr. = ? NPU04684 Lkcs(Marrow)—Neutrophilocytes(band); Blood fraction(specification)— num.fr. = ? Leukocytes(Auer bodies); NPU04989 Lkcs(Marrow)—Plasmocytes; num.fr. = number concentration ? 109/liter NPU04985 Lkcs(Marrow)—Promyelocytes; num.fr. NPU17602 = ? B fract.(spec.)—Leukocytes(Auer bodies); num.c. = NPU14382 Lkcs(Marrow)—Reticulum cells; num.fr. ? × 109/l = ? NPU04668 Lkcs(Marrow)—Blast cells; num.fr. = ? Bone marrow— Leukocytes(Auer bodies); Leukocytes(Pleural fluid; specification)— number concentration Leukocyte type; 109/liter number fraction(list; procedure) NPU14361 Note: The concept Leukocyte in this case also Marrow—Leukocytes(Auer bodies); num.c. = ? × comprises erythrocyte precursors 109/l NPU14115 Lkcs(Plf; spec.)—Leukocyte type; num.fr.(list; proc.) Leukocytes(Blood)— NPU10175 Lkcs(Plf; spec.)— Leukocytes(Auer bodies); Leukocytes(mononucl.); num.fr. = ? number fraction NPU10177 Lkcs(Plf; spec.)—Leukocytes(polynucl.); NPU14362 num.fr. = ? Lkcs(B)—Leukocytes(Auer bodies); num.fr. = ? NPU17037 Lkcs(Plf; spec.)— Leukocytes(unspecified); num.fr. = ? Leukocytes(Bone marrow)— Leukocytes(Auer bodies); Leukocytes(Synovial fluid; specification)— number fraction Leukocyte type; NPU14363 number fraction(list; procedure) Lkcs(Marrow)—Leukocytes(Auer bodies); num.fr. = Note: The concept Leukocyte in this case also ? comprises erythrocyte precursors NPU14114 Cerebrospinal fluid— Lkcs(Synf; spec.)—Leukocyte type; num.fr.(list; Leukocytes(mononuclear); proc.) number concentration NPU10173 Lkcs(Synf; spec.)— 106/liter Leukocytes(mononucl.); num.fr. = ? NPU10763 NPU10174 Lkcs(Synf; spec.)— Csf—Leukocytes(mononucl.); num.c. = ? × 106/l Leukocytes(polynucl.); num.fr. = ? NPU17036 Lkcs(Synf; spec.)— Blood— Leukocytes(unspecified); num.fr. = ? Leukocytes(mononuclear); number concentration Leukocytes(System; specification)— 109/liter Leukocyte type; NPU04851 number fraction(list; procedure) B—Leukocytes(mononucl.); num.c. = ? × 109/l NPU14370 Lkcs(Syst; spec.)—Leukocyte type; num.fr.(list; Leukocytes(Ascites)— proc.) Leukocytes(mononuclear); NPU14364 Syst(spec.)—Leukocytes(mononucl.); number fraction num.fr. = ? NPU10176 NPU14369 Syst(spec.)—Leukocytes(polynucl.); Lkcs(Asc)—Leukocytes(mononucl.); num.fr. = ? num.fr. = ? Leukocytes(Cerebrospinal fluid)— Plasma— Leukocytes(mononuclear); Leukocytelastase antibody(Immunoglobulin G); number fraction arbitrary concentration(procedure) NPU04227 Other term(s): EC3.4.21.37 antibody Lkcs(Csf)—Leukocytes(mononucl.); num.fr.= ? NPU12576 P—Leukocytelastase antibody(IgG); arb.c.(proc.) = ?

Leukocytes(Drain fluid; specification)— Leukocytes(Bone marrow)— Leukocytes(mononuclear); Leukocytes(Pelger-Huët); number fraction number fraction NPU17039 NPU14366 Lkcs(Drain fluid; spec.)—Leukocytes(mononucl.); Lkcs(Marrow)—Leukocytes(Pelger-Huët); num.fr. = num.fr. = ? ?

Leukocytes(Pericardial fluid)— Ascites— Leukocytes(mononuclear); Leukocytes(polynuclear); number fraction number concentration NPU10758 106/liter Lkcs(Pericardialf.)—Leukocytes(mononucl.); NPU10215 num.fr.= ? Asc—Leukocytes(polynucl.); num.c. = ? × 106/l

Leukocytes(Pleural fluid; specification)— Cerebrospinal fluid— Leukocytes(mononuclear); Leukocytes(polynuclear); number fraction number concentration NPU10175 106/liter Lkcs(Plf; spec.)—Leukocytes(mononucl.); num.fr. = NPU10774 ? Csf—Leukocytes(polynucl.); num.c. = ? × 106/l

Leukocytes(Synovial fluid; specification)— Pleural fluid(specification)— Leukocytes(mononuclear); Leukocytes(polynuclear); number fraction number concentration NPU10173 106/liter Lkcs(Synf; spec.)—Leukocytes(mononucl.); num.fr. NPU10216 = ? Plf(spec.)—Leukocytes(polynucl.); num.c. = ? × 106/l System(specification)— Leukocytes(mononuclear); Synovial fluid(specification)— number fraction Leukocytes(polynuclear); NPU14364 number concentration Syst(spec.)—Leukocytes(mononucl.); num.fr. = ? 106/liter NPU10214 Blood— Synf(spec.)—Leukocytes(polynucl.); num.c. = ? × Leukocytes(Pelger-Huët); 106/l number concentration 109/liter Blood— NPU14367 Leukocytes(polynuclear); B—Leukocytes(Pelger-Huët); num.c. = ? × 109/l number concentration 109/liter Blood fraction(specification)— NPU04852 Leukocytes(Pelger-Huët); B—Leukocytes(polynucl.); num.c. = ? × 109/l number concentration 109/liter Leukocytes(Ascites)— NPU17603 Leukocytes(polynuclear); B fract.(spec.)—Leukocytes(Pelger-Huët); num.c. = number fraction ? × 109/l NPU10178 Lkcs(Asc)—Leukocytes(polynucl.); num.fr. = ? Bone marrow— Leukocytes(Pelger-Huët); Leukocytes(Cerebrospinal fluid)— number concentration Leukocytes(polynuclear); 109/liter number fraction NPU14368 NPU10213 Marrow—Leukocytes(Pelger-Huët); num.c. = ? × Lkcs(Csf)—Leukocytes(polynucl.); num.fr. = ? 109/l Leukocytes(Drain fluid; specification)— Leukocytes(Blood)— Leukocytes(polynuclear); Leukocytes(Pelger-Huët); number fraction number fraction NPU17040 NPU14365 Lkcs(Drain fluid; spec.)—Leukocytes(polynucl.); Lkcs(B)—Leukocytes(Pelger-Huët); num.fr. = ? num.fr. = ?

Leukocytes(Pleural fluid; specification)— Leukocytes(Blood)— Leukocytes(polynuclear); Leukocytes(unspecified); number fraction number fraction NPU10177 NPU03984 Lkcs(Plf; spec.)—Leukocytes(polynucl.); num.fr. = ? Lkcs(B)—Leukocytes(unspecified); num.fr. = ?

Leukocytes(Synovial fluid; specification)— Leukocytes(Cerebrospinal fluid)— Leukocytes(polynuclear); Leukocytes(unspecified); number fraction number fraction NPU10174 NPU17035 Lkcs(Synf; spec.)—Leukocytes(polynucl.); num.fr. = Lkcs(Csf)—Leukocytes(unspecified); num.fr. = ? ? Leukocytes(Drain fluid; specification)— System(specification)— Leukocytes(unspecified); Leukocytes(polynuclear); number fraction number fraction NPU17041 NPU14369 Lkcs(Drain fluid; spec.)—Leukocytes(unspecified); Syst(spec.)—Leukocytes(polynucl.); num.fr. = ? num.fr. = ?

Ascites— Leukocytes(Bone marrow)— Leukocytes(unspecified); Leukocytes(unspecified); number concentration number fraction 106/liter NPU04663 NPU17574 Lkcs(Marrow)—Leukocytes(unspecified); num.fr. = ? Asc—Leukocytes(unspecified); num.c. = ? × 106/l Leukocytes(Pleural fluid; specification)— Cerebrospinal fluid— Leukocytes(unspecified); Leukocytes(unspecified); number fraction number concentration NPU17037 106/liter Lkcs(Plf; spec.)—Leukocytes(unspecified); num.fr. = NPU17575 ? Csf—Leukocytes(unspecified); num.c. = ? × 106/l Leukocytes(Synovial fluid; specification)— Pleural fluid(specification)— Leukocytes(unspecified); Leukocytes(unspecified); number fraction number concentration NPU17036 106/liter Lkcs(Synf; spec.)—Leukocytes(unspecified); num.fr. NPU17577 = ? Plf(spec.)—Leukocytes(unspecified); num.c. = ? × 106/l Dialysis solution— Leukocytes; Synovial fluid(specification)— arbitrary concentration(procedure) Leukocytes(unspecified); NPU10760 number concentration Dialysis solution—Leukocytes; arb.c.(proc.) = ? 106/liter NPU17576 Urine— Synf(spec.)—Leukocytes(unspecified); num.c. = ? × Leukocytes; 106/l arbitrary concentration(procedure) NPU03987 Blood— U—Leukocytes; arb.c.(proc.) = ? Leukocytes(unspecified); number concentration Vaginal fluid— 109/liter Leukocytes; NPU17053 arbitrary concentration(procedure) B—Leukocytes(unspecified); num.c. = ? × 109/l NPU14317 Vagf—Leukocytes; arb.c.(proc.) = ? Blood fraction(specification)— Leukocytes(unspecified); Blood— number concentration Leukocytes; 109/liter number concentration(microscopic) NPU17604 109/liter B fract.(spec.)—Leukocytes(unspecified); num.c. = NPU17579 ? × 109/l B—Leukocytes; num.c.(micr.) = ? × 109/l

Urine— Bone marrow— Leukocytes; Leukocytes; number concentration(procedure) number concentration 106/liter 109/liter NPU10505 NPU03619 U—Leukocytes; num.c.(proc.) = ? × 106/l Marrow—Leukocytes; num.c. = ? × 109/l

Ascites— Synovial fluid(specification)— Leukocytes; Leukocytes; number concentration number concentration 106/liter 109/liter NPU08638 NPU14082 Asc—Leukocytes; num.c. = ? × 106/l Synf(spec.)—Leukocytes; num.c. = ? × 109/l

Cerebrospinal fluid— Patient— Leukocytes; Levodopa(administered); number concentration amount-of-substance(oral administration) 106/liter millimole NPU02594 M = 197,2 g/mol Csf—Leukocytes; num.c. = ? × 106/l Other term(s): L-Dopa NPU10457 Drain fluid(specification)— Pt—Levodopa(administered); am.s.(p.o.) = ? mmol Leukocytes; number concentration Urine— 106/liter Levodopa/Creatininium; NPU17178 substance ratio Drain fluid(spec.)—Leukocytes; num.c. = ? × 106/l 10-3 NPU14232 Pleural fluid(specification)— U—Levodopa/Creatininium; subst.ratio = ? × 10-3 Leukocytes; number concentration Plasma— 106/liter Lipid(total); NPU08637 mass concentration Plf(spec.)—Leukocytes; num.c. = ? × 106/l gram/liter NPU03807 Synovial fluid(specification)— P—Lipid(tot.); mass c. = ? g/l Leukocytes; number concentration Faeces(dry)— 106/liter Lipid(total); NPU08639 mass fraction Synf(spec.)—Leukocytes; num.c. = ? × 106/l NPU03844 F(dry)—Lipid(tot.); mass fr. = ? System(specification)— Leukocytes; Kidney— number concentration Lithium clearance; 106/liter volume rate(procedure) NPU10130 milliliter/second Syst(spec.)—Leukocytes; num.c. = ? × 106/l Authority: IUPAC/VII/C-TOX NPU10181 Blood— Kidn.—Lithium clearance; vol.rate(proc.) = ? ml/s Leukocytes; number concentration Patient— 109/liter Lithium ion(administered); NPU02593 amount-of-substance(oral administration) B—Leukocytes; num.c. = ? × 109/l millimole NPU14800 Blood fraction(specification)— Pt—Lithium ion(administered); am.s.(p.o.) = ? mmol Leukocytes; number concentration Urine— 109/liter Lithium ion; NPU17578 amount-of-substance(procedure) B fract.(spec.)—Leukocytes; num.c. = ? × 109/l millimole M = 6,94 g/mol NPU10180 U—Lithium ion; am.s.(proc.) = ? mmol

Dialysis solution— Plasma— Lithium ion; Liver-kidney-microsome antibody(Immunoglobulin substance concentration(therapy) G); millimole/liter arbitrary concentration(procedure) NPU10182 NPU14516 Dialysis solution—Lithium ion; subst.c.(therapy) = ? P—Liver-kidney-microsome antibody(IgG); mmol/l arb.c.(proc.) = ?

Plasma— Blood— Lithium ion; Long QT syndrome DNA; substance concentration(therapy) arbitrary concentration(procedure) millimole/liter NPU17684 M = 6,94 g/mol B—Long QT syndrome DNA; arb.c.(proc.) = ? Authority: IUPAC/VII/C-TOX NPU02613 Blood— P—Lithium ion; subst.c.(therapy) = ? mmol/l Lupus erythematosus particles; arbitrary concentration(procedure) Urine— NPU02617 Lithium ion; B—Lupus erythematosus particles; arb.c.(proc.) = ? substance concentration(therapy) millimole/liter Plasma— M = 6,94 g/mol Lutropin a-chain; NPU13479 arbitrary substance concentration(IS 78/554; U—Lithium ion; subst.c.(therapy) = ? mmol/l procedure) international unit/liter Urine— M = 14 000 g/mol Lithium ion; Recommended calibrator: WHO 1st IS 78/554 substance concentration NPU02620 millimole/liter P—Lutropin a-chain; arb.subst.c.(IS 78/554; proc.) M = 6,94 g/mol = ? int. unit/l Authority: IUPAC/VII/C-TOX NPU04888 Plasma— U—Lithium ion; subst.c. = ? mmol/l Lutropin a-chain; substance concentration Hair— picomole/liter Lithium ion; M = 14 000 g/mol substance content NPU02621 micromole/kilogram P—Lutropin a-chain; subst.c. = ? pmol/l M = 6,94 g/mol Authority: IUPAC/VII/C-TOX Plasma— NPU02612 Lutropin b-chain; Hair—Lithium ion; subst.cont. = ? µmol/kg arbitrary substance concentration(IS 78/556; procedure) Patient— international unit/liter Lithiumcarbonate(administered); M = 15 000 g/mol mass(oral administration) Recommended calibrator: WHO 1st IS 78/556 milligram NPU02622 NPU14801 P—Lutropin b-chain; arb.subst.c.(IS 78/556; proc.) = Pt—Lithiumcarbonate(administered); mass(p.o.) = ? int. unit/l ? mg Plasma— Patient— Lutropin b-chain; Liver; substance concentration mass picomole/liter kilogram M = 15 000 g/mol NPU03803 NPU02623 Pt—Liver; mass = ? kg P—Lutropin b-chain; subst.c. = ? pmol/l

Plasma— Pituitary gland— Livercytosol antibody(Immunoglobulin G); Lutropin secretion; arbitrary concentration(procedure) substance rate(gonadorelin, intravenous NPU14515 administration; list; procedure) P—Livercytosol antibody(IgG); arb.c.(proc.) = ? Note: M(gonadorelin) = 1 182,3 g/mol NPU10441 PitGl—Lutropin secretion; subst.rate(gonadorelin i.v.; list; proc.) © 2000 IUPAC, Pure and Applied Chemistry 72, 747–972 Properties and units in general clinical chemistry 903

NPU10561 Pt—Gonadorelin(administered); international unit/liter am.s.(i.v.) = ? nmol Other term(s): Luteinizing hormone; LH; Lutenin NPU10676 P—Lutropin; arb.subst.c.(IS 80/552; -60 NPU10679 min; proc.) = ? int. unit/l P—Lutropin; arb.subst.c.(IRP 68/40; -30 min; proc.) NPU10677 P—Lutropin; arb.subst.c.(IS 80/552; -30 = ? int. unit/l min; proc.) = ? int. unit/l NPU10436 P—Lutropin; arb.subst.c.(IS 80/552; 0 Plasma— min; proc.) = ? int. unit/l Lutropin; NPU10437 P—Lutropin; arb.subst.c.(IS 80/552; 30 arbitrary substance concentration(IRP 68/40; 60 min; proc.) = ? int. unit/l minutes after challenge; procedure) NPU10438 P—Lutropin; arb.subst.c.(IS 80/552; 60 international unit/liter min; proc.) = ? int. unit/l Other term(s): Luteinizing hormone; LH; Lutenin NPU10439 P—Lutropin; arb.subst.c.(IS 80/552; 90 NPU10432 min; proc.) = ? int. unit/l P—Lutropin; arb.subst.c.(IRP 68/40; 60 min; proc.) NPU10440 P—Lutropin; arb.subst.c.(IS 80/552; 120 = ? int. unit/l min; proc.) = ? int. unit/l NPU10678 P—Lutropin; arb.subst.c.(IRP 68/40; -60 Plasma— min; proc.) = ? int. unit/l Lutropin; NPU10679 P—Lutropin; arb.subst.c.(IRP 68/40; -30 arbitrary substance concentration(IRP 68/40; 60 min; proc.) = ? int. unit/l minutes before challenge; procedure) NPU10430 P—Lutropin; arb.subst.c.(IRP 68/40; 0 international unit/liter min; proc.) = ? int. unit/l Other term(s): Luteinizing hormone; LH; Lutenin NPU10431 P—Lutropin; arb.subst.c.(IRP 68/40; 30 NPU10678 min; proc.) = ? int. unit/l P—Lutropin; arb.subst.c.(IRP 68/40; -60 min; proc.) NPU10432 P—Lutropin; arb.subst.c.(IRP 68/40; 60 = ? int. unit/l min; proc.) = ? int. unit/l NPU10433 P—Lutropin; arb.subst.c.(IRP 68/40; 90 Plasma— min; proc.) = ? int. unit/l Lutropin; NPU10434 P—Lutropin; arb.subst.c.(IRP 68/40; 120 arbitrary substance concentration(IRP 68/40; 90 min; proc.) = ? int. unit/l minutes after challenge; procedure) international unit/liter Plasma— Other term(s): Luteinizing hormone; LH; Lutenin Lutropin; NPU10433 arbitrary substance concentration(IRP 68/40; 0 P—Lutropin; arb.subst.c.(IRP 68/40; 90 min; proc.) minutes after challenge; procedure) = ? int. unit/l international unit/liter Other term(s): Luteinizing hormone; LH; Lutenin Plasma— NPU10430 Lutropin; P—Lutropin; arb.subst.c.(IRP 68/40; 0 min; proc.) = arbitrary substance concentration(IRP 68/40; ? int. unit/l procedure) international unit/liter Plasma— M = 29 000 g/mol Lutropin; Recommended calibrator: WHO 1st IRP 68/40 (for arbitrary substance concentration(IRP 68/40; immunoassay) 120 minutes after challenge; procedure) Other term(s): Luteinizing hormone; LH international unit/liter Authority: IUPAC-IUB 74 Other term(s): Luteinizing hormone; LH; Lutenin NPU04015 NPU10434 P—Lutropin; arb.subst.c.(IRP 68/40; proc.) = ? int. P—Lutropin; arb.subst.c.(IRP 68/40; 120 min; proc.) unit/l = ? int. unit/l Urine— Plasma— Lutropin; Lutropin; arbitrary substance concentration(IRP 68/40; arbitrary substance concentration(IRP 68/40; 30 procedure) minutes after challenge; procedure) international unit/liter international unit/liter M = 29 000 g/mol Other term(s): Luteinizing hormone; LH; Lutenin Recommended calibrator: WHO 1st IRP 68/40 (for NPU10431 immunoassay) P—Lutropin; arb.subst.c.(IRP 68/40; 30 min; proc.) Other term(s): Luteinizing hormone; LH = ? int. unit/l Authority: IUPAC-IUB 74 NPU04016 Plasma— U—Lutropin; arb.subst.c.(IRP 68/40; proc.) = ? int. Lutropin; unit/l arbitrary substance concentration(IRP 68/40; 30 minutes before challenge; procedure)

Plasma— Other term(s): Luteinizing hormone; LH; Lutenin Lutropin; NPU10439 arbitrary substance concentration(IS 80/552; 0 P—Lutropin; arb.subst.c.(IS 80/552; 90 min; proc.) = minutes after challenge; procedure) ? int. unit/l international unit/liter Other term(s): Luteinizing hormone; LH; Lutenin Plasma— NPU10436 Lutropin; P—Lutropin; arb.subst.c.(IS 80/552; 0 min; proc.) = arbitrary substance concentration(IS 80/552; ? int. unit/l procedure) international unit/liter Plasma— M = 29 000 g/mol Lutropin; Recommended calibrator: WHO 2nd IS 80/552 arbitrary substance concentration(IS 80/552; 120 Calibrator(s): WHO 1st IRP 68/40 (for minutes after challenge; procedure) immunoassay) international unit/liter Other term(s): Luteinizing hormone; LH Other term(s): Luteinizing hormone; LH; Lutenin Authority: IUPAC-IUB 74 NPU10440 NPU02618 P—Lutropin; arb.subst.c.(IS 80/552; 120 min; proc.) P—Lutropin; arb.subst.c.(IS 80/552; proc.) = ? int. = ? int. unit/l unit/l

Plasma— Urine— Lutropin; Lutropin; arbitrary substance concentration(IS 80/552; 30 arbitrary substance concentration(IS 80/552; minutes after challenge; procedure) procedure) international unit/liter international unit/liter Other term(s): Luteinizing hormone; LH; Lutenin M = 29 000 g/mol NPU10437 Recommended calibrator: WHO 2nd IS 80/552 P—Lutropin; arb.subst.c.(IS 80/552; 30 min; proc.) = Calibrator(s): WHO 1st IRP 68/40 (for ? int. unit/l immunoassay) Other term(s): Luteinizing hormonr; LH Plasma— Authority: IUPAC-IUB 74 Lutropin; NPU03836 arbitrary substance concentration(IS 80/552; 30 U—Lutropin; arb.subst.c.(IS 80/552; proc.) = ? int. minutes before challenge; procedure) unit/l international unit/liter Other term(s): Luteinizing hormone; LH; Lutenin Plasma— NPU10677 Lutropin; P—Lutropin; arb.subst.c.(IS 80/552; -30 min; proc.) substance concentration = ? int. unit/l mole/liter M = 29 000 g/mol Plasma— Other term(s): Luteinizing hormone; LH Lutropin; Authority: IUPAC-IUB 74 arbitrary substance concentration(IS 80/552; 60 NPU02619 minutes after challenge; procedure) P—Lutropin; subst.c.= ? prefix ? mol/l international unit/liter Other term(s): Luteinizing hormone; LH; Lutenin Blood— NPU10438 Lymphoblasts; P—Lutropin; arb.subst.c.(IS 80/552; 60 min; proc.) = number concentration ? int. unit/l 109/liter NPU04996 Plasma— B—Lymphoblasts; num.c. = ? × 109/l Lutropin; arbitrary substance concentration(IS 80/552; 60 Blood fraction(specification)— minutes before challenge; procedure) Lymphoblasts; international unit/liter number concentration Other term(s): Luteinizing hormone; LH; Lutenin 109/liter NPU10676 NPU17605 P—Lutropin; arb.subst.c.(IS 80/552; -60 min; proc.) B fract.(spec.)—Lymphoblasts; num.c. = ? × 109/l = ? int. unit/l Bone marrow— Plasma— Lymphoblasts; Lutropin; number concentration arbitrary substance concentration(IS 80/552; 90 109/liter minutes after challenge; procedure) NPU04688 international unit/liter Marrow—Lymphoblasts; num.c. = ? × 109/l

Leukocytes(Blood)— Ascites— Lymphoblasts; Lymphocytes+Monocytes; number fraction number concentration NPU04995 106/liter Lkcs(B)—Lymphoblasts; num.fr. = ? NPU08641 Asc—Lymphocytes+Monocytes; num.c. = ? × 106/l Leukocytes(Bone marrow)— Lymphoblasts; Cerebrospinal fluid— number fraction Lymphocytes+Monocytes; NPU04689 number concentration Lkcs(Marrow)—Lymphoblasts; num.fr. = ? 106/liter NPU02637 Blood— Csf—Lymphocytes+Monocytes; num.c. = ? × 106/l Lymphocytes(immature); number concentration Pleural fluid(specification)— 109/liter Lymphocytes+Monocytes; NPU14260 number concentration B—Lymphocytes(immature); num.c. = ? × 109/l 106/liter NPU08640 Lymphocytes(Blood)— Plf(spec.)—Lymphocytes+Monocytes; num.c. = ? × Lymphocytes(vacuolated); 106/l number fraction NPU17000 Synovial fluid(specification)— Lymphocs(B)—Lymphocytes(vacuolated); num.fr. = Lymphocytes+Monocytes; ? number concentration 106/liter Blood— NPU04231 Lymphocytes; Synf(spec.)—Lymphocytes+Monocytes; num.c.= ? morphology(procedure) × 106/l NPU17065 B—Lymphocytes; morphology(proc.) = ? Urine— Lysine/Creatininium; Blood— substance ratio Lymphocytes; 10-3 number concentration NPU14233 109/liter U—Lysine/Creatininium; subst.ratio = ? × 10-3 NPU02636 B—Lymphocytes; num.c. = ? × 109/l Cerebrospinal fluid— Lysine; Blood fraction(specification)— substance concentration Lymphocytes; micromole/liter number concentration M = 146,19 g/mol 109/liter NPU09029 NPU17581 Csf—Lysine; subst.c. = ? µmol/l B fract.(spec.)—Lymphocytes; num.c. = ? × 109/l Plasma— Bone marrow— Lysine; Lymphocytes; substance concentration number concentration micromole/liter 109/liter M = 146,19 g/mol NPU04673 NPU02639 Marrow—Lymphocytes; num.c. = ? × 109/l P—Lysine; subst.c. = ? µmol/l

Leukocytes(Blood)— Urine— Lymphocytes; Lysine; number fraction substance concentration NPU03965 micromole/liter Lkcs(B)—Lymphocytes; num.fr. = ? M = 146,19 g/mol NPU02640 Leukocytes(Bone marrow)— U—Lysine; subst.c. = ? µmol/l Lymphocytes; number fraction NPU04674 Lkcs(Marrow)—Lymphocytes; num.fr. = ?

Plasma— NPU08646 Lysozyme; Secr(Ileum)—Magnesium(II; total); am.s.(proc.) = ? catalytic-activity concentration(37 °C; mmol procedure) katal/liter Urine— NPU03895 Magnesium(II; total); P—Lysozyme; cat.c.(37 °C; proc.)= ? prefix ? kat/l amount-of-substance millimole Plasma— NPU17542 Lysozyme; U—Magnesium(II; total); am.s. = ? mmol substance concentration nanomole/liter Calculus(Urine)— M = 14 500 g/mol Magnesium(II; total); Other term(s): Muramidase arbitrary content(procedure) NPU02641 M = 24,30 g/mol P—Lysozyme; subst.c. = ? nmol/l NPU09234 Calculus(U)—Magnesium(II; total); arb.cont.(proc.) Urine— = ? Lysozyme; substance concentration Plasma— nanomole/liter Magnesium(II; total); M = 14 500 g/mol substance concentration NPU04856 millimole/liter U—Lysozyme; subst.c. = ? nmol/l M = 24,30 g/mol Authority: IFCC/C-BGE; IUPAC/VII/C-TOX Plasma— NPU02647 a-2- P—Magnesium(II; total); subst.c. = ? mmol/l Macroglobulin; substance concentration Secretion(Ileum)— micromole/liter Magnesium(II; total); M = 725 000 g/mol substance concentration NPU02646 millimole/liter P—a-2-Macroglobulin; subst.c. = ? µmol/l M = 24,30 g/mol NPU08645 Calculus(Urine)— Secr(Ileum)—Magnesium(II; total); subst.c. = ? Magnesium ammonium phosphate; mmol/l arbitrary content(procedure) M = 137,3 g/mol System(specification)— NPU10368 Magnesium(II; total); Calculus(U)—Magnesium ammonium phosphate; substance concentration arb.cont.(proc.) = ? millimole/liter M = 24,30 g/mol Calculus(Urine)— NPU14119 Magnesium ammonium phosphate; Syst(spec.)—Magnesium(II; total); subst.c. = ? substance content mmol/l mole/kilogram M = 137,3 g/mol Urine— NPU02649 Magnesium(II; total); Calculus(U)—Magnesium ammonium phosphate; substance concentration subst.cont. = ? mol/kg millimole/liter M = 24,30 g/mol Plasma— Authority: IFCC/C-BGE; IUPAC/VII/C-TOX Magnesium ion; NPU02648 substance concentration U—Magnesium(II; total); subst.c. = ? mmol/l millimole/liter M = 24,30 g/mol Faeces— NPU02650 Magnesium(II; total); P—Magnesium ion; subst.c. = ? mmol/l substance content millimole/kilogram Secretion(Ileum)— M = 24,30 g/mol Magnesium(II; total); NPU04217 amount-of-substance(procedure) F—Magnesium(II; total); subst.cont. = ? mmol/kg millimole M = 24,30 g/mol

Faeces(specification)— Authority: IUPAC/VII-C-TOX Magnesium(II; total); NPU02668 substance content B—Manganese; subst.c. = ? nmol/l millimole/kilogram M = 24,30 g/mol Plasma— NPU08644 Manganese; F(spec.)—Magnesium(II; total); subst.cont. = ? substance concentration mmol/kg nanomole/liter M = 54,94 g/mol Calculus(Urine)— Authority: IUPAC/VII-C-TOX Magnesium(II; total); NPU02669 substance content P—Manganese; subst.c. = ? nmol/l mole/kilogram M = 24,30 g/mol Urine— NPU09240 Manganese; Calculus(U)—Magnesium(II; total); subst.cont. = ? substance concentration mol/kg nanomole/liter M = 54,94 g/mol Patient(Faeces)— Authority: IUPAC/VII-C-TOX Magnesium(II; total); NPU02670 substance rate(procedure) U—Manganese; subst.c. = ? nmol/l millimole/day M = 24,30 g/mol Cells(Blood)— NPU04216 Manganese; Pt(F)—Magnesium(II; total); subst.rate(proc.) = ? substance content mmol/d nanomole/kilogram M = 54,94 g/mol Patient(Urine)— Authority: IUPAC/VII-C-TOX Magnesium(II; total); NPU04891 substance rate(procedure) Cells(B)—Manganese; subst.cont. = ? nmol/kg millimole/day M = 24,30 g/mol Plasma— Authority: IFCC/BGE; IUPAC/VII/C-TOX Mannan-binding lectin; NPU03945 substance concentration Pt(U)—Magnesium(II; total); subst.rate(proc.) = ? nanomole/liter mmol/d NPU09227 P—Mannan-binding lectin; subst.c. = ? nmol/l Faeces(specification)— Magnesium; Plasma— amount-of-substance M-component(specification); millimole arbitrary substance concentration(procedure) NPU17621 arbitrary unit/liter F(spec.)—Magnesium; am.s. = ? mmol NPU08642 P—M-component(spec.); arb.subst.c.(proc.) = ? Urine— arb.unit/l Malate/Creatininium; substance ratio Urine— 10-3 M-component(specification); NPU14234 arbitrary substance concentration(procedure) U—Malate/Creatininium; subst.ratio = ? × 10-3 arbitrary unit/liter NPU08643 Urine— U—M-component(spec.); arb.subst.c.(proc.) = ? Malate; arb.unit/l substance concentration mole/liter Plasma— NPU02651 M-component(specification); U—Malate; subst.c.= ? prefix ? mol/l substance concentration micromole/liter Blood— Other term(s): Myeloma protein; Paraprotein Manganese; NPU02644 substance concentration P—M-component(spec.); subst.c. = ? µmol/l nanomole/liter M = 54,94 g/mol

Urine— NPU17606 M-component(specification); B fract.(spec.)—Megaloblasts; num.c. = ? × 109/l substance concentration micromole/liter Bone marrow— Other term(s): Myeloma protein; Paraprotein Megaloblasts; NPU02645 number concentration U—M-component(spec.); subst.c. = ? µmol/l 109/liter NPU14346 Plasma— Marrow—Megaloblasts; num.c. = ? × 109/l M-component; arbitrary concentration(procedure) Erythrocytes(Blood)— NPU17675 Megaloblasts; P—M-component; arb.c.(proc.) = ? number fraction NPU14371 Urine— Ercs(B)—Megaloblasts; num.fr. = ? M-component; arbitrary concentration(procedure) Leukocytes(Blood)— NPU17676 Megaloblasts; U—M-component; arb.c.(proc.) = ? number fraction NPU14343 Plasma— Lkcs(B)—Megaloblasts; num.fr. = ? M-component; taxon(procedure) Leukocytes(Bone marrow)— Other term(s): Myeloma protein; Paraprotein Megaloblasts; NPU02642 number fraction P—M-component; taxon(proc.) = ? NPU14344 Lkcs(Marrow)—Megaloblasts; num.fr. = ? Urine— M-component; Blood— taxon(procedure) Megalocytes; Other term(s): Myeloma protein; Paraprotein arbitrary concentration(procedure) NPU02643 NPU17094 U—M-component; taxon(proc.)= ? B—Megalocytes; arb.c.(proc.) = ?

Blood— Erythrocytes(Blood)— Megakaryocytes; Megalocytes; number concentration number fraction 109/liter NPU14270 NPU04702 Ercs(B)—Megalocytes; num.fr. = ? B—Megakaryocytes; num.c. = ? × 109/l Urine— Bone marrow— Melanin; Megakaryocytes; arbitrary concentration(procedure) number concentration NPU08647 109/liter U—Melanin; arb.c.(proc.) = ? NPU03993 Marrow—Megakaryocytes; num.c. = ? × 109/l Urine— Melanin; Blood— substance concentration Megaloblasts; millimole/liter arbitrary concentration(procedure) NPU02695 NPU17093 U—Melanin; subst.c. = ? mmol/l B—Megaloblasts; arb.c.(proc.) = ? Urine— Blood— Melanin+Melanogen; Megaloblasts; substance concentration number concentration millimole/liter 109/liter NPU12902 NPU14345 U—Melanin+Melanogen; subst.c. = ? mmol/l B—Megaloblasts; num.c. = ? × 109/l Plasma— Blood fraction(specification)— Melatonin; Megaloblasts; substance concentration number concentration picomole/liter 109/liter M = 232,28 g/mol

NPU09333 Blood fraction(specification)— P—Melatonin; subst.c. = ? pmol/l Metamyelocytes; number concentration Blood— 109/liter Mercury; NPU17607 substance concentration B fract.(spec.)—Metamyelocytes; num.c. = ? × 109/l nanomole/liter M = 200,59 g/mol Bone marrow— Authority: IUPAC/VII-C-TOX Metamyelocytes; NPU02699 number concentration B—Mercury; subst.c. = ? nmol/l 109/liter NPU04675 Plasma— Marrow—Metamyelocytes; num.c. = ? × 109/l Mercury; substance concentration Leukocytes(Blood)— nanomole/liter Metamyelocytes; M = 200,59 g/mol number fraction Authority: IUPAC/VII-C-TOX NPU03977 NPU02701 Lkcs(B)—Metamyelocytes; num.fr. = ? P—Mercury; subst.c. = ? nmol/l Leukocytes(Bone marrow)— Urine— Metamyelocytes; Mercury; number fraction substance concentration NPU04676 nanomole/liter Lkcs(Marrow)—Metamyelocytes; num.fr. = ? M = 200,59 g/mol Authority: IUPAC/VII-C-TOX Cerebrospinal fluid— NPU02702 Methaemoglobin(Fe); U—Mercury; subst.c. = ? nmol/l arbitrary substance concentration(procedure) arbitrary unit/liter Hair— NPU14144 Mercury; Csf—Methaemoglobin(Fe); arb.subst.c.(proc.) = ? substance content arb.unit/l micromole/kilogram M = 200,59 g/mol Haemoglobin(Fe; Blood)— Authority: IUPAC/VII-C-TOX Methaemoglobin(Fe); NPU02700 substance fraction Hair—Mercury; subst.cont. = ? µmol/kg Other term(s): Hemiglobin Authority: IFCC/C-BGE Cells(Blood)— NPU02725 Mercury; Hb(Fe; B)—Methaemoglobin(Fe); subst.fr. = ? substance content nanomole/kilogram Plasma— M = 200,59 g/mol Methanol; Authority: IUPAC/VII-C-TOX substance concentration NPU04893 millimole/liter Cells(B)—Mercury; subst.cont. = ? nmol/kg M = 32,04 g/mol Other term(s): Methyl alcohol Patient(Urine)— NPU02723 Mercury; P—Methanol; subst.c. = ? mmol/l substance rate(procedure) nanomole/day Urine— M = 200,59 g/mol Methionine sulfoxide/Creatininium; NPU04211 substance ratio Pt(U)—Mercury; subst.rate(proc.) = ? nmol/d 10-3 NPU14236 Blood— U—Methionine sulfoxide/Creatininium; subst.ratio = Metamyelocytes; ? × 10-3 number concentration 109/liter Plasma— NPU03978 Methionine sulfoxide; B—Metamyelocytes; num.c. = ? × 109/l substance concentration mole/liter M = 165,2 g/mol NPU02736 P—Methionine sulfoxide; subst.c.= ? prefix ? mol/l © 2000 IUPAC, Pure and Applied Chemistry 72, 747–972 910 H. OLESEN et al.

Urine— Pt(U)—3-Methoxyadrenalinium/Creatininium; Methionine sulfoxide; subst.rate ratio(proc.) = ? × 10-6 substance concentration mole/liter Patient(Urine)— M = 165,2 g/mol 3- NPU02737 Methoxyadrenalinium; U—Methionine sulfoxide; subst.c.= ? prefix ? mol/l substance rate(procedure) micromole/day Urine— NPU17112 Methionine/Creatininium; Pt(U)—3-Methoxyadrenalinium; subst.rate(proc.) = substance ratio ? µmol/d 10-3 NPU14235 Patient(Urine)— U—Methionine/Creatininium; subst.ratio = ? × 10-3 3- Methoxyadrenalinium; Cerebrospinal fluid— substance rate(procedure) Methionine; millimole/day substance concentration M = 197,23 g/mol micromole/liter Other term(s): Metanephrine M = 149,21 g/mol NPU10693 NPU09030 Pt(U)—3-Methoxyadrenalinium; subst.rate(proc.) = Csf—Methionine; subst.c. = ? µmol/l ? mmol/d

Plasma— Urine— Methionine; 3- substance concentration Methoxyadrenalinium+3-Methoxynoradrenalinium; micromole/liter amount-of-substance(procedure) M = 149,21 g/mol micromole NPU02726 NPU17626 P—Methionine; subst.c. = ? µmol/l U—3-Methoxyadrenalinium+3- Methoxynoradrenalinium; am.s.(proc.) = ? µmol Urine— Methionine; Urine— substance concentration 3- micromole/liter Methoxyadrenalinium+3-Methoxynoradrenalinium; M = 149,21 g/mol substance concentration NPU02727 micromole/liter U—Methionine; subst.c. = ? µmol/l Other term(s): Metanephrine+normetanephrine NPU02740 Cerebrospinal fluid— U—3-Methoxyadrenalinium+3- Methotrexate; Methoxynoradrenalinium; subst.c. = ? µmol/l substance concentration micromole/liter Patient(Urine)— M = 454,44 g/mol 3- NPU02738 Methoxynoradrenalinium/Creatininium; Csf—Methotrexate; subst.c. = ? µmol/l substance rate ratio(procedure) 10-6 Plasma— Other term(s): 3-Methoxy noradrenalinium: Methotrexate; Normetanephrine substance concentration NPU10003 micromole/liter Pt(U)—3-Methoxynoradrenalinium/Creatininium; M = 454,44 g/mol subst.rate ratio(proc.) = ? × 10-6 NPU02739 P—Methotrexate; subst.c. = ? µmol/l Patient(Urine)— 3- Patient(Urine)— Methoxynoradrenalinium; 3- substance rate(procedure) Methoxyadrenalinium/Creatininium; micromole/day substance rate ratio(procedure) NPU17113 10-6 Pt(U)—3-Methoxynoradrenalinium; subst.rate(proc.) Other term(s): 3-Methoxy adrenalinium: = ? µmol/d Metanephrine NPU10002

Patient(Urine)— Urine— 3- 3- Methoxynoradrenalinium; Methylhistidine/Creatininium; substance rate(procedure) substance ratio millimole/day 10-3 M = 183,21 g/mol NPU14239 Other term(s): Normetanephrine U—3-Methylhistidine/Creatininium; subst.ratio = ? × NPU10694 10-3 Pt(U)—3-Methoxynoradrenalinium; subst.rate(proc.) = ? mmol/d Plasma— 1- Patient(Urine)— Methylhistidine; Methoxytyramine/Creatininium; substance concentration substance rate ratio(procedure) micromole/liter 10-6 M = 169,19 g/mol NPU10004 NPU02776 Pt(U)—Methoxytyramine/Creatininium; subst.rate P—1-Methylhistidine; subst.c. = ? µmol/l ratio(proc.) = ? × 10-6 Urine— Patient(Urine)— 1- Methoxytyramine; Methylhistidine; substance rate(procedure) substance concentration millimole/day micromole/liter NPU10695 M = 169,19 g/mol Pt(U)—Methoxytyramine; subst.rate(proc.) = ? NPU02777 mmol/d U—1-Methylhistidine; subst.c. = ? µmol/l

Urine— Plasma— Methylcitrate/Creatininium; 3- substance ratio Methylhistidine; 10-3 substance concentration NPU14237 micromole/liter U—Methylcitrate/Creatininium; subst.ratio = ? × 10-3 M = 169,19 g/mol NPU02778 Urine— P—3-Methylhistidine; subst.c. = ? µmol/l Methylcitrate; substance concentration Urine— mole/liter 3- NPU02744 Methylhistidine; U—Methylcitrate; subst.c.= ? prefix ? mol/l substance concentration micromole/liter Cobalamin(Plasma)— M = 169,19 g/mol Methylcobalamin; NPU02779 substance fraction U—3-Methylhistidine; subst.c. = ? µmol/l NPU04958 Cobalamin(P)—Methylcobalamin; subst.fr.= ? Plasma— Methylmalonate; Patient(Urine)— substance concentration Methylhippurate; micromole/liter substance rate(procedure) Note: M (anion) = 117,09 g/mol mole/day NPU02780 NPU02775 P—Methylmalonate; subst.c. = ? µmol/l Pt(U)—Methylhippurate; subst.rate(proc.)= ? prefix ? mol/d Patient(Urine)— Methylmalonate; Urine— substance rate(procedure) 1- micromole/day Methylhistidine/Creatininium; NPU10770 substance ratio Pt(U)—Methylmalonate; subst.rate(proc.) = ? 10-3 µmol/d NPU14238 U—1-Methylhistidine/Creatininium; subst.ratio = ? × 10-3

Patient— Plasma— Metyrapone(administered); b-2- amount-of-substance(oral administration) Microglobulin; millimole substance concentration M = 226,27 g/mol nanomole/liter NPU10524 M = 11 800 g/mol Pt—Metyrapone(administered); am.s.(p.o.) = ? NPU02817 mmol P—b-2-Microglobulin; subst.c. = ? nmol/l

Patient— Urine— Metyrapone(administered); b-2- number of doses Microglobulin; M = 226,27 g/mol substance concentration NPU09113 nanomole/liter Pt—Metyrapone(administered); number of doses = M = 11 800 g/mol ? NPU02818 U—b-2-Microglobulin; subst.c. = ? nmol/l Patient— Metyrapone(administered); Patient(Urine)— substance content(oral administration; amount- b-2- of-substance/body mass) Microglobulin; millimole/kilogram substance rate M = 226,27 g/mol nanomole/day NPU10525 M = 11 800 g/mol Pt—Metyrapone(administered); subst.cont.(p.o.; NPU10285 am.s./body mass) = ? mmol/kg Pt(U)—b-2-Microglobulin; subst.rate = ? nmol/d

Patient— Plasma— Metyrapone(administered); Mitochondrial antibody(Immunoglobulin G); time interval(between doses) arbitrary concentration(procedure) minute NPU14122 M = 226,27 g/mol P—Mitochondrial antibody(IgG); arb.c.(proc.) = ? NPU09114 Pt—Metyrapone(administered); time int.(between Plasma— doses) = ? min Mitochondrial antibody(Immunoglobulin G); arbitrary substance concentration(procedure) Blood— 10³ arbitrary unit/liter Microcytes; NPU09332 arbitrary concentration(procedure) P—Mitochondrial antibody(IgG); arb.subst.c.(proc.) NPU17095 = ? × 10³ arb.unit/l B—Microcytes; arb.c.(proc.) = ? Plasma— Erythrocytes(Blood)— Mitochondrial antibody; Microcytes; arbitrary concentration(procedure) number fraction NPU02834 NPU14271 P—Mitochondrial antibody; arb.c.(proc.) = ? Ercs(B)—Microcytes; num.fr. = ? Plasma— Urine— Mitochondrial antibody; a-1- arbitrary substance concentration(procedure) Microglobulin; arbitrary unit/liter substance concentration NPU14123 micromole/liter P—Mitochondrial antibody; arb.subst.c.(proc.) = ? NPU04129 arb.unit/l U—a-1-Microglobulin; subst.c.=? µmol/l Plasma— Cerebrospinal fluid— Mitotic spindle apparatus antibody(Immunoglobulin b-2- G); Microglobulin; arbitrary concentration(procedure) substance concentration NPU12017 nanomole/liter P—Mitotic spindle apparatus antibody(IgG); M = 11 800 g/mol arb.c.(proc.) = ? NPU10284 Csf—b-2-Microglobulin; subst.c. = ? nmol/l

Plasma— Mitotic spindle apparatus antibody(Immunoglobulin Blood fraction(specification)— G); Monocytes; arbitrary substance concentration(procedure) number concentration arbitrary unit/liter 109/liter NPU12585 NPU17582 P—Mitotic spindle apparatus antibody(IgG); B fract.(spec.)—Monocytes; num.c. = ? × 109/l arb.subst.c.(proc.) = ? arb.unit/l Bone marrow— Plasma— Monocytes; Mitotic spindle apparatus antibody; number concentration arbitrary concentration(procedure) 109/liter NPU02835 NPU04677 P—Mitotic spindle apparatus antibody; arb.c.(proc.) Marrow—Monocytes; num.c. = ? × 109/l = ? Leukocytes(Blood)— Plasma— Monocytes; Mitotic spindle apparatus antibody; number fraction arbitrary substance concentration(procedure) NPU03966 arbitrary unit/liter Lkcs(B)—Monocytes; num.fr. = ? NPU14124 P—Mitotic spindle apparatus antibody; Leukocytes(Bone marrow)— arb.subst.c.(proc.) = ? arb.unit/l Monocytes; number fraction Blood— NPU04678 Molybdenum; Lkcs(Marrow)—Monocytes; num.fr. = ? substance concentration nanomole/liter Plasma— M = 95,94 g/mol Motilin; Authority: IUPAC/VII-C-TOX substance concentration(procedure) NPU02836 picomole/liter B—Molybdenum; subst.c. = ? nmol/l M = 2 700 g/mol NPU08961 Plasma— P—Motilin; subst.c.(proc.) = ? pmol/l Molybdenum; substance concentration Plasma— nanomole/liter Motoric neuropathy antibody; M = 95,94 g/mol property(list; procedure) Authority: IUPAC/VII-C-TOX NPU14517 NPU02838 P—Motoric neuropathy antibody; prop.(list; proc.) P—Molybdenum; subst.c. = ? nmol/l NPU14521 P—Motoric neuropathy(GM1) antibody; arb.subst.c.(proc.) = ? × 10³ arb.unit/l Urine— NPU14518 P—Motoric neuropathy(GM1-asialo) Molybdenum; antibody; arb.subst.c.(proc.) = ? × 10³ arb.unit/l substance concentration NPU14519 P—Motoric neuropathy(GD1a) antibody; nanomole/liter arb.subst.c.(proc.) = ? × 10³ arb.unit/l M = 95,94 g/mol NPU14520 P—Motoric neuropathy(GD1b) antibody; Authority: IUPAC/VII-C-TOX arb.subst.c.(proc.) = ? × 10³ arb.unit/l NPU02839 NPU14522 P—Motoric neuropathy(GQ1b) antibody; U—Molybdenum; subst.c. = ? nmol/l arb.subst.c.(proc.) = ? × 10³ arb.unit/l NPU14526 P—Myeline associated glycoprotein Hair— antibody(IgM); arb.subst.c.(proc.) = ? × 10³ arb.unit/l Molybdenum; NPU14523 P—Neuropathy M-component; substance content arb.c.(IFE; proc.) = ? micromole/kilogram NPU14525 P—Neuropathy(SGPG)-antibody(IgM); M = 95,94 g/mol arb.subst.c.(proc.) = ? × 10³ arb.unit/l Authority: IUPAC/VII-C-TOX NPU02837 Plasma— Hair—Molybdenum; subst.cont. = ? µmol/kg Motoric neuropathy(GD1a) antibody; arbitrary substance concentration(procedure) Blood— 10³ arbitrary unit/liter Monocytes; NPU14519 number concentration P—Motoric neuropathy(GD1a) antibody; 109/liter arb.subst.c.(proc.) = ? × 10³ arb.unit/l NPU02840 B—Monocytes; num.c. = ? × 109/l © 2000 IUPAC, Pure and Applied Chemistry 72, 747–972 914 H. OLESEN et al.

Plasma— Blood fraction(specification)— Motoric neuropathy(GD1b) antibody; Myeloblasts; arbitrary substance concentration(procedure) number concentration 10³ arbitrary unit/liter 109/liter NPU14520 NPU17608 P—Motoric neuropathy(GD1b) antibody; B fract.(spec.)—Myeloblasts; num.c. = ? × 109/l arb.subst.c.(proc.) = ? × 10³ arb.unit/l Bone marrow— Plasma— Myeloblasts; Motoric neuropathy(GM1) antibody; number concentration arbitrary substance concentration(procedure) 109/liter 10³ arbitrary unit/liter NPU04679 NPU14521 Marrow—Myeloblasts; num.c. = ? × 109/l P—Motoric neuropathy(GM1) antibody; arb.subst.c.(proc.) = ? × 10³ arb.unit/l Leukocytes(Blood)— Myeloblasts; Plasma— number fraction Motoric neuropathy(GM1-asialo) antibody; NPU03969 arbitrary substance concentration(procedure) Lkcs(B)—Myeloblasts; num.fr. = ? 10³ arbitrary unit/liter NPU14518 Leukocytes(Bone marrow)— P—Motoric neuropathy(GM1-asialo) antibody; Myeloblasts; arb.subst.c.(proc.) = ? × 10³ arb.unit/l number fraction NPU04680 Plasma— Lkcs(Marrow)—Myeloblasts; num.fr. = ? Motoric neuropathy(GQ1b) antibody; arbitrary substance concentration(procedure) Blood— 10³ arbitrary unit/liter Myelocytes(eosinophil); NPU14522 number concentration P—Motoric neuropathy(GQ1b) antibody; 109/liter arb.subst.c.(proc.) = ? × 10³ arb.unit/l NPU04704 B—Myelocytes(eosinophil); num.c. = ? × 109/l Plasma— Mycophenolate; Blood fraction(specification)— substance concentration Myelocytes(eosinophil); micromole/liter number concentration NPU17173 109/liter P—Mycophenolate; subst.c. = ? µmol/l NPU17609 B fract.(spec.)—Myelocytes(eosinophil); num.c. = ? Cerebrospinal fluid— × 109/l Myelin basic protein; mass concentration Bone marrow— microgram/liter Myelocytes(eosinophil); NPU09340 number concentration Csf—Myelin basic protein; mass c. = ? µg/l 109/liter NPU03994 Plasma— Marrow—Myelocytes(eosinophil); num.c. = ? × 109/l Myeline associated glycoprotein antibody(Immunoglobulin M); Leukocytes(Blood)— arbitrary substance concentration(procedure) Myelocytes(eosinophil); 10³ arbitrary unit/liter number fraction NPU14526 NPU04705 P—Myeline associated glycoprotein antibody(IgM); Lkcs(B)—Myelocytes(eosinophil); num.fr. = ? arb.subst.c.(proc.) = ? × 10³ arb.unit/l Leukocytes(Bone marrow)— Blood— Myelocytes(eosinophil); Myeloblasts; number fraction number concentration NPU04987 109/liter Lkcs(Marrow)—Myelocytes(eosinophil); num.fr. = ? NPU03970 B—Myeloblasts; num.c. = ? × 109/l Blood— Myelocytes(neutrophil); number concentration

109/liter Plasma— NPU04706 Myeloperoxidase antibody(Immunoglobulin G); B—Myelocytes(neutrophil); num.c. = ? × 109/l arbitrary concentration(procedure) Other term(s): MPO antibody Blood fraction(specification)— NPU12575 Myelocytes(neutrophil); P—Myeloperoxidase antibody(IgG); arb.c.(proc.) = number concentration ? 109/liter NPU17610 Plasma— B fract.(spec.)—Myelocytes(neutrophil); num.c. = ? Myeloperoxidase antibody(Immunoglobulin G); × 109/l arbitrary substance concentration(procedure) 10³ arbitrary unit/liter Bone marrow— Other term(s): MPO antibody Myelocytes(neutrophil); NPU12036 number concentration P—Myeloperoxidase antibody(IgG); 109/liter arb.subst.c.(proc.) = ? × 10³ arb.unit/l NPU04089 Marrow—Myelocytes(neutrophil); num.c. = ? × 109/l Urine— Myoglobin; Leukocytes(Blood)— arbitrary concentration(procedure) Myelocytes(neutrophil); M = 17 200 g/mol number fraction NPU09016 NPU04707 U—Myoglobin; arb.c.(proc.) = ? Lkcs(B)—Myelocytes(neutrophil); num.fr. = ? Plasma— Leukocytes(Bone marrow)— Myoglobin; Myelocytes(neutrophil); substance concentration number fraction micromole/liter NPU04986 M = 17 200 g/mol Lkcs(Marrow)—Myelocytes(neutrophil); num.fr. = ? NPU02854 P—Myoglobin; subst.c. = ? µmol/l Blood— Myelocytes; Urine— number concentration Myoglobin; 109/liter substance concentration NPU03976 micromole/liter B—Myelocytes; num.c. = ? × 109/l M = 17 200 g/mol NPU03901 Blood fraction(specification)— U—Myoglobin; subst.c. = ? µmol/l Myelocytes; number concentration Plasma— 109/liter Myoglobin; NPU17611 substance concentration B fract.(spec.)—Myelocytes; num.c. = ? × 109/l nanomole/liter M = 17 200 g/mol Bone marrow— NPU17415 Myelocytes; P—Myoglobin; subst.c. = ? nmol/l number concentration 109/liter Urine— NPU14381 Myoglobin; Marrow—Myelocytes; num.c. = ? × 109/l substance concentration nanomole/liter Leukocytes(Blood)— M = 17 200 g/mol Myelocytes; NPU17416 number fraction U—Myoglobin; subst.c. = ? nmol/l NPU03975 Lkcs(B)—Myelocytes; num.fr. = ? Blood— Naked nuclei; Leukocytes(Bone marrow)— number concentration Myelocytes; 109/liter number fraction NPU17597 NPU14380 B—Naked nuclei; num.c. = ? × 109/l Lkcs(Marrow)—Myelocytes; num.fr. = ?

Blood fraction(specification)— Plasma— Naked nuclei; Neuropathy M-component; number concentration arbitrary concentration(IFE; procedure) 109/liter NPU14523 NPU17630 P—Neuropathy M-component; arb.c.(IFE; proc.) = ? B fract.(spec.)—Naked nuclei; num.c. = ? × 109/l Plasma— Leukocytes(Blood)— Neuropathy(SGPG)-antibody(Immunoglobulin M); Naked nuclei; arbitrary substance concentration(procedure) number fraction 10³ arbitrary unit/liter NPU17619 NPU14525 Lkcs(B)—Naked nuclei; num.fr. = ? P—Neuropathy(SGPG)-antibody(IgM); arb.subst.c.(proc.) = ? × 10³ arb.unit/l Plasma— Neuron specific enolase; Plasma(fasting Patient)— arbitrary substance concentration(procedure) Neuropeptide K; arbitrary unit/liter substance concentration NPU12998 picomole/liter P—Neuron specific enolase; arb.subst.c.(proc.) = ? NPU14024 arb.unit/l P(fPt)—Neuropeptide K; subst.c. = ? pmol/l

Plasma— Urine— Neuron(CNS-lupus) antibody(Immunoglobulin G); Neuropeptide K; arbitrary concentration(procedure) substance concentration NPU14541 picomole/liter P—Neuron(CNS-lupus) antibody(IgG); arb.c.(proc.) NPU14025 = ? U—Neuropeptide K; subst.c. = ? pmol/l

Plasma— Patient(Urine)— Neuronal cell nucleus(Hu)-antistof(Immunoglobulin Neuropeptide K; G); substance rate arbitrary substance concentration(procedure) picomole/day 10³ arbitrary unit/liter NPU14026 NPU14542 Pt(U)—Neuropeptide K; subst.rate = ? pmol/d P—Neuronal cell nucleus(Hu)-antistof(IgG); arb.subst.c.(proc.) = ? × 10³ arb.unit/l Plasma— Neuropeptide Y; Plasma— substance concentration Neuropathy antibody; picomole/liter property(list; procedure) NPU10616 NPU14527 P—Neuropeptide Y; subst.c. = ? pmol/l P—Neuropathy antibody; prop.(list; proc.) NPU14518 P—Motoric neuropathy(GM1-asialo) Urine— antibody; arb.subst.c.(proc.) = ? × 10³ arb.unit/l Neuropeptide Y; NPU14519 P—Motoric neuropathy(GD1a) antibody; substance concentration arb.subst.c.(proc.) = ? × 10³ arb.unit/l picomole/liter NPU14520 P—Motoric neuropathy(GD1b) antibody; NPU14019 arb.subst.c.(proc.) = ? × 10³ arb.unit/l U—Neuropeptide Y; subst.c. = ? pmol/l NPU14521 P—Motoric neuropathy(GM1) antibody; arb.subst.c.(proc.) = ? × 10³ arb.unit/l Patient(Urine)— NPU14522 P—Motoric neuropathy(GQ1b) antibody; Neuropeptide Y; arb.subst.c.(proc.) = ? × 10³ arb.unit/l substance rate NPU14523 P—Neuropathy M-component; picomole/day arb.c.(IFE; proc.) = ? NPU14020 NPU14526 P—Myeline associated glycoprotein Pt(U)—Neuropeptide Y; subst.rate = ? pmol/d antibody(IgM); arb.subst.c.(proc.) = ? × 10³ arb.unit/l NPU14525 P—Neuropathy(SGPG)-antibody(IgM); Plasma(fasting Patient)— arb.subst.c.(proc.) = ? × 10³ arb.unit/l Neurotensin; NPU14528 P—Sensoric neuropathy(Hu) substance concentration antibody(IgG); arb.subst.c.(proc.) = ? × 10³ arb.unit/l picomole/liter NPU14529 P—Sensoric neuropathy(sulfatid) NPU14021 antibody; arb.subst.c.(proc.) = ? × 10³ arb.unit/l P(fPt)—Neurotensin; subst.c. = ? pmol/l

Urine— Plasma— Neurotensin; Neutrophilocyte cytoplasm antibody; substance concentration arbitrary concentration(procedure) picomole/liter NPU02899 NPU14022 P—Neutrophilocyte cytoplasm antibody; U—Neurotensin; subst.c. = ? pmol/l arb.c.(proc.) = ?

Patient(Urine)— Plasma— Neurotensin; Neutrophilocyte cytoplasm antibody; substance rate arbitrary substance concentration(procedure) picomole/day arbitrary unit/liter NPU14023 NPU12011 Pt(U)—Neurotensin; subst.rate = ? pmol/d P—Neutrophilocyte cytoplasm antibody; arb.subst.c.(proc.) = ? arb.unit/l Plasma— Neutrophilocyte antibody; Plasma— arbitrary concentration(procedure) Neutrophilocyte cytoplasmatic cytoplasma NPU02898 antibody(Immunoglobulin G); P—Neutrophilocyte antibody; arb.c.(proc.) = ? arbitrary concentration(procedure) NPU14531 Plasma— P—Neutrophilocyte cytoplasmatic cytoplasma Neutrophilocyte cytoplasm antibody(IgG); arb.c.(proc.) = ? antibody(Immunoglobulin G); arbitrary concentration(list; procedure) Plasma— NPU16401 Neutrophilocyte peripheral cytoplasma P—Neutrophilocyte cytoplasm antibody(IgG); antibody(Immunoglobulin G); arb.c.(list; proc.) arbitrary concentration(procedure) NPU14530 P—Neutrophilocyte cytoplasm NPU14532 antibody(IgG); arb.c.(proc.) = ? P—Neutrophilocyte peripheral cytoplasma NPU14531 P—Neutrophilocyte cytoplasmatic antibody(IgG); arb.c.(proc.) = ? cytoplasma antibody(IgG); arb.c.(proc.) = ? NPU14532 P—Neutrophilocyte peripheral Plasma— cytoplasma antibody(IgG); arb.c.(proc.) = ? Neutrophilocyte peripheral cytoplasma antibody(Immunoglobulin G); Plasma— arbitrary substance concentration(procedure) Neutrophilocyte cytoplasm arbitrary unit/liter antibody(Immunoglobulin G); NPU14533 arbitrary concentration(procedure) P—Neutrophilocyte peripheral cytoplasma NPU14530 antibody(IgG); arb.subst.c.(proc.) = ? arb.unit/l P—Neutrophilocyte cytoplasm antibody(IgG); arb.c.(proc.) = ? Plasma— Neutrophilocyte proteinase 3(Immunoglobulin G); Plasma— arbitrary substance concentration(procedure) Neutrophilocyte cytoplasm arbitrary unit/liter antibody(Immunoglobulin G); Other term(s): anti-Pr3: Pr3-ANCA arbitrary substance concentration(list; NPU12012 procedure) P—Neutrophilocyte proteinase 3(IgG); NPU16402 arb.subst.c.(proc.) = ? arb.unit/l P—Neutrophilocyte cytoplasm antibody(IgG); arb.subst.c.(list; proc.) Blood— NPU12010 P—Neutrophilocyte cytoplasm Neutrophilocytes(band); antibody(IgG); arb.subst.c.(proc.) = ? arb.unit/l number concentration NPU14533 P—Neutrophilocyte peripheral 109/liter cytoplasma antibody(IgG); arb.subst.c.(proc.) = ? NPU03980 arb.unit/l B—Neutrophilocytes(band); num.c. = ? × 109/l

Plasma— Blood fraction(specification)— Neutrophilocyte cytoplasm Neutrophilocytes(band); antibody(Immunoglobulin G); number concentration arbitrary substance concentration(procedure) 109/liter arbitrary unit/liter NPU17613 NPU12010 B fract.(spec.)—Neutrophilocytes(band); num.c. = ? P—Neutrophilocyte cytoplasm antibody(IgG); × 109/l arb.subst.c.(proc.) = ? arb.unit/l

Bone marrow— Urine— Neutrophilocytes(band); Neutrophilocytes; number concentration number concentration(procedure) 109/liter 106/liter NPU04683 NPU02904 Marrow—Neutrophilocytes(band); num.c. = ? × 109/l U—Neutrophilocytes; num.c.(proc.) = ? × 106/l

Leukocytes(Blood)— Ascites— Neutrophilocytes(band); Neutrophilocytes; number fraction number concentration NPU03979 106/liter Lkcs(B)—Neutrophilocytes(band); num.fr. = ? NPU08655 Asc—Neutrophilocytes; num.c. = ? × 106/l Leukocytes(Bone marrow)— Neutrophilocytes(band); Cerebrospinal fluid— number fraction Neutrophilocytes; NPU04684 number concentration Lkcs(Marrow)—Neutrophilocytes(band); num.fr. = ? 106/liter NPU02903 Blood— Csf—Neutrophilocytes; num.c. = ? × 106/l Neutrophilocytes(segmented); morphology(procedure) Pleural fluid(specification)— NPU17069 Neutrophilocytes; B—Neutrophilocytes(segmented); number concentration morphology(proc.) = ? 106/liter NPU08654 Blood— Plf(spec.)—Neutrophilocytes; num.c. = ? × 106/l Neutrophilocytes(segmented); number concentration Synovial fluid(specification)— 109/liter Neutrophilocytes; NPU03982 number concentration B—Neutrophilocytes(segmented); num.c. = ? × 109/l 106/liter NPU04230 Blood fraction(specification)— Synf(spec.)—Neutrophilocytes; num.c.= ? × 106/l Neutrophilocytes(segmented); number concentration Blood— 109/liter Neutrophilocytes; NPU17612 number concentration B fract.(spec.)—Neutrophilocytes(segmented); 109/liter num.c. = ? × 109/l NPU02902 B—Neutrophilocytes; num.c. = ? × 109/l Bone marrow— Neutrophilocytes(segmented); Blood fraction(specification)— number concentration Neutrophilocytes; 109/liter number concentration NPU04681 109/liter Marrow—Neutrophilocytes(segmented); num.c. = ? NPU17584 × 109/l B fract.(spec.)—Neutrophilocytes; num.c. = ? × 109/l

Leukocytes(Blood)— Leukocytes(Ascites)— Neutrophilocytes(segmented); Neutrophilocytes; number fraction number fraction NPU03981 NPU10756 Lkcs(B)—Neutrophilocytes(segmented); num.fr. = ? Lkcs(Asc)—Neutrophilocytes; num.fr.= ?

Leukocytes(Bone marrow)— Leukocytes(Blood)— Neutrophilocytes(segmented); Neutrophilocytes; number fraction number fraction NPU04682 NPU03983 Lkcs(Marrow)—Neutrophilocytes(segmented); Lkcs(B)—Neutrophilocytes; num.fr. = ? num.fr. = ?

Leukocytes(Cerebrospinal fluid)— Urine— Neutrophilocytes; Nitrogen(N); number fraction amount-of-substance(procedure) NPU04226 millimole Lkcs(Csf)—Neutrophilocytes; num.fr.= ? NPU04083 U—Nitrogen(N); am.s.(proc.) = ? mmol Leukocytes(Pericardial fluid)— Neutrophilocytes; Patient(Urine)— number fraction Nitrogen(N); NPU10759 substance rate(procedure) Lkcs(Pericardialf.)—Neutrophilocytes; num.fr.= ? millimole/day NPU02917 Leukocytes(Pleural fluid; specification)— Pt(U)—Nitrogen(N); subst.rate(proc.) = ? mmol/d Neutrophilocytes; number fraction Urine— NPU10753 Noradrenalinium; Lkcs(Plf; spec.)—Neutrophilocytes; num.fr.= ? amount-of-substance(procedure) micromole Leukocytes(Synovial fluid; specification)— NPU17585 Neutrophilocytes; U—Noradrenalinium; am.s.(proc.) = ? µmol number fraction NPU10752 Plasma— Lkcs(Synf; spec.)—Neutrophilocytes; num.fr.= ? Noradrenalinium; substance concentration Plasma— micromole/liter Nickel; M = 169,18 g/mol substance concentration NPU17115 nanomole/liter P—Noradrenalinium; subst.c. = ? µmol/l M = 58,71 g/mol Authority: IUPAC/VII-C-TOX Urine— NPU02906 Noradrenalinium; P—Nickel; subst.c. = ? nmol/l substance concentration micromole/liter Urine— NPU17116 Nickel; U—Noradrenalinium; subst.c. = ? µmol/l substance concentration nanomole/liter Patient(Urine)— M = 58,71 g/mol Noradrenalinium; Authority: IUPAC/VII-C-TOX substance rate(procedure) NPU02907 micromole/day U—Nickel; subst.c. = ? nmol/l NPU17114 Pt(U)—Noradrenalinium; subst.rate(proc.) = ? Hair— µmol/d Nickel; substance content Plasma— micromole/kilogram Nucleolus antibody(Immunoglobulin G); M = 58,71 g/mol arbitrary concentration(procedure) Authority: IUPAC/VII-C-TOX Other term(s): ANA: NPU02905 NPU12013 Hair—Nickel; subst.cont. = ? µmol/kg P—Nucleolus antibody(IgG); arb.c.(proc.) = ?

Plasma— Plasma— Nitrate; Nucleolus antibody(Immunoglobulin G); substance concentration arbitrary substance concentration(procedure) micromole/liter arbitrary unit/liter NPU03851 NPU12583 P—Nitrate; subst.c. = ? µmol/l P—Nucleolus antibody(IgG); arb.subst.c.(proc.) = ? arb.unit/l Plasma— Nitrite; Plasma— substance concentration Nucleolus antibody; micromole/liter arbitrary concentration(procedure) NPU03852 NPU02925 P—Nitrite; subst.c. = ? µmol/l P—Nucleolus antibody; arb.c.(proc.) = ?

Plasma— Nucleolus antibody; Plasma— arbitrary substance concentration(procedure) Nucleus antibody(Immunoglobulin G); arbitrary unit/liter arbitrary concentration(procedure) NPU14125 NPU12018 P—Nucleolus antibody; arb.subst.c.(proc.) = ? P—Nucleus antibody(IgG); arb.c.(proc.) = ? arb.unit/l Plasma— Plasma— Nucleus antibody(Immunoglobulin G); Nucleolus membrane antibody(Immunoglobulin G); arbitrary substance concentration(procedure) arbitrary concentration(procedure) arbitrary unit/liter NPU12582 Authority: IFCC92 P—Nucleolus membrane antibody(IgG); NPU14127 arb.c.(proc.) = ? P—Nucleus antibody(IgG); arb.subst.c.(proc.) = ? arb.unit/l Plasma— Nucleolus membrane antibody(Immunoglobulin G); Plasma— arbitrary substance concentration(procedure) Nucleus antibody; arbitrary unit/liter arbitrary concentration(procedure) NPU12587 Authority: IFCC92 P—Nucleolus membrane antibody(IgG); NPU01481 arb.subst.c.(proc.) = ? arb.unit/l P—Nucleus antibody; arb.c.(proc.) = ?

Amniotic fluid— Plasma— 5'- Nucleus antibody; Nucleotidase; arbitrary substance concentration(list; catalytic-activity concentration(37 °C; procedure) procedure) NPU09331 nanokatal/liter P—Nucleus antibody; arb.subst.c.(list; proc.) NPU03915 NPU12015 P—Centromer antibody(IgG); Amf—5'-Nucleotidase; cat.c.(37 °C; proc.) = ? nkat/l arb.subst.c.(proc.) = ? arb.unit/l NPU12585 P—Mitotic spindle apparatus Plasma— antibody(IgG); arb.subst.c.(proc.) = ? arb.unit/l 5'- NPU12583 P—Nucleolus antibody(IgG); Nucleotidase; arb.subst.c.(proc.) = ? arb.unit/l catalytic-activity concentration(37 °C; NPU14536 P—Nucleus(homogeneous staining)- procedure) antibody(IgG); arb.subst.c.(proc.) = ? arb.unit/l nanokatal/liter NPU14537 P—Nucleus(dot staining)-antibody(IgG); NPU02926 arb.subst.c.(proc.) = ? arb.unit/l P—5'-Nucleotidase; cat.c.(37 °C; proc.) = ? nkat/l NPU14127 P—Nucleus antibody(IgG); arb.subst.c.(proc.) = ? arb.unit/l Plasma— NPU14126 P—Nucleus antibody; arb.subst.c.(proc.) Nucleus antibody(Immunoglobulin G); = ? arb.unit/l arbitrary concentration(list; procedure) NPU12587 P—Nucleolus membrane antibody(IgG); NPU09330 arb.subst.c.(proc.) = ? arb.unit/l P—Nucleus antibody(IgG); arb.c.(list; proc.) NPU12586 P—Nucleus dot antibody(IgG); NPU01518 P—Centromer antibody(IgG); arb.subst.c.(proc.) = ? arb.unit/l arb.c.(proc.) = ? NPU12584 P—Proliferating cell nucleus NPU12017 P—Mitotic spindle apparatus antibody(IgG); arb.subst.c.(proc.) = ? arb.unit/l antibody(IgG); arb.c.(proc.) = ? NPU12013 P—Nucleolus antibody(IgG); Plasma— arb.c.(proc.) = ? Nucleus antibody; NPU14534 P—Nucleus(homogeneous staining)- arbitrary substance concentration(procedure) antibody(IgG); arb.c.(proc.) = ? arbitrary unit/liter NPU14535 P—Nucleus(dot staining)-antibody(IgG); Authority: IFCC92 arb.c.(proc.) = ? NPU14126 NPU12018 P—Nucleus antibody(IgG); arb.c.(proc.) P—Nucleus antibody; arb.subst.c.(proc.) = ? = ? arb.unit/l NPU01481 P—Nucleus antibody; arb.c.(proc.) = ? NPU12582 P—Nucleolus membrane antibody(IgG); Plasma— arb.c.(proc.) = ? Nucleus dot antibody(Immunoglobulin G); NPU12016 P—Nucleus dot antibody(IgG); arbitrary concentration(procedure) arb.c.(proc.) = ? NPU12016 NPU03254 P—Proliferating cell nucleus P—Nucleus dot antibody(IgG); arb.c.(proc.) = ? antibody(IgG); arb.c.(proc.) = ?

Plasma— Urine— Nucleus dot antibody(Immunoglobulin G); Ornithine/Creatininium; arbitrary substance concentration(procedure) substance ratio arbitrary unit/liter 10-3 NPU12586 NPU14240 P—Nucleus dot antibody(IgG); arb.subst.c.(proc.) = U—Ornithine/Creatininium; subst.ratio = ? × 10-3 ? arb.unit/l Cerebrospinal fluid— Plasma— Ornithine; Nucleus(dot staining)-antibody(Immunoglobulin G); substance concentration arbitrary concentration(procedure) micromole/liter NPU14535 M = 132,16 g/mol P—Nucleus(dot staining)-antibody(IgG); NPU09031 arb.c.(proc.) = ? Csf—Ornithine; subst.c. = ? µmol/l

Plasma— Plasma— Nucleus(dot staining)-antibody(Immunoglobulin G); Ornithine; arbitrary substance concentration(procedure) substance concentration arbitrary unit/liter micromole/liter NPU14537 M = 132,16 g/mol P—Nucleus(dot staining)-antibody(IgG); NPU02936 arb.subst.c.(proc.) = ? arb.unit/l P—Ornithine; subst.c. = ? µmol/l

Plasma— Urine— Nucleus(homogeneous staining)- Ornithine; antibody(Immunoglobulin G); substance concentration arbitrary concentration(procedure) micromole/liter NPU14534 M = 132,16 g/mol P—Nucleus(homogeneous staining)-antibody(IgG); NPU02937 arb.c.(proc.) = ? U—Ornithine; subst.c. = ? µmol/l

Plasma— Urine— Nucleus(homogeneous staining)- Orosomucoid/Creatininium; antibody(Immunoglobulin G); substance ratio arbitrary substance concentration(procedure) 10-3 arbitrary unit/liter NPU10195 NPU14536 U—Orosomucoid/Creatininium; subst.ratio = ? × P—Nucleus(homogeneous staining)-antibody(IgG); 10-3 arb.subst.c.(proc.) = ? arb.unit/l Plasma— Patient— Orosomucoid; Octreotide(administered); substance concentration amount-of-substance(subcutanous micromole/liter administration) M = 40 000 g/mol nanomole Other term(s): a-1 acid glycoprotein M = 1 019,26 g/mol NPU02948 Other term(s): Sandostatin; Longastatin P—Orosomucoid; subst.c. = ? µmol/l NPU10638 Pt—Octreotide(administered); am.s.(s.c.) = ? nmol Urine— Orotate; Patient— substance concentration Octreotide(administered); mole/liter substance content(subcutanous administration; NPU02949 amount-of-substance/body mass) U—Orotate; subst.c.= ? prefix ? mol/l nanomole/kilogram M = 1 019,26 g/mol Blood— Other term(s): Sandostatin; Longastatin Osmotic pressure reaction; NPU10639 arbitrary concentration(Free Haemoglobin/all Pt—Octreotide(administered); subst.cont.(s.c.; Haemoglobin = 0,5; 37 °C; pH = 7,40; 0 hours; am.s./body mass) = ? nmol/kg procedure) Other term(s): Osmotic resistance NPU02966 B—Osmotic pressure reaction; arb.c.(Free Hb/all Hb = 0,5; 37 °C; pH = 7,40; 0 h; proc.) = ?

Blood— Urine— Osmotic pressure reaction; Oxoglutarate; arbitrary concentration(Free Haemoglobin/all substance concentration Haemoglobin = 0,5; 37 °C; pH = 7,40; 24 hours; micromole/liter procedure) NPU02986 Other term(s): Osmotic resistance U—Oxoglutarate; subst.c. = ? µmol/l NPU02967 B—Osmotic pressure reaction; arb.c.(Free Hb/all Hb Urine— = 0,5; 37 °C; pH = 7,40; 24 h; proc.) = ? 2- Oxo-isocaproate; Plasma— substance concentration Osteocalcin; mole/liter substance concentration M = 130,14 g/mol nanomole/liter NPU02977 M = 5 845 g/mol U—2-Oxo-isocaproate; subst.c.= ? prefix ? mol/l Other term(s): Bone-GLA-protein NPU02968 Urine— P—Osteocalcin; subst.c. = ? nmol/l 17- Oxosteroid; Plasma— substance concentration(list; procedure) Osteonectin; NPU09096 substance concentration U—17-Oxosteroid; subst.c.(list; proc.) mole/liter NPU09097 U—Androsterone; subst.c. = ? nmol/l NPU02969 NPU02013 U—Etiocholanolone; subst.c. = ? µmol/l P—Osteonectin; subst.c.= ? prefix ? mol/l NPU01855 U—Prasterone; subst.c. = ? nmol/l

Plasma— Urine— Ovary antibody(Immunoglobulin G); 17- arbitrary concentration(procedure) Oxosteroid; NPU14538 substance concentration P—Ovary antibody(IgG); arb.c.(proc.) = ? micromole/liter NPU09361 Calculus(Urine)— U—17-Oxosteroid; subst.c. = ? µmol/l Oxalate; arbitrary content(procedure) Patient(Urine)— NPU09231 17- Calculus(U)—Oxalate; arb.cont.(proc.) = ? Oxosteroid; substance rate(list; procedure) Plasma— NPU10136 Oxalate; Pt(U)—17-Oxosteroid; subst.rate(list; proc.) substance concentration NPU10133 Pt(U)—Androsterone; subst.rate = ? micromole/liter nmol/d NPU02970 NPU10134 Pt(U)—Etiocholanolone; subst.rate = ? P—Oxalate; subst.c. = ? µmol/l µmol/d NPU09095 Pt(U)—17-Oxosteroid; subst.rate(proc.) Urine— = ? µmol/d Oxalate; NPU10135 Pt(U)—Prasterone; subst.rate = ? nmol/ substance concentration d micromole/liter NPU02971 Patient(Urine)— U—Oxalate; subst.c. = ? µmol/l 17- Oxosteroid; Calculus(Urine)— substance rate(procedure) Oxalate; micromole/day substance content NPU09095 mole/kilogram Pt(U)—17-Oxosteroid; subst.rate(proc.) = ? µmol/d NPU09237 Calculus(U)—Oxalate; subst.cont. = ? mol/kg Patient— Oxygen(administered); Patient(Urine)— volume rate Oxalate; liter/minute substance rate(procedure) NPU10167 micromole/day Pt—Oxygen(administered); vol.rate = ? l/min NPU03951 Pt(U)—Oxalate; subst.rate(proc.) = ? µmol/d

Air(respiratory system)— Authority: IFCC/C-BGE

Oxygen(O2); NPU10203

partial pressure Gas(spec.)—Oxygen(O2); part.pr. = ? kPa kilopascal Authority: IFCC/C-BGE Gas(venous Blood)—

NPU03006 Oxygen(O2);

Air(resp.syst.)—Oxygen(O2); part.pr. = ? kPa partial pressure kilopascal Air(specification)— Authority: IFCC/C-BGE

Oxygen(O2); NPU03847

partial pressure Gas(vB)—Oxygen(O2); part.pr. = ? kPa kilopascal NPU03814 Haemoglobin(total; arterial Blood)—

Air(spec.)—Oxygen(O2); part.pr. = ? kPa Oxygen(O2); saturation fraction Gas(arterial Blood)— Authority: IFCC/C-BGE

Oxygen(O2); NPU03011

partial pressure Hb(tot.; aB)—Oxygen(O2); sat.fr. = ? kilopascal Authority: IFCC/C-BGE Haemoglobin(total; capillary Blood)—

NPU03009 Oxygen(O2);

Gas(aB)—Oxygen(O2); part.pr. = ? kPa saturation fraction Authority: IFCC/C-BGE Gas(capillary Blood)— NPU10197

Oxygen(O2); Hb(tot.; cB)—Oxygen(O2); sat.fr. = ? partial pressure kilopascal Haemoglobin(total; cord Blood)—

NPU12514 Oxygen(O2);

Gas(cB)—Oxygen(O2); part.pr. = ? kPa saturation fraction NPU12508

Gas(cord Blood)— Hb(tot.; cordB)—Oxygen(O2); sat.fr. = ?

Oxygen(O2); partial pressure Haemoglobin(total; mixed Blood)—

kilopascal Oxygen(O2); NPU12513 saturation fraction

Gas(cordB)—Oxygen(O2); part.pr. = ? kPa Authority: IFCC/C-BGE NPU09218

Gas(cord Blood; arterial Blood)— Hb(tot.; mixB)—Oxygen(O2); sat.fr. = ?

Oxygen(O2); partial pressure Haemoglobin(total; venous Blood)—

kilopascal Oxygen(O2); NPU17170 saturation fraction

Gas(cordB; aB)—Oxygen(O2); part.pr. = ? kPa Authority: IFCC/C-BGE NPU10199

Gas(cord Blood; venous Blood)— Hb(tot.; vB)—Oxygen(O2); sat.fr. = ?

Oxygen(O2); partial pressure Plasma(arterial Blood)—

kilopascal Oxygen(O2); NPU17171 gas tension(patient body temperature)

Gas(cordB; vB)—Oxygen(O2); part.pr. = ? kPa kilopascal Authority: IFCC/C-BGE

Gas(mixed Blood)— Note: M = 16,00 x 2 g/mol for O2

Oxygen(O2); NPU14104

partial pressure P(aB)—Oxygen(O2); tension(body temp.) = ? kPa kilopascal Authority: IFCC/C-BGE Haemoglobin(Blood)—

NPU09214 Oxygen(O2);

Gas(mixB)—Oxygen(O2); part.pr. = ? kPa gas tension(at halfsaturation) kilopascal Gas(specification)— Authority: IFCC/C-BGE

Oxygen(O2); Note: M = 16,00 x 2 g/mol for O2 partial pressure NPU03010

kilopascal Hb(B)—Oxygen(O2); tension(halfsat.) = ? kPa

Plasma(arterial Blood)— Authority: IFCC/C-BGE

Oxygen(O2); Note: M = 16,00 x 2 g/mol for O2 gas tension NPU03007

kilopascal Air(spec.)—Oxygen(O2); vol.fr. = ? Authority: IFCC/C-BGE

Note: M = 16,00 x 2 g/mol for O2 Plasma(arterial Blood)—

NPU08977 Oxygen(O2; free);

P(aB)—Oxygen(O2); tension = ? kPa substance concentration millimole/liter Plasma(capillary Blood)— Authority: IFCC/C-BGE

Oxygen(O2); Note: M = 16,00 x 2 g/mol for O2 gas tension NPU03012

kilopascal P(aB)—Oxygen(O2; free); subst.c. = ? mmol/l NPU12500

P(cB)—Oxygen(O2); tension = ? kPa Plasma(capillary Blood)—

Oxygen(O2; free); Plasma(cord Blood)— substance concentration

Oxygen(O2); millimole/liter gas tension NPU12503

kilopascal P(cB)—Oxygen(O2; free); subst.c. = ? mmol/l NPU12502

P(cordB)—Oxygen(O2); tension = ? kPa Plasma(cord Blood)—

Oxygen(O2; free); Plasma(cord Blood; arterial Blood)— substance concentration

Oxygen(O2); millimole/liter gas tension NPU12478

kilopascal P(cordB)—Oxygen(O2; free); subst.c. = ? mmol/l NPU17155

P(cordB; aB)—Oxygen(O2); tension = ? kPa Plasma(cord Blood; arterial Blood)—

Oxygen(O2; free); Plasma(cord Blood; venous Blood)— substance concentration

Oxygen(O2); millimole/liter gas tension Authority: IFCC/C-BGE

kilopascal Note: M = 16,00 x 2 g/mol for O2 NPU17156 NPU17157

P(cordB; vB)—Oxygen(O2); tension = ? kPa P(cordB; aB)—Oxygen(O2; free); subst.c. = ? mmol/l

Plasma(mixed Blood)— Plasma(cord Blood; venous Blood)—

Oxygen(O2); Oxygen(O2; free); gas tension substance concentration kilopascal millimole/liter Authority: IFCC/C-BGE Authority: IFCC/C-BGE

Note: M = 16,00 x 2 g/mol for O2 Note: M = 16,00 x 2 g/mol for O2 NPU09215 NPU17158

P(mixB)—Oxygen(O2); tension = ? kPa P(cordB; vB)—Oxygen(O2; free); subst.c. = ? mmol/l

Plasma(venous Blood)— Plasma(mixed Blood)—

Oxygen(O2); Oxygen(O2; free); gas tension substance concentration kilopascal millimole/liter NPU12501 Authority: IFCC/C-BGE

P(vB)—Oxygen(O2); tension = ? kPa Note: M = 16,00 x 2 g/mol for O2 NPU09216

Air(expired)— P(mixB)—Oxygen(O2; free); subst.c. = ? mmol/l

Oxygen(O2); volume fraction Plasma(venous Blood)—

Authority: IFCC/C-BGE Oxygen(O2; free);

Note: M = 16,00 x 2 g/mol for O2 substance concentration NPU03008 millimole/liter

Air(expired)—Oxygen(O2); vol.fr. = ? NPU12504

P(vB)—Oxygen(O2; free); subst.c. = ? mmol/l Air(specification)—

Oxygen(O2); volume fraction

Blood(arterial Blood)— NPU12509

Oxygen(O2; total); Hb(Fe; deoxy+oxy; cordB)—Oxyhaemoglobin(Fe); substance concentration subst.fr. = ? millimole/liter Authority: IFCC/C-BGE Haemoglobin(Fe; deoxy+oxy; mixed Blood)—

Note: M = 16,00 x 2 g/mol for O2 Oxyhaemoglobin(Fe); NPU03849 substance fraction

B(aB)—Oxygen(O2; total); subst.c. = ? mmol/l Authority: IFCC/C-BGE NPU09219 Blood(capillary Blood)— Hb(Fe; deoxy+oxy; mixB)—Oxyhaemoglobin(Fe);

Oxygen(O2; total); subst.fr. = ? substance concentration millimole/liter Haemoglobin(Fe; deoxy+oxy; venous Blood)— NPU12506 Oxyhaemoglobin(Fe);

B(cB)—Oxygen(O2; total); subst.c. = ? mmol/l substance fraction NPU12511 Blood(cord Blood)— Hb(Fe; deoxy+oxy; vB)—Oxyhaemoglobin(Fe);

Oxygen(O2; total); subst.fr. = ? substance concentration millimole/liter Haemoglobin(Fe; total; arterial Blood)— NPU12505 Oxyhaemoglobin(Fe);

B(cordB)—Oxygen(O2; total); subst.c. = ? mmol/l substance fraction Authority: IFCC/C-BGE Blood(mixed Blood)— Note: “total” includes dyshaemoglobin,

Oxygen(O2; total); carboxihaemoglobin, methaemoglobin, substance concentration sulfhaemoglobin millimole/liter NPU03013 Authority: IFCC/C-BGE Hb(Fe; tot.; aB)—Oxyhaemoglobin(Fe); subst.fr. = ?

Note: M = 16,00 x 2 g/mol for O2 NPU09217 Haemoglobin(Fe; total; capillary Blood)—

B(mixB)—Oxygen(O2; total); subst.c. = ? mmol/l Oxyhaemoglobin(Fe); substance fraction Blood(venous Blood)— Authority: IFCC/C-BGE

Oxygen(O2; total); Note: “total” includes dyshaemoglobin, substance concentration carboxihaemoglobin, methaemoglobin, millimole/liter sulfhaemoglobin NPU12507 NPU10754

B(vB)—Oxygen(O2; total); subst.c. = ? mmol/l Hb(Fe; tot.; cB)—Oxyhaemoglobin(Fe); subst.fr. = ?

Cerebrospinal fluid— Haemoglobin(Fe; total; cord Blood)— Oxyhaemoglobin(Fe); Oxyhaemoglobin(Fe); arbitrary substance concentration(procedure) substance fraction arbitrary unit/liter NPU12512 NPU14145 Hb(Fe; tot.; cordB)—Oxyhaemoglobin(Fe); subst.fr. Csf—Oxyhaemoglobin(Fe); arb.subst.c.(proc.) = ? = ? arb.unit/l Haemoglobin(Fe; total; mixed Blood)— Haemoglobin(Fe; deoxy+oxy; arterial Blood)— Oxyhaemoglobin(Fe); Oxyhaemoglobin(Fe); substance fraction substance fraction Authority: IFCC/C-BGE Authority: IFCC/C-BGE Note: “total” includes dyshaemoglobin, NPU03014 carboxihaemoglobin, methaemoglobin, Hb(Fe; deoxy+oxy; aB)—Oxyhaemoglobin(Fe); sulfhaemoglobin subst.fr. = ? NPU09220 Hb(Fe; tot.; mixB)—Oxyhaemoglobin(Fe); subst.fr. = Haemoglobin(Fe; deoxy+oxy; capillary Blood)— ? Oxyhaemoglobin(Fe); substance fraction Haemoglobin(Fe; total; venous Blood)— NPU12510 Oxyhaemoglobin(Fe); Hb(Fe; deoxy+oxy; cB)—Oxyhaemoglobin(Fe); substance fraction subst.fr. = ? Authority: IFCC/C-BGE NPU10265 Haemoglobin(Fe; deoxy+oxy; cord Blood)— Hb(Fe; tot.; vB)—Oxyhaemoglobin(Fe); subst.fr. = ? Oxyhaemoglobin(Fe); substance fraction

Plasma(fasting Patient)— M = 1 142 g/mol Pancreastatin; Other term(s): Cholecystokinin substance concentration Authority: IUPAC-IUB 74 picomole/liter NPU03022 NPU14027 P—Pancreozymin; subst.c. = ? pmol/l P(fPt)—Pancreastatin; subst.c. = ? pmol/l Patient— Plasma— Paracetamol; Pancreatic b-cell antibody; half-life arbitrary concentration(procedure) minute Other term(s): Islet b-cell antibody NPU10317 NPU02509 Pt—Paracetamol; half-life = ? min P—Pancreatic b-cell antibody; arb.c.(proc.) = ? Plasma— Faeces— Paraneoplastic syndrome antibody; Pancreatic elastase I; arbitrary concentration(list; procedure) catalytic-activity content NPU14540 microkatal/kilogram P—Paraneoplastic syndrome antibody; arb.c.(list; NPU17186 proc.) F—Pancreatic elastase I; cat.cont. = ? µkat/kg NPU14541 P—Neuron(CNS-lupus) antibody(IgG); arb.c.(proc.) = ? Plasma— NPU14542 P—Neuronal cell nucleus(Hu)- Pancreatic polypeptide; antistof(IgG); arb.subst.c.(proc.) = ? × 10³ arb.unit/l substance concentration NPU14543 P—Purkinje cell(Yo) antibody(IgG); picomole/liter arb.subst.c.(proc.) = ? × 10³ arb.unit/l M = 4 184 g/mol NPU03021 Plasma— P—Pancreatic polypeptide; subst.c. = ? pmol/l Paraneoplastic syndrome antibody; arbitrary substance concentration(list) Urine— NPU17707 Pancreatic polypeptide; P—Paraneoplastic syndrome antibody; substance concentration arb.subst.c.(list) picomole/liter M = 4 184 g/mol Plasma— NPU14011 Parathyrin; U—Pancreatic polypeptide; subst.c. = ? pmol/l arbitrary substance concentration(IRP 79/500; procedure) Patient(Urine)— international unit/liter Pancreatic polypeptide; M = 9 425 g/mol substance rate Recommended calibrator: WHO 1st IRP 79/500 picomole/day (human) M = 4 184 g/mol Calibrator(s): WHO 1st IRP 71/324 (bovine) NPU14012 Other term(s): Parathyroid hormone; Parathormone; Pt(U)—Pancreatic polypeptide; subst.rate = ? PTH pmol/d Authority: IUPAC-IUB 74 NPU03027 Plasma— P—Parathyrin; arb.subst.c.(IRP 79/500; proc.) = ? Pancreatic-isle cell(IA-2) antibody; int. unit/l arbitrary substance concentration(procedure) 10³ arbitrary unit/liter Plasma— NPU16403 Parathyrin; P—Pancreatic-isle cell(IA-2) antibody; substance concentration arb.subst.c.(proc.) = ? × 10³ arb.unit/l picomole/liter M = 9 425 g/mol Plasma— Other term(s): Parathyroid hormone; Parathormone; Pancreatic-isle cell(ICA)-antibody; PTH arbitrary concentration(procedure) Authority: IUPAC-IUB 74 NPU14539 NPU03028 P—Pancreas island-celle(ICA)-antibody; P—Parathyrin; subst.c. = ? pmol/l arb.c.(proc.) = ? Plasma— Plasma— Parietal cell antibody(Immunoglobulin G); Pancreozymin; arbitrary concentration(procedure) substance concentration NPU12557 picomole/liter P—Parietal cell antibody(IgG); arb.c.(proc.) = ?

Plasma— Cerebrospinal fluid— Parietal cell antibody(Immunoglobulin G); Particle type; arbitrary substance concentration(procedure) number concentration(list; procedure) 10³ arbitrary unit/liter NPU04135 NPU14544 Csf—Particle type; num.c.(list; proc.) P—Parietal cell antibody(IgG); arb.subst.c.(proc.) = NPU04775 Csf—Cells; num.c.= ? × 106/l ? × 10³ arb.unit/l NPU01962 Csf—Erythrocytes; num.c. = ? × 106/l NPU02594 Csf—Leukocytes; num.c. = ? × 106/l Plasma— NPU02637 Csf—Lymphocytes+Monocytes; num.c. Parietal cell antibody; = ? × 106/l arbitrary concentration(procedure) NPU02903 Csf—Neutrophilocytes; num.c. = ? × NPU03029 106/l P—Parietal cell antibody; arb.c.(proc.) = ? Semen— Urine— Particle type; Particle type; number concentration(list; procedure) arbitrary concentration(list; procedure) NPU14074 Other term(s): Urine microscopy Sem—Particle type; num.c.(list; proc.) NPU04222 NPU02595 Sem—Leukocytes; num.c. = ? × 109/l U—Particle type; arb.c.(list; proc.) NPU08718 Sem—Round cells; num.c. = ? × 109/l NPU08592 U—Bacterium; arb.c.(proc.) = ? NPU03455 Sem—Spermatozoa; num.c. = ? × 109/l NPU01817 U—Cylinder, erythrocyte type; arb.c.(proc.) = ? Synovial fluid(specification)— NPU01818 U—Cylinder, granular type; arb.c.(proc.) Particle type; = ? number concentration(list; procedure) NPU01819 U—Cylinder, hyaline type; arb.c.(proc.) = NPU04228 ? Synf(spec.)—Particle type; num.c.(list; proc.) NPU03986 U—Epithelial cells; arb.c.(proc.) = ? NPU04229 Synf(spec.)—Cells; num.c. = ? × 106/l NPU03963 U—Erythrocytes; arb.c.(proc.) = ? NPU08933 Synf(spec.)—Erythrocytes; num.c. = ? × NPU08763 U—Flagellate; arb.c.(proc.) = ? 106/l NPU14314 U—Yeast cells; arb.c.(proc.) = ? NPU08639 Synf(spec.)—Leukocytes; num.c. = ? × NPU08761 U—Crystals; arb.c.(proc.) = ? 106/l NPU03987 U—Leukocytes; arb.c.(proc.) = ? NPU04231 Synf(spec.)—Lymphocytes+Monocytes; NPU17179 U—Slime; arb.c.(proc.) = ? num.c.= ? × 106/l NPU14169 U—Spermatozoa; arb.c.(proc.) = ? NPU04230 Synf(spec.)—Neutrophilocytes; num.c.= NPU12286 U—Trichomonas vaginalis; arb.c.(proc.) ? × 106/l = ? Patient— Vaginal fluid— Pentagastrin(administered); Particle type; substance content(intravenous administration; arbitrary concentration(list; procedure) amount-of-substance/body mass) NPU14318 nanomole/kilogram Vagf—Particle type; arb.c.(list; proc.) Note: M: approx. 600 NPU06687 Vagf—Bacterium(spec.); arb.c.(proc.) = NPU10477 ? Pt—Pentagastrin(administered); subst.cont.(i.v.; NPU14316 Vagf—Clue cells; arb.c.(proc.) = ? am.s./body mass) = ? nmol/kg NPU14317 Vagf—Leukocytes; arb.c.(proc.) = ? NPU12284 Vagf—Trichomonas vaginalis; Plasma— arb.c.(proc.) = ? Pepsinogen A; arbitrary concentration(procedure) Ascites— NPU03043 Particle type; P—Pepsinogen A; arb.c.(proc.) = ? number concentration(list; procedure) NPU08935 Plasma— Asc—Particle type; num.c.(list; proc.) Pepsinogen A; NPU08683 Asc—Cells; num.c. = ? × 106/l substance concentration NPU08934 Asc—Erythrocytes; num.c. = ? × 106/l mole/liter NPU08638 Asc—Leukocytes; num.c. = ? × 106/l NPU03044 NPU08641 Asc—Lymphocytes+Monocytes; num.c. P—Pepsinogen A; subst.c.= ? prefix ? mol/l = ? × 106/l NPU08655 Asc—Neutrophilocytes; num.c. = ? × 106/l

Plasma— M = 165,19 g/mol Peptide YY; Authority: INN substance concentration NPU03069 picomole/liter Csf—Phenylalanine; subst.c. = ? µmol/l NPU10613 P—Peptide YY; subst.c. = ? pmol/l Plasma— Phenylalanine; Plasma— substance concentration Peptidyl dipeptidase A; micromole/liter catalytic-activity concentration(37 °C; M = 165,19 g/mol procedure) Authority: INN microkatal/liter NPU03070 Other term(s): Carboxycathepsin; P—Phenylalanine; subst.c. = ? µmol/l Dipeptidylcarboxypeptidase; Kininase II; Peptidase P; Angiotensin I converting enzyme Urine— Authority: IUB 84 Phenylalanine; NPU01905 substance concentration P—Peptidyl dipeptidase A; cat.c.(37 °C; proc.) = ? micromole/liter µkat/l M = 165,19 g/mol Authority: INN Plasma— NPU03071 Perinuclear antibody(Immunoglobulin G); U—Phenylalanine; subst.c. = ? µmol/l arbitrary concentration(procedure) NPU16404 Urine— P—Perinuclear antibody(IgG); arb.c.(proc.) = ? Phenylethanolamine; arbitrary concentration(procedure) Plasma— M = 137,18 g/mol Perinuclear antibody(Immunoglobulin G); Other term(s): b-Hydroxyphenethylamine arbitrary substance concentration(procedure) NPU04569 10³ arbitrary unit/liter U—Phenylethanolamine; arb.c.(proc.) = ? NPU16405 P—Perinuclear antibody(IgG); arb.subst.c.(proc.) = Urine— ? × 10³ arb.unit/l Phosphate(P; inorganic); amount-of-substance(procedure) Urine— millimole Phenolphthalein; NPU17543 substance concentration U—Phosphate(P; inorganic); am.s.(proc.) = ? mmol mole/liter M = 318,31 g/mol Calculus(Urine)— Authority: INN Phosphate(P; inorganic); NPU04815 arbitrary content(procedure) U—Phenolphthalein; subst.c.= ? prefix ? mol/l NPU09233 Calculus(U)—Phosphate(P; inorganic); Urine— arb.cont.(proc.) = ? Phenylalanine/Creatininium; substance ratio Amniotic fluid— 10-3 Phosphate(P; inorganic); NPU14241 substance concentration U—Phenylalanine/Creatininium; subst.ratio = ? × millimole/liter 10-3 NPU08667 Amf—Phosphate(P; inorganic); subst.c. = ? mmol/l Blood— Phenylalanine; Ascites— substance concentration Phosphate(P; inorganic); micromole/liter substance concentration M = 165,19 g/mol millimole/liter NPU12249 NPU08668 B—Phenylalanine; subst.c. = ? µmol/l Asc—Phosphate(P; inorganic); subst.c. = ? mmol/l

Cerebrospinal fluid— Plasma— Phenylalanine; Phosphate(P; inorganic); substance concentration substance concentration micromole/liter millimole/liter

Authority: IFCC/C-BGE Urine— NPU03096 Phosphoethanolamine/Creatininium; P—Phosphate(P; inorganic); subst.c. = ? mmol/l substance ratio 10-3 System(specification)— NPU14242 Phosphate(P; inorganic); U—Phosphoethanolamine/Creatininium; subst.ratio substance concentration = ? × 10-3 millimole/liter NPU10125 Plasma— Syst(spec.)—Phosphate(P; inorganic); subst.c. = ? Phosphoethanolamine; mmol/l substance concentration micromole/liter Urine— M = 141,1 g/mol Phosphate(P; inorganic); NPU03114 substance concentration P—Phosphoethanolamine; subst.c. = ? µmol/l millimole/liter Authority: IFCC/C-BGE Plasma— NPU03955 Phospholipid, in HDL; U—Phosphate(P; inorganic); subst.c. = ? mmol/l substance concentration millimole/liter Calculus(Urine)— NPU17692 Phosphate(P; inorganic); P—Phospholipid, in HDL; subst.c. = ? mmol/l substance content mole/kilogram Plasma— NPU09239 Phospholipid, in LDL; Calculus(U)—Phosphate(P; inorganic); subst.cont. = substance concentration ? mol/kg millimole/liter NPU17693 Patient(Faeces)— P—Phospholipid, in LDL; subst.c. = ? mmol/l Phosphate(P; inorganic); substance rate(procedure) Plasma— millimole/day Phospholipid, in VLDL; Authority: IFCC/C-BGE substance concentration NPU10264 millimole/liter Pt(F)—Phosphate(P; inorganic); subst.rate(proc.) = NPU17694 ? mmol/d P—Phospholipid, in VLDL; subst.c. = ? mmol/l

Patient(Urine)— Plasma— Phosphate(P; inorganic); Phospholipid; substance rate(procedure) substance concentration millimole/day millimole/liter Authority: IFCC/C-BGE NPU17695 NPU03095 P—Phospholipid; subst.c. = ? mmol/l Pt(U)—Phosphate(P; inorganic); subst.rate(proc.) = ? mmol/d Plasma— Phosphopyruvate hydratase; Amniotic fluid— catalytic-activity concentration(37 °C; Phosphatidylcholine(saturated); procedure) substance concentration katal/liter mole/liter Other term(s): Enolase; 2-Phosphoglycerate NPU03097 dehydratase Amf—Phosphatidylcholine(sat.); subst.c.= ? prefix ? NPU01929 mol/l P—Phosphopyruvate hydratase; cat.c.(37 °C; proc.)= ? prefix ? kat/l Amniotic fluid— Phosphatidylcholine/Sphingomyelin; Urine— substance ratio(procedure) Phosphoserine/Creatininium; Other term(s): Lecithin/Sphingomyelin ratio substance ratio NPU02576 10-3 Amf—Phosphatidylcholine/Sphingomyelin; NPU14243 subst.ratio(proc.) = ? U—Phosphoserine/Creatininium; subst.ratio = ? × 10-3

Plasma— NPU03845 Phosphoserine; Pt—Plasma; rel.volumic mass(20 °C/water, 20 °C; substance concentration proc.) = ? micromole/liter Authority: IUPAC-IUB 84 Blood— NPU10399 Plasmocytes; P—Phosphoserine; subst.c. = ? µmol/l number concentration 109/liter Plasma— NPU04708 Phytanate; B—Plasmocytes; num.c. = ? × 109/l substance concentration mole/liter Blood fraction(specification)— NPU03171 Plasmocytes; P—Phytanate; subst.c.= ? prefix ? mol/l number concentration 109/liter Urine— NPU17614 Pipecolate/Creatininium; B fract.(spec.)—Plasmocytes; num.c. = ? × 109/l substance ratio 10-3 Bone marrow— NPU14244 Plasmocytes; U—Pipecolate/Creatininium; subst.ratio = ? × 10-3 number concentration 109/liter Cerebrospinal fluid— NPU04090 Pipecolate; Marrow—Plasmocytes; num.c. = ? × 109/l substance concentration mole/liter Leukocytes(Blood)— NPU03172 Plasmocytes; Csf—Pipecolate; subst.c.= ? prefix ? mol/l number fraction NPU04709 Plasma— Lkcs(B)—Plasmocytes; num.fr. = ? Pipecolate; substance concentration Leukocytes(Bone marrow)— mole/liter Plasmocytes; NPU03173 number fraction P—Pipecolate; subst.c.= ? prefix ? mol/l NPU04989 Lkcs(Marrow)—Plasmocytes; num.fr. = ? Urine— Pipecolate; Plasma— substance concentration Platinum; mole/liter substance concentration NPU03174 picomole/liter U—Pipecolate; subst.c.= ? prefix ? mol/l M = 195,09 g/mol Authority: IUPAC/VII-C-TOX Plasma— NPU03204 Plain muscle antibody(Immunoglobulin G); P—Platinum; subst.c. = ? pmol/l arbitrary concentration(procedure) NPU12996 Urine— P—Plain muscle antibody(IgG); arb.c.(proc.) = ? Platinum; substance concentration Plasma— picomole/liter Plain muscle antibody; M = 195,09 g/mol arbitrary concentration(procedure) Authority: IUPAC/VII-C-TOX NPU02850 NPU03205 P—Plain muscle antibody; arb.c.(proc.) = ? U—Platinum; subst.c. = ? pmol/l

Patient— Hair— Plasma; Platinum; kinematic viscosity(37 °C) substance content (meter)²/second micromole/kilogram NPU03178 M = 195,09 g/mol Pt—Plasma; kin.visc.(37 °C) = ? m²/s Authority: IUPAC/VII-C-TOX NPU03203 Patient— Hair—Platinum; subst.cont. = ? µmol/kg Plasma; relative volumic mass(20 °C/water, 20 °C; procedure) © 2000 IUPAC, Pure and Applied Chemistry 72, 747–972 Properties and units in general clinical chemistry 931

Patient— NPU14551 Pleural fluid(specification); P—Polymyositis(OJ) antibody; arb.c.(proc.) = ? relative volumic mass(20 °C/water, 20 °C; procedure) Plasma— NPU10186 Polymyositis(PL-12) antibody; Pt—Pleural fluid(spec.); rel.volumic mass(20 °C/ arbitrary concentration(procedure) water, 20 °C; proc.) = ? NPU14547 P—Polymyositis(PL-12) antibody; arb.c.(proc.) = ? Blood— Poikilocytosis; Plasma— arbitrary concentration(procedure) Polymyositis(PL-7) antibody; NPU14274 arbitrary concentration(procedure) B—Poikilocytosis; arb.c.(proc.) = ? NPU14546 P—Polymyositis(PL-7) antibody; arb.c.(proc.) = ? Plasma— Polymyositis antibody; Plasma— arbitrary concentration(list; procedure) Polymyositis(SRP) antibody; NPU14545 arbitrary concentration(procedure) P—Polymyositis antibody; arb.c.(list; proc.) NPU14552 NPU14550 P—Polymyositis(EJ) antibody; P—Polymyositis(SRP) antibody; arb.c.(proc.) = ? arb.c.(proc.) = ? NPU14554 P—Polymyositis(Jo-1) antibody; Plasma— arb.c.(proc.) = ? Polymyositis(U2SnRNP) antibody; NPU14549 P—Polymyositis(Ku) antibody; arbitrary concentration(procedure) arb.c.(proc.) = ? NPU14553 NPU14548 P—Polymyositis(Mi-2) antibody; P—Polymyositis(U2SnRNP) antibody; arb.c.(proc.) arb.c.(proc.) = ? = ? NPU14551 P—Polymyositis(OJ) antibody; arb.c.(proc.) = ? Blood— NPU14547 P—Polymyositis(PL-12) antibody; Porphobilinogen deaminase; arb.c.(proc.) = ? catalytic-activity concentration(37 °C; NPU14546 P—Polymyositis(PL-7) antibody; procedure) arb.c.(proc.) = ? nanokatal/liter NPU14552 P—Polymyositis(SRP) antibody; NPU10201 arb.c.(proc.) = ? B—Porphobilinogen deaminase; cat.c.(37 °C; proc.) NPU14553 P—Polymyositis(U2SnRNP) antibody; = ? nkat/l arb.c.(proc.) = ? Erythrocytes(Blood)— Plasma— Porphobilinogen deaminase; Polymyositis(EJ) antibody; catalytic-activity concentration(37 °C; arbitrary concentration(procedure) procedure) NPU14550 nanokatal/liter P—Polymyositis(EJ) antibody; arb.c.(proc.) = ? NPU10202 Ercs(B)—Porphobilinogen deaminase; cat.c.(37 °C; Plasma— proc.) = ? nkat/l Polymyositis(Jo-1) antibody; arbitrary concentration(procedure) Urine— NPU14554 Porphobilinogen; P—Polymyositis(Jo-1) antibody; arb.c.(proc.) = ? arbitrary concentration(procedure) NPU04864 Plasma— U—Porphobilinogen; arb.c.(proc.)= ? Polymyositis(Ku) antibody; arbitrary concentration(procedure) Urine— NPU14549 Porphobilinogen; P—Polymyositis(Ku) antibody; arb.c.(proc.) = ? substance concentration micromole/liter Plasma— NPU03210 Polymyositis(Mi-2) antibody; U—Porphobilinogen; subst.c. = ? µmol/l arbitrary concentration(procedure) NPU14548 Patient(Urine)— P—Polymyositis(Mi-2) antibody; arb.c.(proc.) = ? Porphobilinogen; substance rate(procedure) Plasma— micromole/day Polymyositis(OJ) antibody; NPU08730 arbitrary concentration(procedure) Pt(U)—Porphobilinogen; subst.rate(proc.) = ? µmol/d

Urine— NPU08633 Porphyrine/Creatininium; Syst(spec.)—Potassium ion; am.s.(proc.) = ? mmol substance ratio 10-3 Faeces— NPU09099 Potassium ion; U—Porphyrine/Creatininium; subst.ratio = ? × 10-3 amount-of-substance millimole Urine— NPU17572 Porphyrine; F—Potassium ion; am.s. = ? mmol arbitrary concentration(procedure) NPU03957 Urine— U—Porphyrine; arb.c.(proc.) = ? Potassium ion; amount-of-substance Faeces— millimole Porphyrine; NPU17573 arbitrary content(list; procedure) U—Potassium ion; am.s. = ? mmol NPU14923 F—Porphyrine; arb.cont.(list; proc.) Amniotic fluid— Potassium ion; Faeces— substance concentration Porphyrine; millimole/liter arbitrary content(procedure) NPU08628 NPU03227 Amf—Potassium ion; subst.c. = ? mmol/l F—Porphyrine; arb.cont.(proc.) = ? Ascites— Erythrocytes(Blood)— Potassium ion; Porphyrine; substance concentration substance concentration millimole/liter micromole/liter NPU17032 NPU10604 Asc—Potassium ion; subst.c. = ? mmol/l Ercs(B)—Porphyrine; subst.c. = ? µmol/l Aspirate(specification)— Urine— Potassium ion; Porphyrine; substance concentration substance concentration millimole/liter micromole/liter NPU14909 NPU03228 Aspir(spec.)—Potassium ion; subst.c. = ? mmol/l U—Porphyrine; subst.c. = ? µmol/l Blood fraction(specification)— Patient(Urine)— Potassium ion; Porphyrine; substance concentration substance rate(procedure) millimole/liter micromole/day NPU17571 NPU10217 B fract.(spec.)—Potassium ion; subst.c. = ? mmol/l Pt(U)—Porphyrine; subst.rate(proc.) = ? µmol/d Dialysis solution— Secretion(Ileum)— Potassium ion; Potassium ion; substance concentration amount-of-substance(procedure) millimole/liter millimole Authority: IFCC/C-BGE NPU08632 NPU10168 Secr(Ileum)—Potassium ion; am.s.(proc.) = ? mmol Dialysis solution—Potassium ion; subst.c. = ? mmol/l Stomach fluid— Potassium ion; Drain fluid(specification)— amount-of-substance(procedure) Potassium ion; millimole substance concentration Authority: IFFC/C-BGE millimole/liter NPU10169 NPU17049 Stomf—Potassium ion; am.s.(proc.) = ? mmol Drain fluid(spec.)—Potassium ion; subst.c. = ? mmol/l System(specification)— Potassium ion; Plasma— amount-of-substance(procedure) Potassium ion; millimole substance concentration

millimole/liter Patient(Urine)— Authority: IFCC/C-BGE Potassium ion; NPU03230 substance rate(procedure) P—Potassium ion; subst.c. = ? mmol/l millimole/day Authority: IFCC/C-BGE Secretion(Ileum)— NPU03229 Potassium ion; Pt(U)—Potassium ion; subst.rate(proc.) = ? mmol/d substance concentration millimole/liter Plasma— NPU08630 Prasterone; Secr(Ileum)—Potassium ion; subst.c. = ? mmol/l substance concentration nanomole/liter Stomach fluid— M = 288,41 g/mol Potassium ion; Other term(s): Dehydroepiandrosterone; DHEA substance concentration Authority: INN millimole/liter NPU01852 Authority: IFCC/C-BGE P—Prasterone; subst.c. = ? nmol/l NPU10170 Stomf—Potassium ion; subst.c. = ? mmol/l Urine— Prasterone; Sweat— substance concentration Potassium ion; nanomole/liter substance concentration M = 288,41 g/mol millimole/liter Other term(s): Dehydroepiandrosterone; DHEA Authority: IFCC/C-BGE Authority: INN NPU03941 NPU01855 Sweat—Potassium ion; subst.c. = ? mmol/l U—Prasterone; subst.c. = ? nmol/l

System(specification)— Patient(Urine)— Potassium ion; Prasterone; substance concentration substance rate millimole/liter nanomole/day NPU08631 NPU10135 Syst(spec.)—Potassium ion; subst.c. = ? mmol/l Pt(U)—Prasterone; subst.rate = ? nmol/d

Urine— Plasma— Potassium ion; Pregnancy protein 1; substance concentration arbitrary concentration(procedure) millimole/liter Other term(s): Pregnancy specific b-1 glycoprotein Authority: IFCC/C-BGE NPU03232 NPU03787 P—Pregnancy protein 1; arb.c.(proc.) = ? U—Potassium ion; subst.c. = ? mmol/l Patient(Urine)— Faeces— Pregnanediol; Potassium ion; substance rate(procedure) substance content micromole/day millimole/kilogram NPU03233 NPU04214 Pt(U)—Pregnanediol; subst.rate(proc.) = ? µmol/d F—Potassium ion; subst.cont. = ? mmol/kg Patient(Urine)— Faeces(specification)— Pregnanetriol; Potassium ion; substance rate(procedure) substance content micromole/day millimole/kilogram NPU03234 NPU08629 Pt(U)—Pregnanetriol; subst.rate(proc.) = ? µmol/d F(spec.)—Potassium ion; subst.cont. = ? mmol/kg Plasma— Patient(Faeces)— Proangiotensin; Potassium ion; arbitrary concentration(procedure) substance rate(procedure) M = 1 295 g/mol millimole/day Other term(s): Angiotensin I NPU04213 Authority: IUPAC-IUB 74 Pt(F)—Potassium ion; subst.rate(proc.) = ? mmol/d NPU03236 P—Proangiotensin; arb.c.(proc.) = ?

Plasma— Endometric cytosol protein— Proangiotensin; Progesterone receptor(total); substance concentration substance content mole/liter nanomole/kilogram M = 1 295 g/mol NPU03244 Other term(s): Angiotensin I Endometric cytosol prot.—Progesterone Authority: IUPAC-IUB 74 receptor(tot.); subst.cont. = ? nmol/kg NPU03237 P—Proangiotensin; subst.c.= ? prefix ? mol/l Cystic fluid(specification)— Progesterone; Urine— substance concentration Prochlorperazine; nanomole/liter arbitrary concentration(procedure) NPU08764 M = 373,94 g/mol Cystf(spec.)—Progesterone; subst.c. = ? nmol/l Authority: INN NPU09045 Plasma— U—Prochlorperazine; arb.c.(proc.) = ? Progesterone; substance concentration Plasma— nanomole/liter Prochlorperazine; M = 314,45 g/mol substance concentration Authority: IUPAC-IUB 89 mole/liter NPU03242 M = 373,94 g/mol P—Progesterone; subst.c. = ? nmol/l Authority: INN NPU09043 Saliva— P—Prochlorperazine; subst.c.= ? prefix ? mol/l Progesterone; substance concentration Urine— nanomole/liter Prochlorperazine; M = 314,45 g/mol substance concentration Authority: IUPAC-IUB 89 mole/liter NPU03243 M = 373,94 g/mol Saliva—Progesterone; subst.c. = ? nmol/l Authority: INN NPU09044 Pancreatic b-cell— U—Prochlorperazine; subst.c.= ? prefix ? mol/l Proinsulin C-peptide secretion; substance rate(glucagon, intravenous Plasma— administration; list; procedure) Procollagen-III-peptide; Note: M (glucagon) = 3 483 g/mol; M (proinsulin C- mass concentration peptide) = 3 019 g/mol; M (glucose) = 180,16 g/mol microgram/liter NPU10393 NPU10227 Pancreatic b-cell—Proinsulin C-peptide secretion; P—Procollagen-III-peptide; mass c. = ? µg/l subst.rate(glucagon i.v.; list; proc.) NPU10389 Pt—Glucagon(administered); am.s.(i.v.) Plasma— = ? nmol Procollagen-I-peptide; NPU10691 Pt—Glucagon(administered); mass concentration subst.cont.(i.v.; am.s./body mass) = ? nmol/kg microgram/liter NPU10390 P—Proinsulin C-peptide; subst.c.(0 min) NPU10226 = ? nmol/l P—Procollagen-I-peptide; mass c. = ? µg/l NPU10391 P—Proinsulin C-peptide; subst.c.(6 min) = ? nmol/l Plasma— NPU08503 B—Glucose; subst.c.(0 min) = ? mmol/l Progastrin; NPU10655 B—Glucose; subst.c.(6 min) = ? mmol/l substance concentration picomole/liter Plasma— NPU17588 Proinsulin C-peptide; P—Progastrin; subst.c. = ? pmol/l arbitrary substance concentration(IRR 84/510; procedure) Endometric cytosol protein— international unit/liter Progesterone receptor(free); M = 3 019 g/mol substance content Recommended calibrator: WHO 1st International nanomole/kilogram Reference Reagent 84/510 NPU03245 Other term(s): C-peptide; Connecting peptide Endometric cytosol prot.—Progesterone NPU03248 receptor(free); subst.cont. = ? nmol/kg P—Proinsulin C-peptide; arb.subst.c.(IRR 84/510; proc.) = ? int. unit/l

Plasma— Plasma— Proinsulin C-peptide; Proinsulin; substance concentration(0 minutes after substance concentration challenge) picomole/liter nanomole/liter M = 9 395 g/mol NPU10390 NPU04020 P—Proinsulin C-peptide; subst.c.(0 min) = ? nmol/l P—Proinsulin; subst.c. = ? pmol/l

Plasma— Plasma(fasting Patient)— Proinsulin C-peptide; Proinsulin; substance concentration(6 minutes after substance concentration challenge) picomole/liter nanomole/liter M = 9 395 g/mol NPU10391 NPU04154 P—Proinsulin C-peptide; subst.c.(6 min) = ? nmol/l P(fPt)—Proinsulin; subst.c. = ? pmol/l

Plasma— Pituitary gland— Proinsulin C-peptide; Prolactin secretion; substance concentration(120 minutes after substance rate(insulin, intravenous challenge) administration; list; procedure) nanomole/liter Note: M (insulin) = 5 807,65 g/mol; M (prolactin) = NPU10392 23 000 g/mol P—Proinsulin C-peptide; subst.c.(120 min) = ? NPU10453 nmol/l PitGl—Prolactin secretion; subst.rate(insulin i.v.; list; proc.) Plasma— NPU10547 Pt—Insulin(administered); Proinsulin C-peptide; subst.cont.(i.v.; am.s./body mass) = ? µmol/kg substance concentration NPU10458 P—Prolactin; subst.c.(0 min) = ? nmol/l nanomole/liter NPU10455 P—Prolactin; subst.c.(30 min) = ? nmol/l M = 3 019 g/mol NPU10451 P—Prolactin; subst.c.(45 min) = ? nmol/l Other term(s): C-peptide; Connecting peptide NPU10459 P—Prolactin; subst.c.(60 min) = ? nmol/l NPU03247 NPU10452 P—Prolactin; subst.c.(90 min) = ? nmol/l P—Proinsulin C-peptide; subst.c. = ? nmol/l NPU04173 P—Glucose; subst.c.(0 min) = ? mmol/l NPU04186 P—Glucose; subst.c.(15 min) = ? Plasma(fasting Patient)— mmol/l Proinsulin C-peptide; NPU04174 P—Glucose; subst.c.(30 min) = ? substance concentration mmol/l nanomole/liter NPU04187 P—Glucose; subst.c.(45 min) = ? M = 3 019 g/mol mmol/l Other term(s): C-peptide; Connecting peptide NPU04175 P—Glucose; subst.c.(60 min) = ? NPU04149 mmol/l P(fPt)—Proinsulin C-peptide; subst.c. = ? nmol/l NPU04965 P—Glucose; subst.c.(75 min) = ? mmol/l Patient(Urine)— NPU04176 P—Glucose; subst.c.(90 min) = ? Proinsulin C-peptide; mmol/l substance rate(procedure) NPU04177 P—Glucose; subst.c.(120 min) = ? nanomole/day mmol/l NPU08978 Pt(U)—Proinsulin C-peptide; subst.rate(proc.) = ? Pituitary gland— nmol/d Prolactin secretion; substance rate(levodopa, oral administration; Plasma— list; procedure) Proinsulin; Note: M (levodopa) = 197,2 g/mol; M (prolactin) = arbitrary substance concentration(IRR 84/611; 23 000 g/mol procedure) NPU10462 international unit/liter PitGl—Prolactin secretion; subst.rate(levodopa p.o.; M = 9 395 g/mol list; proc.) Recommended calibrator: Human pro-insulin NPU10457 Pt—Levodopa(administered); am.s.(p.o.) International Reference Reagent 84/611 = ? mmol NPU03246 NPU10458 P—Prolactin; subst.c.(0 min) = ? nmol/l P—Proinsulin; arb.subst.c.(IRR 84/611; proc.) = ? NPU10459 P—Prolactin; subst.c.(60 min) = ? nmol/l int. unit/l NPU10460 P—Prolactin; subst.c.(120 min) = ? nmol/l NPU10461 P—Prolactin; subst.c.(180 min) = ? nmol/l

Pituitary gland— P—Prolactin; arb.subst.c.(IS 84/500; proc.) = ? int. Prolactin secretion; unit/l substance rate(protirelin, intravenous administration; list; procedure) Plasma— Other term(s): Protirelin: Thyrotropin-releasing Prolactin; hormone substance concentration(0 minutes after Note: M (protirelin) = 362,4 g/mol; M (prolactin) = 23 challenge) 000 g/mol nanomole/liter NPU10456 NPU10458 PitGl—Prolactin secretion; subst.rate(protirelin i.v.; P—Prolactin; subst.c.(0 min) = ? nmol/l list; proc.) NPU10454 Pt—Protirelin(administered); am.s.(i.v.) Plasma— = ? nmol Prolactin; NPU10458 P—Prolactin; subst.c.(0 min) = ? nmol/l substance concentration(15 minutes after NPU10682 P—Prolactin; subst.c.(15 min) = ? nmol/l challenge) NPU10455 P—Prolactin; subst.c.(30 min) = ? nmol/l nanomole/liter NPU10459 P—Prolactin; subst.c.(60 min) = ? nmol/l NPU10682 NPU10460 P—Prolactin; subst.c.(120 min) = ? P—Prolactin; subst.c.(15 min) = ? nmol/l nmol/l NPU10683 P—Prolactin; subst.c.incr.(max. c. minus Plasma— 0 min c.) = ? nmol/l Prolactin; substance concentration(30 minutes after Plasma— challenge) Prolactin; nanomole/liter arbitrary substance concentration(IRP 75/504; NPU10455 procedure) P—Prolactin; subst.c.(30 min) = ? nmol/l international unit/liter M = 23 000 g/mol Plasma— Recommended calibrator: WHO IRP 75/504 Prolactin; Other term(s): Lactotropic hormone; Lactotropin; substance concentration(45 minutes after Mammatropic hormone; Mammatropin challenge) Authority: IUPAC-IUB74 nanomole/liter NPU04022 NPU10451 P—Prolactin; arb.subst.c.(IRP 75/504; proc.) = ? int. P—Prolactin; subst.c.(45 min) = ? nmol/l unit/l Plasma— Plasma— Prolactin; Prolactin; substance concentration(60 minutes after arbitrary substance concentration(IS 83/562; challenge) procedure) nanomole/liter international unit/liter NPU10459 M = 23 000 g/mol P—Prolactin; subst.c.(60 min) = ? nmol/l Recommended calibrator: WHO 2nd IS 83/562 Other term(s): Lactropic hormone; Mammatropic Plasma— hormone; Mammatropin Prolactin; Authority: IUPAC-IUB 74 substance concentration(90 minutes after NPU04021 challenge) P—Prolactin; arb.subst.c.(IS 83/562; proc.) = ? int. nanomole/liter unit/l NPU10452 P—Prolactin; subst.c.(90 min) = ? nmol/l Plasma— Prolactin; Plasma— arbitrary substance concentration(IS 84/500; Prolactin; procedure) substance concentration(120 minutes after international unit/liter challenge) M = 23 000 g/mol nanomole/liter Recommended calibrator: WHO 3rd IS 84/500 NPU10460 Calibrator(s): WHO 2nd IS 83/562; WHO IRP 75/ P—Prolactin; subst.c.(120 min) = ? nmol/l 504 Other term(s): Lactotropic hormone; Lactotropin; Plasma— Mammatropic hormone; Mammatropin Prolactin; Authority: IUPAC-IUB 74 substance concentration(180 minutes after NPU03252 challenge) nanomole/liter

NPU10461 Plasma— P—Prolactin; subst.c.(180 min) = ? nmol/l Proline; substance concentration Plasma— micromole/liter Prolactin; M = 115,13 g/mol substance concentration increment(maximum NPU03256 concentration minus 0 minutes concentration) P—Proline; subst.c. = ? µmol/l nanomole/liter NPU10683 Urine— P—Prolactin; subst.c.incr.(max. c. minus 0 min c.) = Proline; ? nmol/l substance concentration micromole/liter Plasma— M = 115,13 g/mol Prolactin; NPU03257 substance concentration U—Proline; subst.c. = ? µmol/l nanomole/liter M = 23 000 g/mol Blood— Other term(s): Lactotropic hormone; Lactotropin; Promyelocytes; Mammatropic hormone; Mammatropin number concentration Authority: IUPAC-IUB 74 109/liter NPU03253 NPU03974 P—Prolactin; subst.c. = ? nmol/l B—Promyelocytes; num.c. = ? × 109/l

Plasma— Blood fraction(specification)— Proliferating cell nucleus antibody(Immunoglobulin Promyelocytes; G); number concentration arbitrary concentration(procedure) 109/liter NPU03254 NPU17615 P—Proliferating cell nucleus antibody(IgG); B fract.(spec.)—Promyelocytes; num.c. = ? × 109/l arb.c.(proc.) = ? Bone marrow— Plasma— Promyelocytes; Proliferating cell nucleus antibody(Immunoglobulin number concentration G); 109/liter arbitrary substance concentration(procedure) NPU04091 arbitrary unit/liter Marrow—Promyelocytes; num.c. = ? × 109/l NPU12584 P—Proliferating cell nucleus antibody(IgG); Leukocytes(Blood)— arb.subst.c.(proc.) = ? arb.unit/l Promyelocytes; number fraction Erythrocytes(Blood)— NPU03973 Proline dipeptidase; Lkcs(B)—Promyelocytes; num.fr. = ? entitic catalytic activity(37 °C; procedure) attokatal Leukocytes(Bone marrow)— NPU12898 Promyelocytes; Ercs(B)—Proline dipeptidase; entitic cat.act.(37 °C; number fraction proc.) = ? akat NPU04985 Lkcs(Marrow)—Promyelocytes; num.fr. = ? Urine— Proline/Creatininium; Plasma— substance ratio Prostata specific antigen(free); 10-3 mass concentration NPU14245 microgram/liter U—Proline/Creatininium; subst.ratio = ? × 10-3 Other term(s): Prostate-specific antigen; PSA NPU12534 Cerebrospinal fluid— P—Prostata specific antigen(free); mass c. = ? µg/l Proline; substance concentration Prostata specific antigen(Plasma)— micromole/liter Prostata specific antigen(free); M = 115,13 g/mol mass fraction NPU03255 Other term(s): Prostate-specific antigen; PSA Csf—Proline; subst.c. = ? µmol/l NPU09226 Prostata specific antigen(P)—Prostata specific antigen(free); mass fr. = ?

Plasma— NPU14038 Prot.(Csf)—Alpha-globulin; mass fr. = ? Prostata specific antigen(total); NPU04952 Prot.(Csf)—Beta-globulin; mass fr. = ? mass concentration NPU04953 Prot.(Csf)—Gamma-globulin; mass fr. = microgram/liter ? Other term(s): Prostate-specific antigen; PSA NPU08669 Protein(Plasma)— P—Prostata specific antigen(tot.); mass c. = ? µg/l Protein type; mass fraction(list; procedure) Plasma— NPU04196 Prostata specific antigen; Prot.(P)—Protein type; mass fr.(list; proc.) arbitrary concentration(procedure) NPU04939 Prot.(P)—Albumin; mass fr. = ? NPU03275 NPU04940 Prot.(P)—Alpha-1-globulin; mass fr. = ? P—Prostata specific antigen; arb.c.(proc.) = ? NPU04941 Prot.(P)—Alpha-2-globulin; mass fr. = ? NPU09264 Prot.(P)—Alpha-globulin; mass fr. = ? Cerebrospinal fluid— NPU09265 Prot.(P)—Beta-1-globulin; mass fr. = ? Protein type; NPU09266 Prot.(P)—Beta-2-globulin; mass fr. = ? concentration(list; procedure) NPU04942 Prot.(P)—Beta-globulin; mass fr. = ? NPU04865 NPU04943 Prot.(P)—Gamma-globulin; mass fr. = ? Csf—Protein type; conc.(list; proc.) NPU01130 Csf—Albumin; subst.c. = ? µmol/l Protein(Urine)— NPU04980 Csf—Albumin; rel.subst.c.(Csf/P) = ? Protein type; NPU04658 Csf—Alpha-1-globulin; mass c. = ? mg/l mass fraction(list; procedure) NPU04659 Csf—Alpha-2-globulin; mass c. = ? mg/l NPU04823 NPU04660 Csf—Beta-globulin; mass c. = ? mg/l Prot.(U)—Protein type; mass fr.(list; proc.) NPU04661 Csf—Gamma-globulin; mass c. = ? mg/l NPU04944 Prot.(U)—Albumin; mass fr. = ? NPU04099 Csf—Immunoglobulin G; subst.c.= ? NPU04945 Prot.(U)—Alpha-1-globulin; mass fr. = ? µmol/l NPU04946 Prot.(U)—Alpha-2-globulin; mass fr. = ? NPU09335 Csf—Immunoglobulin G; NPU14036 Prot.(U)—Alpha-globulin; mass fr. = ? rel.subst.c.(Csf/P) = ? NPU04947 Prot.(U)—Beta-globulin; mass fr. = ? NPU04948 Prot.(U)—Gamma-globulin; mass fr. = ? Plasma— Protein type; Urine— concentration(list; procedure) Protein; NPU03300 arbitrary concentration(procedure) P—Protein type; conc.(list; proc.) NPU04206 NPU01132 P—Albumin; subst.c. = ? µmol/l U—Protein; arb.c.(proc.)= ? NPU04650 P—Alpha-1-globulin; mass c. = ? g/l NPU04651 P—Alpha-2-globulin; mass c. = ? g/l Urine— NPU09261 P—Alpha-globulin; mass c. = ? g/l Protein; NPU09262 P—Beta-1-globulin; mass c. = ? g/l mass concentration(procedure) NPU09263 P—Beta-2-globulin; mass c. = ? g/l gram/liter NPU04652 P—Beta-globulin; mass c. = ? g/l NPU17167 NPU04653 P—Gamma-globulin; mass c. = ? g/l U—Protein; mass c.(proc.) = ? g/l

Urine— Amniotic fluid— Protein type; Protein; concentration(list; procedure) mass concentration NPU03301 gram/liter U—Protein type; conc.(list; proc.) NPU08673 NPU03903 U—Albumin; subst.c. = ? µmol/l Amf—Protein; mass c. = ? g/l NPU04654 U—Alpha-1-globulin; mass c. = ? mg/l NPU04655 U—Alpha-2-globulin; mass c. = ? mg/l Ascites— NPU14037 U—Alpha-globulin; mass c. = ? mg/l Protein; NPU04656 U—Beta-globulin; mass c. = ? mg/l mass concentration NPU04657 U—Gamma-globulin; mass c. = ? mg/l gram/liter NPU08671 Protein(Cerebrospinal fluid)— Asc—Protein; mass c. = ? g/l Protein type; mass fraction(list; procedure) Breast-milk— NPU04878 Protein; Prot.(Csf)—Protein type; mass fr.(list; proc.) mass concentration NPU04949 Prot.(Csf)—Albumin; mass fr. = ? gram/liter NPU04950 Prot.(Csf)—Alpha-1-globulin; mass fr. = NPU10320 ? Breast-milk—Protein; mass c. = ? g/l NPU04951 Prot.(Csf)—Alpha-2-globulin; mass fr. = ? © 2000 IUPAC, Pure and Applied Chemistry 72, 747–972 Properties and units in general clinical chemistry 939

Cerebrospinal fluid— Plasma— Protein; Proteinase 3 antibody(Immunoglobulin G); mass concentration arbitrary concentration(procedure) gram/liter Other term(s): PR3-ANCA NPU03276 NPU12572 Csf—Protein; mass c. = ? g/l P—Proteinase 3 antibody(IgG); arb.c.(proc.) = ?

Drain fluid(specification)— Plasma— Protein; Proteinase 3 antibody(Immunoglobulin G); mass concentration arbitrary substance concentration(procedure) gram/liter 10³ arbitrary unit/liter NPU17042 Other term(s): PR3-ANCA antibody Drain fluid(spec.)—Protein; mass c. = ? g/l NPU12573 P—Proteinase 3 antibody(IgG); arb.subst.c.(proc.) = Plasma— ? × 10³ arb.unit/l Protein; mass concentration Plasma— gram/liter Proteinase 3 antibody; NPU03278 arbitrary concentration(procedure) P—Protein; mass c. = ? g/l Other term(s): PR3-ANCA NPU12044 Pleural fluid(specification)— P—Proteinase 3 antibody; arb.c.(proc.) = ? Protein; mass concentration Patient— gram/liter Protirelin(administered); NPU08670 amount-of-substance(intravenous Plf(spec.)—Protein; mass c. = ? g/l administration) nanomole Synovial fluid(specification)— M = 362,4 g/mol Protein; Other term(s): Thyrotropin-releasing hormone mass concentration NPU10454 gram/liter Pt—Protirelin(administered); am.s.(i.v.) = ? nmol NPU08672 Synf(spec.)—Protein; mass c. = ? g/l Erythrocytes(Blood)— Protoporphyrin IX; System(specification)— entitic amount-of-substance Protein; attomole mass concentration NPU04155 gram/liter Ercs(B)—Protoporphyrin IX; entitic am.s. = ? amol NPU10131 Syst(spec.)—Protein; mass c. = ? g/l Blood— Protoporphyrin(Zn)/Haemoglobin(Fe); Urine— substance ratio Protein; 10-6 mass concentration NPU03307 gram/liter B—Protoporphyrin(Zn)/Haemoglobin(Fe); NPU03958 subst.ratio = ? × 10-6 U—Protein; mass c. = ? g/l Erythrocytes(Blood)— Patient(Urine)— Protoporphyrin; Protein; arbitrary entitic amount-of- mass rate(procedure) substance(procedure) gram/day arbitrary unit NPU03277 NPU04065 Pt(U)—Protein; mass rate(proc.) = ? g/d Ercs(B)—Protoporphyrin; arb.entitic am.s.(proc.) = ? arb.unit Urine— Protein; Erythrocytes(Blood)— mass(procedure) Protoporphyrin; gram entitic amount-of-substance NPU03812 attomole U—Protein; mass(proc.) = ? g M = 626 g/mol NPU03308 Ercs(B)—Protoporphyrin; entitic am.s. = ? amol

Erythrocytes(Blood)— Urine— Protoporphyrin; d-1- substance concentration Pyrroline-5-carboxylate/Creatininium; micromole/liter substance ratio M = 626 g/mol 10-3 NPU14046 NPU14246 Ercs(B)—Protoporphyrin; subst.c. = ? µmol/l U—d-1-Pyrroline-5-carboxylate/Creatininium; subst.ratio = ? × 10-3 Plasma— Purkinje cell(Yo) antibody(Immunoglobulin G); Urine— arbitrary substance concentration(procedure) d-1- 10³ arbitrary unit/liter Pyrroline-5-carboxylate; NPU14543 substance concentration P—Purkinje cell(Yo) antibody(IgG); mole/liter arb.subst.c.(proc.) = ? × 10³ arb.unit/l NPU03327 U—d-1-Pyrroline-5-carboxylate; subst.c.= ? prefix ? Urine— mol/l Pyridinoline cross-linked carboxy-terminal telopeptide, collagen type/Creatininium; Plasma— substance ratio Pyruvatdehydrogenase antibody; 10-6 arbitrary substance concentration(procedure) NPU14337 10³ arbitrary unit/liter U—Pyridinoline cross-linked carboxy-terminal NPU14556 telopeptide, collagen type/Creatininium; subst.ratio P—Pyruvatdehydrogenase antibody; = ? × 10-6 arb.subst.c.(proc.) = ? × 10³ arb.unit/l

Urine— Erythrocytes(Blood)— Pyridinoline cross-linked carboxy-terminal Pyruvate kinase; telopeptide, collagen type; arbitrary catalytic activity(procedure) substance concentration NPU10322 nanomole/liter Ercs(B)—Pyruvate kinase; arb.cat.act.(proc.) = ? NPU14336 U—Pyridinoline cross-linked carboxy-terminal Erythrocytes(Blood)— telopeptide, collagen type; subst.c. = ? nmol/l Pyruvate kinase; entitic catalytic activity(37 °C; procedure) Urine— attokatal Pyridinoline+Deoxypyridinoline; NPU03340 substance concentration Ercs(B)—Pyruvate kinase; entitic cat.act.(37 °C; millimole/liter proc.) = ? akat NPU14372 U—Pyridinoline+Deoxypyridinoline; subst.c. = ? Blood(arterial Blood)— mmol/l Pyruvate; substance concentration Plasma— micromole/liter Pyridoxal 5-phosphate; M = 88,06 g/mol substance concentration NPU03328 nanomole/liter B(aB)—Pyruvate; subst.c. = ? µmol/l NPU10612 P—Pyridoxal 5-phosphate; subst.c. = ? nmol/l Blood(venous Blood)— Pyruvate; Synovial fluid(specification)— substance concentration Pyrophosphate crystals; micromole/liter arbitrary concentration(procedure) M = 88,06 g/mol NPU03322 NPU09228 Synf(spec.)—Pyrophosphate crystals; arb.c.(proc.) B(vB)—Pyruvate; subst.c. = ? µmol/l = ? Cerebrospinal fluid— Cells(Synovial fluid; specification)— Pyruvate; Pyrophosphate crystals; substance concentration arbitrary entitic number(procedure) micromole/liter NPU03323 M = 88,06 g/mol Cells(Synf; spec.)—Pyrophosphate crystals; NPU03329 arb.entitic num.(proc.) = ? Csf—Pyruvate; subst.c. = ? µmol/l

Plasma(fasting Patient)— Plasma— Pyruvate; Renin; substance concentration catalytic-activity concentration(procedure) micromole/liter microkatal/liter NPU17792 M = 42 270 g/mol P(fPt)—Pyruvate; subst.c. = ? µmol/l Other term(s): Angiotensin-forming enzyme; Angiotensinogenase Patient(Urine)— NPU03352 Pyruvate; P—Renin; cat.c.(proc.) = ? µkat/l substance rate(procedure) micromole/day Plasma— NPU17794 Renin; Pt(U)—Pyruvate; subst.rate(proc.) = ? µmol/d substance concentration(0 minutes after challenge) Kidney— mole/liter Renin secretion; NPU09267 substance rate(furosemide, oral administration; P—Renin; subst.c.(0 min)= ? prefix ? mol/l list; procedure) Note: M (furosemide) = 330,75 g/mol; M (renin) = 42 Plasma— 270 g/mol Renin; NPU10422 substance concentration(300 minutes after Kidn.—Renin secretion; subst.rate(furosemide p.o.; challenge) list; proc.) mole/liter NPU10420 P—Renin; arb.subst.c.(IRP 68/356; 0 NPU09268 min) = ? × 10-3 int.unit/l P—Renin; subst.c.(300 min)= ? prefix ? mol/l NPU10421 P—Renin; arb.subst.c.(IRP 68/356; 300 min) = ? × 10-3 int.unit/l Plasma— NPU09267 P—Renin; subst.c.(0 min)= ? prefix ? Renin; mol/l substance concentration(procedure) NPU09268 P—Renin; subst.c.(300 min)= ? prefix ? mole/liter mol/l M = 42 270 g/mol Other term(s): Angiotensin-forming enzyme; Plasma— Angiotensinogenase Renin; NPU03353 arbitrary substance concentration(IRP 68/356; 0 P—Renin; subst.c.(proc.)= ? prefix ? mol/l minutes after challenge) 10-3 international unit/liter Plasma— NPU10420 Reno pulmonal syndrome; P—Renin; arb.subst.c.(IRP 68/356; 0 min) = ? × 10-3 arbitrary concentration(list; procedure) int.unit/l NPU14557 P—Reno pulmonal syndrome; arb.c.(list; proc.) Plasma— NPU12542 P—Glomerulus membrane Renin; antibody(IgG); arb.c.(proc.) = ? arbitrary substance concentration(IRP 68/356; NPU12575 P—Myeloperoxidase antibody(IgG); 300 minutes after challenge) arb.c.(proc.) = ? 10-3 international unit/liter NPU12572 P—Proteinase 3 antibody(IgG); NPU10421 arb.c.(proc.) = ? P—Renin; arb.subst.c.(IRP 68/356; 300 min) = ? × 10-3 int.unit/l Plasma— Reno pulmonal syndrome; Plasma— arbitrary substance concentration(list; Renin; procedure) arbitrary substance concentration(IRP 68/356; NPU14558 procedure) P—Reno pulmonal syndrome; arb.subst.c.(list; 10-3 international unit/liter proc.) M = 42 270 g/mol NPU12552 P—Glomerulus membrane Recommended calibrator: WHO 1st IRP 68/356 antibody(IgG); arb.subst.c.(proc.) = ? × 10³ arb.unit/l Other term(s): Angiotensin-forming enzyme; NPU12036 P—Myeloperoxidase antibody(IgG); Angiotensinogenase arb.subst.c.(proc.) = ? × 10³ arb.unit/l NPU03351 NPU12573 P—Proteinase 3 antibody(IgG); P—Renin; arb.subst.c.(IRP 68/356; proc.) = ? × 10-3 arb.subst.c.(proc.) = ? × 10³ arb.unit/l int.unit/l

Plasma— Reticulocytes(Blood)— Reticulin antibody(Immunoglobulin A); Reticulocytes(RNA; mean concentration); arbitrary concentration(procedure) number fraction(procedure) NPU12247 NPU17010 P—Reticulin antibody(IgA); arb.c.(proc.) = ? Rtcs(B)—Reticulocytes(mean c.); num.fr.(proc.) = ?

Plasma— Reticulocytes(Blood)— Reticulin antibody(Immunoglobulin G); Reticulocytes(RNA) arbitrary concentration(procedure) number fraction(list; procedure) NPU12248 NPU17012 P—Reticulin antibody(IgG); arb.c.(proc.) = ? Rtcs(B)—Reticuloctyes(RNA); num.fr.(list; proc.) NPU17009 Rtcs(B)—Reticulocytes(RNA; low c.); Plasma— num.fr.(proc.) = ? Reticulin antibody; NPU17010 Rtcs(B)—Reticulocytes(RNA; mean c.); arbitrary concentration(list; procedure) num.fr.(proc.) = ? NPU17105 NPU17011 Rtcs(B)—Reticulocytes(RNA; high c.); P—Reticulin antibody; arb.c.(list; proc.) num.fr.(proc.) = ? NPU12247 P—Reticulin antibody(IgA); arb.c.(proc.) = ? Bone marrow— NPU12248 P—Reticulin antibody(IgG); arb.c.(proc.) Reticulum cells; = ? number concentration 109/liter Plasma— NPU04134 Reticulin antibody; Marrow—Reticulum cells; num.c. = ? × 109/l arbitrary concentration(procedure) NPU03355 Leukocytes(Bone marrow)— P—Reticulin antibody; arb.c.(proc.) = ? Reticulum cells; number fraction Blood— NPU14382 Reticulocytes; Lkcs(Marrow)—Reticulum cells; num.fr. = ? entitic volume femtoliter Patient— NPU17013 Retinol absorption; B—Reticulocytes; entitic vol. = ? fl substance rate(procedure) mole/day Blood— NPU03837 Reticulocytes; Pt—Retinol absorption; subst.rate(proc.)= ? prefix ? number concentration mol/d 109/liter NPU08694 Plasma— B—Reticulocytes; num.c. = ? × 109/l Retinol binding protein; substance concentration Erythrocytes(Blood)— micromole/liter Reticulocytes; M = 21 000 g/mol number fraction NPU03358 10-3 P—Retinol binding protein; subst.c. = ? µmol/l NPU03356 Ercs(B)—Reticulocytes; num.fr. = ? × 10-3 Plasma— Retinol; Reticulocytes(Blood)— substance concentration Reticulocytes(RNA; low concentration); micromole/liter number fraction(procedure) M = 286,44 g/mol NPU17009 Other term(s): Vitamin A Rtcs(B)—Reticulocytes(RNA; low c.); num.fr.(proc.) Authority: INN = ? NPU03357 P—Retinol; subst.c. = ? µmol/l Reticulocytes(Blood)— Reticulocytes(RNA; high concentration); Plasma— number fraction(procedure) Rheumafactor antibody(Immunoglobulin A); NPU17011 arbitrary concentration(procedure) Rtcs(B)—Reticulocytes(RNA(high c.); num.fr.(proc.) Other term(s): Immunoglobulin G Fc antibody = ? NPU10229 P—Rheumafactor antibody(IgA); arb.c.(proc.) = ?

Plasma— Patient(Urine)— Rheumafactor antibody(Immunoglobulin A); Riboflavin; arbitrary substance concentration(procedure) substance rate(procedure) 10³ arbitrary unit/liter micromole/day Other term(s): Rheuma factor NPU03359 NPU12581 Pt(U)—Riboflavin; subst.rate(proc.) = ? µmol/d P—Rheumafactor antibody(IgA); arb.subst.c.(proc.) = ? × 10³ arb.unit/l Plasma— Ribonucleoprotein antibody(Immunoglobulin G); Plasma— arbitrary concentration(procedure) Rheumafactor antibody(Immunoglobulin E); Other term(s): rRNP antibody arbitrary substance concentration(procedure) NPU12569 10³ arbitrary unit/liter P—Ribonucleoprotein antibody(IgG); arb.c.(proc.) = Other term(s): Rheuma factor ? NPU14802 P—Rheumafactor antibody(IgE); arb.subst.c.(proc.) Plasma— = ? × 10³ arb.unit/l Ribonucleoprotein antibody(Immunoglobulin G); arbitrary substance concentration(procedure) Plasma— arbitrary unit/liter Rheumafactor antibody(Immunoglobulin G); NPU14504 arbitrary concentration(procedure) P—Ribonucleoprotein antibody(IgG); NPU10230 arb.subst.c.(proc.) = ? arb.unit/l P—Rheumafactor antibody(IgG); arb.c.(proc.) = ? Plasma— Plasma— Ribonucleoprotein antibody; Rheumafactor antibody(Immunoglobulin G); arbitrary substance concentration(procedure) arbitrary substance concentration(procedure) arbitrary unit/liter 10³ arbitrary unit/liter Other term(s): nRNP-antistof Other term(s): Rheuma factor NPU12023 NPU14803 P—Ribonucleoprotein antibody; arb.subst.c.(proc.) P—Rheumafactor antibody(IgG); arb.subst.c.(proc.) = ? arb.unit/l = ? × 10³ arb.unit/l Plasma— Plasma— Ribonucleoprotein(U1) antibody(Immunoglobulin Rheumafactor antibody(Immunoglobulin M); G); arbitrary concentration(procedure) arbitrary substance concentration(procedure) Other term(s): Rheuma factor 10³ arbitrary unit/liter NPU02483 NPU14505 P—Rheumafactor antibody(IgM); arb.c.(proc.) = ? P—Ribonucleoprotein(U1) antibody(IgG); arb.subst.c.(proc.) = ? × 10³ arb.unit/l Synovial fluid(specification)— Rheumafactor antibody(Immunoglobulin M); Plasma— arbitrary concentration(procedure) RNA polymerase antibody(Immunoglobulin G); NPU10228 arbitrary substance concentration(procedure) Synf(spec.)—Rheumafactor antibody(IgM); 10³ arbitrary unit/liter arb.c.(proc.) = ? NPU14561 P—RNA polymerase antibody(IgG); Plasma— arb.subst.c.(proc.) = ? × 10³ arb.unit/l Rheumafactor antibody(Immunoglobulin M); arbitrary substance concentration(procedure) Blood— 10³ arbitrary unit/liter Rouleau formation; Other term(s): Rheuma factor arbitrary concentration(procedure) NPU12580 NPU17096 P—Rheumafactor antibody(IgM); arb.subst.c.(proc.) B—Rouleau formation; arb.c.(proc.) = ? = ? × 10³ arb.unit/l Blood— Plasma— Rubidium; Rheumafactor antibody(Immunoglobulin M); substance concentration arbitrary substance concentration(WHO micromole/liter calibrator; procedure) M = 85,47 g/mol 10³ international unit/liter Authority: IUPAC/VII-C-TOX NPU16407 NPU03370 P—Rheumafactor antibody(IgM); arb.subst.c.(WHO B—Rubidium; subst.c. = ? µmol/l calib.; proc.) = ? × 10³ int.unit/l

Plasma— Urine— Rubidium; Sarcosine/Creatininium; substance concentration substance ratio micromole/liter 10-3 M = 85,47 g/mol NPU14248 Authority: IUPAC/VII-C-TOX U—Sarcosine/Creatininium; subst.ratio = ? × 10-3 NPU03372 P—Rubidium; subst.c. = ? µmol/l Plasma— Sarcosine; Urine— substance concentration Rubidium; micromole/liter substance concentration M = 89,09 g/mol micromole/liter NPU03396 M = 85,47 g/mol P—Sarcosine; subst.c. = ? µmol/l Authority: IUPAC/VII-C-TOX NPU03373 Urine— U—Rubidium; subst.c. = ? µmol/l Sarcosine; substance concentration Cells(Blood)— micromole/liter Rubidium; M = 89,09 g/mol substance content NPU03397 micromole/kilogram U—Sarcosine; subst.c. = ? µmol/l M = 85,47 g/mol Authority: IUPAC/VII-C-TOX Plasma— NPU04894 Scandium; Cells(B)—Rubidium; subst.cont. = ? µmol/kg substance concentration picomole/liter Hair— M = 44,95 g/mol Rubidium; Authority: IUPAC/VII-C-TOX substance content NPU04896 micromole/kilogram P—Scandium; subst.c. = ? pmol/l M = 85,47 g/mol Authority: IUPAC/VII-C-TOX Blood— NPU03371 Schistocytes; Hair—Rubidium; subst.cont. = ? µmol/kg arbitrary concentration(procedure) NPU17097 Urine— B—Schistocytes; arb.c.(proc.) = ? Saccharopine/Creatininium; substance ratio Plasma— 10-3 Scleroderma(Scl-70) antibody(Immunoglobulin G); NPU14247 arbitrary concentration(procedure) U—Saccharopine/Creatininium; subst.ratio = ? × NPU12562 10-3 P—Scleroderma(Scl-70) antibody(IgG); arb.c.(proc.) = ? Urine— Saccharopine; Plasma— substance concentration Scleroderma(Scl-70) antibody; mole/liter arbitrary concentration(procedure) NPU03374 NPU03402 U—Saccharopine; subst.c.= ? prefix ? mol/l P—Scleroderma(Scl-70) antibody; arb.c.(proc.) = ?

Plasma— Patient— Sarcolemma antibody(Immunoglobulin G); Secretin(administered); arbitrary concentration(procedure) amount-of-substance(intravenous NPU12536 administration) P—Sarcolemma antibody(IgG); arb.c.(proc.) = ? nanomole M = 3 056 g/mol Plasma— Authority: IUPAC-IUB 74 Sarcolemma antibody; NPU10512 arbitrary concentration(procedure) Pt—Secretin(administered); am.s.(i.v.) = ? nmol NPU02851 P—Sarcolemma antibody; arb.c.(proc.) = ? Patient— Secretin(administered); substance content(intravenous administration; amount-of-substance/body mass)

picomole/kilogram Hair— M = 3 056 g/mol Selenium; Authority: IUPAC-IUB 74 substance content NPU10513 micromole/kilogram Pt—Secretin(administered); subst.cont.(i.v.; am.s./ M = 78,96 g/mol body mass) = ? pmol/kg Authority: IUPAC/VII-C-TOX NPU04899 Plasma— Hair—Selenium; subst.cont. = ? µmol/kg Secretin; substance concentration Plasma— picomole/liter Sensoric neuropathy antibody; M = 3 056 g/mol arbitrary substance concentration(list; Authority: IUPAC-IUB 74 procedure) NPU03403 NPU14562 P—Secretin; subst.c. = ? pmol/l P—Sensoric neuropathy antibody; arb.subst.c.(list; proc.) Blood— NPU14526 P—Myeline associated glycoprotein Sedimentation reaction; antibody(IgM); arb.subst.c.(proc.) = ? × 10³ arb.unit/l arbitrary length NPU14523 P—Neuropathy M-component; arbitrary unit arb.c.(IFE; proc.) = ? NPU17589 NPU14525 P—Neuropathy(SGPG)-antibody(IgM); B—Sedimentation reaction; arb.length = ? arb.unit arb.subst.c.(proc.) = ? × 10³ arb.unit/l NPU14528 P—Sensoric neuropathy(Hu) Blood— antibody(IgG); arb.subst.c.(proc.) = ? × 10³ arb.unit/l Sedimentation reaction; NPU14529 P—Sensoric neuropathy(sulfatid) length(procedure) antibody; arb.subst.c.(proc.) = ? × 10³ arb.unit/l millimeter NPU03404 Plasma— B—Sedimentation reaction; length(proc.) = ? mm Sensoric neuropathy antibody; property(list) Blood— NPU17708 Selenium; P—Sensoric neuropathy antibody; prop.(list) substance concentration micromole/liter Plasma— M = 78,96 g/mol Sensoric neuropathy(Hu) antibody(Immunoglobulin Authority: IUPAC/VII-C-TOX G); NPU03893 arbitrary substance concentration(procedure) B—Selenium; subst.c. = ? µmol/l 10³ arbitrary unit/liter NPU14528 Plasma— P—Sensoric neuropathy(Hu) antibody(IgG); Selenium; arb.subst.c.(proc.) = ? × 10³ arb.unit/l substance concentration micromole/liter Plasma— M = 78,96 g/mol Sensoric neuropathy(sulfatid) antibody; Authority: IUPAC/VII-C-TOX arbitrary substance concentration(procedure) NPU04156 10³ arbitrary unit/liter P—Selenium; subst.c. = ? µmol/l NPU14529 P—Sensoric neuropathy(sulfatid) antibody; Urine— arb.subst.c.(proc.) = ? × 10³ arb.unit/l Selenium; substance concentration Urine— micromole/liter Serine/Creatininium; M = 78,96 g/mol substance ratio Authority: IUPAC/VII-C-TOX 10-3 NPU03406 NPU14249 U—Selenium; subst.c. = ? µmol/l U—Serine/Creatininium; subst.ratio = ? × 10-3

Cells(Blood)— Cerebrospinal fluid— Selenium; Serine; substance content substance concentration micromole/kilogram micromole/liter M = 78,96 g/mol M = 105,09 g/mol Authority: IUPAC/VII-C-TOX NPU03414 NPU03405 Csf—Serine; subst.c. = ? µmol/l Cells(B)—Selenium; subst.cont. = ? µmol/kg

Plasma— M = 115 000 g/mol Serine; NPU03419 substance concentration P—Sexual-hormone-binding-globulin; subst.c. = ? micromole/liter nmol/l M = 105,09 g/mol NPU03415 Plasma— P—Serine; subst.c. = ? µmol/l Sialate; substance concentration Urine— mole/liter Serine; NPU03420 substance concentration P—Sialate; subst.c.= ? prefix ? mol/l micromole/liter M = 105,09 g/mol Urine— NPU03416 Sialate; U—Serine; subst.c. = ? µmol/l substance concentration mole/liter Thrombocytes(Blood)— NPU03421 Serotonin; U—Sialate; subst.c.= ? prefix ? mol/l entitic amount-of-substance attomole Blood— M = 176,2 g/mol Sickle cells; Other term(s): 5-Hydroxytryptophane arbitrary concentration(procedure) Note: Platelet(s) is a full synonym to NPU17098 Thrombocyte(s) B—Sickle cells; arb.c.(proc.) = ? NPU03418 Trcs(B)—Serotonin; entitic am.s. = ? amol Erythrocytes(Blood)— Sickle cells; Cerebrospinal fluid— number fraction Serotonin; NPU14272 substance concentration Ercs(B)—Sickle cells; num.fr. = ? nanomole/liter M = 176,2 g/mol Plasma— Other term(s): 5-Hydroxytryptophane Silicon; NPU10236 substance concentration Csf—Serotonin; subst.c. = ? nmol/l micromole/liter M = 28,09 g/mol Plasma— Authority: IUPAC/VII-C-TOX Serotonin; NPU03423 substance concentration P—Silicon; subst.c. = ? µmol/l nanomole/liter M = 176,2 g/mol Urine— Other term(s): 5-Hydroxytryptophane Silicon; NPU03417 substance concentration P—Serotonin; subst.c. = ? nmol/l micromole/liter M = 28,09 g/mol Patient(Urine)— Authority: IUPAC/VII-C-TOX Serotonin; NPU03424 substance rate U—Silicon; subst.c. = ? µmol/l nanomole/day M = 176,2 g/mol Blood— Other term(s): 5-Hydroxytryptophane Silver; NPU10237 substance concentration Pt(U)—Serotonin; subst.rate = ? nmol/d nanomole/liter M = 107,87 g/mol Plasma— Authority: IUPAC/VII-C-TOX Sertindol; NPU03891 substance concentration B—Silver; subst.c. = ? nmol/l mole/liter NPU14500 Plasma— P—Sertindol; subst.c.= ? prefix ? mol/l Silver; substance concentration Plasma— nanomole/liter Sexual-hormone-binding-globulin; M = 107,87 g/mol substance concentration nanomole/liter

Authority: IUPAC/VII-C-TOX NPU12567 P—Sjögren syndrome B antibody(IgG); NPU03425 arb.subst.c.(proc.) = ? × 10³ arb.unit/l P—Silver; subst.c. = ? nmol/l Plasma— Urine— Sjögren syndrome B antibody(Immunoglobulin G); Silver; arbitrary concentration(procedure) substance concentration Other term(s): SSB(La) nanomole/liter NPU12566 M = 107,87 g/mol P—Sjögren syndrome B antibody(IgG); arb.c.(proc.) Authority: IUPAC/VII-C-TOX = ? NPU03892 U—Silver; subst.c. = ? nmol/l Plasma— Sjögren syndrome B antibody(Immunoglobulin G); Hair— arbitrary substance concentration(procedure) Silver; 10³ arbitrary unit/liter substance content Other term(s): SSB(La) micromole/kilogram NPU12567 M = 107,87 g/mol P—Sjögren syndrome B antibody(IgG); Authority: IUPAC/VII-C-TOX arb.subst.c.(proc.) = ? × 10³ arb.unit/l NPU03890 Hair—Silver; subst.cont. = ? µmol/kg Plasma— Sjögren syndrome B antibody; Plasma— arbitrary concentration(procedure) Sjögren syndrome A antibody(Immunoglobulin G); Other term(s): SSB(La) arbitrary concentration(procedure) NPU03427 Other term(s): SSA(Ro) P—Sjögren syndrome B antibody; arb.c.(proc.) = ? NPU12563 P—Sjögren syndrome A antibody(IgG); arb.c.(proc.) Plasma— = ? Sjögren syndrome B antibody; arbitrary substance concentration(procedure) Plasma— arbitrary unit/liter Sjögren syndrome A antibody(Immunoglobulin G); NPU12037 arbitrary substance concentration(procedure) P—Sjögren syndrome B antibody; 10³ arbitrary unit/liter arb.subst.c.(proc.) = ? arb.unit/l Other term(s): SSA(Ro) NPU12564 Urine— P—Sjögren syndrome A antibody(IgG); Slime; arb.subst.c.(proc.) = ? × 10³ arb.unit/l arbitrary concentration(procedure) NPU17179 Plasma— U—Slime; arb.c.(proc.) = ? Sjögren syndrome A antibody; arbitrary concentration(procedure) Plasma— Other term(s): SSA(Ro) Smith’s antibody; NPU03426 arbitrary concentration(procedure) P—Sjögren syndrome A antibody; arb.c.(proc.) = ? Other term(s): anti-Sm NPU03428 Plasma— P—Smith’s antibody; arb.c.(proc.) = ? Sjögren syndrome A antibody; arbitrary substance concentration(procedure) Plasma— arbitrary unit/liter Smith’s antibody; Other term(s): SSA(Ro) arbitrary substance concentration(procedure) NPU12000 arbitrary unit/liter P—Sjögren syndrome A antibody; NPU12024 arb.subst.c.(proc.) = ? arb.unit/l P—Smith’s antibody; arb.subst.c.(proc.) = ? arb.unit/l Plasma— Sjögren syndrome antibody; Blood— arbitrary substance concentration(list; Smudge cells; procedure) arbitrary concentration(procedure) NPU14564 NPU17130 P—Sjögren syndrome antibody; arb.subst.c.(list; B—Smudge cells; arb.c.(proc.) = ? proc.) NPU12564 P—Sjögren syndrome A antibody(IgG); arb.subst.c.(proc.) = ? × 10³ arb.unit/l

Aqueous solution— Aspirate(specification)— Sodium chloride; Sodium ion; molality substance concentration millimole/kilogram millimole/liter M = 58,45 g/mol NPU14910 NPU03991 Aspir(spec.)—Sodium ion; subst.c. = ? mmol/l Aq.sol.—Sodium chloride; molal. = ? mmol/kg Blood fraction(specification)— Sweat— Sodium ion; Sodium ion/Potassium ion; substance concentration substance ratio millimole/liter Authority: IFCC/C-BGE NPU17583 NPU03432 B fract.(spec.)—Sodium ion; subst.c. = ? mmol/l Sweat—Sodium ion/Potassium ion; subst.ratio = ? Cerebrospinal fluid— Secretion(Ileum)— Sodium ion; Sodium ion; substance concentration amount-of-substance(procedure) millimole/liter millimole Authority: IFCC/C-BGE NPU08652 NPU10193 Secr(Ileum)—Sodium ion; am.s.(proc.) = ? mmol Csf—Sodium ion; subst.c. = ? mmol/l

Stomach fluid— Dialysis solution— Sodium ion; Sodium ion; amount-of-substance(procedure) substance concentration millimole millimole/liter Authority: IFCC/C-BGE Authority: IFCC/C-BGE NPU14117 NPU10192 Stomf—Sodium ion; am.s.(proc.) = ? mmol Dialysis solution—Sodium ion; subst.c. = ? mmol/l

System(specification)— Drain fluid(specification)— Sodium ion; Sodium ion; amount-of-substance(procedure) substance concentration millimole millimole/liter NPU08653 NPU17045 Syst(spec.)—Sodium ion; am.s.(proc.) = ? mmol Drain fluid(spec.)—Sodium ion; subst.c. = ? mmol/l

Urine— Plasma— Sodium ion; Sodium ion; amount-of-substance(procedure) substance concentration millimole millimole/liter Authority: IFCC/C-BGE Authority: IFCC/C-BGE NPU03839 NPU03429 U—Sodium ion; am.s.(proc.) = ? mmol P—Sodium ion; subst.c. = ? mmol/l

Faeces(specification)— Secretion(Ileum)— Sodium ion; Sodium ion; amount-of-substance substance concentration millimole millimole/liter NPU17622 NPU08650 F(spec.)—Sodium ion; am.s. = ? mmol Secr(Ileum)—Sodium ion; subst.c. = ? mmol/l

Amniotic fluid— Stomach fluid— Sodium ion; Sodium ion; substance concentration substance concentration millimole/liter millimole/liter NPU08648 Authority: IFCC/C-BGE Amf—Sodium ion; subst.c. = ? mmol/l NPU14116 Stomf—Sodium ion; subst.c. = ? mmol/l Ascites— Sodium ion; Sweat— substance concentration Sodium ion; millimole/liter substance concentration NPU17033 millimole/liter Asc—Sodium ion; subst.c. = ? mmol/l

Authority: IFCC/C-BGE Plasma— NPU03430 Solute; Sweat—Sodium ion; subst.c. = ? mmol/l molality(procedure) millimole/kilogram System(specification)— Authority: IFCC/C-BGE Sodium ion; NPU03433 substance concentration P—Solute; molal.(proc.) = ? mmol/kg millimole/liter NPU08651 Pleural fluid— Syst(spec.)—Sodium ion; subst.c. = ? mmol/l Solute; molality(procedure) Urine— millimole/kilogram Sodium ion; Authority: IFCC/C-BGE substance concentration NPU17023 millimole/liter Plf—Solute; molal.(proc.) = ? mmol/kg Authority: IFCC/C-BGE NPU03431 Sweat— U—Sodium ion; subst.c. = ? mmol/l Solute; molality(procedure) Faeces— millimole/kilogram Sodium ion; Authority: IFCC/C-BGE substance content NPU17182 millimole/kilogram Sweat—Solute; molal.(proc.) = ? mmol/kg NPU04219 F—Sodium ion; subst.cont. = ? mmol/kg Urine— Solute; Faeces(specification)— molality(procedure) Sodium ion; millimole/kilogram substance content Authority: IFCC/C-BGE millimole/kilogram NPU03434 NPU08649 U—Solute; molal.(proc.) = ? mmol/kg F(spec.)—Sodium ion; subst.cont. = ? mmol/kg Plasma— Patient(Faeces)— Somatostatin; Sodium ion; substance concentration substance rate(procedure) picomole/liter millimole/day M = 1 638 g/mol NPU04218 NPU03435 Pt(F)—Sodium ion; subst.rate(proc.) = ? mmol/d P—Somatostatin; subst.c. = ? pmol/l

Patient(Urine)— Urine— Sodium ion; Somatostatin; substance rate(procedure) substance concentration millimole/day picomole/liter NPU03796 M = 1 638 g/mol Pt(U)—Sodium ion; subst.rate(proc.) = ? mmol/d NPU14013 U—Somatostatin; subst.c. = ? pmol/l Ascites— Solute; Patient(Urine)— molality(procedure) Somatostatin; millimole/kilogram substance rate Authority: IFCC/C-BGE picomole/day NPU17024 M = 1 638 g/mol Asc—Solute; molal.(proc.) = ? mmol/kg NPU14014 Pt(U)—Somatostatin; subst.rate = ? pmol/d Faeces— Solute; Pituitary gland— molality(procedure) Somatotropin secretion; millimole/kilogram substance rate(arginine+insulin, intravenous NPU10767 administration; list; procedure) F—Solute; molal.(proc.) = ? mmol/kg Note: M (arginine) = 174,20 g/mol; M (insulin) = 5 807,65 g/mol; M (somatotropin) = 22 124 g/mol NPU10654

PitGl—Somatotropin secretion; mmol/l subst.rate(arginine+insulin i.v.; list; proc.) NPU08506 B—Glucose; subst.c.(90 min) = ? NPU09354 Pt—Arginine(administered); mmol/l subst.cont.(i.v.; am.s./body mass) = ? mol/kg NPU10696 B—Glucose; subst.c.(110 min) = ? NPU10547 Pt—Insulin(administered); mmol/l subst.cont.(i.v.; am.s./body mass) = ? µmol/kg NPU08507 B—Glucose; subst.c.(120 min) = ? NPU10548 Pt—Insulin(administered); mmol/l arb.subst.cont.(i.v.; arb.am.s./body mass; proc.) = ? NPU10697 B—Glucose; subst.c.(135 min) = ? int. unit/kg mmol/l NPU10553 P—Corticotropin; subst.c.(90 min) = ? NPU08508 B—Glucose; subst.c.(150 min) = ? pmol/l mmol/l NPU10641 P—Corticotropin; subst.c.(120 min) = ? NPU08500 B—Glucose; subst.c.(180 min) = ? pmol/l mmol/l NPU10642 P—Corticotropin; subst.c.(135 min) = ? NPU04174 P—Glucose; subst.c.(30 min) = ? pmol/l mmol/l NPU10643 P—Corticotropin; subst.c.(150 min) = ? NPU04175 P—Glucose; subst.c.(60 min) = ? pmol/l mmol/l NPU10644 P—Corticotropin; subst.c.(180 min) = ? NPU04176 P—Glucose; subst.c.(90 min) = ? pmol/l mmol/l NPU04970 P—Cortisol; subst.c.(90 min) = ? nmol/l NPU10652 P—Glucose; subst.c.(110 min) = ? NPU04971 P—Cortisol; subst.c.(120 min) = ? mmol/l nmol/l NPU04177 P—Glucose; subst.c.(120 min) = ? NPU10645 P—Cortisol; subst.c.(135 min) = ? mmol/l nmol/l NPU10653 P—Glucose; subst.c.(135 min) = ? NPU10224 P—Cortisol; subst.c.(150 min) = ? mmol/l nmol/l NPU04178 P—Glucose; subst.c.(150 min) = ? NPU10222 P—Cortisol; subst.c.(180 min) = ? mmol/l nmol/l NPU04179 P—Glucose; subst.c.(180 min) = ? NPU08736 P—Somatotropin; subst.c.(0 min) = ? mmol/l pmol/l NPU08738 P—Somatotropin; subst.c.(30 min) = ? Pituitary gland— pmol/l Somatotropin secretion; NPU08740 P—Somatotropin; subst.c.(60 min) = ? substance rate(clonidine, oral administration; pmol/l list; procedure) NPU08742 P—Somatotropin; subst.c.(90 min) = ? Other term(s): Growth hormone secretion; pmol/l Somatotropin stimulation test NPU08743 P—Somatotropin; subst.c.(120 min) = ? Note: M (clonidine) = 230,10 g/mol pmol/l NPU10346 NPU10646 P—Somatotropin; subst.c.(135 min) = ? PitGl—Somatotropin secretion; subst.rate(clonidine pmol/l p.o.; list; proc.) NPU10647 P—Somatotropin; subst.c.(150 min) = ? NPU10536 Pt—Clonidine(administered); am.s.(p.o.) pmol/l = ? µmol NPU10648 P—Somatotropin; subst.c.(180 min) = ? NPU04139 P—Cortisol; subst.c.(0 min) = ? nmol/l pmol/l NPU04140 P—Cortisol; subst.c.(30 min) = ? nmol/l NPU10357 P—Somatotropin; arb.subst.c.(IS 80/ NPU04968 P—Cortisol; subst.c.(60 min) = ? nmol/l 505; 0 min; proc.) = ? × 10-3 int.unit/l NPU04970 P—Cortisol; subst.c.(90 min) = ? nmol/l NPU10358 P—Somatotropin; arb.subst.c.(IS 80/ NPU04971 P—Cortisol; subst.c.(120 min) = ? 505; 30 min; proc.) = ? × 10-3 int.unit/l nmol/l NPU10359 P—Somatotropin; arb.subst.c.(IS 80/ NPU08736 P—Somatotropin; subst.c.(0 min) = ? 505; 60 min; proc.) = ? × 10-3 int.unit/l pmol/l NPU10360 P—Somatotropin; arb.subst.c.(IS 80/ NPU08738 P—Somatotropin; subst.c.(30 min) = ? 505; 90 min; proc.) = ? × 10-3 int.unit/l pmol/l NPU10361 P—Somatotropin; arb.subst.c.(IS 80/ NPU08740 P—Somatotropin; subst.c.(60 min) = ? 505; 120 min; proc.) = ? × 10-3 int.unit/l pmol/l NPU10649 P—Somatotropin; arb.subst.c.(IS 80/ NPU08742 P—Somatotropin; subst.c.(90 min) = ? 505; 135 min; proc.) = ? × 10-3 int.unit/l pmol/l NPU10650 P—Somatotropin; arb.subst.c.(IS 80/ NPU08743 P—Somatotropin; subst.c.(120 min) = ? 505; 150 min; proc.) = ? × 10-3 int.unit/l pmol/l NPU10651 P—Somatotropin; arb.subst.c.(IS 80/ NPU10357 P—Somatotropin; arb.subst.c.(IS 80/ 505; 180 min; proc.) = ? × 10-3 int.unit/l 505; 0 min; proc.) = ? × 10-3 int.unit/l NPU08504 B—Glucose; subst.c.(30 min) = ? NPU10358 P—Somatotropin; arb.subst.c.(IS 80/ mmol/l 505; 30 min; proc.) = ? × 10-3 int.unit/l NPU08501 B—Glucose; subst.c.(60 min) = ? NPU10359 P—Somatotropin; arb.subst.c.(IS 80/ 505; 60 min; proc.) = ? × 10-3 int.unit/l

NPU10360 P—Somatotropin; arb.subst.c.(IS 80/ NPU08501 B—Glucose; subst.c.(60 min) = ? 505; 90 min; proc.) = ? × 10-3 int.unit/l mmol/l NPU10361 P—Somatotropin; arb.subst.c.(IS 80/ NPU08518 B—Glucose; subst.c.(75 min) = ? 505; 120 min; proc.) = ? × 10-3 int.unit/l mmol/l NPU08506 B—Glucose; subst.c.(90 min) = ? Pituitary gland— mmol/l Somatotropin secretion; NPU08507 B—Glucose; subst.c.(120 min) = ? substance rate(glucose, oral administration; list; mmol/l procedure) NPU08500 B—Glucose; subst.c.(180 min) = ? Other term(s): Growth hormone secretion; mmol/l Somatotropin suppression test NPU08735 B—Glucose; subst.c.(max.; proc.) = ? Note: M (glucose) = 180,16 g/mol; M (somatotropin) mmol/l = 22 124 g/mol NPU04173 P—Glucose; subst.c.(0 min) = ? mmol/l NPU03439 NPU04186 P—Glucose; subst.c.(15 min) = ? PitGl—Somatotropin secretion; subst.rate(glucose mmol/l p.o.; list; proc.) NPU04174 P—Glucose; subst.c.(30 min) = ? NPU10574 Pt—Glucose(administered); am.s.(p.o.) mmol/l = ? mmol NPU04187 P—Glucose; subst.c.(45 min) = ? NPU10575 Pt—Glucose(administered); mmol/l subst.cont.(p.o.; am.s./body mass) = ? mmol/kg NPU04175 P—Glucose; subst.c.(60 min) = ? NPU08736 P—Somatotropin; subst.c.(0 min) = ? mmol/l pmol/l NPU04965 P—Glucose; subst.c.(75 min) = ? NPU08737 P—Somatotropin; subst.c.(15 min) = ? mmol/l pmol/l NPU04176 P—Glucose; subst.c.(90 min) = ? NPU08738 P—Somatotropin; subst.c.(30 min) = ? mmol/l pmol/l NPU04177 P—Glucose; subst.c.(120 min) = ? NPU08739 P—Somatotropin; subst.c.(45 min) = ? mmol/l pmol/l NPU04179 P—Glucose; subst.c.(180 min) = ? NPU08740 P—Somatotropin; subst.c.(60 min) = ? mmol/l pmol/l NPU08734 P—Glucose; subst.c.(max.; proc.) = ? NPU08741 P—Somatotropin; subst.c.(75 min) = ? mmol/l pmol/l NPU08742 P—Somatotropin; subst.c.(90 min) = ? Pituitary gland— pmol/l Somatotropin secretion; NPU08743 P—Somatotropin; subst.c.(120 min) = ? substance rate(insulin, intravenous pmol/l administration; list; procedure) NPU04983 P—Somatotropin; subst.c.(min.; proc.) = Other term(s): Growth hormone secretion; ? pmol/l Somatotropin stimulation test NPU10357 P—Somatotropin; arb.subst.c.(IS 80/ Note: M (insulin) = 5 807,65 g/mol; M (somatotropin) 505; 0 min; proc.) = ? × 10-3 int.unit/l = 22 124 g/mol NPU10350 P—Somatotropin; arb.subst.c.(IS 80/ NPU03438 505; 15 min; proc.) = ? × 10-3 int.unit/l PitGl—Somatotropin secretion; subst.rate(insulin NPU10358 P—Somatotropin; arb.subst.c.(IS 80/ i.v.; list; proc.) 505; 30 min; proc.) = ? × 10-3 int.unit/l NPU10547 Pt—Insulin(administered); NPU10351 P—Somatotropin; arb.subst.c.(IS 80/ subst.cont.(i.v.; am.s./body mass) = ? µmol/kg 505; 45 min; proc.) = ? × 10-3 int.unit/l NPU10548 Pt—Insulin(administered); NPU10359 P—Somatotropin; arb.subst.c.(IS 80/ arb.subst.cont.(i.v.; arb.am.s./body mass; proc.) = ? 505; 60 min; proc.) = ? × 10-3 int.unit/l int. unit/kg NPU10355 P—Somatotropin; arb.subst.c.(IS 80/ NPU08736 P—Somatotropin; subst.c.(0 min) = ? 505; 75 min; proc.) = ? × 10-3 int.unit/l pmol/l NPU10360 P—Somatotropin; arb.subst.c.(IS 80/ NPU08737 P—Somatotropin; subst.c.(15 min) = ? 505; 90 min; proc.) = ? × 10-3 int.unit/l pmol/l NPU10361 P—Somatotropin; arb.subst.c.(IS 80/ NPU08738 P—Somatotropin; subst.c.(30 min) = ? 505; 120 min; proc.) = ? × 10-3 int.unit/l pmol/l NPU10637 P—Somatotropin; arb.subst.c.(IS 80/ NPU08739 P—Somatotropin; subst.c.(45 min) = ? 505; min.; proc.) = ? × 10-3 int.unit/l pmol/l NPU08503 B—Glucose; subst.c.(0 min) = ? mmol/l NPU08740 P—Somatotropin; subst.c.(60 min) = ? NPU08516 B—Glucose; subst.c.(15 min) = ? pmol/l mmol/l NPU08741 P—Somatotropin; subst.c.(75 min) = ? NPU08504 B—Glucose; subst.c.(30 min) = ? pmol/l mmol/l NPU08742 P—Somatotropin; subst.c.(90 min) = ? NPU08517 B—Glucose; subst.c.(45 min) = ? pmol/l mmol/l NPU08743 P—Somatotropin; subst.c.(120 min) = ? pmol/l

NPU04982 P—Somatotropin; subst.c.(max.; proc.) Other term(s): Growth hormone secretion; = ? pmol/l Somatotropin stimulation test NPU10357 P—Somatotropin; arb.subst.c.(IS 80/ Note: M (levodopa) = 197,2 g/mol; M (somatotropin) 505; 0 min; proc.) = ? × 10-3 int.unit/l = 22 124 g/mol NPU10350 P—Somatotropin; arb.subst.c.(IS 80/ NPU10450 505; 15 min; proc.) = ? × 10-3 int.unit/l PitGl—Somatotropin secretion; subst.rate(levodopa NPU10358 P—Somatotropin; arb.subst.c.(IS 80/ p.o.; list; proc.) 505; 30 min; proc.) = ? × 10-3 int.unit/l NPU10457 Pt—Levodopa(administered); am.s.(p.o.) NPU10351 P—Somatotropin; arb.subst.c.(IS 80/ = ? mmol 505; 45 min; proc.) = ? × 10-3 int.unit/l NPU08736 P—Somatotropin; subst.c.(0 min) = ? NPU10359 P—Somatotropin; arb.subst.c.(IS 80/ pmol/l 505; 60 min; proc.) = ? × 10-3 int.unit/l NPU08737 P—Somatotropin; subst.c.(15 min) = ? NPU10355 P—Somatotropin; arb.subst.c.(IS 80/ pmol/l 505; 75 min; proc.) = ? × 10-3 int.unit/l NPU08738 P—Somatotropin; subst.c.(30 min) = ? NPU10360 P—Somatotropin; arb.subst.c.(IS 80/ pmol/l 505; 90 min; proc.) = ? × 10-3 int.unit/l NPU08739 P—Somatotropin; subst.c.(45 min) = ? NPU10361 P—Somatotropin; arb.subst.c.(IS 80/ pmol/l 505; 120 min; proc.) = ? × 10-3 int.unit/l NPU08740 P—Somatotropin; subst.c.(60 min) = ? NPU10687 P—Somatotropin; arb.subst.c.(IS 80/ pmol/l 505; max.; proc.) = ? × 10-3 int.unit/l NPU08741 P—Somatotropin; subst.c.(75 min) = ? NPU08503 B—Glucose; subst.c.(0 min) = ? mmol/l pmol/l NPU08516 B—Glucose; subst.c.(15 min) = ? NPU08742 P—Somatotropin; subst.c.(90 min) = ? mmol/l pmol/l NPU08504 B—Glucose; subst.c.(30 min) = ? NPU08743 P—Somatotropin; subst.c.(120 min) = ? mmol/l pmol/l NPU08517 B—Glucose; subst.c.(45 min) = ? NPU04982 P—Somatotropin; subst.c.(max.; proc.) mmol/l = ? pmol/l NPU08501 B—Glucose; subst.c.(60 min) = ? NPU10357 P—Somatotropin; arb.subst.c.(IS 80/ mmol/l 505; 0 min; proc.) = ? × 10-3 int.unit/l NPU08518 B—Glucose; subst.c.(75 min) = ? NPU10358 P—Somatotropin; arb.subst.c.(IS 80/ mmol/l 505; 30 min; proc.) = ? × 10-3 int.unit/l NPU08506 B—Glucose; subst.c.(90 min) = ? NPU10359 P—Somatotropin; arb.subst.c.(IS 80/ mmol/l 505; 60 min; proc.) = ? × 10-3 int.unit/l NPU08507 B—Glucose; subst.c.(120 min) = ? NPU10360 P—Somatotropin; arb.subst.c.(IS 80/ mmol/l 505; 90 min; proc.) = ? × 10-3 int.unit/l NPU08500 B—Glucose; subst.c.(180 min) = ? NPU10361 P—Somatotropin; arb.subst.c.(IS 80/ mmol/l 505; 120 min; proc.) = ? × 10-3 int.unit/l NPU08519 B—Glucose; subst.c.(min.; proc.) = ? NPU10687 P—Somatotropin; arb.subst.c.(IS 80/ mmol/l 505; max.; proc.) = ? × 10-3 int.unit/l NPU04173 P—Glucose; subst.c.(0 min) = ? mmol/l NPU04186 P—Glucose; subst.c.(15 min) = ? Pituitary gland— mmol/l Somatotropin secretion; NPU04174 P—Glucose; subst.c.(30 min) = ? substance rate(octreotide, subcutaneous mmol/l administration; list; procedure) NPU04187 P—Glucose; subst.c.(45 min) = ? Other term(s): Growth hormone secretion; mmol/l Somatotropin suppression test NPU04175 P—Glucose; subst.c.(60 min) = ? Note: M (octreotide) = 1 019,26 g/mol; M mmol/l (somatotropin) = 22 124 g/mol NPU04965 P—Glucose; subst.c.(75 min) = ? NPU10640 mmol/l PitGl—Somatotropin secretion; NPU04176 P—Glucose; subst.c.(90 min) = ? subst.rate(octreotide s.c.; list; proc.) mmol/l NPU10638 Pt—Octreotide(administered); NPU04177 P—Glucose; subst.c.(120 min) = ? am.s.(s.c.) = ? nmol mmol/l NPU10639 Pt—Octreotide(administered); NPU04179 P—Glucose; subst.c.(180 min) = ? subst.cont.(s.c.; am.s./body mass) = ? nmol/kg mmol/l NPU08736 P—Somatotropin; subst.c.(0 min) = ? NPU04981 P—Glucose; subst.c.(min.; proc.) = ? pmol/l mmol/l NPU08737 P—Somatotropin; subst.c.(15 min) = ? pmol/l Pituitary gland— NPU08738 P—Somatotropin; subst.c.(30 min) = ? Somatotropin secretion; pmol/l substance rate(levodopa, oral administration; NPU08739 P—Somatotropin; subst.c.(45 min) = ? list; procedure) pmol/l

NPU08740 P—Somatotropin; subst.c.(60 min) = ? Plasma— pmol/l Somatotropin; NPU08741 P—Somatotropin; subst.c.(75 min) = ? arbitrary substance concentration(IS 80/505; 0 pmol/l minutes after challenge; procedure) NPU08742 P—Somatotropin; subst.c.(90 min) = ? 10-3 international unit/liter pmol/l NPU10357 NPU08743 P—Somatotropin; subst.c.(120 min) = ? P—Somatotropin; arb.subst.c.(IS 80/505; 0 min; pmol/l proc.) = ? × 10-3 int.unit/l NPU10633 P—Somatotropin; subst.c.(240 min) = ? pmol/l Plasma— NPU10634 P—Somatotropin; subst.c.(360 min) = ? Somatotropin; pmol/l arbitrary substance concentration(IS 80/505; 120 NPU04983 P—Somatotropin; subst.c.(min.; proc.) = minutes after challenge; procedure) ? pmol/l 10-3 international unit/liter NPU10357 P—Somatotropin; arb.subst.c.(IS 80/ NPU10361 505; 0 min; proc.) = ? × 10-3 int.unit/l P—Somatotropin; arb.subst.c.(IS 80/505; 120 min; NPU10358 P—Somatotropin; arb.subst.c.(IS 80/ proc.) = ? × 10-3 int.unit/l 505; 30 min; proc.) = ? × 10-3 int.unit/l NPU10359 P—Somatotropin; arb.subst.c.(IS 80/ Plasma— 505; 60 min; proc.) = ? × 10-3 int.unit/l Somatotropin; NPU10360 P—Somatotropin; arb.subst.c.(IS 80/ arbitrary substance concentration(IS 80/505; 135 505; 90 min; proc.) = ? × 10-3 int.unit/l minutes after challenge; procedure) NPU10361 P—Somatotropin; arb.subst.c.(IS 80/ 10-3 international unit/liter 505; 120 min; proc.) = ? × 10-3 int.unit/l NPU10649 NPU10635 P—Somatotropin; arb.subst.c.(IS 80/ P—Somatotropin; arb.subst.c.(IS 80/505; 135 min; 505; 240 min; proc.) = ? × 10-3 int.unit/l proc.) = ? × 10-3 int.unit/l NPU10636 P—Somatotropin; arb.subst.c.(IS 80/ 505; 360 min; proc.) = ? × 10-3 int.unit/l Plasma— NPU10637 P—Somatotropin; arb.subst.c.(IS 80/ Somatotropin; 505; min.; proc.) = ? × 10-3 int.unit/l arbitrary substance concentration(IS 80/505; 15 minutes after challenge; procedure) Pituitary gland— 10-3 international unit/liter Somatotropin secretion; NPU10350 substance rate(protirelin, intravenous P—Somatotropin; arb.subst.c.(IS 80/505; 15 min; administration; list; procedure) proc.) = ? × 10-3 int.unit/l Note: M (thyrotropin releasing hormone) = ? g/mol NPU10349 Plasma— PitGl—Somatotropin secretion; subst.rate(protirelin Somatotropin; i.v.; list; proc.) arbitrary substance concentration(IS 80/505; 150 NPU10454 Pt—Protirelin(administered); am.s.(i.v.) minutes after challenge; procedure) = ? nmol 10-3 international unit/liter NPU10357 P—Somatotropin; arb.subst.c.(IS 80/ NPU10650 505; 0 min; proc.) = ? × 10-3 int.unit/l P—Somatotropin; arb.subst.c.(IS 80/505; 150 min; NPU10350 P—Somatotropin; arb.subst.c.(IS 80/ proc.) = ? × 10-3 int.unit/l 505; 15 min; proc.) = ? × 10-3 int.unit/l NPU10358 P—Somatotropin; arb.subst.c.(IS 80/ Plasma— 505; 30 min; proc.) = ? × 10-3 int.unit/l Somatotropin; NPU10351 P—Somatotropin; arb.subst.c.(IS 80/ arbitrary substance concentration(IS 80/505; 180 505; 45 min; proc.) = ? × 10-3 int.unit/l minutes after challenge; procedure) NPU10359 P—Somatotropin; arb.subst.c.(IS 80/ 10-3 international unit/liter 505; 60 min; proc.) = ? × 10-3 int.unit/l NPU10651 P—Somatotropin; arb.subst.c.(IS 80/505; 180 min; Plasma— proc.) = ? × 10-3 int.unit/l Somatotropin; arbitrary substance concentration(IRP 66/217; Plasma— procedure) Somatotropin; international unit/liter arbitrary substance concentration(IS 80/505; 240 M = 22 124 g/mol minutes after challenge; procedure) Recommended calibrator: WHO IRP 66/217 10-3 international unit/liter Other term(s): Growth hormone; Somatropic NPU10635 hormone P—Somatotropin; arb.subst.c.(IS 80/505; 240 min; Authority: IUPAC-IUB 74 proc.) = ? × 10-3 int.unit/l NPU04023 P—Somatotropin; arb.subst.c.(IRP 66/217; proc.) = ? int. unit/l

Plasma— Plasma— Somatotropin; Somatotropin; arbitrary substance concentration(IS 80/505; 30 arbitrary substance concentration(IS 80/505; minutes after challenge; procedure) minimum; procedure) 10-3 international unit/liter 10-3 international unit/liter NPU10358 NPU10637 P—Somatotropin; arb.subst.c.(IS 80/505; 30 min; P—Somatotropin; arb.subst.c.(IS 80/505; min.; proc.) = ? × 10-3 int.unit/l proc.) = ? × 10-3 int.unit/l

Plasma— Plasma— Somatotropin; Somatotropin; arbitrary substance concentration(IS 80/505; 360 arbitrary substance concentration(IS 80/505; minutes after challenge; procedure) procedure) 10-3 international unit/liter 10-3 international unit/liter NPU10636 M = 22 124 g/mol P—Somatotropin; arb.subst.c.(IS 80/505; 360 min; Recommended calibrator: WHO 1st IS 80/505 proc.) = ? × 10-3 int.unit/l Calibrator(s): WHO IRP 66/217 Other term(s): Growth hormone; Somatropic Plasma— hormone Somatotropin; Authority: IUPAC-IUB 74 arbitrary substance concentration(IS 80/505; 45 NPU03436 minutes challenge; procedure) P—Somatotropin; arb.subst.c.(IS 80/505; proc.) = ? 10-3 international unit/liter × 10-3 int.unit/l NPU10351 P—Somatotropin; arb.subst.c.(IS 80/505; 45 min; Plasma— proc.) = ? × 10-3 int.unit/l Somatotropin; substance concentration(0 minutes after Plasma— challenge) Somatotropin; picomole/liter arbitrary substance concentration(IS 80/505; 60 NPU08736 minutes after challenge; procedure) P—Somatotropin; subst.c.(0 min) = ? pmol/l 10-3 international unit/liter NPU10359 Plasma— P—Somatotropin; arb.subst.c.(IS 80/505; 60 min; Somatotropin; proc.) = ? × 10-3 int.unit/l substance concentration(15 minutes after challenge) Plasma— picomole/liter Somatotropin; NPU08737 arbitrary substance concentration(IS 80/505; 75 P—Somatotropin; subst.c.(15 min) = ? pmol/l minutes after challenge; procedure) 10-3 international unit/liter Plasma— NPU10355 Somatotropin; P—Somatotropin; arb.subst.c.(IS 80/505; 75 min; substance concentration(30 minutes after proc.) = ? × 10-3 int.unit/l challenge) picomole/liter Plasma— NPU08738 Somatotropin; P—Somatotropin; subst.c.(30 min) = ? pmol/l arbitrary substance concentration(IS 80/505; 90 minutes after challenge; procedure) Plasma— 10-3 international unit/liter Somatotropin; NPU10360 substance concentration(45 minutes after P—Somatotropin; arb.subst.c.(IS 80/505; 90 min; challenge) proc.) = ? × 10-3 int.unit/l picomole/liter NPU08739 Plasma— P—Somatotropin; subst.c.(45 min) = ? pmol/l Somatotropin; arbitrary substance concentration(IS 80/505; Plasma— maximum; procedure) Somatotropin; 10-3 international unit/liter substance concentration(60 minutes after NPU10687 challenge) P—Somatotropin; arb.subst.c.(IS 80/505; max.; picomole/liter proc.) = ? × 10-3 int.unit/l NPU08740 P—Somatotropin; subst.c.(60 min) = ? pmol/l

Plasma— Plasma— Somatotropin; Somatotropin; substance concentration(75 minutes after substance concentration(1 day after challenge) challenge) picomole/liter picomole/liter NPU10448 NPU08741 P—Somatotropin; subst.c.(1 d) = ? pmol/l P—Somatotropin; subst.c.(75 min) = ? pmol/l Plasma— Plasma— Somatotropin; Somatotropin; substance concentration(2 days after challenge) substance concentration(90 minutes after picomole/liter challenge) NPU10449 picomole/liter P—Somatotropin; subst.c.(2 d) = ? pmol/l NPU08742 P—Somatotropin; subst.c.(90 min) = ? pmol/l Plasma— Somatotropin; Plasma— substance concentration(maximum; procedure) Somatotropin; picomole/liter substance concentration(120 minutes after NPU04982 challenge) P—Somatotropin; subst.c.(max.; proc.) = ? pmol/l picomole/liter NPU08743 Plasma— P—Somatotropin; subst.c.(120 min) = ? pmol/l Somatotropin; substance concentration(minimum; procedure) Plasma— picomole/liter Somatotropin; NPU04983 substance concentration(135 minutes after P—Somatotropin; subst.c.(min.; proc.) = ? pmol/l challenge) picomole/liter Plasma— NPU10646 Somatotropin; P—Somatotropin; subst.c.(135 min) = ? pmol/l substance concentration picomole/liter Plasma— M = 22 124 g/mol Somatotropin; Other term(s): Growth hormone; Somatropic substance concentration(150 minutes after hormone challenge) Authority: IUPAC-IUB 74 picomole/liter NPU03437 NPU10647 P—Somatotropin; subst.c. = ? pmol/l P—Somatotropin; subst.c.(150 min) = ? pmol/l Blood— Plasma— Spherocytes; Somatotropin; arbitrary concentration(procedure) substance concentration(180 minutes after NPU17099 challenge) B—Spherocytes; arb.c.(proc.) = ? picomole/liter NPU10648 Erythrocytes(Blood)— P—Somatotropin; subst.c.(180 min) = ? pmol/l Spherocytes; number fraction Plasma— NPU14110 Somatotropin; Ercs(B)—Spherocytes; num.fr. = ? substance concentration(240 minutes after challenge) Patient— picomole/liter Stomach pain; NPU10633 property(procedure) P—Somatotropin; subst.c.(240 min) = ? pmol/l NPU14908 Pt—Stomach pain; prop.(proc.) = ? Plasma— Somatotropin; Blood— substance concentration(360 minutes after Stomatocytes; challenge) arbitrary concentration(procedure) picomole/liter NPU17100 NPU10634 B—Stomatocytes; arb.c.(proc.) = ? P—Somatotropin; subst.c.(360 min) = ? pmol/l

System(specification)— Plasma— Streptokinase; Substance P; arbitrary substance concentration(IS 62/7; substance concentration procedure) picomole/liter international unit/liter M = 1 348 g/mol M = 47 408 g/mol NPU03498 Recommended calibrator: WHO 1st IS 62/7 P—Substance P; subst.c. = ? pmol/l Other term(s): SK; STK NPU04024 Urine— Syst(spec.)—Streptokinase; arb.subst.c.(IS 62/7; Substance P; proc.) = ? int. unit/l substance concentration picomole/liter System(specification)— M = 1 348 g/mol Streptokinase; NPU14015 arbitrary substance concentration(IS 88/826; U—Substance P; subst.c. = ? pmol/l procedure) international unit/liter Patient(Urine)— M = 47 408 g/mol Substance P; Recommended calibrator: WHO 2nd IS 88/826 substance rate Calibrator(s): WHO 1st IS 62/7 picomole/day Other term(s): SK; STK M = 1 348 g/mol NPU03489 NPU14016 Syst(spec.)—Streptokinase; arb.subst.c.(IS 88/826; Pt(U)—Substance P; subst.rate = ? pmol/d proc.) = ? int. unit/l Urine— System(specification)— Succinate; Streptokinase; substance concentration substance concentration micromole/liter mole/liter NPU03499 M = 47 408 g/mol U—Succinate; subst.c. = ? µmol/l Other term(s): SK; STK NPU04025 Urine— Syst(spec.)—Streptokinase; subst.c.= ? prefix ? Succinylacetone; mol/l substance concentration mole/liter Plasma— M = 158,15 g/mol Striated muscle antibody(Immunoglobulin G); NPU03508 arbitrary concentration(procedure) U—Succinylacetone; subst.c.= ? prefix ? mol/l NPU12995 P—Striated muscle antibody(IgG); arb.c.(proc.) = ? Plasma— Succinyloaminoimidazolecarboxamide riboside; Plasma— substance concentration Striated muscle antibody; mole/liter arbitrary concentration(procedure) NPU03509 NPU02852 P—Succinyloaminoimidazolecarboxamide riboside; P—Striated muscle antibody; arb.c.(proc.) = ? subst.c.= ? prefix ? mol/l

Plasma— Intestine, small— Strontium; Sucrose tolerance; substance concentration property(sucrose, oral administration; list; nanomole/liter procedure) M = 87,62 g/mol Other term(s): Saccharose tolerance Authority: IUPAC/VII-C-TOX Note: M (sucrose) = 342,3 g/mol NPU03494 NPU03511 P—Strontium; subst.c. = ? nmol/l Intest., small—Sucrose tolerance; prop.(sucrose p.o.; list; proc.) Cells(Blood)— NPU10594 Pt—Sucrose(administered); am.s.(p.o.) Strontium; = ? mmol substance content NPU10595 Pt—Sucrose(administered); nanomole/kilogram subst.cont.(p.o.; am.s./body mass) = ? mmol/kg M = 87,62 g/mol NPU08503 B—Glucose; subst.c.(0 min) = ? mmol/l Authority: IUPAC/VII-C-TOX NPU08516 B—Glucose; subst.c.(15 min) = ? NPU04901 mmol/l Cells(B)—Strontium; subst.cont. = ? nmol/kg

NPU08504 B—Glucose; subst.c.(30 min) = ? Food—Sucrose-1,6-a-glucan 3(6)-a- mmol/l glucosyltransferase; subst.cont. = ? mol/kg NPU08517 B—Glucose; subst.c.(45 min) = ? mmol/l Patient(Urine)— NPU08501 B—Glucose; subst.c.(60 min) = ? 6- mmol/l Sulfatoxymelatonin; NPU08518 B—Glucose; subst.c.(75 min) = ? substance rate mmol/l micromole/day NPU08506 B—Glucose; subst.c.(90 min) = ? NPU09362 mmol/l Pt(U)—6-Sulfatoxymelatonin; subst.rate = ? µmol/d NPU08507 B—Glucose; subst.c.(120 min) = ? mmol/l Blood— NPU08500 B—Glucose; subst.c.(180 min) = ? Sulfhaemoglobin(Fe); mmol/l substance concentration NPU08515 B—Glucose; subst.c.(360 min) = ? millimole/liter mmol/l M = 16 500 g/mol NPU08502 B—Glucose; subst.c.incr.(max. c. minus NPU04157 0 min c.; proc.) = ? mmol/l B—Sulfhaemoglobin(Fe); subst.c. = ? mmol/l NPU04173 P—Glucose; subst.c.(0 min) = ? mmol/l NPU04186 P—Glucose; subst.c.(15 min) = ? Haemoglobin(Fe; Blood)— mmol/l Sulfhaemoglobin(Fe); NPU04174 P—Glucose; subst.c.(30 min) = ? substance fraction mmol/l M = 16 500 g/mol NPU04187 P—Glucose; subst.c.(45 min) = ? NPU03520 mmol/l Hb(Fe; B)—Sulfhaemoglobin(Fe); subst.fr. = ? NPU04175 P—Glucose; subst.c.(60 min) = ? mmol/l Cobalamin(Plasma)— NPU04965 P—Glucose; subst.c.(75 min) = ? Sulfitocobalamin; mmol/l substance fraction NPU04176 P—Glucose; subst.c.(90 min) = ? NPU04957 mmol/l Cobalamin(P)—Sulfitocobalamin; subst.fr. = ? NPU04177 P—Glucose; subst.c.(120 min) = ? mmol/l Urine— NPU04179 P—Glucose; subst.c.(180 min) = ? Sulfo-L-cysteine/Creatininium; mmol/l substance ratio NPU04185 P—Glucose; subst.c.(360 min) = ? 10-3 mmol/l NPU14250 NPU03841 P—Glucose; subst.c.incr.(max. c. minus U—Sulfo-L-cysteine/Creatininium; subst.ratio = ? × 0 min c.; proc.) = ? mmol/l 10-3

Patient— Plasma— Sucrose(administered); Sulfo-L-cysteine; amount-of-substance(oral administration) substance concentration millimole mole/liter M = 342,30 g/mol NPU03529 NPU10594 P—Sulfo-L-cysteine; subst.c.= ? prefix ? mol/l Pt—Sucrose(administered); am.s.(p.o.) = ? mmol Urine— Patient— Sulfo-L-cysteine; Sucrose(administered); substance concentration substance content(oral administration; amount- mole/liter of-substance/body mass) NPU03530 millimole/kilogram U—Sulfo-L-cysteine; subst.c.= ? prefix ? mol/l M = 342,30 g/mol NPU10595 Patient— Pt—Sucrose(administered); subst.cont.(p.o.; am.s./ Surface; body mass) = ? mmol/kg area (meter)² Food— NPU10218 Sucrose-1,6-a-glucan 3(6)-a-glucosyltransferase; Pt—Surface; area = ? m² substance content mole/kilogram NPU03999

Skin— Blood— Sweat tolerance; Target cells; property(Pilocarpine intracutaneously; list; arbitrary concentration(procedure) procedure) NPU17101 NPU17183 B—Target cells; arb.c.(proc.) = ? Skin—Sweat tolerance; prop.(Pilocarpine i.c.; list; proc.) Erythrocytes(Blood)— NPU01537 Sweat—Chloride; subst.c. = ? mmol/l Target cells; NPU03941 Sweat—Potassium ion; subst.c. = ? number fraction mmol/l NPU14273 NPU03430 Sweat—Sodium ion; subst.c. = ? mmol/l Ercs(B)—Target cells; num.fr. = ? NPU03432 Sweat—Sodium ion/Potassium ion; subst.ratio = ? Urine— NPU17182 Sweat—Solute; molal.(proc.) = ? mmol/ Taurine/Creatininium; kg substance ratio NPU08675 Sweat—Sweat; mass(proc.) = ? mg 10-3 NPU14251 Skin(Arm; left)— U—Taurine/Creatininium; subst.ratio = ? × 10-3 Sweat tolerance; property(Pilocarpine intracutaneously; list; Cerebrospinal fluid— procedure) Taurine; NPU17185 substance concentration Skin(Arm; left)—Sweat tolerance; prop.(Pilocarpine micromole/liter i.c.; list; proc.) M = 125,14 g/mol NPU01537 Sweat—Chloride; subst.c. = ? mmol/l NPU03540 NPU03941 Sweat—Potassium ion; subst.c. = ? Csf—Taurine; subst.c. = ? µmol/l mmol/l NPU03430 Sweat—Sodium ion; subst.c. = ? mmol/l Plasma— NPU03432 Sweat—Sodium ion/Potassium ion; Taurine; subst.ratio = ? substance concentration NPU17182 Sweat—Solute; molal.(proc.) = ? mmol/ micromole/liter kg M = 125,14 g/mol NPU08675 Sweat—Sweat; mass(proc.) = ? mg NPU03541 P—Taurine; subst.c. = ? µmol/l Skin(Arm; right)— Sweat tolerance; Urine— property(Pilocarpine intracutaneously; list; Taurine; procedure) substance concentration NPU17184 micromole/liter Skin(Arm; right)—Sweat tolerance; M = 125,14 g/mol prop.(Pilocarpine i.c.; list; proc.) NPU03542 NPU01537 Sweat—Chloride; subst.c. = ? mmol/l U—Taurine; subst.c. = ? µmol/l NPU03941 Sweat—Potassium ion; subst.c. = ? mmol/l Patient— NPU03430 Sweat—Sodium ion; subst.c. = ? mmol/l Testosterone secretion; NPU03432 Sweat—Sodium ion/Potassium ion; substance rate(choriogonadotropin, subst.ratio = ? intramuscular administration; list; procedure) NPU17182 Sweat—Solute; molal.(proc.) = ? mmol/ Note: M(choriogonadotropin) = 39 000 g/mol kg NPU10429 NPU08675 Sweat—Sweat; mass(proc.) = ? mg Pt—Testosterone secretion; subst.rate(choriogonadotropin i.m.; list; proc.) Sweat— NPU10423 Pt—Choriogonadotropin; Sweat; arb.subst.cont.(i.m.; arb.am.s./body mass; proc.; IS mass(procedure) 75/537)= ? int. unit/kg milligram NPU10424 P—Testosterone(tot.); subst.c.(0 d) = ? NPU08675 nmol/l Sweat—Sweat; mass(proc.) = ? mg NPU10425 P—Testosterone(tot.); subst.c.(1 d) = ? nmol/l Patient— NPU10426 P—Testosterone(tot.); subst.c.(2 d) = ? Synovial fluid(specification); nmol/l relative volumic mass(20 °C/water, 20 °C; NPU10427 P—Testosterone(tot.); subst.c.(3 d) = ? procedure) nmol/l NPU10185 NPU10428 P—Testosterone(tot.); subst.c.(4 d) = ? Pt—Synovial fluid(spec.); rel.volumic mass(20 °C/ nmol/l water, 20 °C; proc.) = ?

Plasma— NPU16485 Testosterone(free); SHBG(P)—Testosterone; subst.fr. = ? substance concentration nanomole/liter Patient(Urine)— M = 288,41 g/mol Testosterone; Authority: IUPAC-IUB 84 substance rate NPU03549 nanomole/day P—Testosterone(free); subst.c. = ? nmol/l M = 288,41 g/mol Authority: IUPAC-IUB 89 Plasma— NPU10231 Testosterone(total); Pt(U)—Testosterone; subst.rate = ? nmol/d substance concentration(0 days after challenge) nanomole/liter Patient— NPU10424 Tetracosactide(administered); P—Testosterone(tot.); subst.c.(0 d) = ? nmol/l amount-of-substance(intramuscular administration) Plasma— nanomole Testosterone(total); M = 2 933,57 g/mol substance concentration(1 day after challenge) Other term(s): Cosyntropin; Cortrosyn nanomole/liter NPU10534 NPU10425 Pt—Tetracosactide(administered); am.s.(i.m.) = ? P—Testosterone(tot.); subst.c.(1 d) = ? nmol/l nmol

Plasma— Patient— Testosterone(total); Tetracosactide(administered); substance concentration(2 days after challenge) amount-of-substance(intravenous nanomole/liter administration) NPU10426 nanomole P—Testosterone(tot.); subst.c.(2 d) = ? nmol/l M = 2 933,57 g/mol Other term(s): Cosyntropin; Cortrosyn Plasma— NPU10688 Testosterone(total); Pt—Tetracosactide(administered); am.s.(i.v.) = ? substance concentration(3 days after challenge) nmol nanomole/liter NPU10427 Patient— P—Testosterone(tot.); subst.c.(3 d) = ? nmol/l Tetracosactide(administered); substance content(intramuscular Plasma— administration; amount-of-substance/body Testosterone(total); mass) substance concentration(4 days after challenge) nanomole/kilogram nanomole/liter M = 2933,57 g/mol NPU10428 Other term(s): Cosyntropin P—Testosterone(tot.); subst.c.(4 d) = ? nmol/l NPU10535 Pt—Tetracosactide(administered); subst.cont.(i.m.; Plasma— am.s./body mass) = ? nmol/kg Testosterone(total); substance concentration Patient— nanomole/liter Tetracosactide(administered); M = 288,41 g/mol substance content(intravenous administration; Authority: IUPAC-IUB 89 amount-of-substance/body mass) NPU03543 nanomole/kilogram P—Testosterone(tot.); subst.c. = ? nmol/l M = 2 933,57 g/mol Other term(s): Cosyntropin Saliva— NPU10689 Testosterone; Pt—Tetracosactide(administered); subst.cont.(i.v.; substance concentration am.s./body mass) = ? nmol/kg nanomole/liter M = 288,41 g/mol Patient(Urine)— Authority: IUPAC-IUB 84 Tetrahydroaldosterone; NPU03544 substance rate(procedure) Saliva—Testosterone; subst.c. = ? nmol/l nanomole/day NPU03550 Sexual-hormone-binding-globulin(Plasma)— Pt(U)—Tetrahydroaldosterone; subst.rate(proc.) = ? Testosterone; nmol/d substance fraction

Plasma— M = 207,34 g/mol Tetranectin(monomer); Authority: IUPAC/VII-C-TOX substance concentration NPU17699 micromole/liter Pt(U)—Thallium; subst.rate = ? nmol/d M = 20 100 g/mol NPU09334 Plasma— P—Tetranectin(monomer); subst.c. = ? µmol/l Thiocyanate; substance concentration Plasma— mole/liter Tetranectin; NPU03555 mass concentration(procedure) P—Thiocyanate; subst.c.= ? prefix ? mol/l milligram/liter NPU09260 Urine— P—Tetranectin; mass c.(proc.) = ? mg/l Threonine/Creatininium; substance ratio Blood— 10-3 Thallium; NPU14252 substance concentration U—Threonine/Creatininium; subst.ratio = ? × 10-3 nanomole/liter M = 204,37 g/mol Cerebrospinal fluid— Authority: IUPAC/VII-C-TOX Threonine; NPU03551 substance concentration B—Thallium; subst.c. = ? nmol/l micromole/liter M = 119,12 g/mol Dialysis solution— NPU03557 Thallium; Csf—Threonine; subst.c. = ? µmol/l substance concentration nanomole/liter Plasma— M = 204,37 g/mol Threonine; Authority: IUPAC/VII-C-TOX substance concentration NPU17698 micromole/liter Dialysis solution—Thallium; subst.c. = ? nmol/l M = 119,12 g/mol NPU03558 Plasma— P—Threonine; subst.c. = ? µmol/l Thallium; substance concentration Urine— nanomole/liter Threonine; M = 204,37 g/mol substance concentration Authority: IUPAC/VII-C-TOX micromole/liter NPU03552 M = 119,12 g/mol P—Thallium; subst.c. = ? nmol/l NPU03559 U—Threonine; subst.c. = ? µmol/l Urine— Thallium; Plasma— substance concentration Thrombocyte antibody; nanomole/liter arbitrary substance concentration(procedure) M = 204,37 g/mol arbitrary unit/liter Authority: IUPAC/VII-C-TOX Other term(s): Thrombocyte specific alloantibody; NPU03553 Thrombocyte autoantibody. Other term(s): U—Thallium; subst.c. = ? nmol/l Platelet(s) is a full synonym to Thrombocyte(s) Authority: ISTH/SSC93 Patient(Urine)— NPU03564 Thallium; P—Thrombocyte antibody; arb.subst.c.(proc.) = ? substance rate arb.unit/l millimole/day M = 207,34 g/mol Thrombocytes(Blood)— Authority: IUPAC/VII-C-TOX Thrombocyte antigen; NPU10233 taxon(Zw, Bak) Pt(U)—Thallium; subst.rate = ? mmol/d Other term(s): Platelet(s) is a full synonym to Thrombocyte(s) Patient(Urine)— NPU03563 Thallium; Trcs(B)—Thrombocyte antigen; taxon(Zw, Bak) = ? substance rate nanomole/day

Blood— Plasma— Thrombocytes; Thyroglobulin; entitic volume substance concentration femtoliter mole/liter Other term(s): Platelet(s) is a full synonym to NPU09009 Thrombocyte(s) P—Thyroglobulin; subst.c.= ? prefix ? mol/l NPU03562 B—Thrombocytes; entitic vol. = ? fl Plasma— Thyroid antibody; Blood— arbitrary concentration(procedure) Thrombocytes; NPU03574 number concentration P—Thyroid antibody; arb.c.(proc.) = ? 109/liter Other term(s): Platelet(s) is a full synonym to Plasma— Thrombocyte(s) Thyroid microsome antibody; NPU03568 arbitrary concentration(procedure) B—Thrombocytes; num.c. = ? × 109/l NPU03575 P—Thyroid microsome antibody; arb.c.(proc.) = ? Blood fraction(specification)— Thrombocytes; Plasma— number concentration Thyroid peroxidase antibody; 109/liter arbitrary concentration(procedure) NPU17586 NPU12558 B fract.(spec.)—Thrombocytes; num.c. = ? × 109/l P—Thyroid peroxidase antibody; arb.c.(proc.) = ?

Plasma— Plasma— Thymidine kinase; Thyroid peroxidase antibody; arbitrary catalytic-activity arbitrary substance concentration(procedure) concentration(procedure) 10³ arbitrary unit/liter arbitrary unit/liter NPU12229 NPU10578 P—Thyroid peroxidase antibody; arb.subst.c.(proc.) P—Thymidine kinase; arb.cat.c.(proc.) = ? arb.unit/l = ? × 10³ arb.unit/l

Plasma— Plasma— Thyreoidea-receptor antibody; Thyroid stimulating immunoglobulin; arbitrary concentration(procedure) arbitrary concentration(procedure) NPU04131 NPU03576 P—Thyreoidea-receptor antibody; arb.c.(proc.)= ? P—Thyroid stimulating immunoglobulin; arb.c.(proc.) = ? Plasma— Thyreoidea-receptor antibody; Plasma— arbitrary substance concentration(procedure) Thyrotropin receptor antibody; arbitrary unit/liter arbitrary substance concentration(procedure) NPU14377 arbitrary unit/liter P—Thyreoidea-receptor antibody; NPU17111 arb.subst.c.(proc.) = ? arb.unit/l P—Thyrotropin receptor antibody; arb.subst.c.(proc.)= ? arb.unit/l Plasma— Thyroglobulin antibody; Pituitary gland— arbitrary substance concentration(procedure; Thyrotropin secretion; IRP 65/93) substance rate(protirelin, intravenous international unit/liter administration; list; procedure) Recommended calibrator: WHO IRP 65/93 Other term(s): Protirelin: Thyrotropin-releasing NPU03573 hormone P—Thyroglobulin antibody; arb.subst.c.(proc.; IRP Note: M (protirelin) = 362,4 g/mol; M (thyrotropin) = 65/93) = ? int. unit/l 30 000 g/mol NPU04198 Plasma— PitGl—Thyrotropin secretion; subst.rate(protirelin Thyroglobulin; i.v.; list; proc.) arbitrary substance concentration(procedure) NPU10454 Pt—Protirelin(administered); am.s.(i.v.) 10³ arbitrary unit/liter = ? nmol NPU03572 NPU04199 P—Thyrotropin; arb.subst.c.(IRP 80/558; P—Thyroglobulin; arb.subst.c.(proc.) = ? × 10³ 0 min; proc.) = ? × 10-3 int.unit/l arb.unit/l

NPU10374 P—Thyrotropin; arb.subst.c.(IRP 80/558; Plasma— 15 min; proc.) = ? × 10-3 int.unit/l Thyrotropin; NPU04200 P—Thyrotropin; arb.subst.c.(IRP 80/558; arbitrary substance concentration(IRP 80/558; 20 min; proc.) = ? × 10-3 int.unit/l 30 minutes after challenge; procedure) NPU08717 P—Thyrotropin; arb.subst.c.(IRP 80/558; 10-3 international unit/liter 30 min; proc.) = ? × 10-3 int.unit/l NPU08717 NPU04201 P—Thyrotropin; arb.subst.c.(IRP 80/558; P—Thyrotropin; arb.subst.c.(IRP 80/558; 30 min; 40 min; proc.) = ? × 10-3 int.unit/l proc.) = ? × 10-3 int.unit/l NPU04202 P—Thyrotropin; arb.subst.c.(IRP 80/558; 60 min; proc.) = ? × 10-3 int.unit/l Plasma— NPU10347 P—Thyrotropin; arb.subst.c.(IRP 80/558; Thyrotropin; 120 min; proc.) = ? × 10-3 int.unit/l arbitrary substance concentration(IRP 80/558; NPU08765 P—Thyrotropin; arb.subst.c.incr.(IRP 80/ 40 minutes after challenge; procedure) 558; max. c. minus 0 min c.) = ? × 10-3 int.unit/l 10-3 international unit/liter NPU04201 Plasma— P—Thyrotropin; arb.subst.c.(IRP 80/558; 40 min; Thyrotropin; proc.) = ? × 10-3 int.unit/l arbitrary substance concentration(IRP 68/38; procedure) Plasma— 10-3 international unit/liter Thyrotropin; M = 30 000 g/mol arbitrary substance concentration(IRP 80/558; Recommended calibrator: WHO IRP 68/38 60 minutes after challenge; procedure) Other term(s): Thyroid stimulating hormone; 10-3 international unit/liter Thyrotropic hormone; TSH NPU04202 Authority: IUPAC-IUB 74 P—Thyrotropin; arb.subst.c.(IRP 80/558; 60 min; NPU04026 proc.) = ? × 10-3 int.unit/l P—Thyrotropin; arb.subst.c.(IRP 68/38; proc.) = ? × 10-3 int.unit/l Plasma— Thyrotropin; Plasma— arbitrary substance concentration(IRP 80/558; Thyrotropin; procedure) arbitrary substance concentration(IRP 80/558; 0 10-3 international unit/liter minutes after challenge; procedure) M = 30 000 g/mol 10-3 international unit/liter Recommended calibrator: WHO 2nd IRP 80/558 NPU04199 Calibrator(s): WHO IRP 68/38 P—Thyrotropin; arb.subst.c.(IRP 80/558; 0 min; Other term(s): Thyroid stimulating hormone; proc.) = ? × 10-3 int.unit/l Thyrotropic hormone; TSH Authority: IUPAC-IUB 74 Plasma— NPU03577 Thyrotropin; P—Thyrotropin; arb.subst.c.(IRP 80/558; proc.) = ? arbitrary substance concentration(IRP 80/558; × 10-3 int.unit/l 120 minutes after challenge; procedure) 10-3 international unit/liter Plasma— NPU10347 Thyrotropin; P—Thyrotropin; arb.subst.c.(IRP 80/558; 120 min; arbitrary substance concentration proc.) = ? × 10-3 int.unit/l increment(IRP 80/558; maximum concentration minus 0 minutes concentration) Plasma— 10-3 international unit/liter Thyrotropin; NPU08765 arbitrary substance concentration(IRP 80/558; P—Thyrotropin; arb.subst.c.incr.(IRP 80/558; max. 15 minutes after challenge; procedure) c. minus 0 min c.) = ? × 10-3 int.unit/l 10-3 international unit/liter NPU10374 Plasma— P—Thyrotropin; arb.subst.c.(IRP 80/558; 15 min; Thyroxine binding globulin; proc.) = ? × 10-3 int.unit/l arbitrary substance concentration(IS 88/638; procedure) Plasma— international unit/liter Thyrotropin; Recommended calibrator: WHO IS 88/638 arbitrary substance concentration(IRP 80/558; NPU03580 20 minutes after challenge; procedure) P—Thyroxine binding globulin; arb.subst.c.(IS 88/ 10-3 international unit/liter 638; proc.) = ? int. unit/l NPU04200 P—Thyrotropin; arb.subst.c.(IRP 80/558; 20 min; proc.) = ? × 10-3 int.unit/l

Plasma— NPU03578 Thyroxine binding globulin; P—Thyroxine(tot.); subst.c. = ? nmol/l substance concentration nanomole/liter Blood— NPU08968 Tin; P—Thyroxine binding globulin; subst.c. = ? nmol/l substance concentration nanomole/liter Plasma— M = 118,69 g/mol Thyroxine(free); Authority: IUPAC/VII-C-TOX substance concentration(0 minutes after NPU03581 challenge) B—Tin; subst.c. = ? nmol/l picomole/liter NPU10370 Plasma— P—Thyroxine(free); subst.c.(0 min) = ? pmol/l Tin; substance concentration Plasma— nanomole/liter Thyroxine(free); M = 118,69 g/mol substance concentration(15 minutes after Authority: IUPAC/VII-C-TOX challenge) NPU03582 picomole/liter P—Tin; subst.c. = ? nmol/l NPU10371 P—Thyroxine(free); subst.c.(15 min) = ? pmol/l Plasma— Tissue polypeptide antigen; Plasma— arbitrary concentration(procedure) Thyroxine(free); NPU03584 substance concentration(30 minutes after P—Tissue polypeptide antigen; arb.c.(proc.) = ? challenge) picomole/liter Plasma— NPU10372 Titanium; P—Thyroxine(free); subst.c.(30 min) = ? pmol/l substance concentration micromole/liter Plasma— M = 47,90 g/mol Thyroxine(free); Authority: IUPAC/VII-C-TOX substance concentration(60 minutes after NPU04902 challenge) P—Titanium; subst.c. = ? µmol/l picomole/liter NPU10373 Urine— P—Thyroxine(free); subst.c.(60 min) = ? pmol/l Titanium; substance concentration Plasma— micromole/liter Thyroxine(free); M = 47,90 g/mol substance concentration(120 minutes after Authority: IUPAC/VII-C-TOX challenge) NPU03585 picomole/liter U—Titanium; subst.c. = ? µmol/l NPU10348 P—Thyroxine(free); subst.c.(120 min) = ? pmol/l Plasma— Tocopherol; Plasma— substance concentration Thyroxine(free); micromole/liter substance concentration M = 430,72 g/mol picomole/liter NPU03589 M = 776,93 g/mol P—Tocopherol; subst.c. = ? µmol/l Authority: IUPAC-IUB 83 NPU03579 Patient— P—Thyroxine(free); subst.c. = ? pmol/l Tolbutamide(administered); amount-of-substance(intravenous Plasma— administration) Thyroxine(total); millimole substance concentration M = 270,34 g/mol nanomole/liter NPU10467 M = 776,93 g/mol Pt—Tolbutamide(administered); am.s.(i.v.) = ? mmol Authority: IUPAC-IUB 83

Patient— Plasma— Tolbutamide(administered); Transglutaminase antibody(Immunoglobulin A); substance content(intravenous administration; arbitrary concentration(procedure) amount-of-substance/body mass) NPU17704 micromole/kilogram P—Transglutaminase antibody(IgA); arb.c.(proc.) = M = 270,34 g/mol ? NPU13487 Pt—Tolbutamide(administered); subst.cont.(i.v.; Plasma— am.s./body mass) = ? µmol/kg Transglutaminase antibody(Immunoglobulin A); arbitrary substance concentration(procedure) Plasma— 10³ arbitrary unit/liter Transcobalamin(free); NPU14566 substance concentration P—Transglutaminase antibody(IgA); picomole/liter arb.subst.c.(proc.) = ? × 10³ arb.unit/l M = 38 000 g/mol Other term(s): Transcobalamin II(free) Plasma— NPU08570 Transthyretin; P—Transcobalamin(free); subst.c. = ? pmol/l substance concentration micromole/liter Plasma— Other term(s): Prealbumin Transcobalamin(total); NPU10319 substance concentration P—Transthyretin; subst.c. = ? µmol/l picomole/liter M = 38 000 g/mol Duodenal fluid— Other term(s): Transcobalamin II(total) Triacylglycerol lipase; NPU03605 catalytic-activity concentration(0-20 minutes P—Transcobalamin(tot.); subst.c. = ? pmol/l postprandial; 37 °C) microkatal/liter Plasma— NPU09249 Transcortin; Duodf—Triacylglycerol lipase; cat.c.(0-20 min; 37 substance concentration °C) = ? µkat/l micromole/liter M = 53 000 g/mol Duodenal fluid— Other term(s): Corticosteroid binding globulin Triacylglycerol lipase; NPU03606 catalytic-activity concentration(20-40 minutes P—Transcortin; subst.c. = ? µmol/l postprandial; 37 °C) microkatal/liter Plasma— NPU09250 Transferrin; Duodf—Triacylglycerol lipase; cat.c.(20-40 min; 37 substance concentration °C) = ? µkat/l micromole/liter M = 81 000 g/mol Duodenal fluid— NPU03607 Triacylglycerol lipase; P—Transferrin; subst.c. = ? µmol/l catalytic-activity concentration(30-150 minutes postprandial; 37 °C) Urine— microkatal/liter Transferrin; NPU09253 substance concentration Duodf—Triacylglycerol lipase; cat.c.(30-150 min; 37 micromole/liter °C) = ? µkat/l M = 81 000 g/mol NPU10768 Amniotic fluid— U—Transferrin; subst.c. = ? µmol/l Triacylglycerol lipase; catalytic-activity concentration(37 °C; Plasma— procedure) Transferrinreceptor fragment; microkatal/liter substance concentration NPU03913 nanomole/liter Amf—Triacylglycerol lipase; cat.c.(37 °C; proc.) = ? Note: M: Receptor 85 000; Transferrin 81 000; µkat/l Complex 166 000 NPU17701 Plasma— P—Transferrinreceptor fragment; subst.c. = ? nmol/l Triacylglycerol lipase; catalytic-activity concentration(37 °C; procedure)

microkatal/liter Plasma(fasting Patient)— Other term(s): Lipase; Tributyrase; Triglyceride Triglyceride; lipase property(list; procedure) NPU03612 NPU17124 P—Triacylglycerol lipase; cat.c.(37 °C; proc.) = ? P(fPt)—Triglyceride; prop.(list; proc.) µkat/l NPU03620 P(fPt)—Triglyceride; subst.c. = ? mmol/l NPU03621 P(fPt)—Triglyceride, in HDL; subst.c. = ? Duodenal fluid— mmol/l Triacylglycerol lipase; NPU03622 P(fPt)—Triglyceride, in LDL; subst.c. = ? catalytic-activity concentration(40-60 minutes mmol/l postprandial; 37 °C) NPU03623 P(fPt)—Triglyceride, in VLDL; subst.c. = microkatal/liter ? mmol/l NPU09251 NPU17125 P(fPt)—Triglyceride, in LDL/Triglyceride, Duodf—Triacylglycerol lipase; cat.c.(40-60 min; in HDL; subst.ratio = ? 37 °C) = ? µkat/l Amniotic fluid— Duodenal fluid— Triglyceride; Triacylglycerol lipase; substance concentration catalytic-activity concentration(60-80 minutes millimole/liter postprandial; 37 °C) NPU10242 microkatal/liter Amf—Triglyceride; subst.c.=? mmol/l NPU09252 Duodf—Triacylglycerol lipase; cat.c.(60-80 min; 37 Ascites— °C) = ? µkat/l Triglyceride; substance concentration Urine— millimole/liter Trichloracetate; NPU17015 substance concentration Asc—Triglyceride; subst.c.=? mmol/l micromole/liter NPU03618 Plasma— U—Trichloracetate; subst.c. = ? µmol/l Triglyceride; substance concentration Plasma(fasting Patient)— millimole/liter Triglyceride, in HDL; NPU04094 substance concentration P—Triglyceride; subst.c.=? mmol/l millimole/liter Note: (H)igh (D)ensity (L)ipoprotein Plasma(fasting Patient)— NPU03621 Triglyceride; P(fPt)—Triglyceride, in HDL; subst.c. = ? mmol/l substance concentration millimole/liter Plasma(fasting Patient)— Other term(s): Triglycerides; Triglyceride, total Triglyceride, in LDL/Triglyceride, in HDL; NPU03620 substance ratio P(fPt)—Triglyceride; subst.c. = ? mmol/l NPU17125 P(fPt)—Triglyceride, in LDL/Triglyceride, in HDL; Pleural fluid— subst.ratio = ? Triglyceride; substance concentration Plasma(fasting Patient)— millimole/liter Triglyceride, in LDL; NPU17018 substance concentration Plf—Triglyceride; subst.c.=? mmol/l millimole/liter Note: (L)ow (D)ensity (L)ipoprotein Plasma— NPU03622 Triiodothyronin(3,3',5'-); P(fPt)—Triglyceride, in LDL; subst.c. = ? mmol/l substance concentration nanomole/liter Plasma(fasting Patient)— NPU04158 Triglyceride, in VLDL; P—Triiodothyronin(3,3',5'-); subst.c. = ? nmol/l substance concentration millimole/liter Plasma— Note: (V)ery (L)ow (D)ensity (L)ipoprotein Triiodothyronine(free); NPU03623 substance concentration P(fPt)—Triglyceride, in VLDL; subst.c. = ? mmol/l picomole/liter M = 651,01 g/mol Authority: IUPAC-IUB 83 NPU03625 P—Triiodothyronine(free); subst.c. = ? pmol/l © 2000 IUPAC, Pure and Applied Chemistry 72, 747–972 966 H. OLESEN et al.

Plasma— Cerebrospinal fluid— Triiodothyronine(total); Tryptophan; substance concentration substance concentration nanomole/liter micromole/liter M = 651,01 g/mol M = 204,22 g/mol Authority: IUPAC-IUB 83 Authority: INN NPU03624 NPU03653 P—Triiodothyronine(tot.); subst.c. = ? nmol/l Csf—Tryptophan; subst.c. = ? µmol/l

Plasma— Urine— Troponin T; Tryptophan; substance concentration substance concentration mole/liter micromole/liter NPU04112 M = 204,22 g/mol P—Troponin T; subst.c.= ? prefix ? mol/l Authority: INN NPU03654 Faeces— U—Tryptophan; subst.c. = ? µmol/l Trypsin; arbitrary content(37 °C; procedure) Plasma— NPU14112 Tubular base membrane antibody(Immunoglobulin F—Trypsin; arb.cont.(37 °C; proc.) = ? G); arbitrary concentration(procedure) Duodenal fluid— NPU12554 Trypsin; P—Tubular base membrane antibody(IgG); catalytic-activity concentration(37 °C; arb.c.(proc.) = ? procedure) microkatal/liter Plasma— NPU10610 Tubular base membrane antibody(Immunoglobulin Duodf—Trypsin; cat.c.(37 °C; proc.) = ? µkat/l G); arbitrary substance concentration(procedure) Plasma— 10³ arbitrary unit/liter Trypsin; NPU12553 catalytic-activity concentration(37 °C; P—Tubular base membrane antibody(IgG); procedure) arb.subst.c.(proc.) = ? × 10³ arb.unit/l microkatal/liter NPU03896 Plasma— P—Trypsin; cat.c.(37 °C; proc.) = ? µkat/l Tubular base membrane antibody; arbitrary substance concentration(procedure) Plasma— arbitrary unit/liter Trypsin+Trypsinogen; NPU12265 substance concentration P—Tubular base membrane antibody; mole/liter arb.subst.c.(proc.) = ? arb.unit/l Note: Code for Trypsin: EC3.4.21.4; Code for Trypsinogen: CAS9002-08-8 Urine— NPU03897 Tyramine/Creatininium; P—Trypsin+Trypsinogen; subst.c.= ? prefix ? mol/l substance ratio 10-3 Plasma— NPU14255 Tryptophan(free); U—Tyramine/Creatininium; subst.ratio = ? × 10-3 substance concentration micromole/liter Cerebrospinal fluid— M = 204,22 g/mol Tyramine; Authority: INN substance concentration NPU03655 mole/liter P—Tryptophan(free); subst.c. = ? µmol/l M = 137,18 g/mol Other term(s): Tyrosamine Urine— NPU03656 Tryptophan/Creatininium; Csf—Tyramine; subst.c.= ? prefix ? mol/l substance ratio 10-3 Urine— NPU14253 Tyramine; U—Tryptophan/Creatininium; subst.ratio = ? × 10-3 substance concentration mole/liter

M = 137,18 g/mol Blood— Other term(s): Tyrosamine Uranium; NPU03657 substance concentration U—Tyramine; subst.c.= ? prefix ? mol/l picomole/liter M = 238,03 g/mol Urine— Authority: IUPAC/VII-C-TOX Tyramine-O-sulphate/Creatininium; NPU03685 substance ratio B—Uranium; subst.c. = ? pmol/l 10-3 NPU14254 Urine— U—Tyramine-O-sulphate/Creatininium; subst.ratio = Uranium; ? × 10-3 substance concentration picomole/liter Urine— M = 238,03 g/mol Tyramine-O-sulphate; Authority: IUPAC/VII-C-TOX substance concentration NPU03686 micromole/liter U—Uranium; subst.c. = ? pmol/l NPU03658 U—Tyramine-O-sulphate; subst.c. = ? µmol/l Synovial fluid(specification)— Urate crystals; Urine— arbitrary concentration(procedure) Tyrosine/Creatininium; NPU03690 substance ratio Synf(spec.)—Urate crystals; arb.c.(proc.) = ? 10-3 NPU14256 Cells(Synovial fluid; specification)— U—Tyrosine/Creatininium; subst.ratio = ? × 10-3 Urate crystals; arbitrary entitic number(procedure) Cerebrospinal fluid— NPU03691 Tyrosine; Cells(Synf; spec.)—Urate crystals; arb.entitic substance concentration num.(proc.) = ? micromole/liter M = 181,19 g/mol Urine— NPU09033 Urate; Csf—Tyrosine; subst.c. = ? µmol/l amount-of-substance(procedure) millimole Plasma— NPU17544 Tyrosine; U—Urate; am.s.(proc.) = ? mmol substance concentration micromole/liter Calculus(Synovial fluid; specification)— M = 181,19 g/mol Urate; NPU03659 arbitrary content(procedure) P—Tyrosine; subst.c. = ? µmol/l M = 310,20 g/mol NPU14109 Urine— Calculus(Synf; spec.)—Urate; arb.cont.(proc.) = ? Tyrosine; substance concentration Calculus(Urine)— micromole/liter Urate; M = 181,19 g/mol arbitrary content(procedure) NPU03660 NPU10369 U—Tyrosine; subst.c. = ? µmol/l Calculus(U)—Urate; arb.cont.(proc.) = ?

Plasma— Plasma— Ubidecarenone; Urate; substance concentration substance concentration millimole/liter micromole/liter Other term(s): Coenzyme Q 10; Ubiquinone NPU09356 NPU08929 P—Urate; subst.c. = ? µmol/l P—Ubidecarenone; subst.c. = ? mmol/l Amniotic fluid— System(specification)— Urate; Unidentified substance; substance concentration arbitrary concentration(procedure) millimole/liter NPU08679 NPU08680 Syst(spec.)—Unidentified substance; arb.c.(proc.) = Amf—Urate; subst.c. = ? mmol/l ?

Plasma— Patient— Urate; Urine sampling; substance concentration duration millimole/liter minute NPU03688 NPU10324 P—Urate; subst.c. = ? mmol/l Pt—Urine sampling; duration = ? min

Synovial fluid(specification)— Urine— Urate; Urine(test strip); substance concentration property(list; procedure) millimole/liter Authority: IFCC/C-BGE NPU03960 NPU14924 Synf(spec.)—Urate; subst.c. = ? mmol/l U—Urine(test strip); prop.(list; proc.) NPU10504 U—Acetoacetate; arb.c.(proc.) = ? System(specification)— NPU01012 U—Acetoacetate; subst.c.(proc.) = ? Urate; mmol/l substance concentration NPU01134 U—Albumin; subst.c.(proc.) = ? µmol/l millimole/liter NPU01341 U—Bacterium, nitrite producing; NPU10132 num.c.(proc.) = ? × 109/l Syst(spec.)—Urate; subst.c. = ? mmol/l NPU10506 U—Bacterium, nitrite producing; arb.c.(proc.) = ? Urine— NPU01372 U—Bilirubins(tot.); arb.c.(proc.) = ? Urate; NPU17162 U—Bilirubins(tot.); subst.c.(proc.) = ? substance concentration µmol/l millimole/liter NPU03842 U—Erythrocytes; num.c.(proc.) = ? × NPU03959 106/l U—Urate; subst.c. = ? mmol/l NPU03963 U—Erythrocytes; arb.c.(proc.) = ? NPU04207 U—Glucose; arb.c.(proc.)= ? Calculus(Urine)— NPU02194 U—Glucose; subst.c.(proc.) = ? mmol/l Urate; NPU02415 U—Hydrogen ion; pH(proc.) = ? substance content NPU02323 U—Haemoglobin(Fe); subst.c.(proc.) = mole/kilogram ? nmol/l NPU03689 NPU02324 U(cell free)—Haemoglobin(Fe); Calculus(U)—Urate; subst.cont. = ? mol/kg subst.c.(proc.) = ? nmol/l NPU04208 U—Haemoglobin; arb.c.(proc.)= ? Patient(Urine)— NPU10505 U—Leukocytes; num.c.(proc.) = ? × Urate; 106/l substance rate(procedure) NPU03987 U—Leukocytes; arb.c.(proc.) = ? millimole/day NPU04206 U—Protein; arb.c.(proc.)= ? NPU03687 NPU17167 U—Protein; mass c.(proc.) = ? g/l Pt(U)—Urate; subst.rate(proc.) = ? mmol/d NPU03694 Pt—Urine; rel.volumic mass(20 °C/ water, 20 °C; proc.) = ? Patient— NPU03697 U—Urobilinogen; arb.c.(proc.) = ? Urine sampling; NPU17168 U—Urobilinogen; subst.c.(proc.) = ? duration µmol/l day NPU10380 Patient— Pt—Urine sampling; duration = ? d Urine; relative volumic mass(20 °C/water, 20 °C; Patient— procedure) Urine sampling; NPU03694 duration Pt—Urine; rel.volumic mass(20 °C/water, 20 °C; hour:minute proc.) = ? NPU10323 Pt—Urine sampling; duration = ? h:min Patient— Urine; Patient— volume(procedure) Urine sampling; milliliter duration Authority: IFCC/C-BGE hour NPU03695 NPU10379 Pt—Urine; vol.(proc.) = ? ml Pt—Urine sampling; duration = ? h

Urine— Plasma— Urobilin; Valproate(free); arbitrary concentration(procedure) substance concentration NPU03696 micromole/liter U—Urobilin; arb.c.(proc.) = ? NPU14378 P—Valproate(free); subst.c. = ? µmol/l Urine— Urobilinogen; Plasma— arbitrary concentration(procedure) Vanadium; NPU03697 substance concentration U—Urobilinogen; arb.c.(proc.) = ? nanomole/liter M = 50,94 g/mol Urine— Authority: IUPAC/VII-C-TOX Urobilinogen; NPU03737 substance concentration(procedure) P—Vanadium; subst.c. = ? nmol/l micromole/liter NPU17168 Urine— U—Urobilinogen; subst.c.(proc.) = ? µmol/l Vanadium; substance concentration Urine— nanomole/liter Uronate/Creatininium; M = 50,94 g/mol substance ratio Authority: IUPAC/VII-C-TOX 10-3 NPU03738 NPU03699 U—Vanadium; subst.c. = ? nmol/l U—Uronate/Creatininium; subst.ratio = ? × 10-3 Hair— Urine— Vanadium; Uronate; substance content substance concentration micromole/kilogram micromole/liter M = 50,94 g/mol NPU03698 Authority: IUPAC/VII-C-TOX U—Uronate; subst.c. = ? µmol/l NPU03736 Hair—Vanadium; subst.cont. = ? µmol/kg Urine— Valine/Creatininium; Urine— substance ratio Vanillylmandelate/Creatininium; 10-3 substance ratio NPU14257 10-3 U—Valine/Creatininium; subst.ratio = ? × 10-3 NPU03802 U—Vanillylmandelate/Creatininium; subst.ratio = ? × Cerebrospinal fluid— 10-3 Valine; substance concentration Urine— micromole/liter Vanillylmandelate; M = 117,15 g/mol amount-of-substance(procedure) NPU03732 micromole Csf—Valine; subst.c. = ? µmol/l NPU17627 U—Vanillylmandelate; am.s.(proc.) = ? µmol Plasma— Valine; Urine— substance concentration Vanillylmandelate; micromole/liter substance concentration M = 117,15 g/mol micromole/liter NPU03733 Other term(s): 4-Hydroxy-3-methoxymandelate P—Valine; subst.c. = ? µmol/l NPU08685 U—Vanillylmandelate; subst.c. = ? µmol/l Urine— Valine; Patient(Urine)— substance concentration Vanillylmandelate; micromole/liter substance rate(procedure) M = 117,15 g/mol micromole/day NPU03734 Other term(s): 4-Hydroxy-3-methoxymandelate U—Valine; subst.c. = ? µmol/l NPU03739 Pt(U)—Vanillylmandelate; subst.rate(proc.) = ? µmol/d

Plasma— NPU14010 Vasoactive intestinal polypeptide; Pt(U)—Vasopressin; subst.rate = ? pmol/d substance concentration picomole/liter Ascites— M = 3 381 g/mol Virocytes; NPU03743 number concentration P—Vasoactive intestinal polypeptide; subst.c. = ? 106/liter pmol/l NPU08689 Asc—Virocytes; num.c. = ? × 106/l Urine— Vasoactive intestinal polypeptide; Cerebrospinal fluid— substance concentration Virocytes; picomole/liter number concentration M = 3 381 g/mol 106/liter NPU14017 NPU08687 U—Vasoactive intestinal polypeptide; subst.c. = ? Csf—Virocytes; num.c. = ? × 106/l pmol/l Pleural fluid(specification)— Patient(Urine)— Virocytes; Vasoactive intestinal polypeptide; number concentration substance rate 106/liter picomole/day NPU08688 M = 3 381 g/mol Plf(spec.)—Virocytes; num.c. = ? × 106/l NPU14018 Pt(U)—Vasoactive intestinal polypeptide; subst.rate Synovial fluid(specification)— = ? pmol/d Virocytes; number concentration Plasma— 106/liter Vasopressin; NPU08690 arbitrary substance concentration(IS 77/501; Synf(spec.)—Virocytes; num.c. = ? × 106/l procedure) international unit/liter Blood— M = 1 084 g/mol Virocytes; Recommended calibrator: WHO 1st IS 77/501 number concentration Other term(s): Adiuretin; Antidiuretic hormone 109/liter Authority: IUPAC-IUB 74 NPU08686 NPU03744 B—Virocytes; num.c. = ? × 109/l P—Vasopressin; arb.subst.c.(IS 77/501; proc.) = ? int. unit/l Blood fraction(specification)— Virocytes; Plasma— number concentration Vasopressin; 109/liter substance concentration NPU17618 picomole/liter B fract.(spec.)—Virocytes; num.c. = ? × 109/l M = 1 084 g/mol Other term(s): Adiuretin; Antidiuretic hormone Leukocytes(Blood)— Authority: IUPAC-IUB 74 Virocytes; NPU03745 number fraction P—Vasopressin; subst.c. = ? pmol/l NPU17620 Lkcs(B)—Virocytes; num.fr. = ? Urine— Vasopressin; Lung— substance concentration Water evaporation; picomole/liter mass rate(procedure) M = 1 084 g/mol gram/day Other term(s): Adiuretin; Antidiuretic hormone NPU03791 NPU14009 Lung—Water evaporation; mass rate(proc.) = ? g/d U—Vasopressin; subst.c. = ? pmol/l Skin(specification)— Patient(Urine)— Water evaporation; Vasopressin; mass rate(procedure) substance rate gram/day picomole/day NPU03790 M = 1 084 g/mol Skin(spec.)—Water evaporation; mass rate(proc.) = Other term(s): Adiuretin; Antidiuretic hormone ? g/d

Air(saturated)— Pt—Xylose(administered); subst.cont.(p.o.; am.s./ Water vapour; body mass) = ? mmol/kg partial pressure(20 °C) kilopascal Urine— NPU04080 Xylose; Air(sat.)—Water vapour; part.pr.(20 °C) = ? kPa relative amount-of-substance(urine 1 d/intake; procedure) Air— NPU04203 Water vapour; U—Xylose; rel.ams.(U 1 d/intake; proc.)= ? relative mass concentration(temperature t; actual/maximum; procedure) Plasma— Other term(s): Relative humidity Xylose; NPU03846 substance concentration(0 minutes after Air—Water vapour; rel.mass c.(temp. t; actual/max.; challenge) proc.) = ? millimole/liter NPU08744 Urine— P—Xylose; subst.c.(0 min)= ? mmol/l Xanthine; substance concentration Plasma— mole/liter Xylose; M = 152,11 g/mol substance concentration(30 minutes after NPU03755 challenge) U—Xanthine; subst.c.= ? prefix ? mol/l millimole/liter NPU10362 Intestine, small— P—Xylose; subst.c.(30 min)= ? mmol/l Xylose tolerance; property(Xylose, oral administration; list; Plasma— procedure) Xylose; Note: M (xylose) = 150,13 g/mol substance concentration(60 minutes after NPU03764 challenge) Intest., small—Xylose tolerance; prop.(Xylose p.o.; millimole/liter list; proc.) NPU08745 NPU10596 Pt—Xylose(administered); am.s.(p.o.) = P—Xylose; subst.c.(60 min)= ? mmol/l ? mmol NPU10597 Pt—Xylose(administered); Plasma— subst.cont.(p.o.; am.s./body mass) = ? mmol/kg Xylose; NPU08744 P—Xylose; subst.c.(0 min)= ? mmol/l substance concentration(90 minutes after NPU10362 P—Xylose; subst.c.(30 min)= ? mmol/l challenge) NPU08745 P—Xylose; subst.c.(60 min)= ? mmol/l millimole/liter NPU10363 P—Xylose; subst.c.(90 min)= ? mmol/l NPU10363 NPU08746 P—Xylose; subst.c.(120 min)= ? mmol/l P—Xylose; subst.c.(90 min)= ? mmol/l NPU10021 P—Xylose; subst.c.(180 min)= ? mmol/l NPU04204 P—Xylose; subst.c.(max.)= ? mmol/l Plasma— NPU04203 U—Xylose; rel.ams.(U 1 d/intake; Xylose; proc.)= ? substance concentration(120 minutes after challenge) Patient— millimole/liter Xylose(administered); NPU08746 amount-of-substance(oral administration) P—Xylose; subst.c.(120 min)= ? mmol/l millimole M = 150,13 g/mol Plasma— Other term(s): D-Xylose Xylose; NPU10596 substance concentration(180 minutes after Pt—Xylose(administered); am.s.(p.o.) = ? mmol challenge) millimole/liter Patient— NPU10021 Xylose(administered); P—Xylose; subst.c.(180 min)= ? mmol/l substance content(oral administration; amount- of-substance/body mass) Plasma— millimole/kilogram Xylose; M = 150,13 g/mol substance concentration(maximum) Other term(s): D-Xylose millimole/liter NPU10597 NPU04204 P—Xylose; subst.c.(max.)= ? mmol/l

Blood— Authority: IUPAC/VII-C-TOX Xylose; NPU03768 substance concentration P—Zinc; subst.c. = ? µmol/l millimole/liter M = 150,13 g/mol Secretion(Ileum)— NPU10771 Zinc; B—Xylose; subst.c.= ? mmol/l substance concentration micromole/liter Plasma— M = 65,38 g/mol Xylose; NPU08692 substance concentration Secr(Ileum)—Zinc; subst.c. = ? µmol/l millimole/liter M = 150,13 g/mol Seminal plasma— NPU10772 Zinc; P—Xylose; subst.c.= ? mmol/l substance concentration micromole/liter Patient(Urine)— M = 65,38 g/mol Xylose; Authority: IUPAC/VII-C-TOX substance rate(procedure) NPU03769 millimole/day SemP—Zinc; subst.c. = ? µmol/l NPU10773 Pt(U)—Xylose; subst.rate(proc.) = ? mmol/d Urine— Zinc; Urine— substance concentration Xylosylserine/Creatininium; micromole/liter substance ratio M = 65,38 g/mol 10-3 Authority: IUPAC/VII-C-TOX NPU14258 NPU03770 U—Xylosylserine/Creatininium; subst.ratio = ? × U—Zinc; subst.c. = ? µmol/l 10-3 Cells(Blood)— Urine— Zinc; Xylosylserine; substance content substance concentration micromole/kilogram mole/liter M = 65,38 g/mol NPU03765 Authority: IUPAC/VII-C-TOX U—Xylosylserine; subst.c.= ? prefix ? mol/l NPU03767 Cells(B)—Zinc; subst.cont. = ? µmol/kg Urine— Yeast cells; Faeces— arbitrary concentration(procedure) Zinc; NPU14314 substance content U—Yeast cells; arb.c.(proc.) = ? micromole/kilogram M = 65,38 g/mol Secretion(Ileum)— Authority: IUPAC/VII-C-TOX Zinc; NPU10261 amount-of-substance(procedure) F—Zinc; subst.cont. = ? µmol/kg micromole M = 65,38 g/mol Hair— NPU08693 Zinc; Secr(Ileum)—Zinc; am.s.(proc.) = ? µmol substance content millimole/kilogram Urine— M = 65,38 g/mol Zinc; Authority: IUPAC/VII-C-TOX amount-of-substance NPU10698 micromole Hair—Zinc; subst.cont. = ? mmol/kg NPU17587 U—Zinc; am.s. = ? µmol Patient(Urine)— Zinc; Plasma— substance rate(procedure) Zinc; micromole/day substance concentration M = 65,38 g/mol micromole/liter Authority: IUPAC/VII-C-TOX M = 65,38 g/mol NPU03961 Pt(U)—Zinc; subst.rate(proc.) = ? µmol/d